data_1xx0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xx0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.535 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 33.7 tt0 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.757 0.313 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -55.65 -37.01 67.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.403 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -103.44 0.46 31.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -71.33 -8.65 55.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.04 0.447 . . . . 0.0 110.52 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -107.64 143.17 15.94 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.23 151.87 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.317 0.579 . . . . 0.0 111.716 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.8 mt -53.25 127.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.162 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.483 HD13 ' CG ' ' A' ' 270' ' ' GLU . 41.2 mm -96.71 -44.84 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.766 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.508 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 60.3 tttp -164.98 132.59 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.52 -173.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.561 ' CB ' HG12 ' A' ' 267' ' ' ILE . 4.8 pt20 -132.91 141.35 48.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.319 0.58 . . . . 0.0 111.795 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 177.51 151.66 9.38 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.79 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 61.6 m -71.01 135.06 47.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.119 0.46 . . . . 0.0 110.116 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.536 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 94.0 mt -131.61 169.51 16.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 8.1 mp -95.0 117.58 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.12 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.83 119.08 38.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.249 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 176.565 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' ' HG3' ' A' ' 311' ' ' GLU . 89.7 m95 . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 24.2 mtpp -110.62 151.5 27.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 0.0 112.246 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.2 101.73 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.2 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 279' ' ' ASP . 96.7 mtt180 -132.62 154.6 49.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.741 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 40.6 ttmt -79.39 120.66 24.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.68 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 35.9 m-85 -103.89 117.2 33.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.561 HG12 ' CB ' ' A' ' 248' ' ' GLN . 18.6 mt -114.83 127.0 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 42.5 tp -99.5 154.42 18.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.906 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -150.67 139.61 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.64 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.617 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 13.5 pt-20 -101.08 -169.95 1.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.595 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.593 ' CB ' ' HD3' ' A' ' 272' ' ' PRO . 0.8 OUTLIER 95.64 -70.17 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 110.9 -178.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 271' ' ' ASP . 14.4 Cg_endo -97.97 -6.66 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.647 1.564 . . . . 0.0 111.876 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 292' ' ' LEU . . . 70.13 93.95 0.08 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.501 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 33.6 m-85 -141.62 119.48 11.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.331 0.586 . . . . 0.0 111.953 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.646 HD23 HD11 ' A' ' 290' ' ' ILE . 38.8 tp -90.86 140.13 30.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.278 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 70.9 m80 -127.65 139.67 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.103 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.503 ' HE2' HG13 ' A' ' 290' ' ' ILE . 1.3 p90 -121.7 136.25 54.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.264 0.554 . . . . 0.0 111.088 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.91 147.48 50.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.555 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 264' ' ' ARG . 7.7 t70 -90.35 132.65 34.98 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 97.1 Cg_endo -72.57 -24.14 19.09 Favored 'Trans proline' 0 CA--C 1.517 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 111.293 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.93 -12.51 23.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.376 -170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.38 59.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.622 -1.275 . . . . 0.0 114.525 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.477 ' HB1' ' CB ' ' A' ' 279' ' ' ASP . . . -171.42 73.02 0.05 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.773 0.286 . . . . 0.0 111.136 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.19 -9.51 59.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.62 134.17 88.52 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.077 167.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.98 105.02 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.906 1.737 . . . . 0.0 112.439 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 283' ' ' ALA . 90.3 mt -61.73 -28.09 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.035 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.7 35.97 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.6 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -121.18 135.67 55.11 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.791 0.329 . . . . 0.0 110.376 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.646 HD11 HD23 ' A' ' 275' ' ' LEU . 27.7 mt -85.42 131.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -85.37 88.66 7.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.633 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 273' ' ' ALA . 51.9 mt -76.56 -26.81 55.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.845 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -52.37 101.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 95.85 10.49 56.39 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.877 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 11.4 p -90.73 147.72 23.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.919 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.07 146.24 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.15 152.46 13.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.417 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 14.3 t -145.98 142.42 28.65 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.678 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 40.7 t -83.73 105.3 14.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.46 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 55.8 t . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.617 ' HB3' HD13 ' A' ' 314' ' ' LEU . 8.9 mp0 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.955 0.407 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.04 -68.42 0.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.926 0.87 . . . . 0.0 110.762 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.518 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 6.1 p30 -85.63 46.4 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 311' ' ' GLU . 0.7 OUTLIER -79.41 130.35 35.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.17 -176.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -127.67 134.0 49.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.417 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 36.9 tt0 -102.08 141.98 34.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.517 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.8 mt -116.34 110.8 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.0 mt -98.32 92.05 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.129 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 75.4 p -60.09 161.92 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.587 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.82 -17.62 61.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.23 0.538 . . . . 0.0 110.396 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.52 3.2 25.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.329 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 70.58 27.55 3.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.685 0.794 . . . . 0.0 111.834 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.61 126.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.019 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -91.35 113.62 25.93 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.23 111.43 23.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.477 ' HB3' ' HH2' ' A' ' 261' ' ' TRP . 45.0 m-85 -85.77 115.28 23.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.784 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 99.0 mt -124.03 154.3 40.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.53 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 31.9 mt-30 -140.73 155.39 46.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.326 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 334' ' ' GLU . . . -115.3 -174.81 2.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.357 0.598 . . . . 0.0 110.112 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 55.1 p -134.16 159.56 71.89 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.843 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.96 -32.48 97.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 111.105 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 24.8 ttpp -59.45 -54.87 41.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.917 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 329' ' ' ALA . 17.5 tp10 -63.92 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.465 -172.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 3.2 ptt180 -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.136 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.705 HG23 ' HZ3' ' A' ' 340' ' ' LYS . 88.0 m -58.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.798 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 4.8 mm-40 -60.73 -37.04 80.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.572 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.508 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 59.8 m95 -76.17 -32.95 59.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.62 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 335' ' ' ARG . 98.2 mt -54.63 -54.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . 0.705 ' HZ3' HG23 ' A' ' 336' ' ' THR . 27.7 mtmm -56.8 -40.99 76.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.72 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' A' ' 247' ' ' LYS . . . -61.04 -56.09 25.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.134 0.492 . . . . 0.0 111.053 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.419 HG23 HD22 ' A' ' 292' ' ' LEU . 2.3 mp -66.34 -38.38 81.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.271 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.88 -41.02 92.07 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.64 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.49 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 12.6 ptm -71.95 -38.19 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.974 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -66.08 -35.83 81.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.396 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -69.18 -10.01 55.65 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.208 -0.307 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.618 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 272' ' ' PRO . 7.8 tp10 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.246 0.546 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -55.77 -30.16 60.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.657 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -113.23 2.42 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.132 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.476 ' HD2' ' OE2' ' A' ' 239' ' ' GLU . 99.7 mtt180 -70.6 -35.78 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 110.04 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.38 150.05 51.36 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.585 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.4 t -81.39 145.64 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.724 0.41 . . . . 0.0 110.701 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.9 mp -70.44 117.9 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 110.378 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 270' ' ' GLU . 48.3 mm -85.52 -36.14 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.37 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.4 tttp -163.35 143.46 8.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.783 -171.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -133.13 157.55 45.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 148.84 155.82 6.87 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.074 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 6.9 p -76.21 141.02 41.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.198 0.499 . . . . 0.0 110.502 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 338' ' ' TRP . 96.1 mt -135.72 153.94 51.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 3.3 mp -86.59 117.5 25.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -103.08 119.2 38.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.555 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.728 176.83 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.542 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 93.2 m95 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 5.5 ttpm? -113.53 160.92 17.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.882 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.98 111.3 35.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.343 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 95.0 mtt180 -137.42 150.64 47.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.05 172.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 36.2 ttpt -84.71 123.24 30.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.754 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 23.0 m-85 -97.77 158.86 15.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.315 0.578 . . . . 0.0 111.72 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.424 HG23 HG22 ' A' ' 245' ' ' ILE . 7.9 mt -150.15 121.29 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.985 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 33.5 tp -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.013 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 51.7 mtt180 -146.48 134.08 20.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.742 0.306 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.619 ' HB3' HD11 ' A' ' 246' ' ' ILE . 37.0 tt0 -112.86 133.75 54.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 272' ' ' PRO . 25.6 m-20 145.17 -54.45 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 125.733 1.895 . . . . 0.0 108.164 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.822 ' HB3' ' HG3' ' A' ' 239' ' ' GLU . 66.2 Cg_endo -100.04 -16.29 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 166.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.14 82.91 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.308 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 57.6 m-85 -143.62 124.53 14.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.413 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.622 HD23 HD13 ' A' ' 290' ' ' ILE . 51.1 tp -89.29 137.49 32.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -124.85 154.71 40.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.655 0.264 . . . . 0.0 110.304 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -147.34 144.49 28.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.5 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.078 ' HA ' HD11 ' A' ' 287' ' ' LEU . 2.6 m-85 -133.92 154.81 50.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.661 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 282' ' ' GLY . 5.5 t70 -87.19 136.42 33.72 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.482 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 93.9 Cg_endo -67.94 -19.82 45.71 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.01 2.473 . . . . 0.0 111.414 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.12 7.98 19.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.19 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . 171.19 140.23 2.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.266 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 72.66 102.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.608 0.718 . . . . 0.0 112.412 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -95.74 -6.59 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.221 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.8 132.56 51.08 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.473 ' HA ' ' CE1' ' A' ' 278' ' ' TYR . 10.8 Cg_endo -51.81 124.62 14.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.382 2.722 . . . . 0.0 114.004 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 1.078 HD11 ' HA ' ' A' ' 278' ' ' TYR . 6.1 mp -81.81 -26.38 34.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.384 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -174.64 174.26 46.5 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.742 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 275' ' ' LEU . . . -141.76 140.85 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.304 . . . . 0.0 111.011 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.622 HD13 HD23 ' A' ' 275' ' ' LEU . 38.9 mt -99.41 137.92 25.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.529 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -84.72 95.3 8.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.774 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.686 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 30.5 mt -77.77 -28.66 50.62 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.88 107.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.872 0.368 . . . . 0.0 111.142 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.67 13.59 62.67 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.276 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.445 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 15.8 p -87.29 146.86 25.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.258 0.552 . . . . 0.0 111.271 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.83 140.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 298' ' ' THR . 57.3 t -116.51 154.49 18.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.444 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -141.65 140.93 33.37 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.245 0.545 . . . . 0.0 109.928 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 7.6 t -87.7 99.13 11.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.746 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 45.6 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 121.127 0.489 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 162.57 13.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.609 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.862 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 11.1 p30 41.75 36.99 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.985 0.914 . . . . 0.0 112.259 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.4 OUTLIER -75.49 129.95 38.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.92 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -125.48 125.4 43.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 38.9 tt0 -96.16 137.01 35.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.212 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -114.4 108.97 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.37 88.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.468 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.445 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.3 p -62.78 171.45 2.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.269 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -65.3 -18.09 65.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.679 0.752 . . . . 0.0 109.541 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.5 -5.0 42.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.489 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 69.28 29.22 4.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.685 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.61 132.11 53.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.733 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.416 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 7.7 m-70 -90.23 114.32 26.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 63.2 m-85 -98.65 115.57 28.97 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.542 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 44.2 m-85 -91.38 115.68 28.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.018 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 317' ' ' ILE . 95.9 mt -128.7 151.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.582 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.506 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.1 mt-30 -142.36 154.92 45.05 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.901 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.88 -175.94 2.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.395 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -76.75 -37.21 56.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.211 0.529 . . . . 0.0 110.248 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 45.5 p -127.48 155.17 77.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.797 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 25.2 Cg_exo -63.23 -21.83 72.25 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.138 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.65 -30.79 17.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.581 0.229 . . . . 0.0 111.221 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.4 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 8.4 tp10 -63.29 -43.56 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.862 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.21 -42.62 95.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.17 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.503 ' HA ' HD13 ' A' ' 339' ' ' ILE . 11.8 m -58.64 -39.22 79.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.493 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 41.4 mt-10 -64.49 -36.75 85.19 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.689 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.432 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 68.8 m95 -72.72 -34.66 67.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.168 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 335' ' ' ARG . 84.6 mt -53.15 -57.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -56.28 -41.97 76.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.971 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 247' ' ' LYS . . . -58.17 -57.16 14.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.81 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.686 HG22 HD23 ' A' ' 292' ' ' LEU . 1.7 mp -60.94 -42.16 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.344 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.74 -42.29 97.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.552 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 11.6 ptm -73.17 -40.84 64.49 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.739 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -61.2 -29.37 69.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.488 0.185 . . . . 0.0 111.179 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 33.1 t -68.03 -14.43 62.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.117 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.722 0.773 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.44 ' HA ' ' CD2' ' A' ' 274' ' ' TYR . 11.6 mp0 -66.22 -12.27 55.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.069 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.97 -13.58 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -56.23 -24.53 42.87 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.65 141.53 18.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.174 175.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.22 153.01 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 23.5 mt -55.61 132.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.392 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.617 HD13 ' HG2' ' A' ' 270' ' ' GLU . 42.9 mm -99.9 -42.09 10.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.331 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 59.8 tttp -166.59 138.12 3.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.208 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 152.62 50.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.351 0.595 . . . . 0.0 112.392 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.67 157.18 9.76 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.656 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 31.8 m -77.07 144.74 38.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.801 0.8 . . . . 0.0 110.305 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.3 mt -142.01 165.39 27.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -96.87 119.03 34.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.542 -0.169 . . . . 0.0 110.542 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.88 120.62 40.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.925 177.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.476 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 72.3 m95 . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.39 131.86 56.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.399 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.05 107.53 12.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.494 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -129.02 156.62 43.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 84.0 tttt -89.95 115.07 26.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.734 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 30.9 m-85 -101.96 118.24 36.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.021 0.438 . . . . 0.0 111.822 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.512 HG12 ' CE1' ' A' ' 278' ' ' TYR . 9.3 mm -112.49 127.33 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 292' ' ' LEU . 39.2 tp -101.32 154.48 18.75 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.62 ' HB2' ' HE1' ' A' ' 276' ' ' HIS . 79.9 mtt-85 -154.89 143.97 21.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.617 ' HG2' HD13 ' A' ' 246' ' ' ILE . 6.3 pt-20 -100.84 -170.44 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.62 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.869 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 32.8 t70 93.13 -72.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.686 1.595 . . . . 0.0 110.498 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.3 Cg_endo -92.64 -3.05 3.66 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 121.124 1.437 . . . . 0.0 112.054 167.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 292' ' ' LEU . . . 64.93 85.67 0.14 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.319 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.3 m-85 -130.71 129.85 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.753 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 29.0 tp -101.74 130.88 48.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.62 ' HE1' ' HB2' ' A' ' 269' ' ' ARG . 22.3 m80 -121.59 130.24 53.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.081 -172.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.406 ' HE1' HG13 ' A' ' 290' ' ' ILE . 8.5 p90 -119.7 133.28 55.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.883 0.849 . . . . 0.0 111.283 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.512 ' CE1' HG12 ' A' ' 267' ' ' ILE . 3.6 m-85 -115.15 149.07 38.21 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.263 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.563 ' HB2' HD11 ' A' ' 287' ' ' LEU . 0.3 OUTLIER -87.99 132.2 40.68 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.68 -15.92 41.57 Favored 'Trans proline' 0 CA--C 1.514 -0.503 0 C-N-CA 123.342 2.695 . . . . 0.0 111.038 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.11 2.23 34.37 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.31 -171.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.46 85.25 0.05 OUTLIER Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.799 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -178.04 107.06 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.275 0.56 . . . . 0.0 111.985 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -83.69 -46.67 12.03 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.72 134.75 46.81 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.238 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.41 137.03 58.08 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.856 2.371 . . . . 0.0 112.259 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 279' ' ' ASP . 58.1 mt -68.08 -29.35 68.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.945 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -167.73 147.0 11.1 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.558 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.04 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 66.1 mt -67.19 142.05 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.347 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -94.54 94.47 8.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.62 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 273' ' ' ALA . 42.7 mt -72.68 -31.24 64.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.928 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -58.6 91.14 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 119.3 -3.68 13.87 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 292' ' ' LEU . 14.2 p -95.81 148.36 22.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.175 0.487 . . . . 0.0 111.419 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.92 150.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 298' ' ' THR . 57.8 t -117.18 159.79 17.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.766 0.317 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 8.8 t -160.02 143.34 13.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.73 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.6 t -80.35 122.68 27.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.701 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 46.6 t . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 111.266 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.547 ' HB3' HD11 ' A' ' 314' ' ' LEU . 17.6 mp0 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.816 0.341 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -135.34 132.16 37.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.726 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.56 35.12 11.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.701 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.0 OUTLIER -75.28 129.86 38.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.554 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -126.99 138.29 53.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 168.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 33.7 tt0 -100.7 133.41 45.19 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.73 102.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.07 91.67 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.966 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.7 p -54.39 159.08 2.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.25 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.6 1.81 2.19 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.865 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -118.34 30.21 7.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.276 0.56 . . . . 0.0 110.428 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 64.8 31.05 11.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.961 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 t -108.78 124.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.195 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -88.88 114.69 25.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -94.58 125.35 39.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.476 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 6.3 m-30 -99.74 114.73 28.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 110.847 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.77 153.28 38.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.386 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.445 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.4 mt-30 -139.52 142.22 37.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.058 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -115.09 165.61 12.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.68 30.2 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 71.7 p -113.82 159.04 37.39 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.086 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.4 -37.89 82.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.945 2.43 . . . . 0.0 111.816 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 30.1 mmtp -64.61 -47.91 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.482 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 11.9 tp10 -55.94 -49.42 73.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.074 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.598 ' HG3' ' N ' ' A' ' 336' ' ' THR . 8.5 ptt180 -60.59 -43.82 96.95 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.611 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.63 ' HA ' HD11 ' A' ' 339' ' ' ILE . 30.9 m -60.32 -37.69 81.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.752 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.478 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 76.5 mm-40 -63.73 -40.72 97.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.482 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.8 m95 -71.34 -33.0 69.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 336' ' ' THR . 98.0 mt -53.32 -57.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -58.75 -39.39 80.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.181 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.41 ' HB3' ' HD3' ' A' ' 247' ' ' LYS . . . -61.65 -53.01 61.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.206 0.526 . . . . 0.0 110.897 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.643 HG22 HD21 ' A' ' 292' ' ' LEU . 1.8 mp -64.27 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.265 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 97.8 mt-30 -63.81 -49.35 73.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.604 0.24 . . . . 0.0 111.34 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.4 ptm -70.05 -24.56 63.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.391 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.15 32.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.608 0.242 . . . . 0.0 111.061 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.7 t -66.66 -19.27 65.73 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 . . . . . 0 C--N 1.328 -0.35 0 O-C-N 121.924 -0.485 . . . . 0.0 111.587 -175.715 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 272' ' ' PRO . 36.5 tt0 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 52.3 mt-10 -52.9 -40.89 63.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.535 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -101.5 -15.64 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -166.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 25.3 mtp180 -53.12 -23.89 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.709 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -87.05 149.5 22.2 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.087 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.94 158.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.111 0.482 . . . . 0.0 110.426 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.623 HG22 HG23 ' A' ' 267' ' ' ILE . 3.0 mm -73.57 116.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.725 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.594 HD11 ' HG2' ' A' ' 270' ' ' GLU . 33.5 mm -83.3 -41.84 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -161.12 149.29 15.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -133.25 157.4 45.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.22 164.83 19.21 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.35 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.1 p -86.19 133.12 33.87 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.3 mt -133.63 155.97 48.72 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.8 mp -91.46 121.82 33.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -108.43 131.4 54.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 33.7 tt0 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.964 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 252' ' ' LEU . 62.7 m95 . . . . . 0 CA--C 1.516 -0.341 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 9.0 ptpt -134.08 165.27 25.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.535 0.683 . . . . 0.0 112.43 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.2 103.15 14.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.207 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.618 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 97.0 mtt180 -126.01 158.24 35.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.197 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.57 106.04 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.404 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.6 m-85 -91.12 148.09 22.61 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.395 0.617 . . . . 0.0 111.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 245' ' ' ILE . 21.0 mt -146.39 118.53 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.298 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 61.1 tp -93.03 139.46 30.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.202 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -139.31 127.67 22.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.709 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -91.1 -172.17 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.224 -174.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.969 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 38.4 t70 94.63 -76.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.66 1.584 . . . . 0.0 109.968 176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.969 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.4 Cg_endo -92.01 -5.67 3.59 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 CA-C-N 121.098 1.428 . . . . 0.0 111.262 166.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 346' ' ' SER . . . 66.31 98.32 0.05 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.975 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 41.4 m-85 -144.74 110.92 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.139 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.571 HD22 HD12 ' A' ' 290' ' ' ILE . 23.8 tp -89.56 121.1 31.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 61.7 m80 -112.58 155.09 24.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.078 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.54 141.46 39.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.351 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -127.57 166.45 17.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.948 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 281' ' ' ALA . 27.5 t70 -95.13 123.4 57.29 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.618 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 83.3 Cg_endo -67.78 -17.53 47.32 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.391 2.728 . . . . 0.0 110.26 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.549 ' HB2' ' OD2' ' A' ' 279' ' ' ASP . . . -89.57 -1.65 58.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.261 -1.791 . . . . 0.0 111.205 -172.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.29 29.78 0.17 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.188 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.0 111.78 13.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.37 1.085 . . . . 0.0 110.901 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.94 -12.66 23.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.831 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.19 141.81 96.48 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.416 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.6 108.78 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.468 2.112 . . . . 0.0 111.517 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.03 5.85 13.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.603 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 167.77 140.55 2.94 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.518 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.435 ' HB1' ' OE1' ' A' ' 240' ' ' GLU . . . -115.57 102.04 9.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 275' ' ' LEU . 59.3 mt -70.82 123.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -82.52 87.11 6.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.017 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 273' ' ' ALA . 78.9 mt -74.56 -27.61 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -48.44 99.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 92.54 18.79 40.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.957 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . . . . . . . . . 14.8 p -95.39 157.92 15.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.303 0.573 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.93 149.93 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 298' ' ' THR . 48.4 t -118.15 158.81 18.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 316' ' ' GLU . 15.0 t -150.86 143.23 24.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.272 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.9 t -80.0 99.44 7.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.451 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.891 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.5 t . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.946 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.501 ' HB3' HD12 ' A' ' 314' ' ' LEU . 6.4 mp0 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.56 -10.14 12.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.653 0.739 . . . . 0.0 110.772 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -122.55 29.77 6.77 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.891 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.2 tt -77.58 135.57 38.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.331 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -129.91 125.87 36.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 298' ' ' THR . 36.0 tt0 -93.62 136.92 33.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.129 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -112.01 103.14 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.56 88.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.656 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 50.1 p -59.21 160.76 6.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.517 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.17 -8.97 27.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.384 0.611 . . . . 0.0 110.671 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.11 4.6 41.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.233 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 64.03 32.12 13.13 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.033 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.37 127.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.709 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -87.63 118.09 26.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 9.0 m-85 -98.93 117.91 34.51 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.6 m-85 -95.46 112.81 24.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.066 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.67 156.41 41.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 30.6 mt-30 -139.45 145.29 38.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.672 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.69 176.48 5.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.455 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.96 -56.48 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.0 111.102 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 39.2 p -124.05 163.43 35.62 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.21 -37.84 40.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.725 2.283 . . . . 0.0 112.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 50.7 mtmt -62.91 -48.98 76.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.924 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.415 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 9.7 tp10 -61.26 -41.89 97.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.145 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 339' ' ' ILE . 17.8 ptt180 -63.17 -42.15 99.34 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.635 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.55 ' HA ' HD12 ' A' ' 339' ' ' ILE . 18.7 m -57.24 -42.3 81.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.767 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 11.1 mm-40 -57.47 -45.29 84.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.858 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.415 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 78.1 m95 -70.55 -31.15 68.08 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 335' ' ' ARG . 89.2 mt -59.86 -56.99 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -55.46 -49.83 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.925 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.3 30.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 0.0 111.431 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.49 HD12 HD12 ' A' ' 317' ' ' ILE . 13.5 mt -71.55 -41.06 72.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.081 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.69 -30.76 71.82 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.461 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.15 -40.79 21.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.695 0.283 . . . . 0.0 110.276 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.18 71.6 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.445 ' HA ' ' HB1' ' A' ' 273' ' ' ALA . 32.9 t -76.91 -0.35 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.772 0.32 . . . . 0.0 111.819 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 62.4 mtp85 . . . . . 0 C--N 1.333 -0.151 0 O-C-N 122.05 -0.406 . . . . 0.0 111.348 -178.768 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.571 ' OE1' ' HD3' ' A' ' 242' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 121.091 0.472 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.63 -26.48 63.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.017 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.477 ' HA ' ' CD ' ' A' ' 269' ' ' ARG . 4.9 m-85 -115.35 1.5 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.255 -174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 239' ' ' GLU . 64.8 mtp180 -72.11 -4.62 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.71 150.83 18.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 72.8 t -81.13 147.8 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.153 0.501 . . . . 0.0 111.139 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 3.9 mt -70.36 111.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.575 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.491 ' HB ' HD23 ' A' ' 268' ' ' LEU . 37.0 mm -77.82 -35.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.227 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -169.18 144.82 3.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.533 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.559 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.12 157.91 40.45 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.19 156.63 8.95 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.696 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.9 p -75.17 137.69 41.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 0.167 . . . . 0.0 110.642 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.6 mt -140.33 159.21 42.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.9 mp -97.78 120.41 38.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -109.33 123.49 49.39 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.454 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.917 175.327 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.553 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 31.3 m95 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.638 0.256 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 28.8 mttt -139.5 150.72 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.581 . . . . 0.0 111.526 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -92.96 99.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.9 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.725 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 70.7 mtt180 -124.06 164.67 18.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -94.26 110.64 22.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.694 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 17.6 m-85 -94.4 151.66 19.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.809 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 248' ' ' GLN . 13.0 mt -144.86 125.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.916 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 48.3 tp -100.09 147.64 25.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.286 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 68.6 mtt-85 -140.91 126.6 19.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.605 ' HG3' ' HA ' ' A' ' 345' ' ' ALA . 19.0 tt0 -106.07 130.38 53.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.6 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.975 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.5 t70 148.39 -59.98 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 125.335 1.647 . . . . 0.0 108.36 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.975 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 11.2 Cg_endo -94.12 -10.41 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.44 2.093 . . . . 0.0 110.768 166.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.601 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 64.48 88.78 0.1 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.839 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -138.32 120.86 16.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 290' ' ' ILE . 33.3 tp -99.78 117.6 34.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.417 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 289' ' ' ALA . 0.7 OUTLIER -110.85 154.85 23.42 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.397 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.71 139.76 47.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.473 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -123.02 166.52 14.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 287' ' ' LEU . 6.8 t70 -88.0 135.36 33.54 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.725 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.6 Cg_endo -70.39 -14.51 34.17 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 111.539 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.11 11.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.516 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . -163.33 136.21 4.17 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.989 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 75.19 123.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.856 0.862 . . . . 0.0 113.262 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.78 -2.74 58.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.75 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 286' ' ' PRO . 1.4 p-10 -85.71 146.15 43.2 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.542 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . 2.6 Cg_endo -75.77 141.47 24.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.169 2.579 . . . . 0.0 113.341 -170.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' A' ' 279' ' ' ASP . 88.7 mt -96.09 7.46 46.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.957 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 143.63 138.08 3.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.646 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . . . -106.08 142.26 36.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.736 0.303 . . . . 0.0 110.76 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 275' ' ' LEU . 59.8 mt -98.41 131.99 44.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -88.38 91.88 8.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.561 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 56.5 mt -73.0 -32.43 65.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.647 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -61.24 96.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.002 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 116.25 2.4 19.94 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.218 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 13.0 p -97.85 154.1 17.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.256 0.551 . . . . 0.0 111.455 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.9 t -119.5 150.45 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 298' ' ' THR . 48.5 t -119.75 158.38 21.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.474 ' N ' HG12 ' A' ' 297' ' ' VAL . 7.6 t -160.11 136.65 8.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.013 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.6 p -73.2 138.32 45.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.164 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 59.0 t . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.107 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' A' ' 314' ' ' LEU . 26.4 mp0 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.82 0.343 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.1 -15.02 61.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 112.037 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 328' ' ' GLN . 83.4 m-20 -122.27 20.67 10.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.22 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.731 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.8 OUTLIER -74.92 132.45 41.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.139 -178.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -131.0 133.02 45.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 43.6 tt0 -93.03 132.82 36.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.744 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 87.2 mt -113.24 105.29 18.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.84 90.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.679 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.551 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 20.4 p -59.56 176.66 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.98 68.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.555 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.58 -8.42 55.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.89 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 68.17 45.19 1.3 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.706 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.29 134.81 43.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.42 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 34.1 m-70 -83.77 112.05 19.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 51.5 m-85 -99.69 103.51 15.18 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 15.9 m-30 -84.49 110.01 18.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.595 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 94.1 mt -118.37 151.89 36.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.508 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 36.0 mt-30 -136.18 146.03 46.4 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.282 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 334' ' ' GLU . . . -108.52 171.99 7.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.876 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.02 68.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -116.46 160.37 36.4 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.57 -23.67 76.21 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.027 2.485 . . . . 0.0 112.477 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.59 -38.67 23.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.597 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 329' ' ' ALA . 7.4 tp10 -57.41 -44.07 84.27 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.48 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.559 ' O ' HG13 ' A' ' 339' ' ' ILE . 21.3 ptt180 -60.46 -40.8 92.51 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.173 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.603 HG23 ' HE2' ' A' ' 340' ' ' LYS . 27.2 m -55.61 -45.24 77.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.503 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -58.94 -36.36 74.65 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.126 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.502 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 86.3 m95 -78.0 -35.32 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 343' ' ' GLN . 82.3 mt -54.25 -55.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . 0.603 ' HE2' HG23 ' A' ' 336' ' ' THR . 51.0 mtmt -58.7 -42.51 88.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.121 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' A' ' 268' ' ' LEU . . . -58.05 -52.14 66.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.919 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.26 -42.95 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 39.0 mt-30 -65.94 -33.45 75.86 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.462 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.7 ptm -80.83 -28.93 36.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.961 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.605 ' HA ' ' HG3' ' A' ' 270' ' ' GLU . . . -80.99 -30.86 34.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.601 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 16.6 p -78.0 -10.85 59.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -177.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 55.7 mt-10 -50.58 -31.67 16.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.738 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.09 -5.85 13.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.432 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -80.48 -14.47 58.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -87.68 148.06 20.88 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 70.0 t -77.37 147.89 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.221 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.4 mp -67.31 119.81 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.91 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.8 -45.18 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.225 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.521 ' HE2' ' NE1' ' A' ' 338' ' ' TRP . 75.1 tttt -165.44 140.74 5.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.249 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -134.32 156.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 111.293 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.47 156.38 8.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 73.5 m -78.44 131.48 36.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.165 0.482 . . . . 0.0 110.415 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.4 mt -133.68 150.55 51.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 261' ' ' TRP . 9.4 mp -79.4 145.15 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 261' ' ' TRP . 25.9 mtmm -128.29 129.31 46.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.22 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 261' ' ' TRP . 50.2 tt0 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.035 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CE2' ' HB2' ' A' ' 254' ' ' GLN . 70.9 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.74 0.305 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 35.7 mmtm -125.63 161.49 27.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 0.0 112.206 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.69 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.86 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.615 ' NH1' HD12 ' A' ' 287' ' ' LEU . 96.4 mtt180 -141.25 149.35 41.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.197 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -77.63 121.16 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.608 -169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.724 ' O ' HD11 ' A' ' 267' ' ' ILE . 21.7 m-85 -95.17 145.56 24.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.623 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.724 HD11 ' O ' ' A' ' 266' ' ' PHE . 16.4 mm -134.51 124.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 39.9 tp -100.92 147.55 26.01 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 240' ' ' GLU . 58.8 mtt-85 -143.53 131.75 21.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -174.9 4.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.446 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 1.0 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 13.7 t70 93.54 -75.89 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 125.83 1.652 . . . . 0.0 110.432 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 1.0 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 6.7 Cg_endo -92.23 -6.94 3.17 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 CA-C-N 121.344 1.516 . . . . 0.0 111.495 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 69.19 93.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.967 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 50.0 m-85 -138.63 112.52 8.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.156 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 46.4 tp -90.38 141.08 29.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.446 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 67.7 m80 -134.46 153.42 51.93 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.29 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -137.19 137.28 38.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.695 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 264' ' ' ARG . 20.2 m-85 -128.13 164.09 23.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.234 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 281' ' ' ALA . 31.0 t70 -93.95 124.92 54.91 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-O 120.925 0.393 . . . . 0.0 110.428 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.547 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 90.4 Cg_endo -70.66 -21.3 29.48 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 123.669 2.913 . . . . 0.0 110.601 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.542 ' HB2' ' OD2' ' A' ' 279' ' ' ASP . . . -81.06 -21.02 40.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.185 -170.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.69 65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.071 -1.062 . . . . 0.0 113.859 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -160.45 120.75 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.852 0.326 . . . . 0.0 111.514 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -90.64 -15.47 30.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.26 137.11 86.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.175 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.3 122.32 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.074 1.849 . . . . 0.0 111.108 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.615 HD12 ' NH1' ' A' ' 264' ' ' ARG . 29.8 mt -81.29 2.85 26.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 161.08 156.83 8.43 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.521 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.92 124.42 43.17 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.611 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 50.4 mt -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -86.29 99.92 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.817 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.436 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 68.4 mt -75.86 -80.0 0.09 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.294 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 346' ' ' SER . 32.3 ttm180 37.71 -90.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -170.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -105.73 51.43 0.76 Allowed Glycine 0 C--N 1.317 -0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.996 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 28.0 p -90.54 122.02 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 110.755 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.48 143.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.1 t -122.18 156.33 26.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.445 HG21 ' HB3' ' A' ' 316' ' ' GLU . 10.8 t -145.34 138.43 26.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.169 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 32.9 t -80.36 99.14 7.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.916 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 25.3 t . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.457 0.646 . . . . 0.0 110.389 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 314' ' ' LEU . 1.5 mp0 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.45 178.87 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 162.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.1 m120 56.33 20.55 4.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.916 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -83.98 136.01 34.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.942 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . 0.415 ' N ' HD21 ' A' ' 314' ' ' LEU . 23.1 p90 -133.36 118.77 18.85 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 298' ' ' THR . 34.9 tt0 -87.2 134.46 33.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.119 -174.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -109.01 104.72 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 21.4 mt -94.06 88.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.977 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 65.1 p -55.46 165.12 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.267 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -72.63 1.37 8.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.59 13.5 25.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.425 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 66.31 32.19 7.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.0 126.98 55.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -94.17 113.04 24.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 30.6 m-85 -96.92 138.58 34.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.462 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 51.6 m-85 -114.89 121.07 42.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.299 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 81.1 mt -133.69 155.45 49.71 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.881 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.6 mt-30 -135.65 135.83 40.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -103.51 175.36 5.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.545 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.83 -53.07 36.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 0.0 110.984 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -114.51 164.08 17.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.531 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . 0.489 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 32.6 Cg_exo -61.34 -35.89 81.62 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.21 1.94 . . . . 0.0 111.255 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.82 -45.93 76.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.688 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.453 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 8.3 tp10 -55.95 -47.48 77.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.664 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 332' ' ' PRO . 0.6 OUTLIER -62.51 -44.42 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.944 -176.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.622 ' HA ' HD11 ' A' ' 339' ' ' ILE . 29.2 m -56.5 -36.97 69.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 340' ' ' LYS . 14.3 mt-10 -77.18 -29.5 54.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.605 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.521 ' NE1' ' HE2' ' A' ' 247' ' ' LYS . 50.3 m95 -67.91 -32.32 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.235 -0.291 . . . . 0.0 110.537 171.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.622 HD11 ' HA ' ' A' ' 336' ' ' THR . 90.1 mt -54.42 -56.32 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 168.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 337' ' ' GLU . 58.6 mtmt -52.14 -47.1 65.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.243 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -55.74 -55.79 28.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.327 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.432 HG23 HD21 ' A' ' 292' ' ' LEU . 2.2 mp -70.16 -36.25 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.902 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 18.5 mt-30 -73.54 -32.69 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.031 -0.418 . . . . 0.0 111.624 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.4 ptm -78.9 -26.41 43.81 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.616 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.14 -35.42 31.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 293' ' ' ARG . 3.2 p -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.01 0.433 . . . . 0.0 112.14 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.828 -170.5 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.453 ' HA ' ' HD2' ' A' ' 242' ' ' ARG . 33.6 tt0 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.584 0.231 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -56.05 -23.0 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.892 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.66 -2.57 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 91.8 mtt180 -75.61 -3.32 33.73 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.968 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -96.23 160.3 22.14 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.53 145.95 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 117.299 0.55 . . . . 0.0 111.24 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 267' ' ' ILE . 6.7 mt -62.57 128.21 23.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.155 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.421 HD11 ' OE1' ' A' ' 270' ' ' GLU . 18.3 mm -94.85 -49.77 12.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.866 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.8 tttp -155.17 137.76 15.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.523 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.17 137.13 50.99 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 174.61 156.09 13.41 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.937 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 12.1 m -84.83 138.73 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.795 0.297 . . . . 0.0 110.291 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 85.5 mt -135.21 172.28 13.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.3 mp -97.52 122.88 41.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.282 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -105.24 118.85 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.225 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 6.3 tp-100 . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.534 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 74.3 m95 . . . . . 0 CA--C 1.515 -0.376 0 CA-C-O 120.908 0.385 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.432 ' HD2' ' NH2' ' A' ' 264' ' ' ARG . 29.3 mttt -103.04 145.75 29.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.556 0.693 . . . . 0.0 111.873 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.91 105.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.23 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.651 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.4 mtt180 -135.34 151.41 50.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.258 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 87.9 tttt -89.93 121.56 32.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.017 0.437 . . . . 0.0 110.77 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 26.1 m-85 -100.81 123.75 45.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.601 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 248' ' ' GLN . 43.9 mt -115.8 125.81 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.363 0.602 . . . . 0.0 110.913 171.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 55.5 tp -101.49 156.06 17.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.044 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 243' ' ' GLY . 62.0 mtt-85 -148.34 138.81 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.421 ' OE1' HD11 ' A' ' 246' ' ' ILE . 2.6 pt-20 -105.45 134.75 48.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.531 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 1.004 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 37.9 t70 147.86 -61.59 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.846 1.659 . . . . 0.0 108.511 170.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 1.004 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 10.9 Cg_endo -94.08 -10.06 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 111.087 168.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 63.24 93.4 0.06 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.091 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 60.2 m-85 -145.53 133.38 21.22 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.127 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 290' ' ' ILE . 60.8 tp -95.9 141.18 29.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 32.6 m80 -130.18 122.99 29.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.454 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.31 127.81 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.366 0.603 . . . . 0.0 111.222 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -117.03 158.59 23.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.105 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.43 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 1.8 t70 -94.96 122.06 61.11 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.651 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -70.69 -19.29 31.86 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 110.776 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -98.87 -4.83 32.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.391 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.15 60.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.317 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.43 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -175.84 101.8 0.07 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 110.851 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -89.34 -4.5 58.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.309 0.576 . . . . 0.0 109.901 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.31 138.68 41.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.64 112.51 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.769 . . . . 0.0 111.406 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.78 -21.1 66.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.138 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 179.9 129.59 1.36 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.057 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.06 104.72 16.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 275' ' ' LEU . 39.8 mt -66.38 134.18 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.099 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -83.19 87.68 6.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.115 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.424 HD12 HG22 ' A' ' 342' ' ' ILE . 45.9 mt -74.05 -26.96 60.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.329 -173.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -51.37 101.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.816 0.341 . . . . 0.0 110.984 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 91.79 14.08 57.1 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.997 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.3 p -89.72 139.07 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.299 0.549 . . . . 0.0 110.96 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 6.4 t -105.22 144.48 14.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.38 155.05 21.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 316' ' ' GLU . 11.9 t -150.23 144.53 25.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.46 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.0 t -87.51 101.29 13.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 28.6 t . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.72 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.635 ' HA ' ' OE1' ' A' ' 328' ' ' GLN . 43.8 mp0 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -85.92 144.72 27.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 335' ' ' ARG . 91.2 m-20 64.33 30.4 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.229 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.9 OUTLIER -73.96 128.41 35.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.839 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -125.38 126.14 44.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 168.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.487 ' OE1' ' HE1' ' A' ' 326' ' ' PHE . 36.3 tt0 -91.51 138.05 31.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 96.9 mt -114.04 108.43 25.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.63 91.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.725 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.2 p -57.24 169.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.31 -27.89 69.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.69 -8.12 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.276 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 70.11 37.26 1.71 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.772 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 31.1 t -99.59 131.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.356 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -93.47 113.86 26.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 54.6 m-85 -99.76 127.76 45.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 16.1 m-30 -100.07 119.59 38.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.176 0.512 . . . . 0.0 111.188 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 93.1 mt -130.68 154.12 48.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.057 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.635 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 20.1 mt-30 -137.71 147.41 44.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.113 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 334' ' ' GLU . . . -120.44 147.59 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.848 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.48 -27.81 68.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.286 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 334' ' ' GLU . 38.1 p -119.1 142.52 32.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.441 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.84 -27.13 84.23 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.296 2.664 . . . . 0.0 112.508 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.583 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 62.7 mttm -71.74 -46.88 57.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.797 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 329' ' ' ALA . 7.1 tp10 -53.12 -49.5 66.4 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.358 0.411 . . . . 0.0 111.147 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.4 ptt180 -60.53 -45.22 94.64 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.35 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.526 ' N ' ' HG3' ' A' ' 335' ' ' ARG . 9.9 m -57.8 -44.13 86.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.842 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 35.2 mm-40 -58.54 -43.17 89.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.463 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 71.1 m95 -71.89 -32.12 67.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 335' ' ' ARG . 95.6 mt -56.57 -57.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -57.02 -49.81 74.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.892 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.75 -54.28 30.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 111.45 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 292' ' ' LEU . 10.7 mt -69.3 -42.83 81.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.782 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 92.8 mt-30 -62.78 -39.47 94.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.402 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 15.6 ptp -76.89 -25.1 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.537 0.208 . . . . 0.0 110.963 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.96 60.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.979 0.419 . . . . 0.0 110.798 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.462 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 45.9 t -79.76 -3.98 49.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.498 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -177.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.559 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 39.0 tt0 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.502 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 1.9 mp0 -59.01 -24.37 62.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.195 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.436 ' HA ' ' CD ' ' A' ' 269' ' ' ARG . 0.3 OUTLIER -111.66 0.28 16.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 58.9 mtt85 -63.38 -26.96 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.082 0.468 . . . . 0.0 110.287 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.05 156.7 30.04 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.023 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.06 148.37 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.31 0.576 . . . . 0.0 111.682 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.487 HG21 HG21 ' A' ' 267' ' ' ILE . 12.9 mt -56.1 115.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.793 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -84.58 -41.9 16.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.02 0.438 . . . . 0.0 110.251 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -167.56 152.02 6.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.277 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.538 ' CB ' HG12 ' A' ' 267' ' ' ILE . 8.7 pt20 -149.62 164.77 34.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 0.0 111.818 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.28 171.57 28.6 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 59.4 m -86.07 139.71 30.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.752 0.776 . . . . 0.0 109.708 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.8 mt -141.48 166.51 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 11.0 mp -102.61 125.63 49.41 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.681 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -105.13 124.54 49.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.831 177.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.558 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 53.5 m95 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 51.7 mttt -106.59 138.92 41.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 112.104 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 102.97 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.922 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.58 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.3 mtt180 -128.71 166.44 18.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.407 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -94.0 113.58 25.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.371 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.5 m-85 -101.97 128.18 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.415 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 248' ' ' GLN . 17.1 mt -121.86 130.81 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.197 0.522 . . . . 0.0 110.66 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.543 HD11 HD13 ' A' ' 292' ' ' LEU . 43.6 tp -101.16 155.01 18.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.855 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 53.9 mtt-85 -149.55 138.86 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.627 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 4.9 pt-20 -93.89 -175.0 3.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.935 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 28.1 t70 93.63 -75.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 C-N-CA 125.814 1.646 . . . . 0.0 110.148 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 9.5 Cg_endo -91.39 -5.72 3.94 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 121.182 1.458 . . . . 0.0 111.671 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 292' ' ' LEU . . . 64.69 91.34 0.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.132 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.2 m-85 -140.5 121.21 14.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.612 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 41.7 tp -89.42 139.39 30.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.177 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 69.4 m80 -129.8 142.7 50.64 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -132.3 140.22 48.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.204 0.526 . . . . 0.0 110.848 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.04 ' HA ' HD12 ' A' ' 287' ' ' LEU . 5.1 m-85 -129.37 162.34 28.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -90.59 122.58 66.93 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.133 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.58 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -68.16 -15.21 42.48 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.184 2.589 . . . . 0.0 111.069 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.89 15.24 15.24 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.06 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -159.24 -112.72 0.32 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.993 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.04 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.33 -0.58 49.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.424 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.537 ' O ' HD13 ' A' ' 287' ' ' LEU . 4.4 m-20 -73.31 139.78 79.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.485 ' HA ' ' CE1' ' A' ' 278' ' ' TYR . 28.8 Cg_endo -61.79 118.8 5.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.019 1.812 . . . . 0.0 112.78 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 1.04 HD12 ' HA ' ' A' ' 278' ' ' TYR . 5.8 mp -84.15 -5.65 59.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.117 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.04 157.56 21.0 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.109 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -135.68 100.67 4.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.211 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.612 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 62.8 mt -84.43 88.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.689 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.565 ' NE2' ' HB2' ' A' ' 293' ' ' ARG . 13.4 t-80 -43.73 106.05 0.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.79 170.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 342' ' ' ILE . 84.7 mt -87.23 -19.89 27.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.867 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.565 ' HB2' ' NE2' ' A' ' 291' ' ' HIS . 96.5 mtt180 -59.35 104.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.363 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 108.16 3.28 33.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.489 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 17.1 p -85.67 147.53 26.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 111.977 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 142.38 29.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 99.6 t -117.83 153.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.963 0.411 . . . . 0.0 110.406 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 316' ' ' GLU . 13.6 t -153.43 145.61 23.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.923 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.7 t -83.76 102.32 12.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.748 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 314' ' ' LEU . 12.7 t . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.614 . . . . 0.0 110.188 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.785 ' HG2' HD11 ' A' ' 314' ' ' LEU . 3.1 mp0 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.539 0.685 . . . . 0.0 112.314 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.82 132.27 54.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.955 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 335' ' ' ARG . 74.2 m-20 67.37 22.76 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.409 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.785 HD11 ' HG2' ' A' ' 311' ' ' GLU . 1.3 tt -66.93 134.7 52.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.997 0.427 . . . . 0.0 109.94 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . 0.475 ' N ' HD23 ' A' ' 314' ' ' LEU . 29.9 p90 -132.47 136.85 46.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 297' ' ' VAL . 34.9 tt0 -99.41 136.67 39.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.781 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.4 mt -115.89 110.84 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.3 mt -101.82 83.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.936 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 72.3 p -62.85 177.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.989 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -64.49 -13.32 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 110.929 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.88 -6.36 54.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.394 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.09 27.67 10.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.763 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.7 130.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -90.41 113.43 25.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.526 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 45.9 m-85 -95.46 119.35 33.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.459 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 3.0 m-85 -96.65 116.03 28.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.895 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 78.2 mt -127.31 157.75 39.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.3 mt-30 -135.99 139.65 43.32 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -110.06 160.68 16.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.336 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -55.64 -50.4 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.247 0.342 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 32.1 p -127.12 162.63 46.84 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.049 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.15 -43.17 61.69 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.393 2.062 . . . . 0.0 111.964 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 337' ' ' GLU . 17.8 tppt? -55.17 -44.92 75.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.036 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 7.7 tp10 -60.39 -52.34 65.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.033 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.564 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.5 ptt180 -59.35 -43.32 92.81 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.977 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.612 HG21 ' HE2' ' A' ' 340' ' ' LYS . 11.1 m -58.64 -40.52 83.62 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.646 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 333' ' ' LYS . 57.0 mt-10 -65.28 -33.15 75.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 121.259 -0.176 . . . . 0.0 110.973 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 334' ' ' GLU . 76.7 m95 -73.43 -38.44 65.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.416 0.15 . . . . 0.0 111.106 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . . . . . . . . . 97.6 mt -53.38 -54.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . 0.612 ' HE2' HG21 ' A' ' 336' ' ' THR . 65.7 mttm -59.87 -40.24 87.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.709 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.64 -54.64 44.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.661 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 292' ' ' LEU . 2.0 mp -64.79 -44.62 96.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.351 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -64.38 -36.79 85.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.3 ptp -81.21 -31.29 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.695 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -74.02 -29.87 62.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.457 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.46 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 42.3 t -67.16 -14.58 63.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.692 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.022 -0.424 . . . . 0.0 111.299 -174.475 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 242' ' ' ARG . 37.9 tt0 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.844 0.354 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.706 ' HB3' ' HE2' ' A' ' 276' ' ' HIS . 1.8 mp0 -60.79 -28.28 68.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -104.55 -5.61 21.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.604 0.24 . . . . 0.0 111.1 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 31.8 mtp180 -64.93 -21.33 66.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 110.503 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.23 152.56 26.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.8 t -84.34 145.26 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.43 0.292 . . . . 0.0 110.665 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.641 HG23 HG22 ' A' ' 267' ' ' ILE . 3.0 mp -69.82 114.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.412 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.661 HD12 ' HG2' ' A' ' 270' ' ' GLU . 25.8 mm -78.99 -43.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.832 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.488 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 53.4 tttp -158.26 139.59 13.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.963 -169.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.401 ' HG3' HG22 ' A' ' 245' ' ' ILE . 1.4 mp0 -127.3 145.35 50.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.81 144.84 4.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.264 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 11.0 m -72.51 137.62 46.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.495 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 99.5 mt -133.65 163.26 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -90.74 123.73 34.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -110.95 117.29 32.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.808 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 5.6 tp-100 . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.53 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 84.9 m95 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.255 0.55 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.92 126.3 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.182 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 81.6 t -91.11 104.34 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.018 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 278' ' ' TYR . 2.8 ptp180 -148.05 162.71 38.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.723 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 278' ' ' TYR . 50.1 tttp -79.32 116.11 19.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.546 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 37.1 m-85 -102.31 124.94 48.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 111.852 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 245' ' ' ILE . 56.6 mt -119.08 128.92 75.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.799 172.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 47.7 tp -98.55 154.97 17.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.672 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 52.7 mtt-85 -147.66 136.24 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.582 0.229 . . . . 0.0 110.452 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.661 ' HG2' HD12 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -100.9 127.31 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.994 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.0 t70 154.36 -65.74 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.456 1.502 . . . . 0.0 108.844 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.994 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 19.6 Cg_endo -96.36 -8.25 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.635 2.223 . . . . 0.0 111.633 173.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 346' ' ' SER . . . 65.16 89.88 0.09 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.839 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 55.8 m-85 -139.87 129.24 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.044 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.604 HD22 HD13 ' A' ' 290' ' ' ILE . 25.6 tp -94.55 134.09 37.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.209 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.706 ' HE2' ' HB3' ' A' ' 240' ' ' GLU . 73.3 m80 -120.47 129.74 53.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.853 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.521 ' HE1' HG13 ' A' ' 290' ' ' ILE . 0.9 OUTLIER -115.08 122.72 47.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.834 176.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 264' ' ' ARG . 50.6 m-85 -106.77 -167.63 1.31 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.751 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -125.82 129.55 24.29 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.755 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.4 Cg_endo -72.51 -19.15 25.22 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 123.16 2.573 . . . . 0.0 111.572 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.02 -28.29 12.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.09 75.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.236 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -175.84 103.07 0.07 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.748 0.419 . . . . 0.0 110.406 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -85.15 -14.03 48.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.625 0.726 . . . . 0.0 109.228 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.84 143.66 26.49 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.243 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.09 143.51 54.33 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.762 2.308 . . . . 0.0 113.412 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -80.39 -7.24 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.123 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 158.61 -179.41 34.3 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.427 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.71 128.95 27.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.471 0.177 . . . . 0.0 110.604 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.604 HD13 HD22 ' A' ' 275' ' ' LEU . 46.1 mt -79.11 136.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -86.53 80.48 8.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 342' ' ' ILE . 64.9 mt -61.36 -59.55 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -18.95 86.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.941 1.4 . . . . 0.0 113.735 -172.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 109.81 20.67 7.52 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.433 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 30.5 p -93.1 145.57 24.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.599 . . . . 0.0 112.235 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.04 146.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.07 156.81 26.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.474 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 11.6 t -145.39 134.25 22.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 110.479 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 14.2 p -82.77 99.25 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.8 t . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.394 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.589 ' HA ' ' OE1' ' A' ' 328' ' ' GLN . 25.9 mp0 . . . . . 0 N--CA 1.441 -0.884 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.04 158.93 22.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.352 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.808 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 8.2 p30 41.41 45.66 2.74 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.308 1.005 . . . . 0.0 111.482 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -77.65 135.31 38.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.452 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . 0.441 ' N ' HD21 ' A' ' 314' ' ' LEU . 30.6 p90 -129.5 121.97 28.3 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 168.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.475 ' CD ' ' HD1' ' A' ' 324' ' ' HIS . 35.1 tt0 -92.2 138.68 31.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.551 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 94.6 mt -111.93 110.33 31.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.9 mt -96.48 85.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 40.4 p -60.98 175.85 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.876 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.53 -20.56 65.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.362 0.601 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.7 3.07 26.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.182 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 57.53 38.57 28.02 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.021 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.36 127.81 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.969 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.475 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 16.3 m-70 -85.15 112.51 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 36.6 m-85 -98.36 125.25 43.42 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.53 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 48.9 m-85 -100.35 119.67 38.78 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.0 111.008 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 96.3 mt -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.507 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 25.5 mt-30 -142.65 150.17 39.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.367 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -108.46 -168.63 1.38 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.388 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.3 -38.78 17.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.398 . . . . 0.0 110.208 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 332' ' ' PRO . 61.9 p -119.48 149.3 47.54 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.644 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . 0.745 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 34.2 Cg_exo -63.3 -14.82 44.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.559 2.839 . . . . 0.0 113.595 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -93.13 -32.81 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.449 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.37 -37.39 87.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 110.296 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.808 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.66 -43.79 97.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.22 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.634 ' HA ' HD11 ' A' ' 339' ' ' ILE . 5.1 m -57.21 -44.23 83.49 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.116 0.484 . . . . 0.0 110.39 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -60.56 -36.93 79.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.055 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.488 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 52.4 m95 -70.96 -30.69 67.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.508 0.194 . . . . 0.0 111.126 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 336' ' ' THR . 74.1 mt -58.94 -51.85 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . 0.598 ' HE2' HG23 ' A' ' 336' ' ' THR . 43.0 mmtt -53.07 -54.68 31.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.554 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.4 ' HB1' ' HD3' ' A' ' 247' ' ' LYS . . . -52.64 -57.18 10.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.814 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 292' ' ' LEU . 35.4 mt -70.44 -42.77 78.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.369 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.76 -33.86 76.98 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.502 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.7 ptm -79.46 -20.97 46.09 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.614 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.96 -22.04 36.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.44 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.529 ' HA ' ' HB1' ' A' ' 273' ' ' ALA . 40.8 t -89.02 9.45 25.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 177.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 242' ' ' ARG . 36.9 tt0 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.62 -41.27 73.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.107 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.44 1.01 37.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.399 -173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 239' ' ' GLU . 99.1 mtt180 -52.86 -40.6 63.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.7 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -82.48 137.63 17.16 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 245' ' ' ILE . 40.1 t -77.16 169.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 244' ' ' VAL . 71.7 mt -56.75 116.6 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.381 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 270' ' ' GLU . 32.9 mm -84.96 -38.79 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.958 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.617 ' HE2' ' CE2' ' A' ' 338' ' ' TRP . 80.5 tttt -169.21 141.49 2.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.716 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.725 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.4 OUTLIER -144.11 162.72 35.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.831 175.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.66 173.0 30.84 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.98 139.18 34.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.611 0.706 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.6 mt -143.72 160.85 39.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.4 mp -98.47 125.96 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -113.72 124.67 52.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.623 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 60.4 tt0 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.651 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.522 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 69.4 m95 . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.487 ' HD3' ' NH2' ' A' ' 264' ' ' ARG . 5.9 mtpt -105.38 140.76 38.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.128 0.49 . . . . 0.0 111.368 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.44 99.01 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.487 ' NH2' ' HD3' ' A' ' 262' ' ' LYS . 55.7 mtt-85 -116.57 148.38 40.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.033 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.31 110.54 18.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 20.1 m-85 -93.98 153.06 18.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.725 HG12 ' HB3' ' A' ' 248' ' ' GLN . 6.9 mt -144.96 125.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.815 0.697 . . . . 0.0 109.856 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.3 tp -99.85 145.39 27.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.102 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -149.56 131.43 15.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . 0.443 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.8 OUTLIER -99.9 -170.72 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.672 -170.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.962 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 12.1 t70 95.02 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.661 1.584 . . . . 0.0 110.253 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.962 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.6 Cg_endo -91.38 -6.29 3.81 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 CA-C-N 120.859 1.342 . . . . 0.0 111.025 164.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.604 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 63.35 95.18 0.05 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.734 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.407 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 14.6 m-85 -137.62 115.27 11.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.616 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 44.7 tp -89.72 139.34 30.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.133 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 274' ' ' TYR . 75.5 m80 -130.24 144.3 51.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.414 ' HB3' ' CE2' ' A' ' 266' ' ' PHE . 8.2 p90 -131.4 139.05 49.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 110.712 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -119.56 -165.09 1.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.22 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -130.13 129.81 22.99 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 -17.08 22.26 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.854 2.369 . . . . 0.0 111.594 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.71 -12.18 17.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.237 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.86 84.32 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.91 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.54 117.32 0.2 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.447 0.641 . . . . 0.0 110.61 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -94.4 -30.54 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.825 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -75.23 142.41 75.3 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.778 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 125.92 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.163 1.908 . . . . 0.0 111.666 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.11 3.41 17.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.098 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 170.36 139.25 2.69 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -110.54 112.13 23.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.82 0.343 . . . . 0.0 110.308 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 63.8 mt -85.16 132.17 32.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.549 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.09 95.66 9.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.59 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.582 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 81.2 mt -79.87 -28.96 39.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.098 -172.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -52.97 103.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.88 0.372 . . . . 0.0 111.103 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 97.08 9.89 55.38 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.012 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' CYS . . . . . 0.433 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.6 p -88.45 144.51 26.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.992 0.425 . . . . 0.0 110.778 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.01 144.62 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 91.4 t -119.38 150.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -148.59 142.01 25.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.463 -175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.7 t -76.36 108.5 9.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.915 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 51.3 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.189 0.519 . . . . 0.0 110.675 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.529 ' HG2' HD13 ' A' ' 314' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 313' ' ' ASN . 44.6 mt-10 -140.73 133.24 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.64 ' HB3' ' HG2' ' A' ' 335' ' ' ARG . 86.1 m-20 76.19 28.51 0.81 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.851 0.719 . . . . 0.0 110.411 -174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.628 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -77.06 126.29 30.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.319 178.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.58 125.49 47.92 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.543 ' HB3' HG23 ' A' ' 298' ' ' THR . 4.8 tp10 -86.41 136.32 33.16 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.893 -174.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.7 103.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.17 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.042 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 38.1 p -53.16 159.21 1.32 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.053 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.67 -1.59 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.902 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.15 4.46 53.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.125 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.81 27.74 11.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.355 172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.38 135.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -82.69 118.95 23.71 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -112.2 97.68 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.178 0.514 . . . . 0.0 110.033 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 87.7 m-85 -80.23 118.74 22.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.273 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.545 ' O ' HD21 ' A' ' 314' ' ' LEU . 87.6 mt -125.9 152.02 46.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 39.4 mt-30 -139.61 144.89 37.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.679 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -117.79 171.94 7.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.837 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.12 -69.04 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.499 0.499 . . . . 0.0 111.34 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 77.1 p -102.55 161.22 23.93 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.005 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' PRO . . . . . 0.63 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 68.3 Cg_exo -52.08 -44.45 45.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.545 2.163 . . . . 0.0 112.07 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 57.8 tttp -55.28 -50.01 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.364 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.413 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 9.0 tp10 -60.54 -42.45 96.56 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.475 -173.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.64 ' HG2' ' HB3' ' A' ' 313' ' ' ASN . 7.0 ppt_? -66.95 -39.03 87.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.348 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' THR . . . . . 0.552 ' HA ' HD13 ' A' ' 339' ' ' ILE . 29.2 m -60.81 -41.77 96.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.838 0.352 . . . . 0.0 110.68 170.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 80.2 mm-40 -59.05 -44.67 91.84 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' TRP . . . . . 0.617 ' CE2' ' HE2' ' A' ' 247' ' ' LYS . 60.4 m95 -65.17 -36.21 83.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.552 HD13 ' HA ' ' A' ' 336' ' ' THR . 99.0 mt -53.17 -53.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.4 mtmt -57.37 -42.18 81.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.709 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.82 42.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.122 0.487 . . . . 0.0 110.81 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.69 -40.99 87.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.495 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -64.77 -36.48 84.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.41 -30.86 33.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.088 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.94 56.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.677 0.275 . . . . 0.0 111.573 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.604 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 30.1 t -75.02 -22.78 58.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 347' ' ' ARG . 42.4 mtm105 . . . . . 0 C--N 1.327 -0.375 0 O-C-N 122.06 -0.4 . . . . 0.0 111.864 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.2 p 44.4 36.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 122.567 1.175 . . . . 0.0 111.981 -175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.9 123.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.629 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -123.13 -164.99 1.26 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -51.11 130.24 25.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.293 0.568 . . . . 0.0 110.96 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.535 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 33.7 tt0 -55.23 -28.67 54.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.603 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -55.65 -37.01 67.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.403 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -103.44 0.46 31.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -71.33 -8.65 55.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.04 0.447 . . . . 0.0 110.52 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -107.64 143.17 15.94 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.23 151.87 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.317 0.579 . . . . 0.0 111.716 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.8 mt -53.25 127.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.162 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.483 HD13 ' CG ' ' A' ' 270' ' ' GLU . 41.2 mm -96.71 -44.84 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.766 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.508 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 60.3 tttp -164.98 132.59 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.52 -173.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.561 ' CB ' HG12 ' A' ' 267' ' ' ILE . 4.8 pt20 -132.91 141.35 48.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.319 0.58 . . . . 0.0 111.795 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 177.51 151.66 9.38 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.79 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 61.6 m -71.01 135.06 47.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.119 0.46 . . . . 0.0 110.116 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.536 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 94.0 mt -131.61 169.51 16.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 8.1 mp -95.0 117.58 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.12 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.83 119.08 38.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.249 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -61.56 111.06 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -151.07 86.74 0.14 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.726 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -74.28 69.57 1.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.435 0.636 . . . . 0.0 111.933 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -98.92 -53.34 3.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -130.99 -44.99 1.03 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.167 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.589 ' HZ1' ' HB3' ' A' ' 259' ' ' LYS . 1.8 mmmp? -98.83 -165.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.543 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -108.19 -51.97 2.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.526 0.679 . . . . 0.0 109.723 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' ' HG3' ' A' ' 311' ' ' GLU . 89.7 m95 -120.16 133.01 55.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.783 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 24.2 mtpp -110.62 151.5 27.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 0.0 112.246 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.2 101.73 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.2 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 279' ' ' ASP . 96.7 mtt180 -132.62 154.6 49.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.741 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 40.6 ttmt -79.39 120.66 24.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.68 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 35.9 m-85 -103.89 117.2 33.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.561 HG12 ' CB ' ' A' ' 248' ' ' GLN . 18.6 mt -114.83 127.0 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 42.5 tp -99.5 154.42 18.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.906 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -150.67 139.61 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.64 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.617 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 13.5 pt-20 -101.08 -169.95 1.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.595 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.593 ' CB ' ' HD3' ' A' ' 272' ' ' PRO . 0.8 OUTLIER 95.64 -70.17 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 110.9 -178.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 271' ' ' ASP . 14.4 Cg_endo -97.97 -6.66 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.647 1.564 . . . . 0.0 111.876 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 292' ' ' LEU . . . 70.13 93.95 0.08 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.501 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 33.6 m-85 -141.62 119.48 11.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.331 0.586 . . . . 0.0 111.953 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.646 HD23 HD11 ' A' ' 290' ' ' ILE . 38.8 tp -90.86 140.13 30.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.278 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 70.9 m80 -127.65 139.67 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.103 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.503 ' HE2' HG13 ' A' ' 290' ' ' ILE . 1.3 p90 -121.7 136.25 54.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.264 0.554 . . . . 0.0 111.088 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.91 147.48 50.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.555 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 264' ' ' ARG . 7.7 t70 -90.35 132.65 34.98 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 97.1 Cg_endo -72.57 -24.14 19.09 Favored 'Trans proline' 0 CA--C 1.517 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 111.293 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.93 -12.51 23.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.376 -170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.38 59.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.622 -1.275 . . . . 0.0 114.525 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.477 ' HB1' ' CB ' ' A' ' 279' ' ' ASP . . . -171.42 73.02 0.05 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.773 0.286 . . . . 0.0 111.136 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.19 -9.51 59.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.62 134.17 88.52 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.077 167.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.98 105.02 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.906 1.737 . . . . 0.0 112.439 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 283' ' ' ALA . 90.3 mt -61.73 -28.09 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.035 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.7 35.97 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.6 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -121.18 135.67 55.11 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.791 0.329 . . . . 0.0 110.376 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.646 HD11 HD23 ' A' ' 275' ' ' LEU . 27.7 mt -85.42 131.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -85.37 88.66 7.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.633 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 273' ' ' ALA . 51.9 mt -76.56 -26.81 55.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.845 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -52.37 101.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 95.85 10.49 56.39 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.877 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 11.4 p -90.73 147.72 23.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.919 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.07 146.24 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.15 152.46 13.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.417 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 14.3 t -145.98 142.42 28.65 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.678 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 40.7 t -83.73 105.3 14.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.46 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 55.8 t -70.79 130.89 34.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.78 29.09 0.13 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.576 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 300' ' ' VAL . 30.3 t 56.68 76.25 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.335 0.588 . . . . 0.0 110.068 -173.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.97 33.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 311' ' ' GLU . 5.8 t -82.19 81.53 8.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.262 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.93 132.85 49.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.408 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.12 3.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.959 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 -168.94 1.79 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.3 153.36 31.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 67.8 m -68.47 76.87 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 111.508 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -84.72 -41.47 16.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.602 0.715 . . . . 0.0 109.193 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.617 ' HB3' HD13 ' A' ' 314' ' ' LEU . 8.9 mp0 -83.87 86.94 7.09 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.699 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.04 -68.42 0.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.926 0.87 . . . . 0.0 110.762 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.518 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 6.1 p30 -85.63 46.4 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 311' ' ' GLU . 0.7 OUTLIER -79.41 130.35 35.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.17 -176.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -127.67 134.0 49.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.417 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 36.9 tt0 -102.08 141.98 34.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.517 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.8 mt -116.34 110.8 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.0 mt -98.32 92.05 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.129 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 75.4 p -60.09 161.92 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.587 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.82 -17.62 61.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.23 0.538 . . . . 0.0 110.396 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.52 3.2 25.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.329 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 70.58 27.55 3.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.685 0.794 . . . . 0.0 111.834 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.61 126.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.019 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -91.35 113.62 25.93 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.23 111.43 23.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.477 ' HB3' ' HH2' ' A' ' 261' ' ' TRP . 45.0 m-85 -85.77 115.28 23.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.784 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 99.0 mt -124.03 154.3 40.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.53 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 31.9 mt-30 -140.73 155.39 46.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.326 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 334' ' ' GLU . . . -115.3 -174.81 2.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.357 0.598 . . . . 0.0 110.112 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 55.1 p -134.16 159.56 71.89 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.843 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.96 -32.48 97.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 111.105 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 24.8 ttpp -59.45 -54.87 41.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.917 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 329' ' ' ALA . 17.5 tp10 -63.92 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.465 -172.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 3.2 ptt180 -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.136 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.705 HG23 ' HZ3' ' A' ' 340' ' ' LYS . 88.0 m -58.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.798 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 4.8 mm-40 -60.73 -37.04 80.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.572 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.508 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 59.8 m95 -76.17 -32.95 59.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.62 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 335' ' ' ARG . 98.2 mt -54.63 -54.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.705 ' HZ3' HG23 ' A' ' 336' ' ' THR . 27.7 mtmm -56.8 -40.99 76.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.72 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' A' ' 247' ' ' LYS . . . -61.04 -56.09 25.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.134 0.492 . . . . 0.0 111.053 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.419 HG23 HD22 ' A' ' 292' ' ' LEU . 2.3 mp -66.34 -38.38 81.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.271 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.88 -41.02 92.07 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.64 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.49 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 12.6 ptm -71.95 -38.19 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.974 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -66.08 -35.83 81.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.396 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -69.18 -10.01 55.65 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.208 -0.307 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -72.66 -23.51 60.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.618 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.4 p -83.9 79.38 9.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.523 0.678 . . . . 0.0 109.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -123.68 63.64 0.55 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 82.3 mttt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.476 -172.108 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.4 t -74.74 74.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.559 0.695 . . . . 0.0 109.468 174.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.93 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.397 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 237' ' ' LEU . 1.9 pt? -136.65 -166.91 1.97 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.262 177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -43.75 131.16 5.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.391 0.615 . . . . 0.0 111.948 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 272' ' ' PRO . 7.8 tp10 -54.06 -35.01 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.055 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -55.77 -30.16 60.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.657 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.403 ' HB2' HD11 ' A' ' 237' ' ' LEU . 21.4 m-85 -113.23 2.42 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.132 -175.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.476 ' HD2' ' OE2' ' A' ' 239' ' ' GLU . 99.7 mtt180 -70.6 -35.78 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 110.04 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.38 150.05 51.36 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.585 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.4 t -81.39 145.64 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.724 0.41 . . . . 0.0 110.701 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.9 mp -70.44 117.9 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 110.378 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 270' ' ' GLU . 48.3 mm -85.52 -36.14 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.37 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.4 tttp -163.35 143.46 8.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.783 -171.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -133.13 157.55 45.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 148.84 155.82 6.87 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.074 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 6.9 p -76.21 141.02 41.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.198 0.499 . . . . 0.0 110.502 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 338' ' ' TRP . 96.1 mt -135.72 153.94 51.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 3.3 mp -86.59 117.5 25.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -103.08 119.2 38.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.555 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 260' ' ' ASN . 35.5 tt0 -65.24 123.45 19.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.728 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -157.95 124.08 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -65.8 159.2 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 72.35 -38.99 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.906 0.882 . . . . 0.0 112.067 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -86.18 57.46 4.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? 67.87 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 254' ' ' GLN . 64.6 t30 -170.16 -42.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.476 0.655 . . . . 0.0 109.47 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.542 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 93.2 m95 -120.45 124.66 45.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.513 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 5.5 ttpm? -113.53 160.92 17.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.882 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.98 111.3 35.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.343 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 95.0 mtt180 -137.42 150.64 47.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.05 172.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 36.2 ttpt -84.71 123.24 30.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.754 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 23.0 m-85 -97.77 158.86 15.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.315 0.578 . . . . 0.0 111.72 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.424 HG23 HG22 ' A' ' 245' ' ' ILE . 7.9 mt -150.15 121.29 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.985 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 33.5 tp -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.013 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 51.7 mtt180 -146.48 134.08 20.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.742 0.306 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.619 ' HB3' HD11 ' A' ' 246' ' ' ILE . 37.0 tt0 -112.86 133.75 54.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.602 ' HB3' ' HE2' ' A' ' 350' ' ' LYS . 25.6 m-20 145.17 -54.45 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 125.733 1.895 . . . . 0.0 108.164 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.822 ' HB3' ' HG3' ' A' ' 239' ' ' GLU . 66.2 Cg_endo -100.04 -16.29 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 166.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.14 82.91 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.308 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 57.6 m-85 -143.62 124.53 14.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.413 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.622 HD23 HD13 ' A' ' 290' ' ' ILE . 51.1 tp -89.29 137.49 32.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -124.85 154.71 40.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.655 0.264 . . . . 0.0 110.304 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -147.34 144.49 28.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.5 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.078 ' HA ' HD11 ' A' ' 287' ' ' LEU . 2.6 m-85 -133.92 154.81 50.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.661 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 282' ' ' GLY . 5.5 t70 -87.19 136.42 33.72 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.482 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 93.9 Cg_endo -67.94 -19.82 45.71 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.01 2.473 . . . . 0.0 111.414 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.12 7.98 19.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.19 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . 171.19 140.23 2.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.266 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 72.66 102.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.608 0.718 . . . . 0.0 112.412 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -95.74 -6.59 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.221 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.8 132.56 51.08 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.473 ' HA ' ' CE1' ' A' ' 278' ' ' TYR . 10.8 Cg_endo -51.81 124.62 14.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.382 2.722 . . . . 0.0 114.004 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 1.078 HD11 ' HA ' ' A' ' 278' ' ' TYR . 6.1 mp -81.81 -26.38 34.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.384 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -174.64 174.26 46.5 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.742 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 275' ' ' LEU . . . -141.76 140.85 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.304 . . . . 0.0 111.011 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.622 HD13 HD23 ' A' ' 275' ' ' LEU . 38.9 mt -99.41 137.92 25.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.529 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -84.72 95.3 8.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.774 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.686 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 30.5 mt -77.77 -28.66 50.62 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.88 107.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.872 0.368 . . . . 0.0 111.142 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.67 13.59 62.67 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.276 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.445 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 15.8 p -87.29 146.86 25.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.258 0.552 . . . . 0.0 111.271 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.83 140.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 298' ' ' THR . 57.3 t -116.51 154.49 18.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.444 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -141.65 140.93 33.37 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.245 0.545 . . . . 0.0 109.928 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 7.6 t -87.7 99.13 11.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.746 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 45.6 t -81.7 110.23 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.45 39.55 0.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.021 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 300' ' ' VAL . 8.5 t 57.28 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.072 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -137.18 78.62 1.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.136 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 44.0 t -170.55 178.11 3.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.414 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 76.6 -60.76 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.131 0.972 . . . . 0.0 111.916 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -171.35 -150.63 7.19 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.7 -51.85 60.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -80.72 116.09 20.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.607 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 54.3 m -75.88 83.53 2.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.383 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -62.58 -39.5 93.91 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.666 0.746 . . . . 0.0 110.245 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.46 87.61 3.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.877 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 162.57 13.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.609 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.862 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 11.1 p30 41.75 36.99 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.985 0.914 . . . . 0.0 112.259 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.4 OUTLIER -75.49 129.95 38.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.92 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -125.48 125.4 43.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 38.9 tt0 -96.16 137.01 35.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.212 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -114.4 108.97 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.37 88.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.468 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.445 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.3 p -62.78 171.45 2.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.269 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -65.3 -18.09 65.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.679 0.752 . . . . 0.0 109.541 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.5 -5.0 42.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.489 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 69.28 29.22 4.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.685 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.61 132.11 53.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.733 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.416 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 7.7 m-70 -90.23 114.32 26.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 63.2 m-85 -98.65 115.57 28.97 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.542 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 44.2 m-85 -91.38 115.68 28.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.018 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 317' ' ' ILE . 95.9 mt -128.7 151.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.582 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.506 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.1 mt-30 -142.36 154.92 45.05 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.901 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.88 -175.94 2.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.395 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -76.75 -37.21 56.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.211 0.529 . . . . 0.0 110.248 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 45.5 p -127.48 155.17 77.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.797 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 25.2 Cg_exo -63.23 -21.83 72.25 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.138 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.65 -30.79 17.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.581 0.229 . . . . 0.0 111.221 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.4 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 8.4 tp10 -63.29 -43.56 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.862 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.21 -42.62 95.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.17 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.503 ' HA ' HD13 ' A' ' 339' ' ' ILE . 11.8 m -58.64 -39.22 79.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.493 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 41.4 mt-10 -64.49 -36.75 85.19 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.689 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.432 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 68.8 m95 -72.72 -34.66 67.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.168 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 335' ' ' ARG . 84.6 mt -53.15 -57.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -56.28 -41.97 76.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.971 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 247' ' ' LYS . . . -58.17 -57.16 14.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.81 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.686 HG22 HD23 ' A' ' 292' ' ' LEU . 1.7 mp -60.94 -42.16 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.344 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.74 -42.29 97.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.552 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 11.6 ptm -73.17 -40.84 64.49 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.739 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -61.2 -29.37 69.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.488 0.185 . . . . 0.0 111.179 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 33.1 t -68.03 -14.43 62.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -74.08 -43.91 55.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 273' ' ' ALA . 35.9 p 62.18 124.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.345 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -69.22 -31.76 72.02 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.01 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.602 ' HE2' ' HB3' ' A' ' 271' ' ' ASP . 43.5 mtmt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.836 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -66.64 82.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.563 0.697 . . . . 0.0 110.888 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.33 120.23 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.9 mp -56.74 116.0 2.9 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 47.4 mmtm -88.75 -179.05 5.92 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.705 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.42 -35.36 75.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.722 0.773 . . . . 0.0 109.202 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.44 ' HA ' ' CD2' ' A' ' 274' ' ' TYR . 11.6 mp0 -66.22 -12.27 55.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.069 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.97 -13.58 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 96.7 mtt180 -56.23 -24.53 42.87 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.65 141.53 18.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.174 175.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.22 153.01 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 23.5 mt -55.61 132.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.392 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.617 HD13 ' HG2' ' A' ' 270' ' ' GLU . 42.9 mm -99.9 -42.09 10.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.331 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 59.8 tttp -166.59 138.12 3.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.208 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 152.62 50.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.351 0.595 . . . . 0.0 112.392 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.67 157.18 9.76 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.656 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 31.8 m -77.07 144.74 38.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.801 0.8 . . . . 0.0 110.305 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.3 mt -142.01 165.39 27.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -96.87 119.03 34.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.542 -0.169 . . . . 0.0 110.542 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.88 120.62 40.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.48 115.45 4.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.925 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -103.1 -178.08 26.48 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.927 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 58.5 -159.81 0.27 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.558 0.343 . . . . 0.0 110.486 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 257' ' ' ARG . 4.0 ptp180 -87.08 55.71 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 110.691 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 68.53 87.26 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.159 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -168.11 -68.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.032 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.76 161.82 18.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.442 . . . . 0.0 110.669 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.476 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 72.3 m95 -124.3 143.89 50.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.512 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.39 131.86 56.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.399 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.05 107.53 12.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.494 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -129.02 156.62 43.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 84.0 tttt -89.95 115.07 26.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.734 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 30.9 m-85 -101.96 118.24 36.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.021 0.438 . . . . 0.0 111.822 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.512 HG12 ' CE1' ' A' ' 278' ' ' TYR . 9.3 mm -112.49 127.33 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 292' ' ' LEU . 39.2 tp -101.32 154.48 18.75 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.62 ' HB2' ' HE1' ' A' ' 276' ' ' HIS . 79.9 mtt-85 -154.89 143.97 21.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.617 ' HG2' HD13 ' A' ' 246' ' ' ILE . 6.3 pt-20 -100.84 -170.44 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.62 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.869 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 32.8 t70 93.13 -72.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.686 1.595 . . . . 0.0 110.498 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.3 Cg_endo -92.64 -3.05 3.66 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 121.124 1.437 . . . . 0.0 112.054 167.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 292' ' ' LEU . . . 64.93 85.67 0.14 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.319 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.3 m-85 -130.71 129.85 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.753 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 29.0 tp -101.74 130.88 48.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.62 ' HE1' ' HB2' ' A' ' 269' ' ' ARG . 22.3 m80 -121.59 130.24 53.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.081 -172.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.406 ' HE1' HG13 ' A' ' 290' ' ' ILE . 8.5 p90 -119.7 133.28 55.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.883 0.849 . . . . 0.0 111.283 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.512 ' CE1' HG12 ' A' ' 267' ' ' ILE . 3.6 m-85 -115.15 149.07 38.21 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.263 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.563 ' HB2' HD11 ' A' ' 287' ' ' LEU . 0.3 OUTLIER -87.99 132.2 40.68 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.68 -15.92 41.57 Favored 'Trans proline' 0 CA--C 1.514 -0.503 0 C-N-CA 123.342 2.695 . . . . 0.0 111.038 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.11 2.23 34.37 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.31 -171.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.46 85.25 0.05 OUTLIER Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.799 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -178.04 107.06 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.275 0.56 . . . . 0.0 111.985 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -83.69 -46.67 12.03 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.72 134.75 46.81 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.238 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.41 137.03 58.08 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.856 2.371 . . . . 0.0 112.259 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 279' ' ' ASP . 58.1 mt -68.08 -29.35 68.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.945 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -167.73 147.0 11.1 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.558 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.04 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 66.1 mt -67.19 142.05 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.347 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -94.54 94.47 8.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.62 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 273' ' ' ALA . 42.7 mt -72.68 -31.24 64.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.928 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -58.6 91.14 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 119.3 -3.68 13.87 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 292' ' ' LEU . 14.2 p -95.81 148.36 22.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.175 0.487 . . . . 0.0 111.419 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.92 150.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 298' ' ' THR . 57.8 t -117.18 159.79 17.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.766 0.317 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 8.8 t -160.02 143.34 13.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.73 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.6 t -80.35 122.68 27.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.701 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 46.6 t -95.58 125.24 48.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 111.266 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.81 45.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.827 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.3 m 55.1 34.32 22.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.3 0.571 . . . . 0.0 110.0 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' H ' HG13 ' A' ' 300' ' ' VAL . 55.8 t30 -80.29 76.85 7.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.718 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 17.7 p -106.27 150.77 25.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.889 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -87.7 100.93 13.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 0.0 110.077 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 142.25 172.98 13.93 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 307' ' ' ARG . 67.5 mtt180 -96.4 172.22 8.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.661 0.231 . . . . 0.0 110.917 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 55.49 46.68 22.6 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.476 0.655 . . . . 0.0 110.974 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.0 p -64.55 119.32 10.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.554 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -104.99 5.18 32.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.241 0.543 . . . . 0.0 110.495 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.547 ' HB3' HD11 ' A' ' 314' ' ' LEU . 17.6 mp0 -74.56 125.87 29.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.73 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -135.34 132.16 37.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.726 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.56 35.12 11.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.701 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.0 OUTLIER -75.28 129.86 38.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.554 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -126.99 138.29 53.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 168.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 33.7 tt0 -100.7 133.41 45.19 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.73 102.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.07 91.67 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.966 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.7 p -54.39 159.08 2.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.25 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.6 1.81 2.19 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.865 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -118.34 30.21 7.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.276 0.56 . . . . 0.0 110.428 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 64.8 31.05 11.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.961 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 t -108.78 124.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.195 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -88.88 114.69 25.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -94.58 125.35 39.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.476 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 6.3 m-30 -99.74 114.73 28.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 110.847 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.77 153.28 38.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.386 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.445 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.4 mt-30 -139.52 142.22 37.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.058 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -115.09 165.61 12.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.68 30.2 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 71.7 p -113.82 159.04 37.39 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.086 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.4 -37.89 82.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.945 2.43 . . . . 0.0 111.816 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 30.1 mmtp -64.61 -47.91 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.482 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 11.9 tp10 -55.94 -49.42 73.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.074 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.598 ' HG3' ' N ' ' A' ' 336' ' ' THR . 8.5 ptt180 -60.59 -43.82 96.95 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.611 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.63 ' HA ' HD11 ' A' ' 339' ' ' ILE . 30.9 m -60.32 -37.69 81.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.752 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.478 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 76.5 mm-40 -63.73 -40.72 97.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.482 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.8 m95 -71.34 -33.0 69.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 336' ' ' THR . 98.0 mt -53.32 -57.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -58.75 -39.39 80.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.181 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.41 ' HB3' ' HD3' ' A' ' 247' ' ' LYS . . . -61.65 -53.01 61.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.206 0.526 . . . . 0.0 110.897 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.643 HG22 HD21 ' A' ' 292' ' ' LEU . 1.8 mp -64.27 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.265 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 97.8 mt-30 -63.81 -49.35 73.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.604 0.24 . . . . 0.0 111.34 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.4 ptm -70.05 -24.56 63.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.391 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.15 32.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.608 0.242 . . . . 0.0 111.061 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.7 t -66.66 -19.27 65.73 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.39 21.49 6.09 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.924 -0.485 . . . . 0.0 111.587 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 270' ' ' GLU . 39.2 p -100.07 167.24 10.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 77.19 53.21 5.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.258 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.079 176.766 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.9 t -77.37 61.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 122.043 0.925 . . . . 0.0 109.783 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.4 mt -98.95 102.13 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.569 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 241' ' ' PHE . 2.3 mp -55.37 109.65 0.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.951 0.882 . . . . 0.0 112.513 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 32.1 mmmt -82.47 -178.23 6.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.543 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 272' ' ' PRO . 36.5 tt0 -54.64 -38.99 67.53 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 52.3 mt-10 -52.9 -40.89 63.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.535 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.436 ' O ' HD22 ' A' ' 237' ' ' LEU . 12.4 m-85 -101.5 -15.64 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -166.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 25.3 mtp180 -53.12 -23.89 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.709 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -87.05 149.5 22.2 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.087 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.94 158.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.111 0.482 . . . . 0.0 110.426 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.623 HG22 HG23 ' A' ' 267' ' ' ILE . 3.0 mm -73.57 116.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.725 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.594 HD11 ' HG2' ' A' ' 270' ' ' GLU . 33.5 mm -83.3 -41.84 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -161.12 149.29 15.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -133.25 157.4 45.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.22 164.83 19.21 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.35 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.1 p -86.19 133.12 33.87 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.3 mt -133.63 155.97 48.72 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.8 mp -91.46 121.82 33.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -108.43 131.4 54.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 33.7 tt0 -77.75 146.28 36.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.964 173.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.98 19.47 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.656 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.22 124.14 28.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 59.43 50.33 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.809 0.814 . . . . 0.0 110.489 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -121.56 -174.06 2.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.713 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -77.05 -61.3 2.03 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.83 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -163.09 -167.39 1.47 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 252' ' ' LEU . 62.7 m95 -68.75 146.06 53.27 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 9.0 ptpt -134.08 165.27 25.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.535 0.683 . . . . 0.0 112.43 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.2 103.15 14.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.207 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.618 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 97.0 mtt180 -126.01 158.24 35.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.197 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.57 106.04 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.404 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.6 m-85 -91.12 148.09 22.61 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.395 0.617 . . . . 0.0 111.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 245' ' ' ILE . 21.0 mt -146.39 118.53 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.298 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 61.1 tp -93.03 139.46 30.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.202 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -139.31 127.67 22.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.78 ' HB2' HG21 ' A' ' 348' ' ' THR . 0.4 OUTLIER -91.1 -172.17 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.224 -174.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.969 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 38.4 t70 94.63 -76.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.66 1.584 . . . . 0.0 109.968 176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.969 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.4 Cg_endo -92.01 -5.67 3.59 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 CA-C-N 121.098 1.428 . . . . 0.0 111.262 166.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 346' ' ' SER . . . 66.31 98.32 0.05 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.975 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 41.4 m-85 -144.74 110.92 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.139 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.571 HD22 HD12 ' A' ' 290' ' ' ILE . 23.8 tp -89.56 121.1 31.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 61.7 m80 -112.58 155.09 24.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.078 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.54 141.46 39.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.351 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -127.57 166.45 17.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.948 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 281' ' ' ALA . 27.5 t70 -95.13 123.4 57.29 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.618 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 83.3 Cg_endo -67.78 -17.53 47.32 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.391 2.728 . . . . 0.0 110.26 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.549 ' HB2' ' OD2' ' A' ' 279' ' ' ASP . . . -89.57 -1.65 58.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.261 -1.791 . . . . 0.0 111.205 -172.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.29 29.78 0.17 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.188 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.0 111.78 13.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.37 1.085 . . . . 0.0 110.901 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.94 -12.66 23.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.831 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.19 141.81 96.48 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.416 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.6 108.78 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.468 2.112 . . . . 0.0 111.517 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.03 5.85 13.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.603 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 167.77 140.55 2.94 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.518 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.435 ' HB1' ' OE1' ' A' ' 240' ' ' GLU . . . -115.57 102.04 9.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 275' ' ' LEU . 59.3 mt -70.82 123.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -82.52 87.11 6.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.017 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 273' ' ' ALA . 78.9 mt -74.56 -27.61 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -48.44 99.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 92.54 18.79 40.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.957 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . . . . . . . . . 14.8 p -95.39 157.92 15.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.303 0.573 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.93 149.93 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 298' ' ' THR . 48.4 t -118.15 158.81 18.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 316' ' ' GLU . 15.0 t -150.86 143.23 24.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.272 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.9 t -80.0 99.44 7.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.451 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.891 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.5 t -76.59 109.8 11.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.946 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -93.67 69.77 4.1 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.781 0.8 . . . . 0.0 109.469 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.624 ' HB3' ' HB3' ' A' ' 309' ' ' SER . 35.2 m 64.43 85.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.469 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -112.91 23.27 13.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.794 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 56.0 m -135.26 160.94 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.997 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -123.48 135.58 54.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 0.0 111.173 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -140.92 -64.85 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -142.84 -39.54 0.33 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -141.73 23.73 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.196 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.624 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 61.8 m 56.21 67.52 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.718 0.77 . . . . 0.0 109.627 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.51 -33.27 73.53 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.936 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.501 ' HB3' HD12 ' A' ' 314' ' ' LEU . 6.4 mp0 -58.15 89.86 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.512 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.56 -10.14 12.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.653 0.739 . . . . 0.0 110.772 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -122.55 29.77 6.77 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.891 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.2 tt -77.58 135.57 38.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.331 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -129.91 125.87 36.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 298' ' ' THR . 36.0 tt0 -93.62 136.92 33.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.129 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -112.01 103.14 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.56 88.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.656 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 50.1 p -59.21 160.76 6.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.517 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.17 -8.97 27.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.384 0.611 . . . . 0.0 110.671 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.11 4.6 41.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.233 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 64.03 32.12 13.13 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.033 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.37 127.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.709 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -87.63 118.09 26.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 9.0 m-85 -98.93 117.91 34.51 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.6 m-85 -95.46 112.81 24.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.066 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.67 156.41 41.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 30.6 mt-30 -139.45 145.29 38.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.672 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.69 176.48 5.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.455 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.96 -56.48 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.0 111.102 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 39.2 p -124.05 163.43 35.62 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.21 -37.84 40.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.725 2.283 . . . . 0.0 112.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 50.7 mtmt -62.91 -48.98 76.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.924 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.415 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 9.7 tp10 -61.26 -41.89 97.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.145 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 339' ' ' ILE . 17.8 ptt180 -63.17 -42.15 99.34 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.635 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.55 ' HA ' HD12 ' A' ' 339' ' ' ILE . 18.7 m -57.24 -42.3 81.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.767 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 11.1 mm-40 -57.47 -45.29 84.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.858 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.415 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 78.1 m95 -70.55 -31.15 68.08 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 335' ' ' ARG . 89.2 mt -59.86 -56.99 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -55.46 -49.83 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.925 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.3 30.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 0.0 111.431 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.49 HD12 HD12 ' A' ' 317' ' ' ILE . 13.5 mt -71.55 -41.06 72.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.081 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.69 -30.76 71.82 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.461 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.15 -40.79 21.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.695 0.283 . . . . 0.0 110.276 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.18 71.6 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.445 ' HA ' ' HB1' ' A' ' 273' ' ' ALA . 32.9 t -76.91 -0.35 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.772 0.32 . . . . 0.0 111.819 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 62.4 mtp85 -92.02 15.98 12.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.05 -0.406 . . . . 0.0 111.348 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.78 HG21 ' HB2' ' A' ' 270' ' ' GLU . 12.2 p -87.66 35.18 0.72 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.15 0.5 . . . . 0.0 112.08 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.52 68.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 82.5 mttt . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.87 176.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.9 70.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.366 0.603 . . . . 0.0 110.384 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.0 mt -106.03 87.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.26 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -140.48 -176.97 4.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 241' ' ' PHE . 49.9 mmtm -46.85 132.21 11.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.613 0.72 . . . . 0.0 111.007 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.571 ' OE1' ' HD3' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -59.59 -34.14 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.791 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.63 -26.48 63.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.017 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.597 ' HB2' HD12 ' A' ' 237' ' ' LEU . 4.9 m-85 -115.35 1.5 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.255 -174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 239' ' ' GLU . 64.8 mtp180 -72.11 -4.62 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.71 150.83 18.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 72.8 t -81.13 147.8 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.153 0.501 . . . . 0.0 111.139 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 3.9 mt -70.36 111.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.575 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.491 ' HB ' HD23 ' A' ' 268' ' ' LEU . 37.0 mm -77.82 -35.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.227 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -169.18 144.82 3.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.533 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.559 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.12 157.91 40.45 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.19 156.63 8.95 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.696 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 12.9 p -75.17 137.69 41.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 0.167 . . . . 0.0 110.642 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.6 mt -140.33 159.21 42.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.9 mp -97.78 120.41 38.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -109.33 123.49 49.39 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.454 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.46 140.18 58.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.917 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -118.15 -112.61 2.56 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.78 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -143.23 161.55 37.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 257' ' ' ARG . 16.3 mmt180 62.82 -170.48 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.755 0.659 . . . . 0.0 110.974 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.53 37.37 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.03 -17.9 18.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.496 ' HB3' ' HD1' ' A' ' 261' ' ' TRP . 4.0 m-20 58.94 -100.12 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.927 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.553 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 31.3 m95 -119.73 162.94 18.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.619 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 28.8 mttt -139.5 150.72 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.581 . . . . 0.0 111.526 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -92.96 99.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.9 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.725 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 70.7 mtt180 -124.06 164.67 18.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -94.26 110.64 22.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.694 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 17.6 m-85 -94.4 151.66 19.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.809 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 248' ' ' GLN . 13.0 mt -144.86 125.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.916 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 48.3 tp -100.09 147.64 25.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.286 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 68.6 mtt-85 -140.91 126.6 19.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.717 ' HG2' HG22 ' A' ' 348' ' ' THR . 19.0 tt0 -106.07 130.38 53.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.6 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.975 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.5 t70 148.39 -59.98 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 125.335 1.647 . . . . 0.0 108.36 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.975 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 11.2 Cg_endo -94.12 -10.41 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.44 2.093 . . . . 0.0 110.768 166.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.601 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 64.48 88.78 0.1 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.839 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -138.32 120.86 16.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 290' ' ' ILE . 33.3 tp -99.78 117.6 34.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.417 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 289' ' ' ALA . 0.7 OUTLIER -110.85 154.85 23.42 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.397 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.71 139.76 47.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.473 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -123.02 166.52 14.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 287' ' ' LEU . 6.8 t70 -88.0 135.36 33.54 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.725 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.6 Cg_endo -70.39 -14.51 34.17 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 111.539 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.11 11.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.516 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . -163.33 136.21 4.17 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.989 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 75.19 123.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.856 0.862 . . . . 0.0 113.262 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.78 -2.74 58.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.75 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 286' ' ' PRO . 1.4 p-10 -85.71 146.15 43.2 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.542 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . 2.6 Cg_endo -75.77 141.47 24.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.169 2.579 . . . . 0.0 113.341 -170.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' A' ' 279' ' ' ASP . 88.7 mt -96.09 7.46 46.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.957 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 143.63 138.08 3.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.646 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . . . -106.08 142.26 36.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.736 0.303 . . . . 0.0 110.76 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 275' ' ' LEU . 59.8 mt -98.41 131.99 44.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -88.38 91.88 8.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.561 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 56.5 mt -73.0 -32.43 65.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.647 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -61.24 96.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.002 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 116.25 2.4 19.94 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.218 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 13.0 p -97.85 154.1 17.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.256 0.551 . . . . 0.0 111.455 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.9 t -119.5 150.45 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 298' ' ' THR . 48.5 t -119.75 158.38 21.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.474 ' N ' HG12 ' A' ' 297' ' ' VAL . 7.6 t -160.11 136.65 8.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.013 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.6 p -73.2 138.32 45.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.164 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 59.0 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.107 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -85.16 42.7 0.96 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.611 ' HB3' ' HA ' ' A' ' 312' ' ' GLU . 11.5 p 46.42 50.41 12.51 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.074 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -128.25 44.57 2.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.408 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.513 ' HB3' ' OE2' ' A' ' 311' ' ' GLU . 41.9 t -86.19 -72.46 0.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -177.04 90.43 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . 0.654 ' HA3' ' HG2' ' A' ' 310' ' ' GLU . . . -137.66 -159.02 8.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.672 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 307' ' ' ARG . 44.2 mtt180 -82.19 -63.37 1.39 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.33 0.586 . . . . 0.0 109.507 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -116.73 -60.89 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 67.5 m -163.28 98.16 0.92 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.169 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.654 ' HG2' ' HA3' ' A' ' 306' ' ' GLY . 7.6 mm-40 -96.44 -39.11 9.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.952 0.882 . . . . 0.0 109.432 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' A' ' 314' ' ' LEU . 26.4 mp0 -81.83 50.13 1.48 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.07 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 302' ' ' SER . 33.4 mt-10 -73.1 -15.02 61.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 112.037 -172.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 328' ' ' GLN . 83.4 m-20 -122.27 20.67 10.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.22 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.731 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.8 OUTLIER -74.92 132.45 41.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.139 -178.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -131.0 133.02 45.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 43.6 tt0 -93.03 132.82 36.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.744 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 87.2 mt -113.24 105.29 18.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.84 90.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.679 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.551 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 20.4 p -59.56 176.66 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.98 68.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.555 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.58 -8.42 55.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.89 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 68.17 45.19 1.3 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.706 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.29 134.81 43.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.42 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 34.1 m-70 -83.77 112.05 19.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 51.5 m-85 -99.69 103.51 15.18 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 15.9 m-30 -84.49 110.01 18.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.595 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 94.1 mt -118.37 151.89 36.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.508 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 36.0 mt-30 -136.18 146.03 46.4 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.282 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 334' ' ' GLU . . . -108.52 171.99 7.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.876 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.02 68.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -116.46 160.37 36.4 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.57 -23.67 76.21 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.027 2.485 . . . . 0.0 112.477 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.59 -38.67 23.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.597 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 329' ' ' ALA . 7.4 tp10 -57.41 -44.07 84.27 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.48 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.559 ' O ' HG13 ' A' ' 339' ' ' ILE . 21.3 ptt180 -60.46 -40.8 92.51 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.173 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.603 HG23 ' HE2' ' A' ' 340' ' ' LYS . 27.2 m -55.61 -45.24 77.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.503 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -58.94 -36.36 74.65 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.126 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.502 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 86.3 m95 -78.0 -35.32 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 343' ' ' GLN . 82.3 mt -54.25 -55.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.603 ' HE2' HG23 ' A' ' 336' ' ' THR . 51.0 mtmt -58.7 -42.51 88.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.121 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' A' ' 268' ' ' LEU . . . -58.05 -52.14 66.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.919 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.26 -42.95 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 39.0 mt-30 -65.94 -33.45 75.86 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.462 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.7 ptm -80.83 -28.93 36.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.961 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.605 ' HA ' ' HG3' ' A' ' 270' ' ' GLU . . . -80.99 -30.86 34.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.601 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 16.6 p -78.0 -10.85 59.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -92.53 29.78 1.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.717 HG22 ' HG2' ' A' ' 270' ' ' GLU . 2.9 p -103.59 145.09 30.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 141.46 28.24 0.18 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.219 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.846 173.476 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 235' ' ' VAL . 7.4 p -77.76 71.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 122.623 1.201 . . . . 0.0 109.527 172.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.1 mt -118.89 117.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.292 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -95.98 -174.96 3.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.335 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.597 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 78.8 mttt -53.71 138.26 35.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -59.11 -26.18 64.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.097 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 55.7 mt-10 -50.58 -31.67 16.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.738 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.576 ' HB2' HD12 ' A' ' 237' ' ' LEU . 31.0 m-85 -114.09 -5.85 13.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.432 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 79.8 mtp180 -80.48 -14.47 58.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -87.68 148.06 20.88 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 70.0 t -77.37 147.89 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.221 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.4 mp -67.31 119.81 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.91 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.8 -45.18 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.225 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.521 ' HE2' ' NE1' ' A' ' 338' ' ' TRP . 75.1 tttt -165.44 140.74 5.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.249 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -134.32 156.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 111.293 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.47 156.38 8.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 73.5 m -78.44 131.48 36.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.165 0.482 . . . . 0.0 110.415 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.4 mt -133.68 150.55 51.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 261' ' ' TRP . 9.4 mp -79.4 145.15 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 261' ' ' TRP . 25.9 mtmm -128.29 129.31 46.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.22 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 261' ' ' TRP . 50.2 tt0 -108.33 143.2 37.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.035 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 63.23 62.3 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.995 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 258' ' ' ARG . 3.8 t60 -157.5 74.37 0.75 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 75.29 -23.97 0.23 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.856 0.862 . . . . 0.0 112.133 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 256' ' ' HIS . 10.3 mmt180 -96.8 165.66 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.07 -73.66 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.144 0.497 . . . . 0.0 110.24 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -96.58 -178.15 4.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.612 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CE2' ' HB2' ' A' ' 254' ' ' GLN . 70.9 m95 -62.67 133.35 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 35.7 mmtm -125.63 161.49 27.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 0.0 112.206 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.69 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.86 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.615 ' NH1' HD12 ' A' ' 287' ' ' LEU . 96.4 mtt180 -141.25 149.35 41.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.197 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -77.63 121.16 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.608 -169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.724 ' O ' HD11 ' A' ' 267' ' ' ILE . 21.7 m-85 -95.17 145.56 24.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.623 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.724 HD11 ' O ' ' A' ' 266' ' ' PHE . 16.4 mm -134.51 124.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 39.9 tp -100.92 147.55 26.01 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 240' ' ' GLU . 58.8 mtt-85 -143.53 131.75 21.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -174.9 4.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.446 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 1.0 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 13.7 t70 93.54 -75.89 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 125.83 1.652 . . . . 0.0 110.432 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 1.0 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 6.7 Cg_endo -92.23 -6.94 3.17 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 CA-C-N 121.344 1.516 . . . . 0.0 111.495 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 69.19 93.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.967 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 50.0 m-85 -138.63 112.52 8.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.156 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 46.4 tp -90.38 141.08 29.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.446 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 67.7 m80 -134.46 153.42 51.93 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.29 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -137.19 137.28 38.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.695 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 264' ' ' ARG . 20.2 m-85 -128.13 164.09 23.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.234 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 281' ' ' ALA . 31.0 t70 -93.95 124.92 54.91 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-O 120.925 0.393 . . . . 0.0 110.428 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.547 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 90.4 Cg_endo -70.66 -21.3 29.48 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 123.669 2.913 . . . . 0.0 110.601 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.542 ' HB2' ' OD2' ' A' ' 279' ' ' ASP . . . -81.06 -21.02 40.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.185 -170.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.69 65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.071 -1.062 . . . . 0.0 113.859 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -160.45 120.75 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.852 0.326 . . . . 0.0 111.514 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -90.64 -15.47 30.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.26 137.11 86.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.175 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.3 122.32 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.074 1.849 . . . . 0.0 111.108 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.615 HD12 ' NH1' ' A' ' 264' ' ' ARG . 29.8 mt -81.29 2.85 26.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 161.08 156.83 8.43 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.521 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.92 124.42 43.17 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.611 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 50.4 mt -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -86.29 99.92 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.817 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.436 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 68.4 mt -75.86 -80.0 0.09 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.294 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.776 ' HG3' ' HA ' ' A' ' 350' ' ' LYS . 32.3 ttm180 37.71 -90.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -170.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -105.73 51.43 0.76 Allowed Glycine 0 C--N 1.317 -0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.996 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 28.0 p -90.54 122.02 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 110.755 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.48 143.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.1 t -122.18 156.33 26.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.445 HG21 ' HB3' ' A' ' 316' ' ' GLU . 10.8 t -145.34 138.43 26.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.169 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 32.9 t -80.36 99.14 7.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.916 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 25.3 t -81.63 101.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.457 0.646 . . . . 0.0 110.389 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.15 58.91 3.84 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.86 0.838 . . . . 0.0 108.798 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 64.0 m 65.76 29.11 10.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.397 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.551 ' HB2' HG12 ' A' ' 300' ' ' VAL . 14.1 m120 -63.06 -16.85 61.28 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.626 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 31.5 t -65.48 126.37 28.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.842 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.414 ' C ' HD21 ' A' ' 305' ' ' ASN . 0.2 OUTLIER 60.99 59.34 2.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.814 178.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.26 -86.15 1.3 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.95 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -148.41 -27.72 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -143.84 95.2 2.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.399 0.619 . . . . 0.0 111.768 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.9 t -101.52 -160.58 0.8 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 166.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -77.49 -36.7 52.42 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.883 0.849 . . . . 0.0 109.476 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 314' ' ' LEU . 1.5 mp0 -52.3 113.44 1.04 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.589 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.45 178.87 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 162.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.1 m120 56.33 20.55 4.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.916 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -83.98 136.01 34.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.942 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . 0.415 ' N ' HD21 ' A' ' 314' ' ' LEU . 23.1 p90 -133.36 118.77 18.85 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 298' ' ' THR . 34.9 tt0 -87.2 134.46 33.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.119 -174.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -109.01 104.72 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 21.4 mt -94.06 88.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.977 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 65.1 p -55.46 165.12 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.267 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -72.63 1.37 8.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.59 13.5 25.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.425 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 66.31 32.19 7.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.0 126.98 55.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -94.17 113.04 24.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 30.6 m-85 -96.92 138.58 34.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.462 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 51.6 m-85 -114.89 121.07 42.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.299 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 81.1 mt -133.69 155.45 49.71 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.881 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.6 mt-30 -135.65 135.83 40.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -103.51 175.36 5.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.545 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.83 -53.07 36.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 0.0 110.984 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -114.51 164.08 17.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.531 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . 0.489 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 32.6 Cg_exo -61.34 -35.89 81.62 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.21 1.94 . . . . 0.0 111.255 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.82 -45.93 76.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.688 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.453 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 8.3 tp10 -55.95 -47.48 77.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.664 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 332' ' ' PRO . 0.6 OUTLIER -62.51 -44.42 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.944 -176.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.622 ' HA ' HD11 ' A' ' 339' ' ' ILE . 29.2 m -56.5 -36.97 69.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 340' ' ' LYS . 14.3 mt-10 -77.18 -29.5 54.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.605 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.521 ' NE1' ' HE2' ' A' ' 247' ' ' LYS . 50.3 m95 -67.91 -32.32 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.235 -0.291 . . . . 0.0 110.537 171.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.622 HD11 ' HA ' ' A' ' 336' ' ' THR . 90.1 mt -54.42 -56.32 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 168.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 337' ' ' GLU . 58.6 mtmt -52.14 -47.1 65.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.243 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -55.74 -55.79 28.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.327 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.432 HG23 HD21 ' A' ' 292' ' ' LEU . 2.2 mp -70.16 -36.25 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.902 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 18.5 mt-30 -73.54 -32.69 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.031 -0.418 . . . . 0.0 111.624 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.4 ptm -78.9 -26.41 43.81 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.616 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.14 -35.42 31.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 293' ' ' ARG . 3.2 p -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.01 0.433 . . . . 0.0 112.14 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -85.35 9.5 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.828 -170.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.4 p -85.2 -28.56 25.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.431 . . . . 0.0 110.224 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -136.62 43.73 1.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.869 -174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.776 ' HA ' ' HG3' ' A' ' 293' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.226 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.05 86.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.112 0.482 . . . . 0.0 111.037 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.29 97.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 241' ' ' PHE . 0.7 OUTLIER -98.38 -167.47 1.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.031 -174.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HB3' ' OE1' ' A' ' 240' ' ' GLU . 45.2 mmtm -82.67 152.74 25.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.923 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.453 ' HA ' ' HD2' ' A' ' 242' ' ' ARG . 33.6 tt0 -54.96 -28.07 48.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.305 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 238' ' ' LYS . 32.4 mp0 -56.05 -23.0 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.456 ' CD2' HD21 ' A' ' 237' ' ' LEU . 1.8 m-85 -112.66 -2.57 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 91.8 mtt180 -75.61 -3.32 33.73 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.968 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -96.23 160.3 22.14 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.53 145.95 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 117.299 0.55 . . . . 0.0 111.24 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 267' ' ' ILE . 6.7 mt -62.57 128.21 23.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.155 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.421 HD11 ' OE1' ' A' ' 270' ' ' GLU . 18.3 mm -94.85 -49.77 12.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.866 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.8 tttp -155.17 137.76 15.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.523 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.17 137.13 50.99 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 174.61 156.09 13.41 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.937 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 12.1 m -84.83 138.73 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.795 0.297 . . . . 0.0 110.291 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 85.5 mt -135.21 172.28 13.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.3 mp -97.52 122.88 41.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.282 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -105.24 118.85 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.225 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 6.3 tp-100 -73.97 110.17 8.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 170.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.18 -62.13 0.27 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.512 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -138.68 135.16 34.53 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 259' ' ' LYS . 8.8 mpt_? -64.91 171.29 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.914 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 257' ' ' ARG . 18.7 mtm180 75.42 -29.12 0.19 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.552 0.741 . . . . 0.0 110.418 -172.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 257' ' ' ARG . 29.4 mmtp -111.58 -35.8 5.68 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 67.25 -103.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.205 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.534 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 74.3 m95 -102.22 122.7 44.71 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.704 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.432 ' HD2' ' NH2' ' A' ' 264' ' ' ARG . 29.3 mttt -103.04 145.75 29.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.556 0.693 . . . . 0.0 111.873 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.91 105.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.23 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.651 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.4 mtt180 -135.34 151.41 50.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.258 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 87.9 tttt -89.93 121.56 32.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.017 0.437 . . . . 0.0 110.77 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 26.1 m-85 -100.81 123.75 45.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.601 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 248' ' ' GLN . 43.9 mt -115.8 125.81 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.363 0.602 . . . . 0.0 110.913 171.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 55.5 tp -101.49 156.06 17.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.044 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 243' ' ' GLY . 62.0 mtt-85 -148.34 138.81 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.421 ' OE1' HD11 ' A' ' 246' ' ' ILE . 2.6 pt-20 -105.45 134.75 48.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.531 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 1.004 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 37.9 t70 147.86 -61.59 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.846 1.659 . . . . 0.0 108.511 170.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 1.004 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 10.9 Cg_endo -94.08 -10.06 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 111.087 168.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 63.24 93.4 0.06 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.091 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 60.2 m-85 -145.53 133.38 21.22 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.127 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 290' ' ' ILE . 60.8 tp -95.9 141.18 29.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 32.6 m80 -130.18 122.99 29.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.454 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.31 127.81 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.366 0.603 . . . . 0.0 111.222 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -117.03 158.59 23.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.105 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.43 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 1.8 t70 -94.96 122.06 61.11 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.651 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -70.69 -19.29 31.86 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 110.776 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -98.87 -4.83 32.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.391 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.15 60.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.317 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.43 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -175.84 101.8 0.07 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 110.851 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -89.34 -4.5 58.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.309 0.576 . . . . 0.0 109.901 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.31 138.68 41.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.64 112.51 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.769 . . . . 0.0 111.406 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.78 -21.1 66.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.138 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 179.9 129.59 1.36 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.057 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.06 104.72 16.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 275' ' ' LEU . 39.8 mt -66.38 134.18 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.099 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -83.19 87.68 6.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.115 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.424 HD12 HG22 ' A' ' 342' ' ' ILE . 45.9 mt -74.05 -26.96 60.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.329 -173.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -51.37 101.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.816 0.341 . . . . 0.0 110.984 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 91.79 14.08 57.1 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.997 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.3 p -89.72 139.07 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.299 0.549 . . . . 0.0 110.96 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 6.4 t -105.22 144.48 14.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.38 155.05 21.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 316' ' ' GLU . 11.9 t -150.23 144.53 25.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.46 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.0 t -87.51 101.29 13.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 28.6 t -74.32 123.7 30.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.49 27.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 111.281 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 312' ' ' GLU . 45.7 m 57.01 51.34 10.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.714 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -113.14 65.52 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 34.1 t -89.2 -65.92 0.97 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.135 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.29 -1.31 48.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.306 0.574 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 149.52 -160.63 28.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -66.75 -33.36 75.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.655 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.32 107.84 19.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.611 171.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.2 m -134.08 152.7 51.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.198 0.523 . . . . 0.0 110.55 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.68 -31.01 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.273 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.635 ' HA ' ' OE1' ' A' ' 328' ' ' GLN . 43.8 mp0 -67.5 68.69 0.1 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.031 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.483 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 37.0 mt-10 -85.92 144.72 27.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 335' ' ' ARG . 91.2 m-20 64.33 30.4 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.229 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.9 OUTLIER -73.96 128.41 35.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.839 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -125.38 126.14 44.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 168.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.487 ' OE1' ' HE1' ' A' ' 326' ' ' PHE . 36.3 tt0 -91.51 138.05 31.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 96.9 mt -114.04 108.43 25.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.63 91.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.725 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.2 p -57.24 169.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.31 -27.89 69.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.69 -8.12 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.276 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 70.11 37.26 1.71 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.772 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 31.1 t -99.59 131.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.356 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -93.47 113.86 26.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 54.6 m-85 -99.76 127.76 45.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 16.1 m-30 -100.07 119.59 38.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.176 0.512 . . . . 0.0 111.188 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 93.1 mt -130.68 154.12 48.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.057 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.635 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 20.1 mt-30 -137.71 147.41 44.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.113 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 334' ' ' GLU . . . -120.44 147.59 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.848 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.48 -27.81 68.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.286 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 334' ' ' GLU . 38.1 p -119.1 142.52 32.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.441 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.84 -27.13 84.23 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.296 2.664 . . . . 0.0 112.508 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.583 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 62.7 mttm -71.74 -46.88 57.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.797 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 329' ' ' ALA . 7.1 tp10 -53.12 -49.5 66.4 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.358 0.411 . . . . 0.0 111.147 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.4 ptt180 -60.53 -45.22 94.64 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.35 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.526 ' N ' ' HG3' ' A' ' 335' ' ' ARG . 9.9 m -57.8 -44.13 86.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.842 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 35.2 mm-40 -58.54 -43.17 89.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.463 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 71.1 m95 -71.89 -32.12 67.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 335' ' ' ARG . 95.6 mt -56.57 -57.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -57.02 -49.81 74.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.892 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.75 -54.28 30.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 111.45 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 292' ' ' LEU . 10.7 mt -69.3 -42.83 81.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.782 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 92.8 mt-30 -62.78 -39.47 94.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.402 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 15.6 ptp -76.89 -25.1 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.537 0.208 . . . . 0.0 110.963 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.96 60.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.979 0.419 . . . . 0.0 110.798 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.462 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 45.9 t -79.76 -3.98 49.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.498 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -77.91 -8.4 58.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 41.8 p -79.21 -18.07 53.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -85.66 60.75 4.64 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.912 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 52.2 mttm . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.946 175.345 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.04 94.45 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 66.2 mt -134.52 122.61 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.639 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -80.27 -170.62 2.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.84 -178.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' OE1' ' A' ' 240' ' ' GLU . 47.0 mmtm -66.0 160.13 24.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.34 0.591 . . . . 0.0 111.795 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.559 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 39.0 tt0 -62.62 -30.19 71.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.439 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.502 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 1.9 mp0 -59.01 -24.37 62.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.195 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.472 ' CD2' HD22 ' A' ' 237' ' ' LEU . 0.3 OUTLIER -111.66 0.28 16.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 58.9 mtt85 -63.38 -26.96 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.082 0.468 . . . . 0.0 110.287 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.05 156.7 30.04 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.023 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.06 148.37 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.31 0.576 . . . . 0.0 111.682 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.487 HG21 HG21 ' A' ' 267' ' ' ILE . 12.9 mt -56.1 115.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.793 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -84.58 -41.9 16.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.02 0.438 . . . . 0.0 110.251 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -167.56 152.02 6.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.277 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.538 ' CB ' HG12 ' A' ' 267' ' ' ILE . 8.7 pt20 -149.62 164.77 34.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 0.0 111.818 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.28 171.57 28.6 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 59.4 m -86.07 139.71 30.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.752 0.776 . . . . 0.0 109.708 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.8 mt -141.48 166.51 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 11.0 mp -102.61 125.63 49.41 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.681 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -105.13 124.54 49.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.59 ' HG2' ' H ' ' A' ' 256' ' ' HIS . 31.5 tt0 -71.58 125.63 27.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.831 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -87.04 23.84 10.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.054 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.59 ' H ' ' HG2' ' A' ' 254' ' ' GLN . 1.3 m80 55.11 71.21 0.55 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 111.896 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 258' ' ' ARG . 82.4 mtm180 61.08 -159.1 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.048 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 257' ' ' ARG . 14.3 ttp180 73.58 -55.29 0.67 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.48 0.487 . . . . 0.0 111.583 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -120.56 -90.93 0.57 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.051 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -173.18 -163.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.558 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 53.5 m95 -95.74 139.04 32.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.341 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 51.7 mttt -106.59 138.92 41.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 112.104 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 102.97 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.922 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.58 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.3 mtt180 -128.71 166.44 18.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.407 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -94.0 113.58 25.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.371 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.5 m-85 -101.97 128.18 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.415 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 248' ' ' GLN . 17.1 mt -121.86 130.81 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.197 0.522 . . . . 0.0 110.66 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.543 HD11 HD13 ' A' ' 292' ' ' LEU . 43.6 tp -101.16 155.01 18.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.855 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 53.9 mtt-85 -149.55 138.86 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.627 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 4.9 pt-20 -93.89 -175.0 3.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.935 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 28.1 t70 93.63 -75.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 C-N-CA 125.814 1.646 . . . . 0.0 110.148 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 9.5 Cg_endo -91.39 -5.72 3.94 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 121.182 1.458 . . . . 0.0 111.671 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 292' ' ' LEU . . . 64.69 91.34 0.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.132 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.2 m-85 -140.5 121.21 14.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.612 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 41.7 tp -89.42 139.39 30.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.177 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 69.4 m80 -129.8 142.7 50.64 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -132.3 140.22 48.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.204 0.526 . . . . 0.0 110.848 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.04 ' HA ' HD12 ' A' ' 287' ' ' LEU . 5.1 m-85 -129.37 162.34 28.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -90.59 122.58 66.93 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.133 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.58 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -68.16 -15.21 42.48 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.184 2.589 . . . . 0.0 111.069 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.89 15.24 15.24 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.06 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -159.24 -112.72 0.32 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.993 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.04 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.33 -0.58 49.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.424 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.537 ' O ' HD13 ' A' ' 287' ' ' LEU . 4.4 m-20 -73.31 139.78 79.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.485 ' HA ' ' CE1' ' A' ' 278' ' ' TYR . 28.8 Cg_endo -61.79 118.8 5.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.019 1.812 . . . . 0.0 112.78 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 1.04 HD12 ' HA ' ' A' ' 278' ' ' TYR . 5.8 mp -84.15 -5.65 59.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.117 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.04 157.56 21.0 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.109 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -135.68 100.67 4.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.211 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.612 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 62.8 mt -84.43 88.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.689 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.565 ' NE2' ' HB2' ' A' ' 293' ' ' ARG . 13.4 t-80 -43.73 106.05 0.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.79 170.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 342' ' ' ILE . 84.7 mt -87.23 -19.89 27.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.867 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.565 ' HB2' ' NE2' ' A' ' 291' ' ' HIS . 96.5 mtt180 -59.35 104.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.363 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 108.16 3.28 33.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.489 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 17.1 p -85.67 147.53 26.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 111.977 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 142.38 29.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 99.6 t -117.83 153.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.963 0.411 . . . . 0.0 110.406 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 316' ' ' GLU . 13.6 t -153.43 145.61 23.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.923 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.7 t -83.76 102.32 12.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.748 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 314' ' ' LEU . 12.7 t -92.47 102.85 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.614 . . . . 0.0 110.188 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . 0.721 ' HG2' HH12 ' A' ' 335' ' ' ARG . 21.0 mt-10 -91.53 74.75 5.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.648 ' HA ' ' HB2' ' A' ' 311' ' ' GLU . 87.7 p 60.71 122.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.182 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -172.08 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.954 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 13.4 t -84.54 80.46 9.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.623 0.725 . . . . 0.0 109.502 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.28 117.75 6.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.391 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.67 -7.68 27.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.42 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.831 ' HA ' ' HE ' ' A' ' 307' ' ' ARG . 1.0 OUTLIER -126.89 -72.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.724 -0.28 . . . . 0.0 111.137 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 310' ' ' GLU . 6.9 tttp -177.41 164.55 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.92 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 302' ' ' SER . 41.1 m -99.66 70.97 1.69 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.127 0.489 . . . . 0.0 109.962 174.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 308' ' ' LYS . 8.6 mm-40 -91.7 -32.38 15.45 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.799 0.809 . . . . 0.0 110.52 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.785 ' HG2' HD11 ' A' ' 314' ' ' LEU . 3.1 mp0 -51.36 125.23 13.72 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.314 -174.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.82 132.27 54.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.955 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 335' ' ' ARG . 74.2 m-20 67.37 22.76 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.409 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.785 HD11 ' HG2' ' A' ' 311' ' ' GLU . 1.3 tt -66.93 134.7 52.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.997 0.427 . . . . 0.0 109.94 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . 0.475 ' N ' HD23 ' A' ' 314' ' ' LEU . 29.9 p90 -132.47 136.85 46.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 297' ' ' VAL . 34.9 tt0 -99.41 136.67 39.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.781 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.4 mt -115.89 110.84 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.3 mt -101.82 83.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.936 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 72.3 p -62.85 177.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.989 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -64.49 -13.32 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 110.929 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.88 -6.36 54.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.394 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.09 27.67 10.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.763 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.7 130.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -90.41 113.43 25.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.526 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 45.9 m-85 -95.46 119.35 33.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.459 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 3.0 m-85 -96.65 116.03 28.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.895 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 78.2 mt -127.31 157.75 39.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.3 mt-30 -135.99 139.65 43.32 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -110.06 160.68 16.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.336 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -55.64 -50.4 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.247 0.342 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 32.1 p -127.12 162.63 46.84 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.049 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.15 -43.17 61.69 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.393 2.062 . . . . 0.0 111.964 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 337' ' ' GLU . 17.8 tppt? -55.17 -44.92 75.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.036 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 7.7 tp10 -60.39 -52.34 65.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.033 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.721 HH12 ' HG2' ' A' ' 301' ' ' GLU . 11.5 ptt180 -59.35 -43.32 92.81 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.977 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.612 HG21 ' HE2' ' A' ' 340' ' ' LYS . 11.1 m -58.64 -40.52 83.62 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.646 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 333' ' ' LYS . 57.0 mt-10 -65.28 -33.15 75.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 121.259 -0.176 . . . . 0.0 110.973 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 334' ' ' GLU . 76.7 m95 -73.43 -38.44 65.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.416 0.15 . . . . 0.0 111.106 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . . . . . . . . . 97.6 mt -53.38 -54.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.612 ' HE2' HG21 ' A' ' 336' ' ' THR . 65.7 mttm -59.87 -40.24 87.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.709 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.64 -54.64 44.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.661 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 292' ' ' LEU . 2.0 mp -64.79 -44.62 96.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.351 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -64.38 -36.79 85.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.3 ptp -81.21 -31.29 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.695 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -74.02 -29.87 62.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.457 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.46 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 42.3 t -67.16 -14.58 63.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.692 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -109.36 18.13 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.022 -0.424 . . . . 0.0 111.299 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 23.8 p -90.41 4.2 51.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.256 0.551 . . . . 0.0 110.73 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -99.66 8.24 59.86 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.432 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.879 -0.582 . . . . 0.0 110.065 178.666 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.67 0.272 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.55 86.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.314 1.054 . . . . 0.0 110.36 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.0 mt -109.65 102.65 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.357 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 241' ' ' PHE . 1.9 pt? -134.52 -166.11 1.76 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.16 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.554 ' HB2' ' CD2' ' A' ' 241' ' ' PHE . 14.2 mmmm -55.54 142.24 34.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.534 0.683 . . . . 0.0 111.152 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 242' ' ' ARG . 37.9 tt0 -64.95 -29.96 70.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.04 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.706 ' HB3' ' HE2' ' A' ' 276' ' ' HIS . 1.8 mp0 -60.79 -28.28 68.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 29.5 m-85 -104.55 -5.61 21.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.604 0.24 . . . . 0.0 111.1 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 31.8 mtp180 -64.93 -21.33 66.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 110.503 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.23 152.56 26.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.8 t -84.34 145.26 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.43 0.292 . . . . 0.0 110.665 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.641 HG23 HG22 ' A' ' 267' ' ' ILE . 3.0 mp -69.82 114.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.412 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.661 HD12 ' HG2' ' A' ' 270' ' ' GLU . 25.8 mm -78.99 -43.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.832 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.488 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 53.4 tttp -158.26 139.59 13.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.963 -169.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.401 ' HG3' HG22 ' A' ' 245' ' ' ILE . 1.4 mp0 -127.3 145.35 50.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.81 144.84 4.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.264 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 11.0 m -72.51 137.62 46.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.495 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 99.5 mt -133.65 163.26 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -90.74 123.73 34.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -110.95 117.29 32.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.808 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 5.6 tp-100 -62.55 104.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -91.29 -40.9 5.33 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.055 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -170.16 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.78 0.29 . . . . 0.0 110.898 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.662 ' HG2' ' H ' ' A' ' 258' ' ' ARG . 34.2 ttp85 -176.91 -177.39 0.76 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . 0.662 ' H ' ' HG2' ' A' ' 257' ' ' ARG . 50.1 ttt180 70.82 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.508 0.723 . . . . 0.0 110.373 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -79.12 -26.81 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t30 69.79 -79.91 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.253 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.53 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 84.9 m95 -101.73 134.84 44.25 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.693 -172.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.92 126.3 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.182 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 81.6 t -91.11 104.34 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.018 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 278' ' ' TYR . 2.8 ptp180 -148.05 162.71 38.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.723 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 278' ' ' TYR . 50.1 tttp -79.32 116.11 19.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.546 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 37.1 m-85 -102.31 124.94 48.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 111.852 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 245' ' ' ILE . 56.6 mt -119.08 128.92 75.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.799 172.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 47.7 tp -98.55 154.97 17.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.672 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 52.7 mtt-85 -147.66 136.24 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.582 0.229 . . . . 0.0 110.452 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.661 ' HG2' HD12 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -100.9 127.31 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.994 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.0 t70 154.36 -65.74 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.456 1.502 . . . . 0.0 108.844 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.994 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 19.6 Cg_endo -96.36 -8.25 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.635 2.223 . . . . 0.0 111.633 173.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 346' ' ' SER . . . 65.16 89.88 0.09 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.839 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 55.8 m-85 -139.87 129.24 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.044 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.604 HD22 HD13 ' A' ' 290' ' ' ILE . 25.6 tp -94.55 134.09 37.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.209 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.706 ' HE2' ' HB3' ' A' ' 240' ' ' GLU . 73.3 m80 -120.47 129.74 53.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.853 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.521 ' HE1' HG13 ' A' ' 290' ' ' ILE . 0.9 OUTLIER -115.08 122.72 47.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.834 176.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 264' ' ' ARG . 50.6 m-85 -106.77 -167.63 1.31 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.751 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -125.82 129.55 24.29 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.755 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.4 Cg_endo -72.51 -19.15 25.22 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 123.16 2.573 . . . . 0.0 111.572 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.02 -28.29 12.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.09 75.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.236 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -175.84 103.07 0.07 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.748 0.419 . . . . 0.0 110.406 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -85.15 -14.03 48.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.625 0.726 . . . . 0.0 109.228 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.84 143.66 26.49 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.243 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.09 143.51 54.33 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.762 2.308 . . . . 0.0 113.412 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -80.39 -7.24 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.123 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 158.61 -179.41 34.3 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.427 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.71 128.95 27.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.471 0.177 . . . . 0.0 110.604 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.604 HD13 HD22 ' A' ' 275' ' ' LEU . 46.1 mt -79.11 136.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -86.53 80.48 8.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 342' ' ' ILE . 64.9 mt -61.36 -59.55 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -18.95 86.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.941 1.4 . . . . 0.0 113.735 -172.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 109.81 20.67 7.52 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.433 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 30.5 p -93.1 145.57 24.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.599 . . . . 0.0 112.235 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.04 146.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.07 156.81 26.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.474 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 11.6 t -145.39 134.25 22.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 110.479 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 14.2 p -82.77 99.25 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.8 t -83.83 118.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.394 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.39 139.7 46.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -47.83 95.69 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.578 1.174 . . . . 0.0 113.186 -166.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.31 112.67 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.568 174.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.48 21.08 2.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.13 68.65 0.76 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.218 0.532 . . . . 0.0 109.697 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 167.48 -123.18 1.1 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.053 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -135.48 143.84 46.06 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.054 0.142 . . . . 0.0 110.647 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 56.92 84.46 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.722 0.639 . . . . 0.0 112.026 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.9 p -80.44 115.19 19.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.333 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -90.27 -29.71 17.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.37 1.081 . . . . 0.0 108.254 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.589 ' HA ' ' OE1' ' A' ' 328' ' ' GLN . 25.9 mp0 -62.62 101.16 0.23 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.761 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.04 158.93 22.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.352 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.808 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 8.2 p30 41.41 45.66 2.74 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.308 1.005 . . . . 0.0 111.482 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -77.65 135.31 38.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.452 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . 0.441 ' N ' HD21 ' A' ' 314' ' ' LEU . 30.6 p90 -129.5 121.97 28.3 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 168.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.475 ' CD ' ' HD1' ' A' ' 324' ' ' HIS . 35.1 tt0 -92.2 138.68 31.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.551 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 94.6 mt -111.93 110.33 31.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.9 mt -96.48 85.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 40.4 p -60.98 175.85 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.876 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.53 -20.56 65.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.362 0.601 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.7 3.07 26.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.182 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 57.53 38.57 28.02 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.021 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.36 127.81 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.969 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.475 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 16.3 m-70 -85.15 112.51 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 36.6 m-85 -98.36 125.25 43.42 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.53 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 48.9 m-85 -100.35 119.67 38.78 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.0 111.008 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 96.3 mt -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.507 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 25.5 mt-30 -142.65 150.17 39.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.367 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -108.46 -168.63 1.38 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.388 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.3 -38.78 17.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.398 . . . . 0.0 110.208 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 332' ' ' PRO . 61.9 p -119.48 149.3 47.54 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.644 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . 0.745 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 34.2 Cg_exo -63.3 -14.82 44.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.559 2.839 . . . . 0.0 113.595 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -93.13 -32.81 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.449 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.37 -37.39 87.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 110.296 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.808 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.66 -43.79 97.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.22 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.634 ' HA ' HD11 ' A' ' 339' ' ' ILE . 5.1 m -57.21 -44.23 83.49 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.116 0.484 . . . . 0.0 110.39 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -60.56 -36.93 79.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.055 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.488 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 52.4 m95 -70.96 -30.69 67.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.508 0.194 . . . . 0.0 111.126 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 336' ' ' THR . 74.1 mt -58.94 -51.85 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.598 ' HE2' HG23 ' A' ' 336' ' ' THR . 43.0 mmtt -53.07 -54.68 31.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.554 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.4 ' HB1' ' HD3' ' A' ' 247' ' ' LYS . . . -52.64 -57.18 10.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.814 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 292' ' ' LEU . 35.4 mt -70.44 -42.77 78.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.369 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.76 -33.86 76.98 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.502 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.7 ptm -79.46 -20.97 46.09 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.614 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.96 -22.04 36.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.44 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.529 ' HA ' ' HB1' ' A' ' 273' ' ' ALA . 40.8 t -89.02 9.45 25.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -117.24 22.37 12.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' THR . . . . . 0.65 HG23 ' HB2' ' A' ' 270' ' ' GLU . 16.6 p -86.37 9.06 19.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.753 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -101.24 -53.04 1.03 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.467 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.42 176.143 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 235' ' ' VAL . 1.3 m-20 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.437 ' H ' ' HB3' ' A' ' 234' ' ' ASP . 7.2 p -66.28 75.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 122.548 1.166 . . . . 0.0 110.466 172.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 78.6 mt -101.33 106.64 19.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.42 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 241' ' ' PHE . 0.7 OUTLIER -74.04 -165.48 0.31 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.197 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.07 166.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.942 0.877 . . . . 0.0 112.862 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 242' ' ' ARG . 36.9 tt0 -70.17 -29.12 65.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.584 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.62 -41.27 73.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.107 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.498 ' HB2' HD11 ' A' ' 237' ' ' LEU . 2.0 m-85 -101.44 1.01 37.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.399 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 239' ' ' GLU . 99.1 mtt180 -52.86 -40.6 63.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.7 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -82.48 137.63 17.16 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 245' ' ' ILE . 40.1 t -77.16 169.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 244' ' ' VAL . 71.7 mt -56.75 116.6 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.381 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 270' ' ' GLU . 32.9 mm -84.96 -38.79 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.958 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.617 ' HE2' ' CE2' ' A' ' 338' ' ' TRP . 80.5 tttt -169.21 141.49 2.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.716 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.725 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.4 OUTLIER -144.11 162.72 35.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.831 175.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.66 173.0 30.84 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.98 139.18 34.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.611 0.706 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.6 mt -143.72 160.85 39.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.4 mp -98.47 125.96 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -113.72 124.67 52.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.623 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 60.4 tt0 -80.39 152.8 28.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.651 175.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 138.31 165.68 10.4 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.277 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 22.3 m170 69.97 136.72 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.652 0.739 . . . . 0.0 112.035 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -79.07 158.86 27.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.465 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 60.8 31.91 20.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.596 0.712 . . . . 0.0 109.667 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -164.21 163.55 22.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.535 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 261' ' ' TRP . 3.8 p30 -129.96 -85.69 0.53 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.522 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 69.4 m95 -118.39 130.8 56.19 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.487 ' HD3' ' NH2' ' A' ' 264' ' ' ARG . 5.9 mtpt -105.38 140.76 38.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.128 0.49 . . . . 0.0 111.368 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.44 99.01 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.487 ' NH2' ' HD3' ' A' ' 262' ' ' LYS . 55.7 mtt-85 -116.57 148.38 40.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.033 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.31 110.54 18.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 20.1 m-85 -93.98 153.06 18.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.725 HG12 ' HB3' ' A' ' 248' ' ' GLN . 6.9 mt -144.96 125.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.815 0.697 . . . . 0.0 109.856 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.3 tp -99.85 145.39 27.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.102 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -149.56 131.43 15.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . 0.443 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.8 OUTLIER -99.9 -170.72 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.672 -170.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.962 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 12.1 t70 95.02 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.661 1.584 . . . . 0.0 110.253 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.962 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.6 Cg_endo -91.38 -6.29 3.81 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 CA-C-N 120.859 1.342 . . . . 0.0 111.025 164.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.604 ' CB ' ' HA ' ' A' ' 346' ' ' SER . . . 63.35 95.18 0.05 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.734 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.407 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 14.6 m-85 -137.62 115.27 11.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.616 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 44.7 tp -89.72 139.34 30.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.133 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 274' ' ' TYR . 75.5 m80 -130.24 144.3 51.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.414 ' HB3' ' CE2' ' A' ' 266' ' ' PHE . 8.2 p90 -131.4 139.05 49.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 110.712 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -119.56 -165.09 1.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.22 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -130.13 129.81 22.99 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 -17.08 22.26 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.854 2.369 . . . . 0.0 111.594 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.71 -12.18 17.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.237 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.86 84.32 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.91 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.54 117.32 0.2 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.447 0.641 . . . . 0.0 110.61 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -94.4 -30.54 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.825 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -75.23 142.41 75.3 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.778 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 125.92 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.163 1.908 . . . . 0.0 111.666 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.11 3.41 17.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.098 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 170.36 139.25 2.69 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -110.54 112.13 23.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.82 0.343 . . . . 0.0 110.308 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 63.8 mt -85.16 132.17 32.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.549 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.09 95.66 9.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.59 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.582 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 81.2 mt -79.87 -28.96 39.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.098 -172.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -52.97 103.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.88 0.372 . . . . 0.0 111.103 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 97.08 9.89 55.38 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.012 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' CYS . . . . . 0.433 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.6 p -88.45 144.51 26.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.992 0.425 . . . . 0.0 110.778 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.01 144.62 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 91.4 t -119.38 150.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -148.59 142.01 25.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.463 -175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.7 t -76.36 108.5 9.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.915 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 51.3 t -97.2 110.32 24.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.189 0.519 . . . . 0.0 110.675 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.17 51.52 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.419 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.2 t 68.38 104.15 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.846 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -178.11 50.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.131 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 24.9 t -73.5 157.91 35.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.739 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.78 71.71 5.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.308 0.575 . . . . 0.0 111.059 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -156.56 -125.34 0.88 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.76 148.16 32.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 67.47 122.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.055 0.847 . . . . 0.0 111.834 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.0 p -68.17 107.81 2.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -107.76 -48.88 3.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.073 0.939 . . . . 0.0 109.683 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.529 ' HG2' HD13 ' A' ' 314' ' ' LEU . 0.8 OUTLIER -61.75 138.66 58.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.751 -172.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 313' ' ' ASN . 44.6 mt-10 -140.73 133.24 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.64 ' HB3' ' HG2' ' A' ' 335' ' ' ARG . 86.1 m-20 76.19 28.51 0.81 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.851 0.719 . . . . 0.0 110.411 -174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.628 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -77.06 126.29 30.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.319 178.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.58 125.49 47.92 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.543 ' HB3' HG23 ' A' ' 298' ' ' THR . 4.8 tp10 -86.41 136.32 33.16 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.893 -174.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.7 103.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.17 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.042 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 38.1 p -53.16 159.21 1.32 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.053 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.67 -1.59 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.902 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.15 4.46 53.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.125 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.81 27.74 11.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.355 172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.38 135.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -82.69 118.95 23.71 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -112.2 97.68 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.178 0.514 . . . . 0.0 110.033 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 87.7 m-85 -80.23 118.74 22.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.273 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.545 ' O ' HD21 ' A' ' 314' ' ' LEU . 87.6 mt -125.9 152.02 46.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 39.4 mt-30 -139.61 144.89 37.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.679 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -117.79 171.94 7.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.837 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.12 -69.04 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.499 0.499 . . . . 0.0 111.34 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 77.1 p -102.55 161.22 23.93 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.005 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' PRO . . . . . 0.63 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 68.3 Cg_exo -52.08 -44.45 45.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.545 2.163 . . . . 0.0 112.07 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 57.8 tttp -55.28 -50.01 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.364 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.413 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 9.0 tp10 -60.54 -42.45 96.56 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.475 -173.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.64 ' HG2' ' HB3' ' A' ' 313' ' ' ASN . 7.0 ppt_? -66.95 -39.03 87.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.348 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.552 ' HA ' HD13 ' A' ' 339' ' ' ILE . 29.2 m -60.81 -41.77 96.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.838 0.352 . . . . 0.0 110.68 170.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 80.2 mm-40 -59.05 -44.67 91.84 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' TRP . . . . . 0.617 ' CE2' ' HE2' ' A' ' 247' ' ' LYS . 60.4 m95 -65.17 -36.21 83.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.552 HD13 ' HA ' ' A' ' 336' ' ' THR . 99.0 mt -53.17 -53.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.4 mtmt -57.37 -42.18 81.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.709 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.82 42.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.122 0.487 . . . . 0.0 110.81 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.69 -40.99 87.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.495 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -64.77 -36.48 84.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.41 -30.86 33.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.088 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.94 56.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.677 0.275 . . . . 0.0 111.573 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.604 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 30.1 t -75.02 -22.78 58.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 347' ' ' ARG . 42.4 mtm105 -101.34 25.32 8.41 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.06 -0.4 . . . . 0.0 111.864 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.6 p -82.5 112.14 19.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.891 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -144.16 10.82 2.04 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.346 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.124 179.268 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.569 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 33.7 tt0 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.757 0.313 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 60.1 mt-10 -55.65 -37.01 67.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.403 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -103.44 0.46 31.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -71.33 -8.65 55.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.04 0.447 . . . . 0.0 110.52 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -107.64 143.17 15.94 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.23 151.87 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.317 0.579 . . . . 0.0 111.716 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.8 mt -53.25 127.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.162 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.494 HD11 ' CG ' ' A' ' 270' ' ' GLU . 41.2 mm -96.71 -44.84 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.766 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.524 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 60.3 tttp -164.98 132.59 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.52 -173.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.562 ' CB ' HG12 ' A' ' 267' ' ' ILE . 4.8 pt20 -132.91 141.35 48.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.319 0.58 . . . . 0.0 111.795 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 177.51 151.66 9.38 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.79 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 61.6 m -71.01 135.06 47.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.119 0.46 . . . . 0.0 110.116 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.542 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 94.0 mt -131.61 169.51 16.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 8.1 mp -95.0 117.58 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.12 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.83 119.08 38.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.249 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 176.565 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.532 ' CZ2' ' HG3' ' A' ' 311' ' ' GLU . 89.7 m95 . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 24.2 mtpp -110.62 151.5 27.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 0.0 112.246 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.2 101.73 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.2 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 96.7 mtt180 -132.62 154.6 49.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.741 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 40.6 ttmt -79.39 120.66 24.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.68 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 35.9 m-85 -103.89 117.2 33.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 248' ' ' GLN . 18.6 mt -114.83 127.0 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 42.5 tp -99.5 154.42 18.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.906 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -150.67 139.61 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.64 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.631 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 13.5 pt-20 -101.08 -169.95 1.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.595 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 270' ' ' GLU . 0.8 OUTLIER 95.64 -70.17 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 110.9 -178.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 271' ' ' ASP . 14.4 Cg_endo -97.97 -6.66 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.647 1.564 . . . . 0.0 111.876 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 70.13 93.95 0.08 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.501 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 33.6 m-85 -141.62 119.48 11.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.331 0.586 . . . . 0.0 111.953 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 290' ' ' ILE . 38.8 tp -90.86 140.13 30.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.278 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 70.9 m80 -127.65 139.67 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.103 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.514 ' HE2' HG13 ' A' ' 290' ' ' ILE . 1.3 p90 -121.7 136.25 54.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.264 0.554 . . . . 0.0 111.088 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.91 147.48 50.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.555 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.528 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 7.7 t70 -90.35 132.65 34.98 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 97.1 Cg_endo -72.57 -24.14 19.09 Favored 'Trans proline' 0 CA--C 1.517 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 111.293 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.93 -12.51 23.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.376 -170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.38 59.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.622 -1.275 . . . . 0.0 114.525 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -171.42 73.02 0.05 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.773 0.286 . . . . 0.0 111.136 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.19 -9.51 59.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.62 134.17 88.52 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.077 167.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.98 105.02 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.906 1.737 . . . . 0.0 112.439 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.73 -28.09 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.035 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.7 35.97 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.6 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -121.18 135.67 55.11 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.791 0.329 . . . . 0.0 110.376 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.7 HD12 HD23 ' A' ' 275' ' ' LEU . 27.7 mt -85.42 131.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -85.37 88.66 7.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.633 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 51.9 mt -76.56 -26.81 55.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.845 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 293' ' ' ARG . 21.4 ttt180 -52.37 101.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 95.85 10.49 56.39 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.877 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 11.4 p -90.73 147.72 23.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.919 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.07 146.24 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.15 152.46 13.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 14.3 t -145.98 142.42 28.65 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.678 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 40.7 t -83.73 105.3 14.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.46 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 55.8 t . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.894 ' HB3' HD12 ' A' ' 314' ' ' LEU . 8.9 mp0 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.955 0.407 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.04 -68.42 0.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.926 0.87 . . . . 0.0 110.762 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 6.1 p30 -85.63 46.4 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 311' ' ' GLU . 0.7 OUTLIER -79.41 130.35 35.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.17 -176.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -127.67 134.0 49.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 36.9 tt0 -102.08 141.98 34.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.517 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.8 mt -116.34 110.8 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.0 mt -98.32 92.05 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.129 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.417 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 75.4 p -60.09 161.92 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.587 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.82 -17.62 61.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.23 0.538 . . . . 0.0 110.396 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.52 3.2 25.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.329 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 70.58 27.55 3.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.685 0.794 . . . . 0.0 111.834 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.61 126.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.019 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -91.35 113.62 25.93 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.23 111.43 23.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HD2' HD11 ' A' ' 314' ' ' LEU . 45.0 m-85 -85.77 115.28 23.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.784 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 99.0 mt -124.03 154.3 40.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.53 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 31.9 mt-30 -140.73 155.39 46.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.326 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.3 -174.81 2.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.357 0.598 . . . . 0.0 110.112 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 55.1 p -134.16 159.56 71.89 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.843 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.96 -32.48 97.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 111.105 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 24.8 ttpp -59.45 -54.87 41.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.917 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 17.5 tp10 -63.92 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.465 -172.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 3.2 ptt180 -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.136 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.644 HG22 ' NZ ' ' A' ' 340' ' ' LYS . 88.0 m -58.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.798 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 4.8 mm-40 -60.73 -37.04 80.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.572 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.524 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 59.8 m95 -76.17 -32.95 59.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.62 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 335' ' ' ARG . 98.2 mt -54.63 -54.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.644 ' NZ ' HG22 ' A' ' 336' ' ' THR . 27.7 mtmm -56.8 -40.99 76.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.72 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.521 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.04 -56.09 25.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.134 0.492 . . . . 0.0 111.053 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.446 HG23 HD22 ' A' ' 292' ' ' LEU . 2.3 mp -66.34 -38.38 81.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.271 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -65.88 -41.02 92.07 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.64 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 12.6 ptm -71.95 -38.19 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.974 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -66.08 -35.83 81.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.396 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -69.18 -10.01 55.65 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.208 -0.307 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.618 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.866 ' HG3' ' HB3' ' A' ' 272' ' ' PRO . 7.8 tp10 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.246 0.546 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -55.77 -30.16 60.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.657 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -113.23 2.42 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.132 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 239' ' ' GLU . 99.7 mtt180 -70.6 -35.78 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 110.04 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.38 150.05 51.36 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.585 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.4 t -81.39 145.64 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.724 0.41 . . . . 0.0 110.701 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.9 mp -70.44 117.9 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 110.378 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 270' ' ' GLU . 48.3 mm -85.52 -36.14 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.37 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.4 tttp -163.35 143.46 8.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.783 -171.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -133.13 157.55 45.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 148.84 155.82 6.87 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.074 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 6.9 p -76.21 141.02 41.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.198 0.499 . . . . 0.0 110.502 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 338' ' ' TRP . 96.1 mt -135.72 153.94 51.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 3.3 mp -86.59 117.5 25.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -103.08 119.2 38.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.555 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 35.5 tt0 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.728 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.553 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 93.2 m95 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 5.5 ttpm? -113.53 160.92 17.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.882 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.98 111.3 35.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.343 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 95.0 mtt180 -137.42 150.64 47.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.05 172.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 36.2 ttpt -84.71 123.24 30.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.754 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 23.0 m-85 -97.77 158.86 15.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.315 0.578 . . . . 0.0 111.72 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 245' ' ' ILE . 7.9 mt -150.15 121.29 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.985 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 33.5 tp -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.013 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 51.7 mtt180 -146.48 134.08 20.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.742 0.306 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.642 ' HB3' HD11 ' A' ' 246' ' ' ILE . 37.0 tt0 -112.86 133.75 54.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.579 ' HB2' ' HD3' ' A' ' 272' ' ' PRO . 25.6 m-20 145.17 -54.45 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 125.733 1.895 . . . . 0.0 108.164 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.866 ' HB3' ' HG3' ' A' ' 239' ' ' GLU . 66.2 Cg_endo -100.04 -16.29 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 166.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.811 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.14 82.91 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.308 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 57.6 m-85 -143.62 124.53 14.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.413 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 51.1 tp -89.29 137.49 32.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -124.85 154.71 40.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.655 0.264 . . . . 0.0 110.304 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -147.34 144.49 28.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.5 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.095 ' HA ' HD13 ' A' ' 287' ' ' LEU . 2.6 m-85 -133.92 154.81 50.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.661 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 282' ' ' GLY . 5.5 t70 -87.19 136.42 33.72 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.482 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 93.9 Cg_endo -67.94 -19.82 45.71 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.01 2.473 . . . . 0.0 111.414 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.12 7.98 19.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.19 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . 171.19 140.23 2.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.266 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 72.66 102.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.608 0.718 . . . . 0.0 112.412 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -95.74 -6.59 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.221 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.8 132.56 51.08 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 10.8 Cg_endo -51.81 124.62 14.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.382 2.722 . . . . 0.0 114.004 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.095 HD13 ' HA ' ' A' ' 278' ' ' TYR . 6.1 mp -81.81 -26.38 34.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.384 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -174.64 174.26 46.5 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.742 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 275' ' ' LEU . . . -141.76 140.85 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.304 . . . . 0.0 111.011 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 38.9 mt -99.41 137.92 25.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.529 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -84.72 95.3 8.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.774 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.811 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 30.5 mt -77.77 -28.66 50.62 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.88 107.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.872 0.368 . . . . 0.0 111.142 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.67 13.59 62.67 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.276 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 15.8 p -87.29 146.86 25.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.258 0.552 . . . . 0.0 111.271 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.83 140.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.51 154.49 18.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -141.65 140.93 33.37 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.245 0.545 . . . . 0.0 109.928 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 7.6 t -87.7 99.13 11.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.746 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 45.6 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 121.127 0.489 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 162.57 13.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.609 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.884 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 11.1 p30 41.75 36.99 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.985 0.914 . . . . 0.0 112.259 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.4 OUTLIER -75.49 129.95 38.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.92 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -125.48 125.4 43.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 38.9 tt0 -96.16 137.01 35.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.212 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -114.4 108.97 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.37 88.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.468 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.3 p -62.78 171.45 2.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.269 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -65.3 -18.09 65.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.679 0.752 . . . . 0.0 109.541 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.5 -5.0 42.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.489 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 69.28 29.22 4.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.685 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.61 132.11 53.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.733 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.44 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 7.7 m-70 -90.23 114.32 26.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 63.2 m-85 -98.65 115.57 28.97 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 44.2 m-85 -91.38 115.68 28.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.018 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.508 ' O ' HD23 ' A' ' 314' ' ' LEU . 95.9 mt -128.7 151.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.582 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.1 mt-30 -142.36 154.92 45.05 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.901 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.88 -175.94 2.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.395 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -76.75 -37.21 56.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.211 0.529 . . . . 0.0 110.248 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 45.5 p -127.48 155.17 77.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.797 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 25.2 Cg_exo -63.23 -21.83 72.25 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.138 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.65 -30.79 17.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.581 0.229 . . . . 0.0 111.221 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -43.56 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.884 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.21 -42.62 95.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.17 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.524 ' HA ' HD12 ' A' ' 339' ' ' ILE . 11.8 m -58.64 -39.22 79.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 41.4 mt-10 -64.49 -36.75 85.19 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.689 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.446 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 68.8 m95 -72.72 -34.66 67.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.168 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 336' ' ' THR . 84.6 mt -53.15 -57.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -56.28 -41.97 76.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.971 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.466 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.17 -57.16 14.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.81 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.714 HG23 HD22 ' A' ' 292' ' ' LEU . 1.7 mp -60.94 -42.16 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.344 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.74 -42.29 97.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.552 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.545 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 11.6 ptm -73.17 -40.84 64.49 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.739 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -61.2 -29.37 69.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.488 0.185 . . . . 0.0 111.179 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 33.1 t -68.03 -14.43 62.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.117 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.722 0.773 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 274' ' ' TYR . 11.6 mp0 -66.22 -12.27 55.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.069 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.97 -13.58 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -56.23 -24.53 42.87 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.65 141.53 18.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.174 175.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.22 153.01 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 23.5 mt -55.61 132.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.392 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 270' ' ' GLU . 42.9 mm -99.9 -42.09 10.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.331 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 59.8 tttp -166.59 138.12 3.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.208 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.447 ' HB3' HD12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -136.58 152.62 50.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.351 0.595 . . . . 0.0 112.392 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.67 157.18 9.76 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.656 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 31.8 m -77.07 144.74 38.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.801 0.8 . . . . 0.0 110.305 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.3 mt -142.01 165.39 27.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -96.87 119.03 34.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.542 -0.169 . . . . 0.0 110.542 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.88 120.62 40.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.925 177.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 72.3 m95 . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.39 131.86 56.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.399 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.05 107.53 12.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.494 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -129.02 156.62 43.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 84.0 tttt -89.95 115.07 26.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.734 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 30.9 m-85 -101.96 118.24 36.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.021 0.438 . . . . 0.0 111.822 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' CE1' ' A' ' 278' ' ' TYR . 9.3 mm -112.49 127.33 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 292' ' ' LEU . 39.2 tp -101.32 154.48 18.75 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.622 ' HB2' ' HE1' ' A' ' 276' ' ' HIS . 79.9 mtt-85 -154.89 143.97 21.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 246' ' ' ILE . 6.3 pt-20 -100.84 -170.44 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.62 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.881 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 32.8 t70 93.13 -72.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.686 1.595 . . . . 0.0 110.498 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.3 Cg_endo -92.64 -3.05 3.66 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 121.124 1.437 . . . . 0.0 112.054 167.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.77 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.93 85.67 0.14 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.319 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.3 m-85 -130.71 129.85 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.753 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 29.0 tp -101.74 130.88 48.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.622 ' HE1' ' HB2' ' A' ' 269' ' ' ARG . 22.3 m80 -121.59 130.24 53.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.081 -172.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' A' ' 290' ' ' ILE . 8.5 p90 -119.7 133.28 55.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.883 0.849 . . . . 0.0 111.283 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.539 ' CE1' HG12 ' A' ' 267' ' ' ILE . 3.6 m-85 -115.15 149.07 38.21 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.263 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.578 ' HB2' HD11 ' A' ' 287' ' ' LEU . 0.3 OUTLIER -87.99 132.2 40.68 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.68 -15.92 41.57 Favored 'Trans proline' 0 CA--C 1.514 -0.503 0 C-N-CA 123.342 2.695 . . . . 0.0 111.038 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.11 2.23 34.37 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.31 -171.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.46 85.25 0.05 OUTLIER Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.799 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -178.04 107.06 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.275 0.56 . . . . 0.0 111.985 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -83.69 -46.67 12.03 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.72 134.75 46.81 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.238 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.41 137.03 58.08 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.856 2.371 . . . . 0.0 112.259 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 279' ' ' ASP . 58.1 mt -68.08 -29.35 68.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.945 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -167.73 147.0 11.1 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.558 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.04 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 66.1 mt -67.19 142.05 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.347 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -94.54 94.47 8.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.62 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.77 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 42.7 mt -72.68 -31.24 64.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.928 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -58.6 91.14 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 119.3 -3.68 13.87 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 292' ' ' LEU . 14.2 p -95.81 148.36 22.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.175 0.487 . . . . 0.0 111.419 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.92 150.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 339' ' ' ILE . 57.8 t -117.18 159.79 17.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.766 0.317 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 8.8 t -160.02 143.34 13.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.73 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.6 t -80.35 122.68 27.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 46.6 t . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 111.266 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.562 ' HB3' HD12 ' A' ' 314' ' ' LEU . 17.6 mp0 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.816 0.341 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -135.34 132.16 37.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.726 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.56 35.12 11.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.0 OUTLIER -75.28 129.86 38.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.554 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -126.99 138.29 53.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 168.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.495 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 33.7 tt0 -100.7 133.41 45.19 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 78.5 mt -112.73 102.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.07 91.67 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.966 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.7 p -54.39 159.08 2.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.25 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.6 1.81 2.19 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.865 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -118.34 30.21 7.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.276 0.56 . . . . 0.0 110.428 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 64.8 31.05 11.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.961 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 t -108.78 124.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.195 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -88.88 114.69 25.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 6.9 m-30 -94.58 125.35 39.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.496 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 6.3 m-30 -99.74 114.73 28.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 110.847 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.77 153.28 38.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.386 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 26.4 mt-30 -139.52 142.22 37.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.058 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.09 165.61 12.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.68 30.2 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 71.7 p -113.82 159.04 37.39 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.086 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.4 -37.89 82.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.945 2.43 . . . . 0.0 111.816 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 30.1 mmtp -64.61 -47.91 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 11.9 tp10 -55.94 -49.42 73.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.074 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 336' ' ' THR . 8.5 ptt180 -60.59 -43.82 96.95 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.611 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 339' ' ' ILE . 30.9 m -60.32 -37.69 81.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.752 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.503 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 76.5 mm-40 -63.73 -40.72 97.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.49 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 75.8 m95 -71.34 -33.0 69.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 336' ' ' THR . 98.0 mt -53.32 -57.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -58.75 -39.39 80.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.181 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.468 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.65 -53.01 61.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.206 0.526 . . . . 0.0 110.897 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.709 HG23 HD22 ' A' ' 292' ' ' LEU . 1.8 mp -64.27 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.265 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 97.8 mt-30 -63.81 -49.35 73.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.604 0.24 . . . . 0.0 111.34 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.4 ptm -70.05 -24.56 63.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.391 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.15 32.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.608 0.242 . . . . 0.0 111.061 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.7 t -66.66 -19.27 65.73 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 . . . . . 0 C--N 1.328 -0.35 0 O-C-N 121.924 -0.485 . . . . 0.0 111.587 -175.715 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 272' ' ' PRO . 36.5 tt0 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 52.3 mt-10 -52.9 -40.89 63.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.535 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -101.5 -15.64 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -166.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 25.3 mtp180 -53.12 -23.89 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -87.05 149.5 22.2 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.087 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 245' ' ' ILE . 97.4 t -85.94 158.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.111 0.482 . . . . 0.0 110.426 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mm -73.57 116.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.725 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.628 HD11 ' HG2' ' A' ' 270' ' ' GLU . 33.5 mm -83.3 -41.84 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -161.12 149.29 15.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -133.25 157.4 45.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.22 164.83 19.21 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.35 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.1 p -86.19 133.12 33.87 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.3 mt -133.63 155.97 48.72 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.8 mp -91.46 121.82 33.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -108.43 131.4 54.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 33.7 tt0 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.964 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 252' ' ' LEU . 62.7 m95 . . . . . 0 CA--C 1.516 -0.341 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 9.0 ptpt -134.08 165.27 25.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.535 0.683 . . . . 0.0 112.43 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.2 103.15 14.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.207 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.653 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 97.0 mtt180 -126.01 158.24 35.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.197 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.57 106.04 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.404 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.6 m-85 -91.12 148.09 22.61 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.395 0.617 . . . . 0.0 111.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 245' ' ' ILE . 21.0 mt -146.39 118.53 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.298 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 61.1 tp -93.03 139.46 30.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.202 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -139.31 127.67 22.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.725 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -91.1 -172.17 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.224 -174.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.976 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 38.4 t70 94.63 -76.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.66 1.584 . . . . 0.0 109.968 176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.976 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.4 Cg_endo -92.01 -5.67 3.59 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 CA-C-N 121.098 1.428 . . . . 0.0 111.262 166.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.31 98.32 0.05 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.975 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 41.4 m-85 -144.74 110.92 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.139 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.593 HD23 HD12 ' A' ' 290' ' ' ILE . 23.8 tp -89.56 121.1 31.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 61.7 m80 -112.58 155.09 24.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.078 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.54 141.46 39.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.351 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 283' ' ' ALA . 3.3 m-85 -127.57 166.45 17.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.948 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 27.5 t70 -95.13 123.4 57.29 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.653 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 83.3 Cg_endo -67.78 -17.53 47.32 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.391 2.728 . . . . 0.0 110.26 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.544 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -89.57 -1.65 58.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.261 -1.791 . . . . 0.0 111.205 -172.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.29 29.78 0.17 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.188 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -129.0 111.78 13.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.37 1.085 . . . . 0.0 110.901 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.94 -12.66 23.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.831 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.19 141.81 96.48 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.416 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.6 108.78 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.468 2.112 . . . . 0.0 111.517 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.03 5.85 13.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.603 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 167.77 140.55 2.94 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.518 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.439 ' HB2' ' OE1' ' A' ' 240' ' ' GLU . . . -115.57 102.04 9.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.593 HD12 HD23 ' A' ' 275' ' ' LEU . 59.3 mt -70.82 123.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -82.52 87.11 6.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.017 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 78.9 mt -74.56 -27.61 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -48.44 99.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 92.54 18.79 40.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.957 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' CYS . . . . . . . . . . . . . 14.8 p -95.39 157.92 15.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.303 0.573 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.93 149.93 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 298' ' ' THR . 48.4 t -118.15 158.81 18.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.0 t -150.86 143.23 24.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.272 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.9 t -80.0 99.44 7.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.451 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.5 t . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.946 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' A' ' 314' ' ' LEU . 6.4 mp0 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.56 -10.14 12.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.653 0.739 . . . . 0.0 110.772 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -122.55 29.77 6.77 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.897 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.2 tt -77.58 135.57 38.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.331 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -129.91 125.87 36.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 298' ' ' THR . 36.0 tt0 -93.62 136.92 33.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.129 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -112.01 103.14 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.56 88.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.656 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 50.1 p -59.21 160.76 6.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.517 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.17 -8.97 27.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.384 0.611 . . . . 0.0 110.671 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.11 4.6 41.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.233 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 64.03 32.12 13.13 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.033 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.37 127.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.709 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -87.63 118.09 26.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 9.0 m-85 -98.93 117.91 34.51 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.6 m-85 -95.46 112.81 24.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.066 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 96.5 mt -126.67 156.41 41.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.728 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.515 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 30.6 mt-30 -139.45 145.29 38.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.672 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.69 176.48 5.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.455 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.96 -56.48 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.0 111.102 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 39.2 p -124.05 163.43 35.62 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.21 -37.84 40.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.725 2.283 . . . . 0.0 112.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 50.7 mtmt -62.91 -48.98 76.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.924 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -61.26 -41.89 97.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.145 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 339' ' ' ILE . 17.8 ptt180 -63.17 -42.15 99.34 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.635 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 339' ' ' ILE . 18.7 m -57.24 -42.3 81.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.767 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 11.1 mm-40 -57.47 -45.29 84.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.858 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -70.55 -31.15 68.08 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 336' ' ' THR . 89.2 mt -59.86 -56.99 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -55.46 -49.83 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.925 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.3 30.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 0.0 111.431 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 317' ' ' ILE . 13.5 mt -71.55 -41.06 72.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.081 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.69 -30.76 71.82 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.461 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.15 -40.79 21.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.695 0.283 . . . . 0.0 110.276 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.18 71.6 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.56 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 32.9 t -76.91 -0.35 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.772 0.32 . . . . 0.0 111.819 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 62.4 mtp85 . . . . . 0 C--N 1.333 -0.151 0 O-C-N 122.05 -0.406 . . . . 0.0 111.348 -178.768 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.592 ' OE1' ' HD3' ' A' ' 242' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 121.091 0.472 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 269' ' ' ARG . 20.7 mt-10 -58.63 -26.48 63.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.017 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.486 ' HA ' ' CD ' ' A' ' 269' ' ' ARG . 4.9 m-85 -115.35 1.5 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.255 -174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.592 ' HD3' ' OE1' ' A' ' 239' ' ' GLU . 64.8 mtp180 -72.11 -4.62 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.71 150.83 18.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 72.8 t -81.13 147.8 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.153 0.501 . . . . 0.0 111.139 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 3.9 mt -70.36 111.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.575 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 268' ' ' LEU . 37.0 mm -77.82 -35.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.227 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -169.18 144.82 3.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.533 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.58 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.12 157.91 40.45 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.19 156.63 8.95 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.696 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 264' ' ' ARG . 12.9 p -75.17 137.69 41.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 0.167 . . . . 0.0 110.642 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.6 mt -140.33 159.21 42.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.9 mp -97.78 120.41 38.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -109.33 123.49 49.39 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.454 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.917 175.327 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 31.3 m95 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.638 0.256 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 28.8 mttt -139.5 150.72 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.581 . . . . 0.0 111.526 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -92.96 99.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.9 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.746 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 70.7 mtt180 -124.06 164.67 18.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -94.26 110.64 22.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.694 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 17.6 m-85 -94.4 151.66 19.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.809 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 248' ' ' GLN . 13.0 mt -144.86 125.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.916 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.596 HD22 ' HB1' ' A' ' 341' ' ' ALA . 48.3 tp -100.09 147.64 25.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.286 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 68.6 mtt-85 -140.91 126.6 19.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 345' ' ' ALA . 19.0 tt0 -106.07 130.38 53.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.6 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.994 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.5 t70 148.39 -59.98 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 125.335 1.647 . . . . 0.0 108.36 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.994 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 11.2 Cg_endo -94.12 -10.41 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.44 2.093 . . . . 0.0 110.768 166.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.48 88.78 0.1 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.839 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -138.32 120.86 16.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 290' ' ' ILE . 33.3 tp -99.78 117.6 34.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.417 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 0.7 OUTLIER -110.85 154.85 23.42 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.397 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.71 139.76 47.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.473 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -123.02 166.52 14.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.488 ' HB2' HD11 ' A' ' 287' ' ' LEU . 6.8 t70 -88.0 135.36 33.54 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.746 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.6 Cg_endo -70.39 -14.51 34.17 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 111.539 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.11 11.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.516 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . -163.33 136.21 4.17 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.989 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 75.19 123.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.856 0.862 . . . . 0.0 113.262 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.78 -2.74 58.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.75 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 286' ' ' PRO . 1.4 p-10 -85.71 146.15 43.2 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.562 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . 2.6 Cg_endo -75.77 141.47 24.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.169 2.579 . . . . 0.0 113.341 -170.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 279' ' ' ASP . 88.7 mt -96.09 7.46 46.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.957 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 143.63 138.08 3.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.646 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . . . -106.08 142.26 36.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.736 0.303 . . . . 0.0 110.76 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 275' ' ' LEU . 59.8 mt -98.41 131.99 44.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -88.38 91.88 8.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 56.5 mt -73.0 -32.43 65.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.647 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -61.24 96.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.002 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 116.25 2.4 19.94 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.218 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.575 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 13.0 p -97.85 154.1 17.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.256 0.551 . . . . 0.0 111.455 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.9 t -119.5 150.45 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 298' ' ' THR . 48.5 t -119.75 158.38 21.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 7.6 t -160.11 136.65 8.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.013 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.6 p -73.2 138.32 45.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.164 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.745 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 59.0 t . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.107 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.673 ' HB3' HD12 ' A' ' 314' ' ' LEU . 26.4 mp0 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.82 0.343 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.1 -15.02 61.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 112.037 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 328' ' ' GLN . 83.4 m-20 -122.27 20.67 10.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.22 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.745 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.8 OUTLIER -74.92 132.45 41.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.139 -178.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -131.0 133.02 45.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 43.6 tt0 -93.03 132.82 36.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.744 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 87.2 mt -113.24 105.29 18.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.84 90.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.679 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.575 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 20.4 p -59.56 176.66 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.98 68.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.555 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.58 -8.42 55.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.89 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 68.17 45.19 1.3 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.706 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.29 134.81 43.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 34.1 m-70 -83.77 112.05 19.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 51.5 m-85 -99.69 103.51 15.18 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 15.9 m-30 -84.49 110.01 18.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.595 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 94.1 mt -118.37 151.89 36.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.508 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 36.0 mt-30 -136.18 146.03 46.4 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.282 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -108.52 171.99 7.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.876 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.02 68.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -116.46 160.37 36.4 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.57 -23.67 76.21 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.027 2.485 . . . . 0.0 112.477 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.59 -38.67 23.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.597 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.543 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.4 tp10 -57.41 -44.07 84.27 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.48 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 339' ' ' ILE . 21.3 ptt180 -60.46 -40.8 92.51 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.173 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 340' ' ' LYS . 27.2 m -55.61 -45.24 77.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.503 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.426 ' HA ' ' HE3' ' A' ' 340' ' ' LYS . 74.7 mm-40 -58.94 -36.36 74.65 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.126 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.475 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 86.3 m95 -78.0 -35.32 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 343' ' ' GLN . 82.3 mt -54.25 -55.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 336' ' ' THR . 51.0 mtmt -58.7 -42.51 88.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.121 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.596 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.05 -52.14 66.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.919 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.26 -42.95 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 39.0 mt-30 -65.94 -33.45 75.86 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.462 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.7 ptm -80.83 -28.93 36.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.961 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 270' ' ' GLU . . . -80.99 -30.86 34.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.605 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 16.6 p -78.0 -10.85 59.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -177.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 272' ' ' PRO . 3.6 mp0 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 55.7 mt-10 -50.58 -31.67 16.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.738 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.09 -5.85 13.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.432 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -80.48 -14.47 58.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -87.68 148.06 20.88 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 70.0 t -77.37 147.89 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.221 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.4 mp -67.31 119.81 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.91 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.8 -45.18 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.225 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.544 ' HE2' ' NE1' ' A' ' 338' ' ' TRP . 75.1 tttt -165.44 140.74 5.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.249 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.485 ' HB3' HD12 ' A' ' 267' ' ' ILE . 4.4 pt20 -134.32 156.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 111.293 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.47 156.38 8.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 73.5 m -78.44 131.48 36.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.165 0.482 . . . . 0.0 110.415 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.4 mt -133.68 150.55 51.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.4 mp -79.4 145.15 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 261' ' ' TRP . 25.9 mtmm -128.29 129.31 46.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.22 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 261' ' ' TRP . 50.2 tt0 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.035 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.577 ' CE2' ' HB2' ' A' ' 254' ' ' GLN . 70.9 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.74 0.305 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 35.7 mmtm -125.63 161.49 27.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 0.0 112.206 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.69 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.86 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.622 ' NH1' HD13 ' A' ' 287' ' ' LEU . 96.4 mtt180 -141.25 149.35 41.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.197 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -77.63 121.16 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.608 -169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.736 ' O ' HD13 ' A' ' 267' ' ' ILE . 21.7 m-85 -95.17 145.56 24.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.623 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 266' ' ' PHE . 16.4 mm -134.51 124.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 39.9 tp -100.92 147.55 26.01 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 240' ' ' GLU . 58.8 mtt-85 -143.53 131.75 21.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -174.9 4.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.446 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.996 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 13.7 t70 93.54 -75.89 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 125.83 1.652 . . . . 0.0 110.432 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.996 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 6.7 Cg_endo -92.23 -6.94 3.17 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 CA-C-N 121.344 1.516 . . . . 0.0 111.495 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 69.19 93.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.967 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 50.0 m-85 -138.63 112.52 8.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.156 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 46.4 tp -90.38 141.08 29.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.446 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 67.7 m80 -134.46 153.42 51.93 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.29 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -137.19 137.28 38.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.695 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 267' ' ' ILE . 20.2 m-85 -128.13 164.09 23.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.234 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 281' ' ' ALA . 31.0 t70 -93.95 124.92 54.91 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-O 120.925 0.393 . . . . 0.0 110.428 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.59 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 90.4 Cg_endo -70.66 -21.3 29.48 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 123.669 2.913 . . . . 0.0 110.601 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.564 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -81.06 -21.02 40.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.185 -170.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.69 65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.071 -1.062 . . . . 0.0 113.859 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -160.45 120.75 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.852 0.326 . . . . 0.0 111.514 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -90.64 -15.47 30.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.26 137.11 86.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.175 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.3 122.32 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.074 1.849 . . . . 0.0 111.108 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.622 HD13 ' NH1' ' A' ' 264' ' ' ARG . 29.8 mt -81.29 2.85 26.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 161.08 156.83 8.43 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.521 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.92 124.42 43.17 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.633 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 50.4 mt -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -86.29 99.92 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.817 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.583 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 68.4 mt -75.86 -80.0 0.09 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.294 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 346' ' ' SER . 32.3 ttm180 37.71 -90.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -170.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -105.73 51.43 0.76 Allowed Glycine 0 C--N 1.317 -0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.996 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 28.0 p -90.54 122.02 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 110.755 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.48 143.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.1 t -122.18 156.33 26.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 316' ' ' GLU . 10.8 t -145.34 138.43 26.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.169 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 32.9 t -80.36 99.14 7.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.925 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 25.3 t . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.457 0.646 . . . . 0.0 110.389 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.675 ' HB3' HD12 ' A' ' 314' ' ' LEU . 1.5 mp0 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.45 178.87 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 162.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.1 m120 56.33 20.55 4.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.925 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -83.98 136.01 34.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.942 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 338' ' ' TRP . 23.1 p90 -133.36 118.77 18.85 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -87.2 134.46 33.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.119 -174.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -109.01 104.72 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 21.4 mt -94.06 88.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.977 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 65.1 p -55.46 165.12 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.267 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -72.63 1.37 8.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.59 13.5 25.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.425 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 66.31 32.19 7.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.0 126.98 55.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -94.17 113.04 24.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.507 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 30.6 m-85 -96.92 138.58 34.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.476 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 51.6 m-85 -114.89 121.07 42.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.299 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 81.1 mt -133.69 155.45 49.71 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.881 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.6 mt-30 -135.65 135.83 40.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -103.51 175.36 5.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.545 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.83 -53.07 36.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 0.0 110.984 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -114.51 164.08 17.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.531 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 32.6 Cg_exo -61.34 -35.89 81.62 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.21 1.94 . . . . 0.0 111.255 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.82 -45.93 76.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.688 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.458 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 8.3 tp10 -55.95 -47.48 77.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.664 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 332' ' ' PRO . 0.6 OUTLIER -62.51 -44.42 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.944 -176.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -56.5 -36.97 69.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.58 ' HA ' ' HE2' ' A' ' 340' ' ' LYS . 14.3 mt-10 -77.18 -29.5 54.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.605 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.544 ' NE1' ' HE2' ' A' ' 247' ' ' LYS . 50.3 m95 -67.91 -32.32 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.235 -0.291 . . . . 0.0 110.537 171.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 336' ' ' THR . 90.1 mt -54.42 -56.32 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 168.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 337' ' ' GLU . 58.6 mtmt -52.14 -47.1 65.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.243 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -55.74 -55.79 28.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.327 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.432 HG23 HD22 ' A' ' 292' ' ' LEU . 2.2 mp -70.16 -36.25 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.902 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 18.5 mt-30 -73.54 -32.69 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.031 -0.418 . . . . 0.0 111.624 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.4 ptm -78.9 -26.41 43.81 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.616 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.14 -35.42 31.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 293' ' ' ARG . 3.2 p -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.01 0.433 . . . . 0.0 112.14 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.828 -170.5 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 242' ' ' ARG . 33.6 tt0 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.584 0.231 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -56.05 -23.0 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.892 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.66 -2.57 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 91.8 mtt180 -75.61 -3.32 33.73 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.968 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -96.23 160.3 22.14 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.53 145.95 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 117.299 0.55 . . . . 0.0 111.24 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 267' ' ' ILE . 6.7 mt -62.57 128.21 23.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.155 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.43 HD11 ' OE1' ' A' ' 270' ' ' GLU . 18.3 mm -94.85 -49.77 12.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.866 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.8 tttp -155.17 137.76 15.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.539 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.17 137.13 50.99 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 174.61 156.09 13.41 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.937 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 12.1 m -84.83 138.73 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.795 0.297 . . . . 0.0 110.291 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 85.5 mt -135.21 172.28 13.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.3 mp -97.52 122.88 41.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.282 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -105.24 118.85 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.225 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 6.3 tp-100 . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.554 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 74.3 m95 . . . . . 0 CA--C 1.515 -0.376 0 CA-C-O 120.908 0.385 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.442 ' HD2' ' NH2' ' A' ' 264' ' ' ARG . 29.3 mttt -103.04 145.75 29.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.556 0.693 . . . . 0.0 111.873 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.91 105.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.23 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.701 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.4 mtt180 -135.34 151.41 50.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.258 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 87.9 tttt -89.93 121.56 32.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.017 0.437 . . . . 0.0 110.77 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 26.1 m-85 -100.81 123.75 45.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.601 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 248' ' ' GLN . 43.9 mt -115.8 125.81 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.363 0.602 . . . . 0.0 110.913 171.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 55.5 tp -101.49 156.06 17.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.044 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 243' ' ' GLY . 62.0 mtt-85 -148.34 138.81 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' A' ' 246' ' ' ILE . 2.6 pt-20 -105.45 134.75 48.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.531 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 1.005 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 37.9 t70 147.86 -61.59 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.846 1.659 . . . . 0.0 108.511 170.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 10.9 Cg_endo -94.08 -10.06 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 111.087 168.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.24 93.4 0.06 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.091 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.631 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 60.2 m-85 -145.53 133.38 21.22 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.127 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 290' ' ' ILE . 60.8 tp -95.9 141.18 29.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 32.6 m80 -130.18 122.99 29.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.454 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.31 127.81 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.366 0.603 . . . . 0.0 111.222 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -117.03 158.59 23.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.105 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.501 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 1.8 t70 -94.96 122.06 61.11 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.701 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -70.69 -19.29 31.86 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 110.776 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -98.87 -4.83 32.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.391 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.15 60.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.317 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.501 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -175.84 101.8 0.07 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 110.851 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -89.34 -4.5 58.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.309 0.576 . . . . 0.0 109.901 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.31 138.68 41.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.64 112.51 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.769 . . . . 0.0 111.406 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.78 -21.1 66.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.138 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 179.9 129.59 1.36 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.057 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.06 104.72 16.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.679 HD12 HD23 ' A' ' 275' ' ' LEU . 39.8 mt -66.38 134.18 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.099 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -83.19 87.68 6.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.115 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 45.9 mt -74.05 -26.96 60.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.329 -173.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -51.37 101.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.816 0.341 . . . . 0.0 110.984 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 91.79 14.08 57.1 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.997 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.3 p -89.72 139.07 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.299 0.549 . . . . 0.0 110.96 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 6.4 t -105.22 144.48 14.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.38 155.05 21.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 316' ' ' GLU . 11.9 t -150.23 144.53 25.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.46 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.0 t -87.51 101.29 13.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 28.6 t . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.72 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.774 ' HA ' ' NE2' ' A' ' 328' ' ' GLN . 43.8 mp0 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -85.92 144.72 27.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 335' ' ' ARG . 91.2 m-20 64.33 30.4 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.229 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.9 OUTLIER -73.96 128.41 35.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.839 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -125.38 126.14 44.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 168.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.486 ' OE1' ' HE1' ' A' ' 326' ' ' PHE . 36.3 tt0 -91.51 138.05 31.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 96.9 mt -114.04 108.43 25.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.63 91.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.725 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.2 p -57.24 169.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.31 -27.89 69.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.69 -8.12 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.276 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 70.11 37.26 1.71 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.772 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 31.1 t -99.59 131.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.356 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -93.47 113.86 26.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 54.6 m-85 -99.76 127.76 45.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 16.1 m-30 -100.07 119.59 38.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.176 0.512 . . . . 0.0 111.188 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 93.1 mt -130.68 154.12 48.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.057 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.774 ' NE2' ' HA ' ' A' ' 311' ' ' GLU . 69.7 mt-30 -137.71 147.41 44.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.113 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -120.44 147.59 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.848 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.48 -27.81 68.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.286 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 334' ' ' GLU . 38.1 p -119.1 142.52 32.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.441 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.84 -27.13 84.23 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.296 2.664 . . . . 0.0 112.508 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.595 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 62.7 mttm -71.74 -46.88 57.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.797 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.1 tp10 -53.12 -49.5 66.4 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.358 0.411 . . . . 0.0 111.147 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.4 ptt180 -60.53 -45.22 94.64 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.35 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 335' ' ' ARG . 9.9 m -57.8 -44.13 86.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.842 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 35.2 mm-40 -58.54 -43.17 89.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.478 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 71.1 m95 -71.89 -32.12 67.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 335' ' ' ARG . 95.6 mt -56.57 -57.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.1 mtmt -57.02 -49.81 74.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.892 176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -51.75 -54.28 30.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 111.45 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.512 HG23 HD13 ' A' ' 292' ' ' LEU . 10.7 mt -69.3 -42.83 81.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.782 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 27.3 mt-30 -62.78 -39.47 94.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.402 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 15.6 ptp -76.89 -25.1 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.537 0.208 . . . . 0.0 110.963 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.96 60.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.979 0.419 . . . . 0.0 110.798 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 45.9 t -79.76 -3.98 49.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.498 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -177.728 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 39.0 tt0 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.01 -24.37 62.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.195 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.435 ' HA ' ' CD ' ' A' ' 269' ' ' ARG . 0.3 OUTLIER -111.66 0.28 16.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 58.9 mtt85 -63.38 -26.96 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.082 0.468 . . . . 0.0 110.287 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.05 156.7 30.04 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.023 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.06 148.37 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.31 0.576 . . . . 0.0 111.682 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 267' ' ' ILE . 12.9 mt -56.1 115.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.793 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -84.58 -41.9 16.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.02 0.438 . . . . 0.0 110.251 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -167.56 152.02 6.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.277 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.548 ' CB ' HG12 ' A' ' 267' ' ' ILE . 8.7 pt20 -149.62 164.77 34.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 0.0 111.818 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.28 171.57 28.6 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 59.4 m -86.07 139.71 30.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.752 0.776 . . . . 0.0 109.708 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.8 mt -141.48 166.51 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 11.0 mp -102.61 125.63 49.41 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.681 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -105.13 124.54 49.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.831 177.696 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 53.5 m95 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 51.7 mttt -106.59 138.92 41.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 112.104 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 102.97 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.922 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.632 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.3 mtt180 -128.71 166.44 18.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.407 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -94.0 113.58 25.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.371 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.5 m-85 -101.97 128.18 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.415 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.548 HG12 ' CB ' ' A' ' 248' ' ' GLN . 17.1 mt -121.86 130.81 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.197 0.522 . . . . 0.0 110.66 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.555 HD11 HD11 ' A' ' 292' ' ' LEU . 43.6 tp -101.16 155.01 18.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.855 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.435 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 53.9 mtt-85 -149.55 138.86 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.637 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 4.9 pt-20 -93.89 -175.0 3.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.941 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 28.1 t70 93.63 -75.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 C-N-CA 125.814 1.646 . . . . 0.0 110.148 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 9.5 Cg_endo -91.39 -5.72 3.94 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 121.182 1.458 . . . . 0.0 111.671 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.69 91.34 0.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.132 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.2 m-85 -140.5 121.21 14.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 41.7 tp -89.42 139.39 30.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.177 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.8 142.7 50.64 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -132.3 140.22 48.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.204 0.526 . . . . 0.0 110.848 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' HD13 ' A' ' 287' ' ' LEU . 5.1 m-85 -129.37 162.34 28.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -90.59 122.58 66.93 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.133 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.632 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -68.16 -15.21 42.48 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.184 2.589 . . . . 0.0 111.069 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.89 15.24 15.24 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.06 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -159.24 -112.72 0.32 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.993 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.04 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.33 -0.58 49.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.424 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 287' ' ' LEU . 4.4 m-20 -73.31 139.78 79.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 28.8 Cg_endo -61.79 118.8 5.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.019 1.812 . . . . 0.0 112.78 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.023 HD13 ' HA ' ' A' ' 278' ' ' TYR . 5.8 mp -84.15 -5.65 59.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.117 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.04 157.56 21.0 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.109 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -135.68 100.67 4.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.211 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 62.8 mt -84.43 88.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.689 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.577 ' NE2' ' HB2' ' A' ' 293' ' ' ARG . 13.4 t-80 -43.73 106.05 0.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.79 170.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 84.7 mt -87.23 -19.89 27.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.867 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.577 ' HB2' ' NE2' ' A' ' 291' ' ' HIS . 96.5 mtt180 -59.35 104.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.363 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 108.16 3.28 33.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.489 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 17.1 p -85.67 147.53 26.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 111.977 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 142.38 29.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 99.6 t -117.83 153.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.963 0.411 . . . . 0.0 110.406 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 316' ' ' GLU . 13.6 t -153.43 145.61 23.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.923 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.7 t -83.76 102.32 12.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.748 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 314' ' ' LEU . 12.7 t . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.614 . . . . 0.0 110.188 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.729 ' HG2' HD12 ' A' ' 314' ' ' LEU . 3.1 mp0 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.539 0.685 . . . . 0.0 112.314 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.82 132.27 54.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.955 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 335' ' ' ARG . 74.2 m-20 67.37 22.76 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.409 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 311' ' ' GLU . 1.3 tt -66.93 134.7 52.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.997 0.427 . . . . 0.0 109.94 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.453 ' N ' HD23 ' A' ' 314' ' ' LEU . 29.9 p90 -132.47 136.85 46.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.492 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -99.41 136.67 39.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.781 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.4 mt -115.89 110.84 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.3 mt -101.82 83.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.936 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 72.3 p -62.85 177.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.989 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -64.49 -13.32 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 110.929 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.88 -6.36 54.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.394 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.09 27.67 10.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.763 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.7 130.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -90.41 113.43 25.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 45.9 m-85 -95.46 119.35 33.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.475 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 3.0 m-85 -96.65 116.03 28.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.895 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 78.2 mt -127.31 157.75 39.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.673 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.3 mt-30 -135.99 139.65 43.32 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -110.06 160.68 16.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.336 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -55.64 -50.4 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.247 0.342 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 32.1 p -127.12 162.63 46.84 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.049 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.15 -43.17 61.69 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.393 2.062 . . . . 0.0 111.964 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 337' ' ' GLU . 17.8 tppt? -55.17 -44.92 75.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.036 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 7.7 tp10 -60.39 -52.34 65.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.033 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.565 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.5 ptt180 -59.35 -43.32 92.81 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.977 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.645 HG22 ' HE2' ' A' ' 340' ' ' LYS . 11.1 m -58.64 -40.52 83.62 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.646 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 333' ' ' LYS . 57.0 mt-10 -65.28 -33.15 75.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 121.259 -0.176 . . . . 0.0 110.973 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' A' ' 334' ' ' GLU . 76.7 m95 -73.43 -38.44 65.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.416 0.15 . . . . 0.0 111.106 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 336' ' ' THR . 97.6 mt -53.38 -54.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.645 ' HE2' HG22 ' A' ' 336' ' ' THR . 65.7 mttm -59.87 -40.24 87.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.709 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.64 -54.64 44.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.661 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.636 HG23 HD22 ' A' ' 292' ' ' LEU . 2.0 mp -64.79 -44.62 96.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.351 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -64.38 -36.79 85.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.3 ptp -81.21 -31.29 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.695 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -74.02 -29.87 62.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.457 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.47 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 42.3 t -67.16 -14.58 63.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.692 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.022 -0.424 . . . . 0.0 111.299 -174.475 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 242' ' ' ARG . 37.9 tt0 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.844 0.354 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 240' ' ' GLU . 1.8 mp0 -60.79 -28.28 68.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -104.55 -5.61 21.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.604 0.24 . . . . 0.0 111.1 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 31.8 mtp180 -64.93 -21.33 66.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 110.503 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.23 152.56 26.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.8 t -84.34 145.26 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.43 0.292 . . . . 0.0 110.665 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mp -69.82 114.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.412 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 270' ' ' GLU . 25.8 mm -78.99 -43.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.832 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.5 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 53.4 tttp -158.26 139.59 13.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.963 -169.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.424 ' HG3' HG21 ' A' ' 245' ' ' ILE . 1.4 mp0 -127.3 145.35 50.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.81 144.84 4.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.264 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 11.0 m -72.51 137.62 46.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 99.5 mt -133.65 163.26 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -90.74 123.73 34.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 327' ' ' LEU . 64.3 tttm -110.95 117.29 32.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.808 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 5.6 tp-100 . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.55 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 84.9 m95 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.255 0.55 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.92 126.3 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.182 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 81.6 t -91.11 104.34 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.018 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 278' ' ' TYR . 2.8 ptp180 -148.05 162.71 38.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.723 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 50.1 tttp -79.32 116.11 19.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.546 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 37.1 m-85 -102.31 124.94 48.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 111.852 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 245' ' ' ILE . 56.6 mt -119.08 128.92 75.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.799 172.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 47.7 tp -98.55 154.97 17.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.672 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 52.7 mtt-85 -147.66 136.24 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.582 0.229 . . . . 0.0 110.452 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.684 ' HG2' HD11 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -100.9 127.31 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 1.008 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.0 t70 154.36 -65.74 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.456 1.502 . . . . 0.0 108.844 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 19.6 Cg_endo -96.36 -8.25 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.635 2.223 . . . . 0.0 111.633 173.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 346' ' ' SER . . . 65.16 89.88 0.09 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.839 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 55.8 m-85 -139.87 129.24 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.044 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 290' ' ' ILE . 25.6 tp -94.55 134.09 37.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.209 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 73.3 m80 -120.47 129.74 53.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.853 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.543 ' HE1' HG13 ' A' ' 290' ' ' ILE . 0.9 OUTLIER -115.08 122.72 47.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.834 176.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.624 ' O ' ' HB2' ' A' ' 264' ' ' ARG . 50.6 m-85 -106.77 -167.63 1.31 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.751 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 17.4 t70 -125.82 129.55 24.29 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.755 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.4 Cg_endo -72.51 -19.15 25.22 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 123.16 2.573 . . . . 0.0 111.572 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.02 -28.29 12.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.09 75.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.236 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -175.84 103.07 0.07 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.748 0.419 . . . . 0.0 110.406 171.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -85.15 -14.03 48.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.625 0.726 . . . . 0.0 109.228 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.84 143.66 26.49 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.243 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.09 143.51 54.33 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.762 2.308 . . . . 0.0 113.412 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -80.39 -7.24 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.123 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 158.61 -179.41 34.3 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.427 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.71 128.95 27.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.471 0.177 . . . . 0.0 110.604 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.653 HD12 HD23 ' A' ' 275' ' ' LEU . 46.1 mt -79.11 136.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -86.53 80.48 8.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.588 HD13 HG23 ' A' ' 342' ' ' ILE . 64.9 mt -61.36 -59.55 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -18.95 86.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.941 1.4 . . . . 0.0 113.735 -172.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 109.81 20.67 7.52 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.433 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 30.5 p -93.1 145.57 24.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.599 . . . . 0.0 112.235 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.04 146.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.07 156.81 26.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 11.6 t -145.39 134.25 22.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 110.479 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 14.2 p -82.77 99.25 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.8 t . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.394 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.785 ' HA ' HE22 ' A' ' 328' ' ' GLN . 25.9 mp0 . . . . . 0 N--CA 1.441 -0.884 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.04 158.93 22.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.352 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.831 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 8.2 p30 41.41 45.66 2.74 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.308 1.005 . . . . 0.0 111.482 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.706 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -77.65 135.31 38.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.452 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -129.5 121.97 28.3 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.487 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 35.1 tt0 -92.2 138.68 31.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.551 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 94.6 mt -111.93 110.33 31.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.9 mt -96.48 85.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 40.4 p -60.98 175.85 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.876 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.53 -20.56 65.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.362 0.601 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.7 3.07 26.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.182 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 57.53 38.57 28.02 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.021 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.36 127.81 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.969 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -85.15 112.51 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 36.6 m-85 -98.36 125.25 43.42 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.55 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 48.9 m-85 -100.35 119.67 38.78 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.0 111.008 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 96.3 mt -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.507 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.785 HE22 ' HA ' ' A' ' 311' ' ' GLU . 77.9 mt-30 -142.65 150.17 39.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.367 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -108.46 -168.63 1.38 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.388 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.3 -38.78 17.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.398 . . . . 0.0 110.208 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 332' ' ' PRO . 61.9 p -119.48 149.3 47.54 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.644 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 34.2 Cg_exo -63.3 -14.82 44.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.559 2.839 . . . . 0.0 113.595 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -93.13 -32.81 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.449 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.37 -37.39 87.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 110.296 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.831 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.66 -43.79 97.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.22 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.66 ' HA ' HD12 ' A' ' 339' ' ' ILE . 5.1 m -57.21 -44.23 83.49 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.116 0.484 . . . . 0.0 110.39 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -60.56 -36.93 79.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.055 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.5 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 52.4 m95 -70.96 -30.69 67.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.508 0.194 . . . . 0.0 111.126 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 336' ' ' THR . 74.1 mt -58.94 -51.85 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 336' ' ' THR . 43.0 mmtt -53.07 -54.68 31.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.554 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -52.64 -57.18 10.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.814 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.588 HG23 HD13 ' A' ' 292' ' ' LEU . 35.4 mt -70.44 -42.77 78.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.369 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.76 -33.86 76.98 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.502 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.7 ptm -79.46 -20.97 46.09 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.614 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.96 -22.04 36.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.44 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 40.8 t -89.02 9.45 25.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 177.89 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 242' ' ' ARG . 36.9 tt0 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.62 -41.27 73.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.107 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.44 1.01 37.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.399 -173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.455 ' HG3' ' HA ' ' A' ' 239' ' ' GLU . 99.1 mtt180 -52.86 -40.6 63.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.7 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -82.48 137.63 17.16 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 245' ' ' ILE . 40.1 t -77.16 169.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.546 ' N ' HG12 ' A' ' 244' ' ' VAL . 71.7 mt -56.75 116.6 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.381 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 270' ' ' GLU . 32.9 mm -84.96 -38.79 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.958 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.627 ' HE2' ' CE2' ' A' ' 338' ' ' TRP . 80.5 tttt -169.21 141.49 2.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.716 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.744 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.4 OUTLIER -144.11 162.72 35.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.831 175.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.66 173.0 30.84 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.98 139.18 34.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.611 0.706 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.6 mt -143.72 160.85 39.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.4 mp -98.47 125.96 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -113.72 124.67 52.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.623 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 60.4 tt0 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.651 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.522 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 69.4 m95 . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.502 ' HD3' ' NH2' ' A' ' 264' ' ' ARG . 5.9 mtpt -105.38 140.76 38.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.128 0.49 . . . . 0.0 111.368 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.44 99.01 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.502 ' NH2' ' HD3' ' A' ' 262' ' ' LYS . 55.7 mtt-85 -116.57 148.38 40.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.033 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.31 110.54 18.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 20.1 m-85 -93.98 153.06 18.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.744 HG12 ' HB3' ' A' ' 248' ' ' GLN . 6.9 mt -144.96 125.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.815 0.697 . . . . 0.0 109.856 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.3 tp -99.85 145.39 27.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.102 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -149.56 131.43 15.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.8 OUTLIER -99.9 -170.72 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.672 -170.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.987 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 12.1 t70 95.02 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.661 1.584 . . . . 0.0 110.253 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.987 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.6 Cg_endo -91.38 -6.29 3.81 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 CA-C-N 120.859 1.342 . . . . 0.0 111.025 164.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.35 95.18 0.05 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.734 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 14.6 m-85 -137.62 115.27 11.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 44.7 tp -89.72 139.34 30.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.133 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 274' ' ' TYR . 75.5 m80 -130.24 144.3 51.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.416 ' HB3' ' CE2' ' A' ' 266' ' ' PHE . 8.2 p90 -131.4 139.05 49.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 110.712 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -119.56 -165.09 1.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.22 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -130.13 129.81 22.99 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 -17.08 22.26 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.854 2.369 . . . . 0.0 111.594 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.71 -12.18 17.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.237 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.86 84.32 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.91 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.54 117.32 0.2 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.447 0.641 . . . . 0.0 110.61 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -94.4 -30.54 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.825 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -75.23 142.41 75.3 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.778 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 125.92 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.163 1.908 . . . . 0.0 111.666 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.11 3.41 17.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.098 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 170.36 139.25 2.69 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -110.54 112.13 23.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.82 0.343 . . . . 0.0 110.308 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 63.8 mt -85.16 132.17 32.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.549 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.09 95.66 9.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.59 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.751 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 81.2 mt -79.87 -28.96 39.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.098 -172.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -52.97 103.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.88 0.372 . . . . 0.0 111.103 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 97.08 9.89 55.38 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.012 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' CYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.6 p -88.45 144.51 26.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.992 0.425 . . . . 0.0 110.778 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.01 144.62 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 91.4 t -119.38 150.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -148.59 142.01 25.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.463 -175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.7 t -76.36 108.5 9.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.915 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 51.3 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.189 0.519 . . . . 0.0 110.675 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.512 ' HG2' HD12 ' A' ' 314' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 313' ' ' ASN . 44.6 mt-10 -140.73 133.24 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' A' ' 335' ' ' ARG . 86.1 m-20 76.19 28.51 0.81 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.851 0.719 . . . . 0.0 110.411 -174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -77.06 126.29 30.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.319 178.022 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.58 125.49 47.92 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.572 ' HB3' HG22 ' A' ' 298' ' ' THR . 4.8 tp10 -86.41 136.32 33.16 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.893 -174.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.7 103.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.17 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.042 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.463 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 38.1 p -53.16 159.21 1.32 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.053 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.67 -1.59 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.902 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.15 4.46 53.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.125 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.81 27.74 11.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.355 172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.38 135.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -82.69 118.95 23.71 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -112.2 97.68 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.178 0.514 . . . . 0.0 110.033 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 87.7 m-85 -80.23 118.74 22.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.273 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 314' ' ' LEU . 87.6 mt -125.9 152.02 46.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 39.4 mt-30 -139.61 144.89 37.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.679 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -117.79 171.94 7.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.837 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.12 -69.04 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.499 0.499 . . . . 0.0 111.34 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 77.1 p -102.55 161.22 23.93 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.005 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' PRO . . . . . 0.641 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 68.3 Cg_exo -52.08 -44.45 45.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.545 2.163 . . . . 0.0 112.07 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 57.8 tttp -55.28 -50.01 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.364 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.54 -42.45 96.56 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.475 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 313' ' ' ASN . 7.0 ppt_? -66.95 -39.03 87.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.348 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' THR . . . . . 0.572 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -60.81 -41.77 96.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.838 0.352 . . . . 0.0 110.68 170.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 80.2 mm-40 -59.05 -44.67 91.84 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' TRP . . . . . 0.627 ' CE2' ' HE2' ' A' ' 247' ' ' LYS . 60.4 m95 -65.17 -36.21 83.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 336' ' ' THR . 99.0 mt -53.17 -53.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.4 mtmt -57.37 -42.18 81.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.709 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.82 42.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.122 0.487 . . . . 0.0 110.81 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 292' ' ' LEU . 2.1 mp -66.69 -40.99 87.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.495 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.77 -36.48 84.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.41 -30.86 33.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.088 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.94 56.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.677 0.275 . . . . 0.0 111.573 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.614 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 30.1 t -75.02 -22.78 58.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 347' ' ' ARG . 42.4 mtm105 . . . . . 0 C--N 1.327 -0.375 0 O-C-N 122.06 -0.4 . . . . 0.0 111.864 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.2 p 44.4 36.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 122.567 1.175 . . . . 0.0 111.981 -175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.9 123.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.629 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 237' ' ' LEU . 2.4 pt? -123.13 -164.99 1.26 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -51.11 130.24 25.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.293 0.568 . . . . 0.0 110.96 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.569 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 33.7 tt0 -55.23 -28.67 54.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.603 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 60.1 mt-10 -55.65 -37.01 67.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.403 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 237' ' ' LEU . 34.0 m-85 -103.44 0.46 31.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -71.33 -8.65 55.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.04 0.447 . . . . 0.0 110.52 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -107.64 143.17 15.94 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.23 151.87 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.317 0.579 . . . . 0.0 111.716 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.8 mt -53.25 127.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.162 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.494 HD11 ' CG ' ' A' ' 270' ' ' GLU . 41.2 mm -96.71 -44.84 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.766 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.524 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 60.3 tttp -164.98 132.59 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.52 -173.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.562 ' CB ' HG12 ' A' ' 267' ' ' ILE . 4.8 pt20 -132.91 141.35 48.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.319 0.58 . . . . 0.0 111.795 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 177.51 151.66 9.38 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.79 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 61.6 m -71.01 135.06 47.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.119 0.46 . . . . 0.0 110.116 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.542 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 94.0 mt -131.61 169.51 16.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 8.1 mp -95.0 117.58 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.12 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.83 119.08 38.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.249 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -61.56 111.06 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -151.07 86.74 0.14 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.726 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -74.28 69.57 1.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.435 0.636 . . . . 0.0 111.933 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -98.92 -53.34 3.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -130.99 -44.99 1.03 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.167 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -98.83 -165.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.543 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -108.19 -51.97 2.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.526 0.679 . . . . 0.0 109.723 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.532 ' CZ2' ' HG3' ' A' ' 311' ' ' GLU . 89.7 m95 -120.16 133.01 55.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.783 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 24.2 mtpp -110.62 151.5 27.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 0.0 112.246 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.2 101.73 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.2 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 96.7 mtt180 -132.62 154.6 49.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.741 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 40.6 ttmt -79.39 120.66 24.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.68 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 35.9 m-85 -103.89 117.2 33.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 248' ' ' GLN . 18.6 mt -114.83 127.0 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 42.5 tp -99.5 154.42 18.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.906 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -150.67 139.61 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.64 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.631 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 13.5 pt-20 -101.08 -169.95 1.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.595 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 270' ' ' GLU . 0.8 OUTLIER 95.64 -70.17 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 110.9 -178.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 271' ' ' ASP . 14.4 Cg_endo -97.97 -6.66 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.647 1.564 . . . . 0.0 111.876 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 70.13 93.95 0.08 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.501 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 33.6 m-85 -141.62 119.48 11.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.331 0.586 . . . . 0.0 111.953 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 290' ' ' ILE . 38.8 tp -90.86 140.13 30.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.278 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 70.9 m80 -127.65 139.67 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.103 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.514 ' HE2' HG13 ' A' ' 290' ' ' ILE . 1.3 p90 -121.7 136.25 54.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.264 0.554 . . . . 0.0 111.088 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.91 147.48 50.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.555 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.528 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 7.7 t70 -90.35 132.65 34.98 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 97.1 Cg_endo -72.57 -24.14 19.09 Favored 'Trans proline' 0 CA--C 1.517 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 111.293 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.93 -12.51 23.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.376 -170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.38 59.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.622 -1.275 . . . . 0.0 114.525 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -171.42 73.02 0.05 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.773 0.286 . . . . 0.0 111.136 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.19 -9.51 59.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.62 134.17 88.52 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.077 167.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.98 105.02 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.906 1.737 . . . . 0.0 112.439 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.73 -28.09 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.035 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.7 35.97 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.6 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -121.18 135.67 55.11 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.791 0.329 . . . . 0.0 110.376 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.7 HD12 HD23 ' A' ' 275' ' ' LEU . 27.7 mt -85.42 131.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -85.37 88.66 7.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.633 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 51.9 mt -76.56 -26.81 55.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.845 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 293' ' ' ARG . 21.4 ttt180 -52.37 101.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 95.85 10.49 56.39 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.877 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 11.4 p -90.73 147.72 23.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.919 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.07 146.24 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.15 152.46 13.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 14.3 t -145.98 142.42 28.65 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.678 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 40.7 t -83.73 105.3 14.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.46 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 55.8 t -70.79 130.89 34.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.78 29.09 0.13 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.576 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t 56.68 76.25 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.335 0.588 . . . . 0.0 110.068 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.97 33.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 311' ' ' GLU . 5.8 t -82.19 81.53 8.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.262 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.93 132.85 49.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.408 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.12 3.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.959 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 -168.94 1.79 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.3 153.36 31.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 67.8 m -68.47 76.87 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 111.508 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -84.72 -41.47 16.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.602 0.715 . . . . 0.0 109.193 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.894 ' HB3' HD12 ' A' ' 314' ' ' LEU . 8.9 mp0 -83.87 86.94 7.09 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.699 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.04 -68.42 0.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.926 0.87 . . . . 0.0 110.762 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 6.1 p30 -85.63 46.4 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 311' ' ' GLU . 0.7 OUTLIER -79.41 130.35 35.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.17 -176.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -127.67 134.0 49.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 36.9 tt0 -102.08 141.98 34.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.517 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.8 mt -116.34 110.8 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.0 mt -98.32 92.05 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.129 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.417 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 75.4 p -60.09 161.92 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.587 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.82 -17.62 61.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.23 0.538 . . . . 0.0 110.396 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.52 3.2 25.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.329 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 70.58 27.55 3.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.685 0.794 . . . . 0.0 111.834 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.61 126.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.019 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -91.35 113.62 25.93 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.23 111.43 23.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HD2' HD11 ' A' ' 314' ' ' LEU . 45.0 m-85 -85.77 115.28 23.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.784 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 99.0 mt -124.03 154.3 40.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.53 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 31.9 mt-30 -140.73 155.39 46.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.326 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.3 -174.81 2.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.357 0.598 . . . . 0.0 110.112 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 55.1 p -134.16 159.56 71.89 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.843 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.96 -32.48 97.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 111.105 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 24.8 ttpp -59.45 -54.87 41.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.917 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 17.5 tp10 -63.92 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.465 -172.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 3.2 ptt180 -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.136 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.644 HG22 ' NZ ' ' A' ' 340' ' ' LYS . 88.0 m -58.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.798 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 4.8 mm-40 -60.73 -37.04 80.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.572 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.524 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 59.8 m95 -76.17 -32.95 59.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.62 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 335' ' ' ARG . 98.2 mt -54.63 -54.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.644 ' NZ ' HG22 ' A' ' 336' ' ' THR . 27.7 mtmm -56.8 -40.99 76.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.72 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.521 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.04 -56.09 25.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.134 0.492 . . . . 0.0 111.053 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.446 HG23 HD22 ' A' ' 292' ' ' LEU . 2.3 mp -66.34 -38.38 81.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.271 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -65.88 -41.02 92.07 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.64 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 12.6 ptm -71.95 -38.19 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.974 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -66.08 -35.83 81.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.396 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -69.18 -10.01 55.65 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.208 -0.307 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -72.66 -23.51 60.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.618 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.4 p -83.9 79.38 9.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.523 0.678 . . . . 0.0 109.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -123.68 63.64 0.55 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 82.3 mttt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.476 -172.108 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 235' ' ' VAL . 7.0 m-20 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 234' ' ' ASP . 30.4 t -74.74 74.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.559 0.695 . . . . 0.0 109.468 174.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.93 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.397 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 241' ' ' PHE . 1.9 pt? -136.65 -166.91 1.97 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.262 177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 18.8 mmtp -43.75 131.16 5.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.391 0.615 . . . . 0.0 111.948 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.866 ' HG3' ' HB3' ' A' ' 272' ' ' PRO . 7.8 tp10 -54.06 -35.01 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.055 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -55.77 -30.16 60.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.657 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.504 ' HB2' HD11 ' A' ' 237' ' ' LEU . 21.4 m-85 -113.23 2.42 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.132 -175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 239' ' ' GLU . 99.7 mtt180 -70.6 -35.78 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 110.04 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.38 150.05 51.36 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.585 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.4 t -81.39 145.64 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.724 0.41 . . . . 0.0 110.701 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.9 mp -70.44 117.9 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 110.378 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 270' ' ' GLU . 48.3 mm -85.52 -36.14 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.37 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.4 tttp -163.35 143.46 8.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.783 -171.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -133.13 157.55 45.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 148.84 155.82 6.87 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.074 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 6.9 p -76.21 141.02 41.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.198 0.499 . . . . 0.0 110.502 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 338' ' ' TRP . 96.1 mt -135.72 153.94 51.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 3.3 mp -86.59 117.5 25.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -103.08 119.2 38.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.555 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 260' ' ' ASN . 35.5 tt0 -65.24 123.45 19.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.728 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -157.95 124.08 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -65.8 159.2 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 72.35 -38.99 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.906 0.882 . . . . 0.0 112.067 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -86.18 57.46 4.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? 67.87 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 254' ' ' GLN . 64.6 t30 -170.16 -42.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.476 0.655 . . . . 0.0 109.47 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.553 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 93.2 m95 -120.45 124.66 45.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.513 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 5.5 ttpm? -113.53 160.92 17.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.882 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.98 111.3 35.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.343 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 95.0 mtt180 -137.42 150.64 47.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.05 172.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 36.2 ttpt -84.71 123.24 30.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.754 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 23.0 m-85 -97.77 158.86 15.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.315 0.578 . . . . 0.0 111.72 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 245' ' ' ILE . 7.9 mt -150.15 121.29 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.985 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 33.5 tp -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.013 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 51.7 mtt180 -146.48 134.08 20.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.742 0.306 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.642 ' HB3' HD11 ' A' ' 246' ' ' ILE . 37.0 tt0 -112.86 133.75 54.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.605 ' HB3' ' HE2' ' A' ' 350' ' ' LYS . 25.6 m-20 145.17 -54.45 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 125.733 1.895 . . . . 0.0 108.164 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.866 ' HB3' ' HG3' ' A' ' 239' ' ' GLU . 66.2 Cg_endo -100.04 -16.29 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 166.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.811 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.14 82.91 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.308 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 57.6 m-85 -143.62 124.53 14.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.413 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 51.1 tp -89.29 137.49 32.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -124.85 154.71 40.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.655 0.264 . . . . 0.0 110.304 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -147.34 144.49 28.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.5 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.095 ' HA ' HD13 ' A' ' 287' ' ' LEU . 2.6 m-85 -133.92 154.81 50.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.661 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 282' ' ' GLY . 5.5 t70 -87.19 136.42 33.72 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.482 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 93.9 Cg_endo -67.94 -19.82 45.71 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.01 2.473 . . . . 0.0 111.414 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.12 7.98 19.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.19 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . 171.19 140.23 2.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.266 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 72.66 102.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.608 0.718 . . . . 0.0 112.412 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -95.74 -6.59 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.221 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.8 132.56 51.08 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 10.8 Cg_endo -51.81 124.62 14.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.382 2.722 . . . . 0.0 114.004 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.095 HD13 ' HA ' ' A' ' 278' ' ' TYR . 6.1 mp -81.81 -26.38 34.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.384 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -174.64 174.26 46.5 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.742 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 275' ' ' LEU . . . -141.76 140.85 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.304 . . . . 0.0 111.011 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 38.9 mt -99.41 137.92 25.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.529 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -84.72 95.3 8.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.774 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.811 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 30.5 mt -77.77 -28.66 50.62 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.88 107.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.872 0.368 . . . . 0.0 111.142 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.67 13.59 62.67 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.276 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 15.8 p -87.29 146.86 25.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.258 0.552 . . . . 0.0 111.271 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.83 140.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.51 154.49 18.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -141.65 140.93 33.37 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.245 0.545 . . . . 0.0 109.928 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 7.6 t -87.7 99.13 11.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.746 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 45.6 t -81.7 110.23 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.45 39.55 0.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.021 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 8.5 t 57.28 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.072 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -137.18 78.62 1.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.136 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 44.0 t -170.55 178.11 3.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.414 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 76.6 -60.76 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.131 0.972 . . . . 0.0 111.916 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -171.35 -150.63 7.19 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.7 -51.85 60.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -80.72 116.09 20.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.607 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 54.3 m -75.88 83.53 2.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.383 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -62.58 -39.5 93.91 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.666 0.746 . . . . 0.0 110.245 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.46 87.61 3.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.877 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 162.57 13.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.609 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.884 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 11.1 p30 41.75 36.99 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.985 0.914 . . . . 0.0 112.259 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.4 OUTLIER -75.49 129.95 38.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.92 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -125.48 125.4 43.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 38.9 tt0 -96.16 137.01 35.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.212 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -114.4 108.97 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.37 88.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.468 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.3 p -62.78 171.45 2.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.269 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -65.3 -18.09 65.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.679 0.752 . . . . 0.0 109.541 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.5 -5.0 42.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.489 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 69.28 29.22 4.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.685 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.61 132.11 53.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.733 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.44 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 7.7 m-70 -90.23 114.32 26.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 63.2 m-85 -98.65 115.57 28.97 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 44.2 m-85 -91.38 115.68 28.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.018 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.508 ' O ' HD23 ' A' ' 314' ' ' LEU . 95.9 mt -128.7 151.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.582 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.1 mt-30 -142.36 154.92 45.05 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.901 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.88 -175.94 2.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.395 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -76.75 -37.21 56.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.211 0.529 . . . . 0.0 110.248 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 45.5 p -127.48 155.17 77.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.797 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 25.2 Cg_exo -63.23 -21.83 72.25 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.138 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.65 -30.79 17.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.581 0.229 . . . . 0.0 111.221 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -43.56 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.884 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.21 -42.62 95.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.17 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.524 ' HA ' HD12 ' A' ' 339' ' ' ILE . 11.8 m -58.64 -39.22 79.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 41.4 mt-10 -64.49 -36.75 85.19 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.689 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.446 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 68.8 m95 -72.72 -34.66 67.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.168 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 336' ' ' THR . 84.6 mt -53.15 -57.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -56.28 -41.97 76.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.971 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.466 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.17 -57.16 14.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.81 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.714 HG23 HD22 ' A' ' 292' ' ' LEU . 1.7 mp -60.94 -42.16 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.344 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.74 -42.29 97.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.552 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.545 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 11.6 ptm -73.17 -40.84 64.49 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.739 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -61.2 -29.37 69.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.488 0.185 . . . . 0.0 111.179 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 33.1 t -68.03 -14.43 62.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -74.08 -43.91 55.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 35.9 p 62.18 124.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.345 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -69.22 -31.76 72.02 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.01 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.605 ' HE2' ' HB3' ' A' ' 271' ' ' ASP . 43.5 mtmt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.836 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -66.64 82.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.563 0.697 . . . . 0.0 110.888 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.33 120.23 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.9 mp -56.74 116.0 2.9 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 47.4 mmtm -88.75 -179.05 5.92 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.705 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.42 -35.36 75.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.722 0.773 . . . . 0.0 109.202 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 274' ' ' TYR . 11.6 mp0 -66.22 -12.27 55.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.069 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.97 -13.58 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 96.7 mtt180 -56.23 -24.53 42.87 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.65 141.53 18.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.174 175.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.22 153.01 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 23.5 mt -55.61 132.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.392 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 270' ' ' GLU . 42.9 mm -99.9 -42.09 10.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.331 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 59.8 tttp -166.59 138.12 3.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.208 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.447 ' HB3' HD12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -136.58 152.62 50.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.351 0.595 . . . . 0.0 112.392 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.67 157.18 9.76 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.656 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 31.8 m -77.07 144.74 38.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.801 0.8 . . . . 0.0 110.305 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.3 mt -142.01 165.39 27.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -96.87 119.03 34.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.542 -0.169 . . . . 0.0 110.542 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.88 120.62 40.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.48 115.45 4.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.925 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -103.1 -178.08 26.48 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.927 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 58.5 -159.81 0.27 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.558 0.343 . . . . 0.0 110.486 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 257' ' ' ARG . 4.0 ptp180 -87.08 55.71 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 110.691 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 68.53 87.26 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.159 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -168.11 -68.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.032 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.76 161.82 18.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.442 . . . . 0.0 110.669 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 72.3 m95 -124.3 143.89 50.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.512 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.39 131.86 56.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.399 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.05 107.53 12.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.494 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -129.02 156.62 43.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 84.0 tttt -89.95 115.07 26.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.734 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 30.9 m-85 -101.96 118.24 36.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.021 0.438 . . . . 0.0 111.822 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' CE1' ' A' ' 278' ' ' TYR . 9.3 mm -112.49 127.33 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 292' ' ' LEU . 39.2 tp -101.32 154.48 18.75 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.622 ' HB2' ' HE1' ' A' ' 276' ' ' HIS . 79.9 mtt-85 -154.89 143.97 21.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 246' ' ' ILE . 6.3 pt-20 -100.84 -170.44 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.62 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.881 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 32.8 t70 93.13 -72.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.686 1.595 . . . . 0.0 110.498 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.3 Cg_endo -92.64 -3.05 3.66 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 121.124 1.437 . . . . 0.0 112.054 167.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.77 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.93 85.67 0.14 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.319 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.3 m-85 -130.71 129.85 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.753 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 29.0 tp -101.74 130.88 48.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.622 ' HE1' ' HB2' ' A' ' 269' ' ' ARG . 22.3 m80 -121.59 130.24 53.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.081 -172.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' A' ' 290' ' ' ILE . 8.5 p90 -119.7 133.28 55.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.883 0.849 . . . . 0.0 111.283 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.539 ' CE1' HG12 ' A' ' 267' ' ' ILE . 3.6 m-85 -115.15 149.07 38.21 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.263 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.578 ' HB2' HD11 ' A' ' 287' ' ' LEU . 0.3 OUTLIER -87.99 132.2 40.68 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.68 -15.92 41.57 Favored 'Trans proline' 0 CA--C 1.514 -0.503 0 C-N-CA 123.342 2.695 . . . . 0.0 111.038 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.11 2.23 34.37 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.31 -171.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.46 85.25 0.05 OUTLIER Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.799 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -178.04 107.06 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.275 0.56 . . . . 0.0 111.985 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -83.69 -46.67 12.03 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.72 134.75 46.81 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.238 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.41 137.03 58.08 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.856 2.371 . . . . 0.0 112.259 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 279' ' ' ASP . 58.1 mt -68.08 -29.35 68.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.945 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -167.73 147.0 11.1 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.558 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.04 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 66.1 mt -67.19 142.05 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.347 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -94.54 94.47 8.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.62 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.77 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 42.7 mt -72.68 -31.24 64.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.928 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -58.6 91.14 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 119.3 -3.68 13.87 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 292' ' ' LEU . 14.2 p -95.81 148.36 22.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.175 0.487 . . . . 0.0 111.419 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.92 150.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 339' ' ' ILE . 57.8 t -117.18 159.79 17.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.766 0.317 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 8.8 t -160.02 143.34 13.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.73 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.6 t -80.35 122.68 27.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 46.6 t -95.58 125.24 48.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 111.266 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.81 45.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.827 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.3 m 55.1 34.32 22.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.3 0.571 . . . . 0.0 110.0 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.424 ' H ' HG12 ' A' ' 300' ' ' VAL . 55.8 t30 -80.29 76.85 7.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.718 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 17.7 p -106.27 150.77 25.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.889 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -87.7 100.93 13.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 0.0 110.077 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 142.25 172.98 13.93 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 307' ' ' ARG . 67.5 mtt180 -96.4 172.22 8.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.661 0.231 . . . . 0.0 110.917 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 55.49 46.68 22.6 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.476 0.655 . . . . 0.0 110.974 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.0 p -64.55 119.32 10.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.554 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -104.99 5.18 32.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.241 0.543 . . . . 0.0 110.495 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.562 ' HB3' HD12 ' A' ' 314' ' ' LEU . 17.6 mp0 -74.56 125.87 29.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.73 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -135.34 132.16 37.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.726 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.56 35.12 11.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.0 OUTLIER -75.28 129.86 38.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.554 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -126.99 138.29 53.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 168.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.495 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 33.7 tt0 -100.7 133.41 45.19 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 78.5 mt -112.73 102.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.07 91.67 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.966 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.7 p -54.39 159.08 2.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.25 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.6 1.81 2.19 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.865 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -118.34 30.21 7.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.276 0.56 . . . . 0.0 110.428 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 64.8 31.05 11.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.961 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 t -108.78 124.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.195 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -88.88 114.69 25.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 6.9 m-30 -94.58 125.35 39.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.496 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 6.3 m-30 -99.74 114.73 28.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 110.847 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.77 153.28 38.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.386 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 26.4 mt-30 -139.52 142.22 37.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.058 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.09 165.61 12.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.68 30.2 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 71.7 p -113.82 159.04 37.39 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.086 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.4 -37.89 82.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.945 2.43 . . . . 0.0 111.816 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 30.1 mmtp -64.61 -47.91 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 11.9 tp10 -55.94 -49.42 73.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.074 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 336' ' ' THR . 8.5 ptt180 -60.59 -43.82 96.95 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.611 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 339' ' ' ILE . 30.9 m -60.32 -37.69 81.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.752 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.503 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 76.5 mm-40 -63.73 -40.72 97.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.49 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 75.8 m95 -71.34 -33.0 69.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 336' ' ' THR . 98.0 mt -53.32 -57.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -58.75 -39.39 80.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.181 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.468 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.65 -53.01 61.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.206 0.526 . . . . 0.0 110.897 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.709 HG23 HD22 ' A' ' 292' ' ' LEU . 1.8 mp -64.27 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.265 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 97.8 mt-30 -63.81 -49.35 73.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.604 0.24 . . . . 0.0 111.34 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.4 ptm -70.05 -24.56 63.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.391 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.15 32.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.608 0.242 . . . . 0.0 111.061 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.7 t -66.66 -19.27 65.73 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.39 21.49 6.09 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.924 -0.485 . . . . 0.0 111.587 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 270' ' ' GLU . 39.2 p -100.07 167.24 10.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 77.19 53.21 5.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.258 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.079 176.766 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.9 t -77.37 61.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 122.043 0.925 . . . . 0.0 109.783 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.4 mt -98.95 102.13 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.569 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 241' ' ' PHE . 2.3 mp -55.37 109.65 0.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.951 0.882 . . . . 0.0 112.513 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 32.1 mmmt -82.47 -178.23 6.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.543 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 272' ' ' PRO . 36.5 tt0 -54.64 -38.99 67.53 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 52.3 mt-10 -52.9 -40.89 63.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.535 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.45 ' O ' HD23 ' A' ' 237' ' ' LEU . 12.4 m-85 -101.5 -15.64 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -166.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 25.3 mtp180 -53.12 -23.89 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -87.05 149.5 22.2 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.087 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 245' ' ' ILE . 97.4 t -85.94 158.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.111 0.482 . . . . 0.0 110.426 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mm -73.57 116.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.725 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.628 HD11 ' HG2' ' A' ' 270' ' ' GLU . 33.5 mm -83.3 -41.84 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -161.12 149.29 15.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -133.25 157.4 45.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.22 164.83 19.21 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.35 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.1 p -86.19 133.12 33.87 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.3 mt -133.63 155.97 48.72 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.8 mp -91.46 121.82 33.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -108.43 131.4 54.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 33.7 tt0 -77.75 146.28 36.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.964 173.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.98 19.47 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.656 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.22 124.14 28.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 59.43 50.33 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.809 0.814 . . . . 0.0 110.489 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -121.56 -174.06 2.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.713 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -77.05 -61.3 2.03 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.83 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -163.09 -167.39 1.47 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 252' ' ' LEU . 62.7 m95 -68.75 146.06 53.27 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 9.0 ptpt -134.08 165.27 25.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.535 0.683 . . . . 0.0 112.43 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.2 103.15 14.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.207 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.653 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 97.0 mtt180 -126.01 158.24 35.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.197 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.57 106.04 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.404 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.6 m-85 -91.12 148.09 22.61 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.395 0.617 . . . . 0.0 111.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 245' ' ' ILE . 21.0 mt -146.39 118.53 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.298 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 61.1 tp -93.03 139.46 30.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.202 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -139.31 127.67 22.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.785 ' HB2' HG21 ' A' ' 348' ' ' THR . 0.4 OUTLIER -91.1 -172.17 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.224 -174.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.976 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 38.4 t70 94.63 -76.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.66 1.584 . . . . 0.0 109.968 176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.976 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.4 Cg_endo -92.01 -5.67 3.59 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 CA-C-N 121.098 1.428 . . . . 0.0 111.262 166.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.31 98.32 0.05 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.975 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 41.4 m-85 -144.74 110.92 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.139 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.593 HD23 HD12 ' A' ' 290' ' ' ILE . 23.8 tp -89.56 121.1 31.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 61.7 m80 -112.58 155.09 24.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.078 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.54 141.46 39.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.351 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 283' ' ' ALA . 3.3 m-85 -127.57 166.45 17.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.948 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 27.5 t70 -95.13 123.4 57.29 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.653 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 83.3 Cg_endo -67.78 -17.53 47.32 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.391 2.728 . . . . 0.0 110.26 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.544 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -89.57 -1.65 58.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.261 -1.791 . . . . 0.0 111.205 -172.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.29 29.78 0.17 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.188 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -129.0 111.78 13.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.37 1.085 . . . . 0.0 110.901 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.94 -12.66 23.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.831 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.19 141.81 96.48 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.416 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.6 108.78 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.468 2.112 . . . . 0.0 111.517 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.03 5.85 13.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.603 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 167.77 140.55 2.94 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.518 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.439 ' HB2' ' OE1' ' A' ' 240' ' ' GLU . . . -115.57 102.04 9.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.593 HD12 HD23 ' A' ' 275' ' ' LEU . 59.3 mt -70.82 123.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -82.52 87.11 6.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.017 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 78.9 mt -74.56 -27.61 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -48.44 99.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 92.54 18.79 40.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.957 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' CYS . . . . . . . . . . . . . 14.8 p -95.39 157.92 15.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.303 0.573 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.93 149.93 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 298' ' ' THR . 48.4 t -118.15 158.81 18.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.0 t -150.86 143.23 24.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.272 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.9 t -80.0 99.44 7.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.451 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.5 t -76.59 109.8 11.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.946 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -93.67 69.77 4.1 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.781 0.8 . . . . 0.0 109.469 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 309' ' ' SER . 35.2 m 64.43 85.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.469 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -112.91 23.27 13.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.794 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 56.0 m -135.26 160.94 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.997 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -123.48 135.58 54.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 0.0 111.173 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -140.92 -64.85 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -142.84 -39.54 0.33 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -141.73 23.73 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.196 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 61.8 m 56.21 67.52 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.718 0.77 . . . . 0.0 109.627 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.51 -33.27 73.53 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.936 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 311' ' ' GLU . 6.4 mp0 -58.15 89.86 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.512 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.56 -10.14 12.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.653 0.739 . . . . 0.0 110.772 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -122.55 29.77 6.77 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.897 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.2 tt -77.58 135.57 38.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.331 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -129.91 125.87 36.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 298' ' ' THR . 36.0 tt0 -93.62 136.92 33.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.129 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -112.01 103.14 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.56 88.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.656 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 50.1 p -59.21 160.76 6.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.517 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.17 -8.97 27.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.384 0.611 . . . . 0.0 110.671 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.11 4.6 41.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.233 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 64.03 32.12 13.13 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.033 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.37 127.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.709 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -87.63 118.09 26.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 9.0 m-85 -98.93 117.91 34.51 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.6 m-85 -95.46 112.81 24.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.066 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 96.5 mt -126.67 156.41 41.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.728 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.515 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 30.6 mt-30 -139.45 145.29 38.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.672 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.69 176.48 5.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.455 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.96 -56.48 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.0 111.102 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 39.2 p -124.05 163.43 35.62 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.21 -37.84 40.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.725 2.283 . . . . 0.0 112.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 50.7 mtmt -62.91 -48.98 76.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.924 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -61.26 -41.89 97.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.145 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 339' ' ' ILE . 17.8 ptt180 -63.17 -42.15 99.34 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.635 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 339' ' ' ILE . 18.7 m -57.24 -42.3 81.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.767 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 11.1 mm-40 -57.47 -45.29 84.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.858 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -70.55 -31.15 68.08 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 336' ' ' THR . 89.2 mt -59.86 -56.99 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -55.46 -49.83 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.925 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.3 30.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 0.0 111.431 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 317' ' ' ILE . 13.5 mt -71.55 -41.06 72.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.081 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.69 -30.76 71.82 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.461 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.15 -40.79 21.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.695 0.283 . . . . 0.0 110.276 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.18 71.6 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.56 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 32.9 t -76.91 -0.35 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.772 0.32 . . . . 0.0 111.819 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 62.4 mtp85 -92.02 15.98 12.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.05 -0.406 . . . . 0.0 111.348 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.785 HG21 ' HB2' ' A' ' 270' ' ' GLU . 12.2 p -87.66 35.18 0.72 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.15 0.5 . . . . 0.0 112.08 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.52 68.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 82.5 mttt . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.87 176.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.9 70.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.366 0.603 . . . . 0.0 110.384 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.0 mt -106.03 87.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.26 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -140.48 -176.97 4.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 241' ' ' PHE . 49.9 mmtm -46.85 132.21 11.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.613 0.72 . . . . 0.0 111.007 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.592 ' OE1' ' HD3' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -59.59 -34.14 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.791 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 269' ' ' ARG . 20.7 mt-10 -58.63 -26.48 63.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.017 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 237' ' ' LEU . 4.9 m-85 -115.35 1.5 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.255 -174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.592 ' HD3' ' OE1' ' A' ' 239' ' ' GLU . 64.8 mtp180 -72.11 -4.62 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.71 150.83 18.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 72.8 t -81.13 147.8 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.153 0.501 . . . . 0.0 111.139 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 3.9 mt -70.36 111.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.575 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 268' ' ' LEU . 37.0 mm -77.82 -35.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.227 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -169.18 144.82 3.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.533 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.58 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.12 157.91 40.45 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.19 156.63 8.95 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.696 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 264' ' ' ARG . 12.9 p -75.17 137.69 41.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 0.167 . . . . 0.0 110.642 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.6 mt -140.33 159.21 42.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.9 mp -97.78 120.41 38.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -109.33 123.49 49.39 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.454 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -62.46 140.18 58.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.917 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -118.15 -112.61 2.56 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.78 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -143.23 161.55 37.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 257' ' ' ARG . 16.3 mmt180 62.82 -170.48 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.755 0.659 . . . . 0.0 110.974 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.53 37.37 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.03 -17.9 18.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.5 ' HB3' ' HD1' ' A' ' 261' ' ' TRP . 4.0 m-20 58.94 -100.12 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.927 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 31.3 m95 -119.73 162.94 18.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.619 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 28.8 mttt -139.5 150.72 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.581 . . . . 0.0 111.526 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -92.96 99.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.9 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.746 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 70.7 mtt180 -124.06 164.67 18.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -94.26 110.64 22.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.694 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 17.6 m-85 -94.4 151.66 19.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.809 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 248' ' ' GLN . 13.0 mt -144.86 125.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.916 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.596 HD22 ' HB1' ' A' ' 341' ' ' ALA . 48.3 tp -100.09 147.64 25.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.286 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 68.6 mtt-85 -140.91 126.6 19.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.739 ' HG2' HG21 ' A' ' 348' ' ' THR . 19.0 tt0 -106.07 130.38 53.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.6 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.994 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.5 t70 148.39 -59.98 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 125.335 1.647 . . . . 0.0 108.36 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.994 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 11.2 Cg_endo -94.12 -10.41 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.44 2.093 . . . . 0.0 110.768 166.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.48 88.78 0.1 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.839 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -138.32 120.86 16.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 290' ' ' ILE . 33.3 tp -99.78 117.6 34.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.417 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 0.7 OUTLIER -110.85 154.85 23.42 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.397 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.71 139.76 47.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.473 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -123.02 166.52 14.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.488 ' HB2' HD11 ' A' ' 287' ' ' LEU . 6.8 t70 -88.0 135.36 33.54 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.746 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.6 Cg_endo -70.39 -14.51 34.17 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 111.539 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.11 11.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.516 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . -163.33 136.21 4.17 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.989 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 75.19 123.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.856 0.862 . . . . 0.0 113.262 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.78 -2.74 58.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.75 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 286' ' ' PRO . 1.4 p-10 -85.71 146.15 43.2 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.562 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . 2.6 Cg_endo -75.77 141.47 24.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.169 2.579 . . . . 0.0 113.341 -170.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 279' ' ' ASP . 88.7 mt -96.09 7.46 46.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.957 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 143.63 138.08 3.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.646 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . . . -106.08 142.26 36.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.736 0.303 . . . . 0.0 110.76 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 275' ' ' LEU . 59.8 mt -98.41 131.99 44.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -88.38 91.88 8.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 56.5 mt -73.0 -32.43 65.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.647 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -61.24 96.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.002 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 116.25 2.4 19.94 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.218 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.575 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 13.0 p -97.85 154.1 17.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.256 0.551 . . . . 0.0 111.455 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.9 t -119.5 150.45 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 298' ' ' THR . 48.5 t -119.75 158.38 21.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 7.6 t -160.11 136.65 8.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.013 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.6 p -73.2 138.32 45.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.164 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.745 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 59.0 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.107 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -85.16 42.7 0.96 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 312' ' ' GLU . 11.5 p 46.42 50.41 12.51 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.074 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -128.25 44.57 2.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.408 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.516 ' HB3' ' OE2' ' A' ' 311' ' ' GLU . 41.9 t -86.19 -72.46 0.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -177.04 90.43 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 310' ' ' GLU . . . -137.66 -159.02 8.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.672 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 307' ' ' ARG . 44.2 mtt180 -82.19 -63.37 1.39 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.33 0.586 . . . . 0.0 109.507 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -116.73 -60.89 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 67.5 m -163.28 98.16 0.92 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.169 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.683 ' HG2' ' HA3' ' A' ' 306' ' ' GLY . 7.6 mm-40 -96.44 -39.11 9.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.952 0.882 . . . . 0.0 109.432 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.673 ' HB3' HD12 ' A' ' 314' ' ' LEU . 26.4 mp0 -81.83 50.13 1.48 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.07 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.642 ' HA ' ' HB3' ' A' ' 302' ' ' SER . 33.4 mt-10 -73.1 -15.02 61.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 112.037 -172.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 328' ' ' GLN . 83.4 m-20 -122.27 20.67 10.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.22 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.745 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.8 OUTLIER -74.92 132.45 41.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.139 -178.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -131.0 133.02 45.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 43.6 tt0 -93.03 132.82 36.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.744 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 87.2 mt -113.24 105.29 18.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.84 90.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.679 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.575 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 20.4 p -59.56 176.66 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.98 68.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.555 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.58 -8.42 55.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.89 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 68.17 45.19 1.3 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.706 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.29 134.81 43.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 34.1 m-70 -83.77 112.05 19.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 51.5 m-85 -99.69 103.51 15.18 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 15.9 m-30 -84.49 110.01 18.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.595 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 94.1 mt -118.37 151.89 36.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.508 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 36.0 mt-30 -136.18 146.03 46.4 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.282 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -108.52 171.99 7.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.876 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.02 68.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -116.46 160.37 36.4 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.57 -23.67 76.21 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.027 2.485 . . . . 0.0 112.477 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.59 -38.67 23.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.597 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.543 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.4 tp10 -57.41 -44.07 84.27 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.48 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 339' ' ' ILE . 21.3 ptt180 -60.46 -40.8 92.51 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.173 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 340' ' ' LYS . 27.2 m -55.61 -45.24 77.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.503 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.426 ' HA ' ' HE3' ' A' ' 340' ' ' LYS . 74.7 mm-40 -58.94 -36.36 74.65 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.126 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.475 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 86.3 m95 -78.0 -35.32 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 343' ' ' GLN . 82.3 mt -54.25 -55.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 336' ' ' THR . 51.0 mtmt -58.7 -42.51 88.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.121 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.596 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.05 -52.14 66.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.919 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.26 -42.95 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 39.0 mt-30 -65.94 -33.45 75.86 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.462 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.7 ptm -80.83 -28.93 36.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.961 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 270' ' ' GLU . . . -80.99 -30.86 34.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.605 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 16.6 p -78.0 -10.85 59.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -92.53 29.78 1.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.739 HG21 ' HG2' ' A' ' 270' ' ' GLU . 2.9 p -103.59 145.09 30.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 141.46 28.24 0.18 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.219 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.846 173.476 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 235' ' ' VAL . 7.4 p -77.76 71.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 122.623 1.201 . . . . 0.0 109.527 172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.1 mt -118.89 117.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.292 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -95.98 -174.96 3.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.335 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 78.8 mttt -53.71 138.26 35.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 272' ' ' PRO . 3.6 mp0 -59.11 -26.18 64.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.097 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 55.7 mt-10 -50.58 -31.67 16.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.738 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.589 ' HB2' HD11 ' A' ' 237' ' ' LEU . 31.0 m-85 -114.09 -5.85 13.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.432 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 79.8 mtp180 -80.48 -14.47 58.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -87.68 148.06 20.88 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 70.0 t -77.37 147.89 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.221 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.4 mp -67.31 119.81 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.91 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.8 -45.18 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.225 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.544 ' HE2' ' NE1' ' A' ' 338' ' ' TRP . 75.1 tttt -165.44 140.74 5.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.249 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.485 ' HB3' HD12 ' A' ' 267' ' ' ILE . 4.4 pt20 -134.32 156.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 111.293 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.47 156.38 8.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 73.5 m -78.44 131.48 36.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.165 0.482 . . . . 0.0 110.415 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.4 mt -133.68 150.55 51.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.4 mp -79.4 145.15 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 261' ' ' TRP . 25.9 mtmm -128.29 129.31 46.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.22 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 261' ' ' TRP . 50.2 tt0 -108.33 143.2 37.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.035 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 63.23 62.3 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.995 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -157.5 74.37 0.75 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 75.29 -23.97 0.23 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.856 0.862 . . . . 0.0 112.133 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -96.8 165.66 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.07 -73.66 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.144 0.497 . . . . 0.0 110.24 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -96.58 -178.15 4.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.612 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.577 ' CE2' ' HB2' ' A' ' 254' ' ' GLN . 70.9 m95 -62.67 133.35 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 35.7 mmtm -125.63 161.49 27.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 0.0 112.206 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.69 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.86 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.622 ' NH1' HD13 ' A' ' 287' ' ' LEU . 96.4 mtt180 -141.25 149.35 41.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.197 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -77.63 121.16 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.608 -169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.736 ' O ' HD13 ' A' ' 267' ' ' ILE . 21.7 m-85 -95.17 145.56 24.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.623 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 266' ' ' PHE . 16.4 mm -134.51 124.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 39.9 tp -100.92 147.55 26.01 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 240' ' ' GLU . 58.8 mtt-85 -143.53 131.75 21.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -174.9 4.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.446 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.996 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 13.7 t70 93.54 -75.89 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 125.83 1.652 . . . . 0.0 110.432 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.996 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 6.7 Cg_endo -92.23 -6.94 3.17 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 CA-C-N 121.344 1.516 . . . . 0.0 111.495 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 69.19 93.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.967 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 50.0 m-85 -138.63 112.52 8.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.156 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 46.4 tp -90.38 141.08 29.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.446 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 67.7 m80 -134.46 153.42 51.93 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.29 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -137.19 137.28 38.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.695 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 267' ' ' ILE . 20.2 m-85 -128.13 164.09 23.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.234 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 281' ' ' ALA . 31.0 t70 -93.95 124.92 54.91 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-O 120.925 0.393 . . . . 0.0 110.428 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.59 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 90.4 Cg_endo -70.66 -21.3 29.48 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 123.669 2.913 . . . . 0.0 110.601 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.564 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -81.06 -21.02 40.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.185 -170.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.69 65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.071 -1.062 . . . . 0.0 113.859 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -160.45 120.75 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.852 0.326 . . . . 0.0 111.514 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -90.64 -15.47 30.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.26 137.11 86.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.175 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.3 122.32 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.074 1.849 . . . . 0.0 111.108 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.622 HD13 ' NH1' ' A' ' 264' ' ' ARG . 29.8 mt -81.29 2.85 26.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 161.08 156.83 8.43 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.521 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.92 124.42 43.17 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.633 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 50.4 mt -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -86.29 99.92 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.817 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.583 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 68.4 mt -75.86 -80.0 0.09 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.294 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.803 ' HG3' ' HA ' ' A' ' 350' ' ' LYS . 32.3 ttm180 37.71 -90.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -170.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -105.73 51.43 0.76 Allowed Glycine 0 C--N 1.317 -0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.996 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 28.0 p -90.54 122.02 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 110.755 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.48 143.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.1 t -122.18 156.33 26.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 316' ' ' GLU . 10.8 t -145.34 138.43 26.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.169 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 32.9 t -80.36 99.14 7.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.925 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 25.3 t -81.63 101.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.457 0.646 . . . . 0.0 110.389 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.15 58.91 3.84 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.86 0.838 . . . . 0.0 108.798 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 64.0 m 65.76 29.11 10.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.397 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.552 ' HB2' HG13 ' A' ' 300' ' ' VAL . 14.1 m120 -63.06 -16.85 61.28 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.626 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 31.5 t -65.48 126.37 28.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.842 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 60.99 59.34 2.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.814 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.26 -86.15 1.3 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.95 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -148.41 -27.72 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -143.84 95.2 2.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.399 0.619 . . . . 0.0 111.768 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.9 t -101.52 -160.58 0.8 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 166.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -77.49 -36.7 52.42 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.883 0.849 . . . . 0.0 109.476 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.675 ' HB3' HD12 ' A' ' 314' ' ' LEU . 1.5 mp0 -52.3 113.44 1.04 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.589 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.45 178.87 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 162.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.1 m120 56.33 20.55 4.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.925 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -83.98 136.01 34.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.942 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 338' ' ' TRP . 23.1 p90 -133.36 118.77 18.85 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -87.2 134.46 33.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.119 -174.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -109.01 104.72 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 21.4 mt -94.06 88.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.977 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 65.1 p -55.46 165.12 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.267 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -72.63 1.37 8.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.59 13.5 25.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.425 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 66.31 32.19 7.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.0 126.98 55.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -94.17 113.04 24.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.507 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 30.6 m-85 -96.92 138.58 34.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.476 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 51.6 m-85 -114.89 121.07 42.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.299 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 81.1 mt -133.69 155.45 49.71 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.881 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.6 mt-30 -135.65 135.83 40.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -103.51 175.36 5.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.545 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.83 -53.07 36.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 0.0 110.984 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -114.51 164.08 17.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.531 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 32.6 Cg_exo -61.34 -35.89 81.62 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.21 1.94 . . . . 0.0 111.255 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.82 -45.93 76.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.688 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.458 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 8.3 tp10 -55.95 -47.48 77.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.664 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 332' ' ' PRO . 0.6 OUTLIER -62.51 -44.42 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.944 -176.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -56.5 -36.97 69.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.58 ' HA ' ' HE2' ' A' ' 340' ' ' LYS . 14.3 mt-10 -77.18 -29.5 54.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.605 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.544 ' NE1' ' HE2' ' A' ' 247' ' ' LYS . 50.3 m95 -67.91 -32.32 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.235 -0.291 . . . . 0.0 110.537 171.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 336' ' ' THR . 90.1 mt -54.42 -56.32 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 168.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 337' ' ' GLU . 58.6 mtmt -52.14 -47.1 65.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.243 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -55.74 -55.79 28.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.327 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.432 HG23 HD22 ' A' ' 292' ' ' LEU . 2.2 mp -70.16 -36.25 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.902 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 18.5 mt-30 -73.54 -32.69 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.031 -0.418 . . . . 0.0 111.624 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.4 ptm -78.9 -26.41 43.81 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.616 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.14 -35.42 31.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 293' ' ' ARG . 3.2 p -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.01 0.433 . . . . 0.0 112.14 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -85.35 9.5 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.828 -170.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.4 p -85.2 -28.56 25.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.431 . . . . 0.0 110.224 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -136.62 43.73 1.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.869 -174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.803 ' HA ' ' HG3' ' A' ' 293' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.226 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.05 86.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.112 0.482 . . . . 0.0 111.037 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.29 97.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.7 OUTLIER -98.38 -167.47 1.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.031 -174.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.478 ' HB3' ' OE1' ' A' ' 240' ' ' GLU . 45.2 mmtm -82.67 152.74 25.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.923 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 242' ' ' ARG . 33.6 tt0 -54.96 -28.07 48.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.305 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.478 ' OE1' ' HB3' ' A' ' 238' ' ' LYS . 32.4 mp0 -56.05 -23.0 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 237' ' ' LEU . 1.8 m-85 -112.66 -2.57 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 91.8 mtt180 -75.61 -3.32 33.73 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.968 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -96.23 160.3 22.14 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.53 145.95 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 117.299 0.55 . . . . 0.0 111.24 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 267' ' ' ILE . 6.7 mt -62.57 128.21 23.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.155 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.43 HD11 ' OE1' ' A' ' 270' ' ' GLU . 18.3 mm -94.85 -49.77 12.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.866 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.8 tttp -155.17 137.76 15.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.539 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.17 137.13 50.99 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 174.61 156.09 13.41 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.937 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 12.1 m -84.83 138.73 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.795 0.297 . . . . 0.0 110.291 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 85.5 mt -135.21 172.28 13.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.3 mp -97.52 122.88 41.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.282 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -105.24 118.85 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.225 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 6.3 tp-100 -73.97 110.17 8.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 170.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.18 -62.13 0.27 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.512 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -138.68 135.16 34.53 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' A' ' 259' ' ' LYS . 8.8 mpt_? -64.91 171.29 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.914 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 257' ' ' ARG . 18.7 mtm180 75.42 -29.12 0.19 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.552 0.741 . . . . 0.0 110.418 -172.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 257' ' ' ARG . 29.4 mmtp -111.58 -35.8 5.68 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 67.25 -103.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.205 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.554 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 74.3 m95 -102.22 122.7 44.71 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.704 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.442 ' HD2' ' NH2' ' A' ' 264' ' ' ARG . 29.3 mttt -103.04 145.75 29.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.556 0.693 . . . . 0.0 111.873 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.91 105.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.23 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.701 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.4 mtt180 -135.34 151.41 50.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.258 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 87.9 tttt -89.93 121.56 32.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.017 0.437 . . . . 0.0 110.77 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 26.1 m-85 -100.81 123.75 45.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.601 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 248' ' ' GLN . 43.9 mt -115.8 125.81 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.363 0.602 . . . . 0.0 110.913 171.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 55.5 tp -101.49 156.06 17.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.044 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 243' ' ' GLY . 62.0 mtt-85 -148.34 138.81 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' A' ' 246' ' ' ILE . 2.6 pt-20 -105.45 134.75 48.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.531 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 1.005 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 37.9 t70 147.86 -61.59 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.846 1.659 . . . . 0.0 108.511 170.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 10.9 Cg_endo -94.08 -10.06 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 111.087 168.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.24 93.4 0.06 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.091 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.631 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 60.2 m-85 -145.53 133.38 21.22 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.127 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 290' ' ' ILE . 60.8 tp -95.9 141.18 29.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 32.6 m80 -130.18 122.99 29.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.454 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.31 127.81 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.366 0.603 . . . . 0.0 111.222 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -117.03 158.59 23.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.105 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.501 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 1.8 t70 -94.96 122.06 61.11 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.701 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -70.69 -19.29 31.86 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 110.776 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -98.87 -4.83 32.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.391 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.15 60.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.317 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.501 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -175.84 101.8 0.07 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 110.851 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -89.34 -4.5 58.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.309 0.576 . . . . 0.0 109.901 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.31 138.68 41.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.64 112.51 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.769 . . . . 0.0 111.406 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.78 -21.1 66.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.138 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 179.9 129.59 1.36 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.057 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.06 104.72 16.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.679 HD12 HD23 ' A' ' 275' ' ' LEU . 39.8 mt -66.38 134.18 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.099 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -83.19 87.68 6.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.115 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 45.9 mt -74.05 -26.96 60.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.329 -173.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -51.37 101.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.816 0.341 . . . . 0.0 110.984 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 91.79 14.08 57.1 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.997 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.3 p -89.72 139.07 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.299 0.549 . . . . 0.0 110.96 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 6.4 t -105.22 144.48 14.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.38 155.05 21.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 316' ' ' GLU . 11.9 t -150.23 144.53 25.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.46 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.0 t -87.51 101.29 13.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 28.6 t -74.32 123.7 30.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.49 27.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 111.281 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.492 ' OG ' ' HA ' ' A' ' 312' ' ' GLU . 45.7 m 57.01 51.34 10.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.714 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -113.14 65.52 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 34.1 t -89.2 -65.92 0.97 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.135 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.29 -1.31 48.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.306 0.574 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 149.52 -160.63 28.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -66.75 -33.36 75.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.655 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.32 107.84 19.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.611 171.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.2 m -134.08 152.7 51.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.198 0.523 . . . . 0.0 110.55 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.68 -31.01 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.273 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.774 ' HA ' ' NE2' ' A' ' 328' ' ' GLN . 43.8 mp0 -67.5 68.69 0.1 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.031 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.492 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 37.0 mt-10 -85.92 144.72 27.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 335' ' ' ARG . 91.2 m-20 64.33 30.4 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.229 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.9 OUTLIER -73.96 128.41 35.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.839 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -125.38 126.14 44.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 168.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.486 ' OE1' ' HE1' ' A' ' 326' ' ' PHE . 36.3 tt0 -91.51 138.05 31.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 96.9 mt -114.04 108.43 25.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.63 91.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.725 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.2 p -57.24 169.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.31 -27.89 69.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.69 -8.12 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.276 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 70.11 37.26 1.71 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.772 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 31.1 t -99.59 131.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.356 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -93.47 113.86 26.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 54.6 m-85 -99.76 127.76 45.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 16.1 m-30 -100.07 119.59 38.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.176 0.512 . . . . 0.0 111.188 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 93.1 mt -130.68 154.12 48.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.057 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.774 ' NE2' ' HA ' ' A' ' 311' ' ' GLU . 69.7 mt-30 -137.71 147.41 44.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.113 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -120.44 147.59 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.848 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.48 -27.81 68.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.286 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 334' ' ' GLU . 38.1 p -119.1 142.52 32.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.441 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.84 -27.13 84.23 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.296 2.664 . . . . 0.0 112.508 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.595 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 62.7 mttm -71.74 -46.88 57.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.797 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.1 tp10 -53.12 -49.5 66.4 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.358 0.411 . . . . 0.0 111.147 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.4 ptt180 -60.53 -45.22 94.64 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.35 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 335' ' ' ARG . 9.9 m -57.8 -44.13 86.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.842 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 35.2 mm-40 -58.54 -43.17 89.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.478 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 71.1 m95 -71.89 -32.12 67.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 335' ' ' ARG . 95.6 mt -56.57 -57.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.1 mtmt -57.02 -49.81 74.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.892 176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -51.75 -54.28 30.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 111.45 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.512 HG23 HD13 ' A' ' 292' ' ' LEU . 10.7 mt -69.3 -42.83 81.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.782 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 27.3 mt-30 -62.78 -39.47 94.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.402 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 15.6 ptp -76.89 -25.1 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.537 0.208 . . . . 0.0 110.963 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.96 60.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.979 0.419 . . . . 0.0 110.798 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 45.9 t -79.76 -3.98 49.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.498 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -77.91 -8.4 58.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 41.8 p -79.21 -18.07 53.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -85.66 60.75 4.64 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.912 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 52.2 mttm . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.946 175.345 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.04 94.45 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 66.2 mt -134.52 122.61 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.639 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -80.27 -170.62 2.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.84 -178.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.445 ' HB3' ' OE1' ' A' ' 240' ' ' GLU . 47.0 mmtm -66.0 160.13 24.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.34 0.591 . . . . 0.0 111.795 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 39.0 tt0 -62.62 -30.19 71.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.439 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 238' ' ' LYS . 1.9 mp0 -59.01 -24.37 62.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.195 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.517 ' CD2' HD22 ' A' ' 237' ' ' LEU . 0.3 OUTLIER -111.66 0.28 16.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 58.9 mtt85 -63.38 -26.96 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.082 0.468 . . . . 0.0 110.287 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.05 156.7 30.04 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.023 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.06 148.37 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.31 0.576 . . . . 0.0 111.682 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 267' ' ' ILE . 12.9 mt -56.1 115.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.793 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -84.58 -41.9 16.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.02 0.438 . . . . 0.0 110.251 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -167.56 152.02 6.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.277 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.548 ' CB ' HG12 ' A' ' 267' ' ' ILE . 8.7 pt20 -149.62 164.77 34.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 0.0 111.818 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.28 171.57 28.6 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 59.4 m -86.07 139.71 30.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.752 0.776 . . . . 0.0 109.708 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.8 mt -141.48 166.51 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 11.0 mp -102.61 125.63 49.41 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.681 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -105.13 124.54 49.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.657 ' HG2' ' H ' ' A' ' 256' ' ' HIS . 31.5 tt0 -71.58 125.63 27.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.831 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -87.04 23.84 10.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.054 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.657 ' H ' ' HG2' ' A' ' 254' ' ' GLN . 1.3 m80 55.11 71.21 0.55 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 111.896 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 258' ' ' ARG . 82.4 mtm180 61.08 -159.1 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.048 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 257' ' ' ARG . 14.3 ttp180 73.58 -55.29 0.67 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.48 0.487 . . . . 0.0 111.583 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -120.56 -90.93 0.57 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.051 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -173.18 -163.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 53.5 m95 -95.74 139.04 32.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.341 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 51.7 mttt -106.59 138.92 41.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 112.104 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 102.97 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.922 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.632 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.3 mtt180 -128.71 166.44 18.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.407 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -94.0 113.58 25.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.371 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.5 m-85 -101.97 128.18 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.415 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.548 HG12 ' CB ' ' A' ' 248' ' ' GLN . 17.1 mt -121.86 130.81 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.197 0.522 . . . . 0.0 110.66 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.555 HD11 HD11 ' A' ' 292' ' ' LEU . 43.6 tp -101.16 155.01 18.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.855 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.435 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 53.9 mtt-85 -149.55 138.86 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.637 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 4.9 pt-20 -93.89 -175.0 3.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.941 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 28.1 t70 93.63 -75.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 C-N-CA 125.814 1.646 . . . . 0.0 110.148 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 9.5 Cg_endo -91.39 -5.72 3.94 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 121.182 1.458 . . . . 0.0 111.671 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.69 91.34 0.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.132 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.2 m-85 -140.5 121.21 14.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 41.7 tp -89.42 139.39 30.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.177 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -129.8 142.7 50.64 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -132.3 140.22 48.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.204 0.526 . . . . 0.0 110.848 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' HD13 ' A' ' 287' ' ' LEU . 5.1 m-85 -129.37 162.34 28.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -90.59 122.58 66.93 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.133 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.632 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -68.16 -15.21 42.48 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.184 2.589 . . . . 0.0 111.069 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.89 15.24 15.24 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.06 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -159.24 -112.72 0.32 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.993 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.04 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.33 -0.58 49.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.424 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 287' ' ' LEU . 4.4 m-20 -73.31 139.78 79.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 28.8 Cg_endo -61.79 118.8 5.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.019 1.812 . . . . 0.0 112.78 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.023 HD13 ' HA ' ' A' ' 278' ' ' TYR . 5.8 mp -84.15 -5.65 59.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.117 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.04 157.56 21.0 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.109 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -135.68 100.67 4.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.211 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 62.8 mt -84.43 88.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.689 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.577 ' NE2' ' HB2' ' A' ' 293' ' ' ARG . 13.4 t-80 -43.73 106.05 0.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.79 170.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 84.7 mt -87.23 -19.89 27.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.867 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.577 ' HB2' ' NE2' ' A' ' 291' ' ' HIS . 96.5 mtt180 -59.35 104.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.363 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 108.16 3.28 33.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.489 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 17.1 p -85.67 147.53 26.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 111.977 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 142.38 29.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 99.6 t -117.83 153.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.963 0.411 . . . . 0.0 110.406 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 316' ' ' GLU . 13.6 t -153.43 145.61 23.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.923 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.7 t -83.76 102.32 12.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.748 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 314' ' ' LEU . 12.7 t -92.47 102.85 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.614 . . . . 0.0 110.188 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.747 ' HG2' HH12 ' A' ' 335' ' ' ARG . 21.0 mt-10 -91.53 74.75 5.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.665 ' HA ' ' HB2' ' A' ' 311' ' ' GLU . 87.7 p 60.71 122.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.182 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -172.08 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.954 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 308' ' ' LYS . 13.4 t -84.54 80.46 9.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.623 0.725 . . . . 0.0 109.502 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.28 117.75 6.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.391 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.67 -7.68 27.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.42 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.849 ' HA ' ' HE ' ' A' ' 307' ' ' ARG . 1.0 OUTLIER -126.89 -72.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.724 -0.28 . . . . 0.0 111.137 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 310' ' ' GLU . 6.9 tttp -177.41 164.55 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.92 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.1 m -99.66 70.97 1.69 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.127 0.489 . . . . 0.0 109.962 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 308' ' ' LYS . 8.6 mm-40 -91.7 -32.38 15.45 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.799 0.809 . . . . 0.0 110.52 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.729 ' HG2' HD12 ' A' ' 314' ' ' LEU . 3.1 mp0 -51.36 125.23 13.72 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.314 -174.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.82 132.27 54.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.955 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 335' ' ' ARG . 74.2 m-20 67.37 22.76 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.409 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 311' ' ' GLU . 1.3 tt -66.93 134.7 52.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.997 0.427 . . . . 0.0 109.94 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.453 ' N ' HD23 ' A' ' 314' ' ' LEU . 29.9 p90 -132.47 136.85 46.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.492 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -99.41 136.67 39.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.781 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.4 mt -115.89 110.84 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.3 mt -101.82 83.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.936 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 72.3 p -62.85 177.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.989 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -64.49 -13.32 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 110.929 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.88 -6.36 54.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.394 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.09 27.67 10.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.763 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.7 130.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -90.41 113.43 25.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 45.9 m-85 -95.46 119.35 33.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.475 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 3.0 m-85 -96.65 116.03 28.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.895 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 78.2 mt -127.31 157.75 39.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.673 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.3 mt-30 -135.99 139.65 43.32 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -110.06 160.68 16.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.336 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -55.64 -50.4 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.247 0.342 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 32.1 p -127.12 162.63 46.84 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.049 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.15 -43.17 61.69 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.393 2.062 . . . . 0.0 111.964 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 337' ' ' GLU . 17.8 tppt? -55.17 -44.92 75.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.036 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 7.7 tp10 -60.39 -52.34 65.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.033 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.747 HH12 ' HG2' ' A' ' 301' ' ' GLU . 11.5 ptt180 -59.35 -43.32 92.81 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.977 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.645 HG22 ' HE2' ' A' ' 340' ' ' LYS . 11.1 m -58.64 -40.52 83.62 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.646 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 333' ' ' LYS . 57.0 mt-10 -65.28 -33.15 75.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 121.259 -0.176 . . . . 0.0 110.973 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' A' ' 334' ' ' GLU . 76.7 m95 -73.43 -38.44 65.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.416 0.15 . . . . 0.0 111.106 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 336' ' ' THR . 97.6 mt -53.38 -54.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.645 ' HE2' HG22 ' A' ' 336' ' ' THR . 65.7 mttm -59.87 -40.24 87.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.709 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.64 -54.64 44.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.661 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.636 HG23 HD22 ' A' ' 292' ' ' LEU . 2.0 mp -64.79 -44.62 96.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.351 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -64.38 -36.79 85.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.3 ptp -81.21 -31.29 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.695 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -74.02 -29.87 62.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.457 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.47 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 42.3 t -67.16 -14.58 63.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.692 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -109.36 18.13 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.022 -0.424 . . . . 0.0 111.299 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 23.8 p -90.41 4.2 51.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.256 0.551 . . . . 0.0 110.73 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -99.66 8.24 59.86 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.432 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.879 -0.582 . . . . 0.0 110.065 178.666 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.67 0.272 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.55 86.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.314 1.054 . . . . 0.0 110.36 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.0 mt -109.65 102.65 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.357 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 241' ' ' PHE . 1.9 pt? -134.52 -166.11 1.76 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.16 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 241' ' ' PHE . 14.2 mmmm -55.54 142.24 34.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.534 0.683 . . . . 0.0 111.152 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 242' ' ' ARG . 37.9 tt0 -64.95 -29.96 70.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.04 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 240' ' ' GLU . 1.8 mp0 -60.79 -28.28 68.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.565 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 29.5 m-85 -104.55 -5.61 21.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.604 0.24 . . . . 0.0 111.1 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 31.8 mtp180 -64.93 -21.33 66.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 110.503 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.23 152.56 26.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.8 t -84.34 145.26 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.43 0.292 . . . . 0.0 110.665 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mp -69.82 114.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.412 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 270' ' ' GLU . 25.8 mm -78.99 -43.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.832 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.5 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 53.4 tttp -158.26 139.59 13.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.963 -169.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.424 ' HG3' HG21 ' A' ' 245' ' ' ILE . 1.4 mp0 -127.3 145.35 50.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.81 144.84 4.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.264 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 11.0 m -72.51 137.62 46.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 99.5 mt -133.65 163.26 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -90.74 123.73 34.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 327' ' ' LEU . 64.3 tttm -110.95 117.29 32.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.808 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 5.6 tp-100 -62.55 104.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -91.29 -40.9 5.33 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.055 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -170.16 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.78 0.29 . . . . 0.0 110.898 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.693 ' HG2' ' H ' ' A' ' 258' ' ' ARG . 34.2 ttp85 -176.91 -177.39 0.76 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.693 ' H ' ' HG2' ' A' ' 257' ' ' ARG . 50.1 ttt180 70.82 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.508 0.723 . . . . 0.0 110.373 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -79.12 -26.81 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t30 69.79 -79.91 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.253 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.55 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 84.9 m95 -101.73 134.84 44.25 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.693 -172.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.92 126.3 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.182 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 81.6 t -91.11 104.34 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.018 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 278' ' ' TYR . 2.8 ptp180 -148.05 162.71 38.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.723 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 50.1 tttp -79.32 116.11 19.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.546 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 37.1 m-85 -102.31 124.94 48.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 111.852 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 245' ' ' ILE . 56.6 mt -119.08 128.92 75.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.799 172.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 47.7 tp -98.55 154.97 17.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.672 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 52.7 mtt-85 -147.66 136.24 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.582 0.229 . . . . 0.0 110.452 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.688 ' HB2' HG21 ' A' ' 348' ' ' THR . 0.8 OUTLIER -100.9 127.31 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 1.008 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.0 t70 154.36 -65.74 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.456 1.502 . . . . 0.0 108.844 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 19.6 Cg_endo -96.36 -8.25 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.635 2.223 . . . . 0.0 111.633 173.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 346' ' ' SER . . . 65.16 89.88 0.09 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.839 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 55.8 m-85 -139.87 129.24 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.044 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 290' ' ' ILE . 25.6 tp -94.55 134.09 37.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.209 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 73.3 m80 -120.47 129.74 53.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.853 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.543 ' HE1' HG13 ' A' ' 290' ' ' ILE . 0.9 OUTLIER -115.08 122.72 47.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.834 176.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.624 ' O ' ' HB2' ' A' ' 264' ' ' ARG . 50.6 m-85 -106.77 -167.63 1.31 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.751 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 17.4 t70 -125.82 129.55 24.29 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.755 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.4 Cg_endo -72.51 -19.15 25.22 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 123.16 2.573 . . . . 0.0 111.572 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.02 -28.29 12.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.09 75.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.236 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -175.84 103.07 0.07 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.748 0.419 . . . . 0.0 110.406 171.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -85.15 -14.03 48.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.625 0.726 . . . . 0.0 109.228 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.84 143.66 26.49 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.243 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.09 143.51 54.33 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.762 2.308 . . . . 0.0 113.412 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -80.39 -7.24 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.123 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 158.61 -179.41 34.3 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.427 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.71 128.95 27.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.471 0.177 . . . . 0.0 110.604 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.653 HD12 HD23 ' A' ' 275' ' ' LEU . 46.1 mt -79.11 136.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -86.53 80.48 8.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.588 HD13 HG23 ' A' ' 342' ' ' ILE . 64.9 mt -61.36 -59.55 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -18.95 86.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.941 1.4 . . . . 0.0 113.735 -172.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 109.81 20.67 7.52 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.433 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 30.5 p -93.1 145.57 24.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.599 . . . . 0.0 112.235 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.04 146.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.07 156.81 26.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 11.6 t -145.39 134.25 22.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 110.479 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 14.2 p -82.77 99.25 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.8 t -83.83 118.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.394 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.39 139.7 46.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -47.83 95.69 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.578 1.174 . . . . 0.0 113.186 -166.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.31 112.67 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.568 174.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.48 21.08 2.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.13 68.65 0.76 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.218 0.532 . . . . 0.0 109.697 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 167.48 -123.18 1.1 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.053 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -135.48 143.84 46.06 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.054 0.142 . . . . 0.0 110.647 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 56.92 84.46 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.722 0.639 . . . . 0.0 112.026 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.9 p -80.44 115.19 19.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.333 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -90.27 -29.71 17.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.37 1.081 . . . . 0.0 108.254 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.785 ' HA ' HE22 ' A' ' 328' ' ' GLN . 25.9 mp0 -62.62 101.16 0.23 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.761 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.04 158.93 22.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.352 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.831 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 8.2 p30 41.41 45.66 2.74 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.308 1.005 . . . . 0.0 111.482 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.706 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -77.65 135.31 38.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.452 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -129.5 121.97 28.3 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.487 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 35.1 tt0 -92.2 138.68 31.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.551 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 94.6 mt -111.93 110.33 31.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.9 mt -96.48 85.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 40.4 p -60.98 175.85 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.876 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.53 -20.56 65.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.362 0.601 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.7 3.07 26.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.182 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 57.53 38.57 28.02 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.021 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.36 127.81 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.969 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -85.15 112.51 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 36.6 m-85 -98.36 125.25 43.42 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.55 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 48.9 m-85 -100.35 119.67 38.78 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.0 111.008 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 96.3 mt -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.507 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.785 HE22 ' HA ' ' A' ' 311' ' ' GLU . 77.9 mt-30 -142.65 150.17 39.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.367 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -108.46 -168.63 1.38 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.388 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.3 -38.78 17.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.398 . . . . 0.0 110.208 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 332' ' ' PRO . 61.9 p -119.48 149.3 47.54 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.644 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 34.2 Cg_exo -63.3 -14.82 44.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.559 2.839 . . . . 0.0 113.595 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -93.13 -32.81 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.449 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.37 -37.39 87.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 110.296 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.831 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.66 -43.79 97.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.22 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.66 ' HA ' HD12 ' A' ' 339' ' ' ILE . 5.1 m -57.21 -44.23 83.49 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.116 0.484 . . . . 0.0 110.39 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -60.56 -36.93 79.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.055 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.5 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 52.4 m95 -70.96 -30.69 67.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.508 0.194 . . . . 0.0 111.126 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 336' ' ' THR . 74.1 mt -58.94 -51.85 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 336' ' ' THR . 43.0 mmtt -53.07 -54.68 31.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.554 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -52.64 -57.18 10.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.814 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.588 HG23 HD13 ' A' ' 292' ' ' LEU . 35.4 mt -70.44 -42.77 78.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.369 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.76 -33.86 76.98 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.502 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.7 ptm -79.46 -20.97 46.09 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.614 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.96 -22.04 36.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.44 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 40.8 t -89.02 9.45 25.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -117.24 22.37 12.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.688 HG21 ' HB2' ' A' ' 270' ' ' GLU . 16.6 p -86.37 9.06 19.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.753 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -101.24 -53.04 1.03 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.467 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.42 176.143 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 235' ' ' VAL . 1.3 m-20 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.407 ' H ' ' HB3' ' A' ' 234' ' ' ASP . 7.2 p -66.28 75.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 122.548 1.166 . . . . 0.0 110.466 172.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 78.6 mt -101.33 106.64 19.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.42 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.462 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.7 OUTLIER -74.04 -165.48 0.31 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.197 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' A' ' 237' ' ' LEU . 81.4 mttt -56.07 166.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.942 0.877 . . . . 0.0 112.862 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 242' ' ' ARG . 36.9 tt0 -70.17 -29.12 65.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.584 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.62 -41.27 73.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.107 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.462 ' CD2' HD22 ' A' ' 237' ' ' LEU . 2.0 m-85 -101.44 1.01 37.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.399 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.455 ' HG3' ' HA ' ' A' ' 239' ' ' GLU . 99.1 mtt180 -52.86 -40.6 63.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.7 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -82.48 137.63 17.16 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 245' ' ' ILE . 40.1 t -77.16 169.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.546 ' N ' HG12 ' A' ' 244' ' ' VAL . 71.7 mt -56.75 116.6 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.381 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 270' ' ' GLU . 32.9 mm -84.96 -38.79 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.958 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.627 ' HE2' ' CE2' ' A' ' 338' ' ' TRP . 80.5 tttt -169.21 141.49 2.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.716 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.744 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.4 OUTLIER -144.11 162.72 35.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.831 175.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.66 173.0 30.84 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.98 139.18 34.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.611 0.706 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.6 mt -143.72 160.85 39.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.4 mp -98.47 125.96 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -113.72 124.67 52.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.623 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 60.4 tt0 -80.39 152.8 28.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.651 175.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 138.31 165.68 10.4 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.277 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 22.3 m170 69.97 136.72 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.652 0.739 . . . . 0.0 112.035 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 257' ' ' ARG . 11.6 ptt180 -79.07 158.86 27.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.465 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 60.8 31.91 20.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.596 0.712 . . . . 0.0 109.667 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -164.21 163.55 22.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.535 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 254' ' ' GLN . 3.8 p30 -129.96 -85.69 0.53 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.522 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 69.4 m95 -118.39 130.8 56.19 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.502 ' HD3' ' NH2' ' A' ' 264' ' ' ARG . 5.9 mtpt -105.38 140.76 38.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.128 0.49 . . . . 0.0 111.368 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.44 99.01 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.502 ' NH2' ' HD3' ' A' ' 262' ' ' LYS . 55.7 mtt-85 -116.57 148.38 40.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.033 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.31 110.54 18.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 20.1 m-85 -93.98 153.06 18.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.744 HG12 ' HB3' ' A' ' 248' ' ' GLN . 6.9 mt -144.96 125.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.815 0.697 . . . . 0.0 109.856 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.3 tp -99.85 145.39 27.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.102 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -149.56 131.43 15.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.8 OUTLIER -99.9 -170.72 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.672 -170.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.987 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 12.1 t70 95.02 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.661 1.584 . . . . 0.0 110.253 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.987 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.6 Cg_endo -91.38 -6.29 3.81 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 CA-C-N 120.859 1.342 . . . . 0.0 111.025 164.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.35 95.18 0.05 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.734 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 14.6 m-85 -137.62 115.27 11.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 44.7 tp -89.72 139.34 30.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.133 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 274' ' ' TYR . 75.5 m80 -130.24 144.3 51.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.416 ' HB3' ' CE2' ' A' ' 266' ' ' PHE . 8.2 p90 -131.4 139.05 49.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 110.712 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -119.56 -165.09 1.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.22 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -130.13 129.81 22.99 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 -17.08 22.26 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.854 2.369 . . . . 0.0 111.594 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.71 -12.18 17.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.237 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.86 84.32 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.91 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.54 117.32 0.2 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.447 0.641 . . . . 0.0 110.61 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -94.4 -30.54 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.825 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -75.23 142.41 75.3 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.778 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 125.92 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.163 1.908 . . . . 0.0 111.666 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.11 3.41 17.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.098 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 170.36 139.25 2.69 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -110.54 112.13 23.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.82 0.343 . . . . 0.0 110.308 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 63.8 mt -85.16 132.17 32.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.549 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.09 95.66 9.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.59 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.751 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 81.2 mt -79.87 -28.96 39.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.098 -172.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -52.97 103.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.88 0.372 . . . . 0.0 111.103 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 97.08 9.89 55.38 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.012 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' CYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.6 p -88.45 144.51 26.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.992 0.425 . . . . 0.0 110.778 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.01 144.62 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 91.4 t -119.38 150.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -148.59 142.01 25.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.463 -175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.7 t -76.36 108.5 9.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.915 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 51.3 t -97.2 110.32 24.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.189 0.519 . . . . 0.0 110.675 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.17 51.52 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.419 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.2 t 68.38 104.15 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.846 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -178.11 50.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.131 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 24.9 t -73.5 157.91 35.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.739 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -78.78 71.71 5.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.308 0.575 . . . . 0.0 111.059 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -156.56 -125.34 0.88 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.76 148.16 32.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 67.47 122.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.055 0.847 . . . . 0.0 111.834 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.0 p -68.17 107.81 2.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -107.76 -48.88 3.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.073 0.939 . . . . 0.0 109.683 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 311' ' ' GLU . 0.8 OUTLIER -61.75 138.66 58.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.751 -172.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 313' ' ' ASN . 44.6 mt-10 -140.73 133.24 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' A' ' 335' ' ' ARG . 86.1 m-20 76.19 28.51 0.81 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.851 0.719 . . . . 0.0 110.411 -174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -77.06 126.29 30.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.319 178.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.58 125.49 47.92 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.572 ' HB3' HG22 ' A' ' 298' ' ' THR . 4.8 tp10 -86.41 136.32 33.16 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.893 -174.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.7 103.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.17 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.042 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.463 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 38.1 p -53.16 159.21 1.32 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.053 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.67 -1.59 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.902 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.15 4.46 53.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.125 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.81 27.74 11.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.355 172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.38 135.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -82.69 118.95 23.71 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -112.2 97.68 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.178 0.514 . . . . 0.0 110.033 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 87.7 m-85 -80.23 118.74 22.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.273 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 314' ' ' LEU . 87.6 mt -125.9 152.02 46.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 39.4 mt-30 -139.61 144.89 37.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.679 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -117.79 171.94 7.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.837 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.12 -69.04 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.499 0.499 . . . . 0.0 111.34 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 77.1 p -102.55 161.22 23.93 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.005 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' PRO . . . . . 0.641 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 68.3 Cg_exo -52.08 -44.45 45.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.545 2.163 . . . . 0.0 112.07 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 57.8 tttp -55.28 -50.01 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.364 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.54 -42.45 96.56 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.475 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 313' ' ' ASN . 7.0 ppt_? -66.95 -39.03 87.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.348 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.572 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -60.81 -41.77 96.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.838 0.352 . . . . 0.0 110.68 170.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 80.2 mm-40 -59.05 -44.67 91.84 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' TRP . . . . . 0.627 ' CE2' ' HE2' ' A' ' 247' ' ' LYS . 60.4 m95 -65.17 -36.21 83.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 336' ' ' THR . 99.0 mt -53.17 -53.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.4 mtmt -57.37 -42.18 81.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.709 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.82 42.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.122 0.487 . . . . 0.0 110.81 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 292' ' ' LEU . 2.1 mp -66.69 -40.99 87.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.495 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.77 -36.48 84.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.41 -30.86 33.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.088 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.94 56.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.677 0.275 . . . . 0.0 111.573 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.614 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 30.1 t -75.02 -22.78 58.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 347' ' ' ARG . 42.4 mtm105 -101.34 25.32 8.41 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.06 -0.4 . . . . 0.0 111.864 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.6 p -82.5 112.14 19.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.891 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -144.16 10.82 2.04 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.346 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.124 179.268 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.569 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 33.7 tt0 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.757 0.313 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 60.1 mt-10 -55.65 -37.01 67.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.403 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -103.44 0.46 31.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -71.33 -8.65 55.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.04 0.447 . . . . 0.0 110.52 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -107.64 143.17 15.94 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.23 151.87 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.317 0.579 . . . . 0.0 111.716 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.8 mt -53.25 127.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.162 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.494 HD11 ' CG ' ' A' ' 270' ' ' GLU . 41.2 mm -96.71 -44.84 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.766 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.524 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 60.3 tttp -164.98 132.59 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.52 -173.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.562 ' CB ' HG12 ' A' ' 267' ' ' ILE . 4.8 pt20 -132.91 141.35 48.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.319 0.58 . . . . 0.0 111.795 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 177.51 151.66 9.38 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.79 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 61.6 m -71.01 135.06 47.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.119 0.46 . . . . 0.0 110.116 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.542 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 94.0 mt -131.61 169.51 16.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 8.1 mp -95.0 117.58 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.12 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.83 119.08 38.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.249 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 176.565 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.532 ' CZ2' ' HG3' ' A' ' 311' ' ' GLU . 89.7 m95 . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 24.2 mtpp -110.62 151.5 27.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 0.0 112.246 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.2 101.73 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.2 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 96.7 mtt180 -132.62 154.6 49.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.741 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 40.6 ttmt -79.39 120.66 24.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.68 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 35.9 m-85 -103.89 117.2 33.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 248' ' ' GLN . 18.6 mt -114.83 127.0 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 42.5 tp -99.5 154.42 18.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.906 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -150.67 139.61 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.64 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.631 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 13.5 pt-20 -101.08 -169.95 1.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.595 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 270' ' ' GLU . 0.8 OUTLIER 95.64 -70.17 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 110.9 -178.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 271' ' ' ASP . 14.4 Cg_endo -97.97 -6.66 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.647 1.564 . . . . 0.0 111.876 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 70.13 93.95 0.08 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.501 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 33.6 m-85 -141.62 119.48 11.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.331 0.586 . . . . 0.0 111.953 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 290' ' ' ILE . 38.8 tp -90.86 140.13 30.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.278 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 70.9 m80 -127.65 139.67 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.103 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.514 ' HE2' HG13 ' A' ' 290' ' ' ILE . 1.3 p90 -121.7 136.25 54.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.264 0.554 . . . . 0.0 111.088 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.91 147.48 50.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.555 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.528 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 7.7 t70 -90.35 132.65 34.98 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 97.1 Cg_endo -72.57 -24.14 19.09 Favored 'Trans proline' 0 CA--C 1.517 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 111.293 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.93 -12.51 23.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.376 -170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.38 59.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.622 -1.275 . . . . 0.0 114.525 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -171.42 73.02 0.05 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.773 0.286 . . . . 0.0 111.136 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.19 -9.51 59.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.62 134.17 88.52 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.077 167.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.98 105.02 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.906 1.737 . . . . 0.0 112.439 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.73 -28.09 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.035 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.7 35.97 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.6 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -121.18 135.67 55.11 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.791 0.329 . . . . 0.0 110.376 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.7 HD12 HD23 ' A' ' 275' ' ' LEU . 27.7 mt -85.42 131.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -85.37 88.66 7.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.633 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 51.9 mt -76.56 -26.81 55.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.845 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 293' ' ' ARG . 21.4 ttt180 -52.37 101.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 95.85 10.49 56.39 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.877 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 11.4 p -90.73 147.72 23.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.919 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.07 146.24 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.15 152.46 13.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 14.3 t -145.98 142.42 28.65 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.678 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 40.7 t -83.73 105.3 14.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.46 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 55.8 t . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.894 ' HB3' HD12 ' A' ' 314' ' ' LEU . 8.9 mp0 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.955 0.407 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.04 -68.42 0.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.926 0.87 . . . . 0.0 110.762 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 6.1 p30 -85.63 46.4 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 311' ' ' GLU . 0.7 OUTLIER -79.41 130.35 35.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.17 -176.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -127.67 134.0 49.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 36.9 tt0 -102.08 141.98 34.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.517 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.8 mt -116.34 110.8 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.0 mt -98.32 92.05 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.129 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.417 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 75.4 p -60.09 161.92 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.587 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.82 -17.62 61.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.23 0.538 . . . . 0.0 110.396 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.52 3.2 25.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.329 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 70.58 27.55 3.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.685 0.794 . . . . 0.0 111.834 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.61 126.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.019 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -91.35 113.62 25.93 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.23 111.43 23.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HD2' HD11 ' A' ' 314' ' ' LEU . 45.0 m-85 -85.77 115.28 23.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.784 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 99.0 mt -124.03 154.3 40.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.53 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 31.9 mt-30 -140.73 155.39 46.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.326 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.3 -174.81 2.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.357 0.598 . . . . 0.0 110.112 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 55.1 p -134.16 159.56 71.89 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.843 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.96 -32.48 97.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 111.105 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 24.8 ttpp -59.45 -54.87 41.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.917 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 17.5 tp10 -63.92 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.465 -172.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 3.2 ptt180 -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.136 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.644 HG22 ' NZ ' ' A' ' 340' ' ' LYS . 88.0 m -58.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.798 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 4.8 mm-40 -60.73 -37.04 80.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.572 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.524 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 59.8 m95 -76.17 -32.95 59.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.62 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 335' ' ' ARG . 98.2 mt -54.63 -54.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.644 ' NZ ' HG22 ' A' ' 336' ' ' THR . 27.7 mtmm -56.8 -40.99 76.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.72 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.521 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.04 -56.09 25.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.134 0.492 . . . . 0.0 111.053 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.446 HG23 HD22 ' A' ' 292' ' ' LEU . 2.3 mp -66.34 -38.38 81.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.271 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.88 -41.02 92.07 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.64 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 12.6 ptm -71.95 -38.19 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.974 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -66.08 -35.83 81.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.396 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -69.18 -10.01 55.65 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.208 -0.307 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.618 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.866 ' HG3' ' HB3' ' A' ' 272' ' ' PRO . 7.8 tp10 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.246 0.546 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -55.77 -30.16 60.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.657 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -113.23 2.42 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.132 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 239' ' ' GLU . 99.7 mtt180 -70.6 -35.78 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 110.04 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.38 150.05 51.36 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.585 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.4 t -81.39 145.64 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.724 0.41 . . . . 0.0 110.701 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.9 mp -70.44 117.9 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 110.378 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 270' ' ' GLU . 48.3 mm -85.52 -36.14 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.37 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.4 tttp -163.35 143.46 8.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.783 -171.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -133.13 157.55 45.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 148.84 155.82 6.87 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.074 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 6.9 p -76.21 141.02 41.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.198 0.499 . . . . 0.0 110.502 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 338' ' ' TRP . 96.1 mt -135.72 153.94 51.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 3.3 mp -86.59 117.5 25.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -103.08 119.2 38.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.555 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 35.5 tt0 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.728 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.553 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 93.2 m95 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 5.5 ttpm? -113.53 160.92 17.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.882 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.98 111.3 35.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.343 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 95.0 mtt180 -137.42 150.64 47.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.05 172.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 36.2 ttpt -84.71 123.24 30.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.754 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 23.0 m-85 -97.77 158.86 15.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.315 0.578 . . . . 0.0 111.72 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 245' ' ' ILE . 7.9 mt -150.15 121.29 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.985 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 33.5 tp -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.013 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 51.7 mtt180 -146.48 134.08 20.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.742 0.306 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.642 ' HB3' HD11 ' A' ' 246' ' ' ILE . 37.0 tt0 -112.86 133.75 54.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.579 ' HB2' ' HD3' ' A' ' 272' ' ' PRO . 25.6 m-20 145.17 -54.45 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 125.733 1.895 . . . . 0.0 108.164 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.866 ' HB3' ' HG3' ' A' ' 239' ' ' GLU . 66.2 Cg_endo -100.04 -16.29 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 166.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.811 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.14 82.91 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.308 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 57.6 m-85 -143.62 124.53 14.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.413 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 51.1 tp -89.29 137.49 32.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -124.85 154.71 40.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.655 0.264 . . . . 0.0 110.304 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -147.34 144.49 28.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.5 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.095 ' HA ' HD13 ' A' ' 287' ' ' LEU . 2.6 m-85 -133.92 154.81 50.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.661 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 282' ' ' GLY . 5.5 t70 -87.19 136.42 33.72 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.482 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 93.9 Cg_endo -67.94 -19.82 45.71 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.01 2.473 . . . . 0.0 111.414 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.12 7.98 19.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.19 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . 171.19 140.23 2.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.266 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 72.66 102.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.608 0.718 . . . . 0.0 112.412 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -95.74 -6.59 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.221 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.8 132.56 51.08 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 10.8 Cg_endo -51.81 124.62 14.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.382 2.722 . . . . 0.0 114.004 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.095 HD13 ' HA ' ' A' ' 278' ' ' TYR . 6.1 mp -81.81 -26.38 34.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.384 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -174.64 174.26 46.5 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.742 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 275' ' ' LEU . . . -141.76 140.85 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.304 . . . . 0.0 111.011 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 38.9 mt -99.41 137.92 25.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.529 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -84.72 95.3 8.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.774 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.811 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 30.5 mt -77.77 -28.66 50.62 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.88 107.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.872 0.368 . . . . 0.0 111.142 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.67 13.59 62.67 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.276 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 15.8 p -87.29 146.86 25.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.258 0.552 . . . . 0.0 111.271 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.83 140.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.51 154.49 18.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -141.65 140.93 33.37 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.245 0.545 . . . . 0.0 109.928 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 7.6 t -87.7 99.13 11.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.746 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 45.6 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 121.127 0.489 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 162.57 13.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.609 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.884 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 11.1 p30 41.75 36.99 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.985 0.914 . . . . 0.0 112.259 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.4 OUTLIER -75.49 129.95 38.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.92 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -125.48 125.4 43.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 38.9 tt0 -96.16 137.01 35.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.212 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -114.4 108.97 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.37 88.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.468 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.3 p -62.78 171.45 2.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.269 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -65.3 -18.09 65.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.679 0.752 . . . . 0.0 109.541 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.5 -5.0 42.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.489 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 69.28 29.22 4.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.685 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.61 132.11 53.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.733 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.44 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 7.7 m-70 -90.23 114.32 26.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 63.2 m-85 -98.65 115.57 28.97 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 44.2 m-85 -91.38 115.68 28.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.018 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.508 ' O ' HD23 ' A' ' 314' ' ' LEU . 95.9 mt -128.7 151.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.582 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.1 mt-30 -142.36 154.92 45.05 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.901 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.88 -175.94 2.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.395 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -76.75 -37.21 56.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.211 0.529 . . . . 0.0 110.248 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 45.5 p -127.48 155.17 77.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.797 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 25.2 Cg_exo -63.23 -21.83 72.25 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.138 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.65 -30.79 17.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.581 0.229 . . . . 0.0 111.221 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -43.56 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.884 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.21 -42.62 95.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.17 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.524 ' HA ' HD12 ' A' ' 339' ' ' ILE . 11.8 m -58.64 -39.22 79.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 41.4 mt-10 -64.49 -36.75 85.19 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.689 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.446 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 68.8 m95 -72.72 -34.66 67.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.168 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 336' ' ' THR . 84.6 mt -53.15 -57.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -56.28 -41.97 76.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.971 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.466 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.17 -57.16 14.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.81 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.714 HG23 HD22 ' A' ' 292' ' ' LEU . 1.7 mp -60.94 -42.16 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.344 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.74 -42.29 97.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.552 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.545 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 11.6 ptm -73.17 -40.84 64.49 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.739 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -61.2 -29.37 69.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.488 0.185 . . . . 0.0 111.179 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 33.1 t -68.03 -14.43 62.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.117 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.722 0.773 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 274' ' ' TYR . 11.6 mp0 -66.22 -12.27 55.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.069 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.97 -13.58 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -56.23 -24.53 42.87 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.65 141.53 18.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.174 175.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.22 153.01 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 23.5 mt -55.61 132.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.392 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 270' ' ' GLU . 42.9 mm -99.9 -42.09 10.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.331 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 59.8 tttp -166.59 138.12 3.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.208 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.447 ' HB3' HD12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -136.58 152.62 50.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.351 0.595 . . . . 0.0 112.392 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.67 157.18 9.76 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.656 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 31.8 m -77.07 144.74 38.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.801 0.8 . . . . 0.0 110.305 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.3 mt -142.01 165.39 27.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -96.87 119.03 34.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.542 -0.169 . . . . 0.0 110.542 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.88 120.62 40.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.925 177.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 72.3 m95 . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.39 131.86 56.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.399 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.05 107.53 12.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.494 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -129.02 156.62 43.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 84.0 tttt -89.95 115.07 26.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.734 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 30.9 m-85 -101.96 118.24 36.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.021 0.438 . . . . 0.0 111.822 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' CE1' ' A' ' 278' ' ' TYR . 9.3 mm -112.49 127.33 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 292' ' ' LEU . 39.2 tp -101.32 154.48 18.75 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.622 ' HB2' ' HE1' ' A' ' 276' ' ' HIS . 79.9 mtt-85 -154.89 143.97 21.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 246' ' ' ILE . 6.3 pt-20 -100.84 -170.44 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.62 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.881 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 32.8 t70 93.13 -72.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.686 1.595 . . . . 0.0 110.498 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.3 Cg_endo -92.64 -3.05 3.66 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 121.124 1.437 . . . . 0.0 112.054 167.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.77 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.93 85.67 0.14 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.319 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.3 m-85 -130.71 129.85 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.753 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 29.0 tp -101.74 130.88 48.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.622 ' HE1' ' HB2' ' A' ' 269' ' ' ARG . 22.3 m80 -121.59 130.24 53.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.081 -172.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' A' ' 290' ' ' ILE . 8.5 p90 -119.7 133.28 55.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.883 0.849 . . . . 0.0 111.283 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.539 ' CE1' HG12 ' A' ' 267' ' ' ILE . 3.6 m-85 -115.15 149.07 38.21 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.263 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.578 ' HB2' HD11 ' A' ' 287' ' ' LEU . 0.3 OUTLIER -87.99 132.2 40.68 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.68 -15.92 41.57 Favored 'Trans proline' 0 CA--C 1.514 -0.503 0 C-N-CA 123.342 2.695 . . . . 0.0 111.038 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.11 2.23 34.37 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.31 -171.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.46 85.25 0.05 OUTLIER Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.799 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -178.04 107.06 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.275 0.56 . . . . 0.0 111.985 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -83.69 -46.67 12.03 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.72 134.75 46.81 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.238 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.41 137.03 58.08 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.856 2.371 . . . . 0.0 112.259 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 279' ' ' ASP . 58.1 mt -68.08 -29.35 68.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.945 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -167.73 147.0 11.1 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.558 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.04 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 66.1 mt -67.19 142.05 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.347 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -94.54 94.47 8.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.62 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.77 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 42.7 mt -72.68 -31.24 64.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.928 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -58.6 91.14 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 119.3 -3.68 13.87 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 292' ' ' LEU . 14.2 p -95.81 148.36 22.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.175 0.487 . . . . 0.0 111.419 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.92 150.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 339' ' ' ILE . 57.8 t -117.18 159.79 17.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.766 0.317 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 8.8 t -160.02 143.34 13.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.73 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.6 t -80.35 122.68 27.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 46.6 t . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 111.266 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.562 ' HB3' HD12 ' A' ' 314' ' ' LEU . 17.6 mp0 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.816 0.341 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -135.34 132.16 37.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.726 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.56 35.12 11.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.0 OUTLIER -75.28 129.86 38.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.554 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -126.99 138.29 53.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 168.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.495 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 33.7 tt0 -100.7 133.41 45.19 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 78.5 mt -112.73 102.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.07 91.67 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.966 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.7 p -54.39 159.08 2.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.25 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.6 1.81 2.19 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.865 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -118.34 30.21 7.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.276 0.56 . . . . 0.0 110.428 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 64.8 31.05 11.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.961 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 t -108.78 124.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.195 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -88.88 114.69 25.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 6.9 m-30 -94.58 125.35 39.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.496 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 6.3 m-30 -99.74 114.73 28.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 110.847 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.77 153.28 38.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.386 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 26.4 mt-30 -139.52 142.22 37.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.058 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.09 165.61 12.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.68 30.2 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 71.7 p -113.82 159.04 37.39 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.086 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.4 -37.89 82.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.945 2.43 . . . . 0.0 111.816 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 30.1 mmtp -64.61 -47.91 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 11.9 tp10 -55.94 -49.42 73.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.074 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 336' ' ' THR . 8.5 ptt180 -60.59 -43.82 96.95 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.611 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 339' ' ' ILE . 30.9 m -60.32 -37.69 81.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.752 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.503 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 76.5 mm-40 -63.73 -40.72 97.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.49 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 75.8 m95 -71.34 -33.0 69.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 336' ' ' THR . 98.0 mt -53.32 -57.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -58.75 -39.39 80.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.181 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.468 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.65 -53.01 61.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.206 0.526 . . . . 0.0 110.897 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.709 HG23 HD22 ' A' ' 292' ' ' LEU . 1.8 mp -64.27 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.265 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 97.8 mt-30 -63.81 -49.35 73.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.604 0.24 . . . . 0.0 111.34 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.4 ptm -70.05 -24.56 63.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.391 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.15 32.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.608 0.242 . . . . 0.0 111.061 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.7 t -66.66 -19.27 65.73 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 . . . . . 0 C--N 1.328 -0.35 0 O-C-N 121.924 -0.485 . . . . 0.0 111.587 -175.715 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 272' ' ' PRO . 36.5 tt0 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 52.3 mt-10 -52.9 -40.89 63.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.535 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -101.5 -15.64 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -166.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 25.3 mtp180 -53.12 -23.89 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -87.05 149.5 22.2 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.087 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 245' ' ' ILE . 97.4 t -85.94 158.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.111 0.482 . . . . 0.0 110.426 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mm -73.57 116.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.725 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.628 HD11 ' HG2' ' A' ' 270' ' ' GLU . 33.5 mm -83.3 -41.84 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -161.12 149.29 15.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -133.25 157.4 45.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.22 164.83 19.21 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.35 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.1 p -86.19 133.12 33.87 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.3 mt -133.63 155.97 48.72 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.8 mp -91.46 121.82 33.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -108.43 131.4 54.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 33.7 tt0 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.964 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 252' ' ' LEU . 62.7 m95 . . . . . 0 CA--C 1.516 -0.341 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 9.0 ptpt -134.08 165.27 25.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.535 0.683 . . . . 0.0 112.43 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.2 103.15 14.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.207 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.653 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 97.0 mtt180 -126.01 158.24 35.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.197 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.57 106.04 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.404 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.6 m-85 -91.12 148.09 22.61 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.395 0.617 . . . . 0.0 111.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 245' ' ' ILE . 21.0 mt -146.39 118.53 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.298 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 61.1 tp -93.03 139.46 30.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.202 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -139.31 127.67 22.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.725 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -91.1 -172.17 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.224 -174.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.976 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 38.4 t70 94.63 -76.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.66 1.584 . . . . 0.0 109.968 176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.976 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.4 Cg_endo -92.01 -5.67 3.59 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 CA-C-N 121.098 1.428 . . . . 0.0 111.262 166.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.31 98.32 0.05 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.975 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 41.4 m-85 -144.74 110.92 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.139 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.593 HD23 HD12 ' A' ' 290' ' ' ILE . 23.8 tp -89.56 121.1 31.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 61.7 m80 -112.58 155.09 24.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.078 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.54 141.46 39.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.351 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 283' ' ' ALA . 3.3 m-85 -127.57 166.45 17.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.948 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 27.5 t70 -95.13 123.4 57.29 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.653 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 83.3 Cg_endo -67.78 -17.53 47.32 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.391 2.728 . . . . 0.0 110.26 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.544 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -89.57 -1.65 58.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.261 -1.791 . . . . 0.0 111.205 -172.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.29 29.78 0.17 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.188 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -129.0 111.78 13.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.37 1.085 . . . . 0.0 110.901 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.94 -12.66 23.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.831 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.19 141.81 96.48 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.416 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.6 108.78 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.468 2.112 . . . . 0.0 111.517 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.03 5.85 13.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.603 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 167.77 140.55 2.94 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.518 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.439 ' HB2' ' OE1' ' A' ' 240' ' ' GLU . . . -115.57 102.04 9.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.593 HD12 HD23 ' A' ' 275' ' ' LEU . 59.3 mt -70.82 123.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -82.52 87.11 6.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.017 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 78.9 mt -74.56 -27.61 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -48.44 99.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 92.54 18.79 40.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.957 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . . . . . . . . . 14.8 p -95.39 157.92 15.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.303 0.573 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.93 149.93 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 298' ' ' THR . 48.4 t -118.15 158.81 18.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.0 t -150.86 143.23 24.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.272 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.9 t -80.0 99.44 7.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.451 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.5 t . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.946 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' A' ' 314' ' ' LEU . 6.4 mp0 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.56 -10.14 12.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.653 0.739 . . . . 0.0 110.772 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -122.55 29.77 6.77 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.897 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.2 tt -77.58 135.57 38.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.331 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -129.91 125.87 36.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 298' ' ' THR . 36.0 tt0 -93.62 136.92 33.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.129 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -112.01 103.14 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.56 88.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.656 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 50.1 p -59.21 160.76 6.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.517 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.17 -8.97 27.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.384 0.611 . . . . 0.0 110.671 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.11 4.6 41.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.233 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 64.03 32.12 13.13 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.033 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.37 127.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.709 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -87.63 118.09 26.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 9.0 m-85 -98.93 117.91 34.51 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.6 m-85 -95.46 112.81 24.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.066 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 96.5 mt -126.67 156.41 41.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.728 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.515 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 30.6 mt-30 -139.45 145.29 38.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.672 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.69 176.48 5.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.455 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.96 -56.48 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.0 111.102 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 39.2 p -124.05 163.43 35.62 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.21 -37.84 40.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.725 2.283 . . . . 0.0 112.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 50.7 mtmt -62.91 -48.98 76.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.924 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -61.26 -41.89 97.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.145 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 339' ' ' ILE . 17.8 ptt180 -63.17 -42.15 99.34 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.635 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 339' ' ' ILE . 18.7 m -57.24 -42.3 81.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.767 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 11.1 mm-40 -57.47 -45.29 84.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.858 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -70.55 -31.15 68.08 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 336' ' ' THR . 89.2 mt -59.86 -56.99 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -55.46 -49.83 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.925 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.3 30.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 0.0 111.431 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 317' ' ' ILE . 13.5 mt -71.55 -41.06 72.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.081 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.69 -30.76 71.82 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.461 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.15 -40.79 21.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.695 0.283 . . . . 0.0 110.276 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.18 71.6 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.56 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 32.9 t -76.91 -0.35 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.772 0.32 . . . . 0.0 111.819 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 62.4 mtp85 . . . . . 0 C--N 1.333 -0.151 0 O-C-N 122.05 -0.406 . . . . 0.0 111.348 -178.768 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.592 ' OE1' ' HD3' ' A' ' 242' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 121.091 0.472 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 269' ' ' ARG . 20.7 mt-10 -58.63 -26.48 63.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.017 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.486 ' HA ' ' CD ' ' A' ' 269' ' ' ARG . 4.9 m-85 -115.35 1.5 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.255 -174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.592 ' HD3' ' OE1' ' A' ' 239' ' ' GLU . 64.8 mtp180 -72.11 -4.62 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.71 150.83 18.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 72.8 t -81.13 147.8 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.153 0.501 . . . . 0.0 111.139 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 3.9 mt -70.36 111.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.575 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 268' ' ' LEU . 37.0 mm -77.82 -35.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.227 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -169.18 144.82 3.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.533 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.58 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.12 157.91 40.45 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.19 156.63 8.95 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.696 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 264' ' ' ARG . 12.9 p -75.17 137.69 41.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 0.167 . . . . 0.0 110.642 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.6 mt -140.33 159.21 42.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.9 mp -97.78 120.41 38.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -109.33 123.49 49.39 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.454 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.917 175.327 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 31.3 m95 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.638 0.256 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 28.8 mttt -139.5 150.72 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.581 . . . . 0.0 111.526 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -92.96 99.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.9 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.746 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 70.7 mtt180 -124.06 164.67 18.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -94.26 110.64 22.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.694 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 17.6 m-85 -94.4 151.66 19.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.809 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 248' ' ' GLN . 13.0 mt -144.86 125.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.916 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.596 HD22 ' HB1' ' A' ' 341' ' ' ALA . 48.3 tp -100.09 147.64 25.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.286 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 68.6 mtt-85 -140.91 126.6 19.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 345' ' ' ALA . 19.0 tt0 -106.07 130.38 53.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.6 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.994 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.5 t70 148.39 -59.98 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 125.335 1.647 . . . . 0.0 108.36 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.994 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 11.2 Cg_endo -94.12 -10.41 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.44 2.093 . . . . 0.0 110.768 166.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.48 88.78 0.1 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.839 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -138.32 120.86 16.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 290' ' ' ILE . 33.3 tp -99.78 117.6 34.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.417 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 0.7 OUTLIER -110.85 154.85 23.42 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.397 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.71 139.76 47.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.473 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -123.02 166.52 14.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.488 ' HB2' HD11 ' A' ' 287' ' ' LEU . 6.8 t70 -88.0 135.36 33.54 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.746 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.6 Cg_endo -70.39 -14.51 34.17 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 111.539 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.11 11.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.516 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . -163.33 136.21 4.17 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.989 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 75.19 123.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.856 0.862 . . . . 0.0 113.262 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.78 -2.74 58.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.75 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 286' ' ' PRO . 1.4 p-10 -85.71 146.15 43.2 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.562 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . 2.6 Cg_endo -75.77 141.47 24.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.169 2.579 . . . . 0.0 113.341 -170.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 279' ' ' ASP . 88.7 mt -96.09 7.46 46.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.957 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 143.63 138.08 3.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.646 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . . . -106.08 142.26 36.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.736 0.303 . . . . 0.0 110.76 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 275' ' ' LEU . 59.8 mt -98.41 131.99 44.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -88.38 91.88 8.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 56.5 mt -73.0 -32.43 65.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.647 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -61.24 96.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.002 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 116.25 2.4 19.94 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.218 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.575 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 13.0 p -97.85 154.1 17.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.256 0.551 . . . . 0.0 111.455 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.9 t -119.5 150.45 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 298' ' ' THR . 48.5 t -119.75 158.38 21.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 7.6 t -160.11 136.65 8.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.013 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.6 p -73.2 138.32 45.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.164 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.745 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 59.0 t . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.107 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.673 ' HB3' HD12 ' A' ' 314' ' ' LEU . 26.4 mp0 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.82 0.343 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.1 -15.02 61.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 112.037 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 328' ' ' GLN . 83.4 m-20 -122.27 20.67 10.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.22 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.745 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.8 OUTLIER -74.92 132.45 41.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.139 -178.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -131.0 133.02 45.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 43.6 tt0 -93.03 132.82 36.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.744 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 87.2 mt -113.24 105.29 18.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.84 90.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.679 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.575 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 20.4 p -59.56 176.66 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.98 68.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.555 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.58 -8.42 55.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.89 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 68.17 45.19 1.3 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.706 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.29 134.81 43.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 34.1 m-70 -83.77 112.05 19.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 51.5 m-85 -99.69 103.51 15.18 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 15.9 m-30 -84.49 110.01 18.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.595 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 94.1 mt -118.37 151.89 36.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.508 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 36.0 mt-30 -136.18 146.03 46.4 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.282 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -108.52 171.99 7.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.876 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.02 68.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -116.46 160.37 36.4 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.57 -23.67 76.21 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.027 2.485 . . . . 0.0 112.477 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.59 -38.67 23.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.597 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.543 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.4 tp10 -57.41 -44.07 84.27 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.48 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 339' ' ' ILE . 21.3 ptt180 -60.46 -40.8 92.51 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.173 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 340' ' ' LYS . 27.2 m -55.61 -45.24 77.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.503 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.426 ' HA ' ' HE3' ' A' ' 340' ' ' LYS . 74.7 mm-40 -58.94 -36.36 74.65 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.126 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.475 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 86.3 m95 -78.0 -35.32 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 343' ' ' GLN . 82.3 mt -54.25 -55.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 336' ' ' THR . 51.0 mtmt -58.7 -42.51 88.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.121 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.596 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.05 -52.14 66.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.919 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.26 -42.95 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 39.0 mt-30 -65.94 -33.45 75.86 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.462 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.7 ptm -80.83 -28.93 36.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.961 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 270' ' ' GLU . . . -80.99 -30.86 34.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.605 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 16.6 p -78.0 -10.85 59.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -177.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 272' ' ' PRO . 3.6 mp0 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 55.7 mt-10 -50.58 -31.67 16.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.738 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.09 -5.85 13.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.432 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -80.48 -14.47 58.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -87.68 148.06 20.88 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 70.0 t -77.37 147.89 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.221 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.4 mp -67.31 119.81 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.91 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.8 -45.18 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.225 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.544 ' HE2' ' NE1' ' A' ' 338' ' ' TRP . 75.1 tttt -165.44 140.74 5.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.249 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.485 ' HB3' HD12 ' A' ' 267' ' ' ILE . 4.4 pt20 -134.32 156.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 111.293 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.47 156.38 8.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 73.5 m -78.44 131.48 36.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.165 0.482 . . . . 0.0 110.415 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.4 mt -133.68 150.55 51.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.4 mp -79.4 145.15 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 261' ' ' TRP . 25.9 mtmm -128.29 129.31 46.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.22 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 261' ' ' TRP . 50.2 tt0 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.035 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.577 ' CE2' ' HB2' ' A' ' 254' ' ' GLN . 70.9 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.74 0.305 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 35.7 mmtm -125.63 161.49 27.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 0.0 112.206 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.69 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.86 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.622 ' NH1' HD13 ' A' ' 287' ' ' LEU . 96.4 mtt180 -141.25 149.35 41.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.197 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -77.63 121.16 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.608 -169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.736 ' O ' HD13 ' A' ' 267' ' ' ILE . 21.7 m-85 -95.17 145.56 24.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.623 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 266' ' ' PHE . 16.4 mm -134.51 124.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 39.9 tp -100.92 147.55 26.01 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 240' ' ' GLU . 58.8 mtt-85 -143.53 131.75 21.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -174.9 4.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.446 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.996 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 13.7 t70 93.54 -75.89 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 125.83 1.652 . . . . 0.0 110.432 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.996 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 6.7 Cg_endo -92.23 -6.94 3.17 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 CA-C-N 121.344 1.516 . . . . 0.0 111.495 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 69.19 93.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.967 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 50.0 m-85 -138.63 112.52 8.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.156 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 46.4 tp -90.38 141.08 29.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.446 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 67.7 m80 -134.46 153.42 51.93 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.29 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -137.19 137.28 38.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.695 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 267' ' ' ILE . 20.2 m-85 -128.13 164.09 23.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.234 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 281' ' ' ALA . 31.0 t70 -93.95 124.92 54.91 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-O 120.925 0.393 . . . . 0.0 110.428 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.59 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 90.4 Cg_endo -70.66 -21.3 29.48 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 123.669 2.913 . . . . 0.0 110.601 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.564 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -81.06 -21.02 40.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.185 -170.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.69 65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.071 -1.062 . . . . 0.0 113.859 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -160.45 120.75 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.852 0.326 . . . . 0.0 111.514 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -90.64 -15.47 30.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.26 137.11 86.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.175 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.3 122.32 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.074 1.849 . . . . 0.0 111.108 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.622 HD13 ' NH1' ' A' ' 264' ' ' ARG . 29.8 mt -81.29 2.85 26.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 161.08 156.83 8.43 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.521 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.92 124.42 43.17 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.633 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 50.4 mt -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -86.29 99.92 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.817 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.583 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 68.4 mt -75.86 -80.0 0.09 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.294 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 346' ' ' SER . 32.3 ttm180 37.71 -90.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -170.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -105.73 51.43 0.76 Allowed Glycine 0 C--N 1.317 -0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.996 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 28.0 p -90.54 122.02 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 110.755 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.48 143.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.1 t -122.18 156.33 26.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 316' ' ' GLU . 10.8 t -145.34 138.43 26.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.169 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 32.9 t -80.36 99.14 7.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.925 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 25.3 t . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.457 0.646 . . . . 0.0 110.389 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.675 ' HB3' HD12 ' A' ' 314' ' ' LEU . 1.5 mp0 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.45 178.87 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 162.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.1 m120 56.33 20.55 4.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.925 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -83.98 136.01 34.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.942 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 338' ' ' TRP . 23.1 p90 -133.36 118.77 18.85 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -87.2 134.46 33.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.119 -174.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -109.01 104.72 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 21.4 mt -94.06 88.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.977 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 65.1 p -55.46 165.12 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.267 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -72.63 1.37 8.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.59 13.5 25.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.425 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 66.31 32.19 7.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.0 126.98 55.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -94.17 113.04 24.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.507 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 30.6 m-85 -96.92 138.58 34.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.476 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 51.6 m-85 -114.89 121.07 42.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.299 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 81.1 mt -133.69 155.45 49.71 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.881 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.6 mt-30 -135.65 135.83 40.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -103.51 175.36 5.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.545 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.83 -53.07 36.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 0.0 110.984 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -114.51 164.08 17.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.531 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 32.6 Cg_exo -61.34 -35.89 81.62 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.21 1.94 . . . . 0.0 111.255 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.82 -45.93 76.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.688 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.458 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 8.3 tp10 -55.95 -47.48 77.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.664 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 332' ' ' PRO . 0.6 OUTLIER -62.51 -44.42 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.944 -176.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -56.5 -36.97 69.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.58 ' HA ' ' HE2' ' A' ' 340' ' ' LYS . 14.3 mt-10 -77.18 -29.5 54.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.605 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.544 ' NE1' ' HE2' ' A' ' 247' ' ' LYS . 50.3 m95 -67.91 -32.32 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.235 -0.291 . . . . 0.0 110.537 171.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 336' ' ' THR . 90.1 mt -54.42 -56.32 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 168.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 337' ' ' GLU . 58.6 mtmt -52.14 -47.1 65.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.243 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -55.74 -55.79 28.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.327 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.432 HG23 HD22 ' A' ' 292' ' ' LEU . 2.2 mp -70.16 -36.25 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.902 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 18.5 mt-30 -73.54 -32.69 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.031 -0.418 . . . . 0.0 111.624 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.4 ptm -78.9 -26.41 43.81 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.616 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.14 -35.42 31.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 293' ' ' ARG . 3.2 p -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.01 0.433 . . . . 0.0 112.14 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.828 -170.5 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 242' ' ' ARG . 33.6 tt0 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.584 0.231 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -56.05 -23.0 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.892 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.66 -2.57 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 91.8 mtt180 -75.61 -3.32 33.73 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.968 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -96.23 160.3 22.14 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.53 145.95 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 117.299 0.55 . . . . 0.0 111.24 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 267' ' ' ILE . 6.7 mt -62.57 128.21 23.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.155 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.43 HD11 ' OE1' ' A' ' 270' ' ' GLU . 18.3 mm -94.85 -49.77 12.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.866 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.8 tttp -155.17 137.76 15.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.539 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.17 137.13 50.99 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 174.61 156.09 13.41 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.937 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 12.1 m -84.83 138.73 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.795 0.297 . . . . 0.0 110.291 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 85.5 mt -135.21 172.28 13.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.3 mp -97.52 122.88 41.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.282 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -105.24 118.85 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.225 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 6.3 tp-100 . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.554 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 74.3 m95 . . . . . 0 CA--C 1.515 -0.376 0 CA-C-O 120.908 0.385 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.442 ' HD2' ' NH2' ' A' ' 264' ' ' ARG . 29.3 mttt -103.04 145.75 29.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.556 0.693 . . . . 0.0 111.873 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.91 105.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.23 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.701 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.4 mtt180 -135.34 151.41 50.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.258 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 87.9 tttt -89.93 121.56 32.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.017 0.437 . . . . 0.0 110.77 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 26.1 m-85 -100.81 123.75 45.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.601 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 248' ' ' GLN . 43.9 mt -115.8 125.81 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.363 0.602 . . . . 0.0 110.913 171.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 55.5 tp -101.49 156.06 17.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.044 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 243' ' ' GLY . 62.0 mtt-85 -148.34 138.81 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' A' ' 246' ' ' ILE . 2.6 pt-20 -105.45 134.75 48.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.531 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 1.005 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 37.9 t70 147.86 -61.59 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.846 1.659 . . . . 0.0 108.511 170.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 10.9 Cg_endo -94.08 -10.06 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 111.087 168.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.24 93.4 0.06 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.091 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.631 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 60.2 m-85 -145.53 133.38 21.22 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.127 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 290' ' ' ILE . 60.8 tp -95.9 141.18 29.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 32.6 m80 -130.18 122.99 29.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.454 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.31 127.81 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.366 0.603 . . . . 0.0 111.222 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -117.03 158.59 23.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.105 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.501 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 1.8 t70 -94.96 122.06 61.11 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.701 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -70.69 -19.29 31.86 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 110.776 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -98.87 -4.83 32.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.391 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.15 60.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.317 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.501 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -175.84 101.8 0.07 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 110.851 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -89.34 -4.5 58.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.309 0.576 . . . . 0.0 109.901 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.31 138.68 41.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.64 112.51 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.769 . . . . 0.0 111.406 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.78 -21.1 66.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.138 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 179.9 129.59 1.36 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.057 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.06 104.72 16.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.679 HD12 HD23 ' A' ' 275' ' ' LEU . 39.8 mt -66.38 134.18 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.099 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -83.19 87.68 6.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.115 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 45.9 mt -74.05 -26.96 60.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.329 -173.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -51.37 101.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.816 0.341 . . . . 0.0 110.984 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 91.79 14.08 57.1 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.997 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.3 p -89.72 139.07 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.299 0.549 . . . . 0.0 110.96 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 6.4 t -105.22 144.48 14.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.38 155.05 21.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 316' ' ' GLU . 11.9 t -150.23 144.53 25.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.46 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.0 t -87.51 101.29 13.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 28.6 t . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.72 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.634 ' HA ' ' OE1' ' A' ' 328' ' ' GLN . 43.8 mp0 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -85.92 144.72 27.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 335' ' ' ARG . 91.2 m-20 64.33 30.4 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.229 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.9 OUTLIER -73.96 128.41 35.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.839 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -125.38 126.14 44.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 168.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.486 ' OE1' ' HE1' ' A' ' 326' ' ' PHE . 36.3 tt0 -91.51 138.05 31.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 96.9 mt -114.04 108.43 25.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.63 91.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.725 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.2 p -57.24 169.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.31 -27.89 69.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.69 -8.12 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.276 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 70.11 37.26 1.71 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.772 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 31.1 t -99.59 131.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.356 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -93.47 113.86 26.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 54.6 m-85 -99.76 127.76 45.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 16.1 m-30 -100.07 119.59 38.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.176 0.512 . . . . 0.0 111.188 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 93.1 mt -130.68 154.12 48.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.057 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.634 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 20.1 mt-30 -137.71 147.41 44.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.113 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -120.44 147.59 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.848 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.48 -27.81 68.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.286 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 334' ' ' GLU . 38.1 p -119.1 142.52 32.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.441 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.84 -27.13 84.23 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.296 2.664 . . . . 0.0 112.508 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.595 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 62.7 mttm -71.74 -46.88 57.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.797 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.1 tp10 -53.12 -49.5 66.4 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.358 0.411 . . . . 0.0 111.147 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.4 ptt180 -60.53 -45.22 94.64 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.35 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 335' ' ' ARG . 9.9 m -57.8 -44.13 86.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.842 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 35.2 mm-40 -58.54 -43.17 89.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.478 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 71.1 m95 -71.89 -32.12 67.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 335' ' ' ARG . 95.6 mt -56.57 -57.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.1 mtmt -57.02 -49.81 74.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.892 176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -51.75 -54.28 30.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 111.45 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.512 HG23 HD13 ' A' ' 292' ' ' LEU . 10.7 mt -69.3 -42.83 81.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.782 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 92.8 mt-30 -62.78 -39.47 94.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.402 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 15.6 ptp -76.89 -25.1 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.537 0.208 . . . . 0.0 110.963 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.96 60.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.979 0.419 . . . . 0.0 110.798 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 45.9 t -79.76 -3.98 49.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.498 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -177.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 39.0 tt0 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 1.9 mp0 -59.01 -24.37 62.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.195 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.435 ' HA ' ' CD ' ' A' ' 269' ' ' ARG . 0.3 OUTLIER -111.66 0.28 16.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 58.9 mtt85 -63.38 -26.96 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.082 0.468 . . . . 0.0 110.287 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.05 156.7 30.04 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.023 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.06 148.37 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.31 0.576 . . . . 0.0 111.682 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 267' ' ' ILE . 12.9 mt -56.1 115.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.793 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -84.58 -41.9 16.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.02 0.438 . . . . 0.0 110.251 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -167.56 152.02 6.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.277 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.548 ' CB ' HG12 ' A' ' 267' ' ' ILE . 8.7 pt20 -149.62 164.77 34.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 0.0 111.818 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.28 171.57 28.6 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 59.4 m -86.07 139.71 30.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.752 0.776 . . . . 0.0 109.708 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.8 mt -141.48 166.51 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 11.0 mp -102.61 125.63 49.41 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.681 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -105.13 124.54 49.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.831 177.696 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 53.5 m95 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 51.7 mttt -106.59 138.92 41.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 112.104 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 102.97 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.922 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.632 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.3 mtt180 -128.71 166.44 18.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.407 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -94.0 113.58 25.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.371 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.5 m-85 -101.97 128.18 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.415 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.548 HG12 ' CB ' ' A' ' 248' ' ' GLN . 17.1 mt -121.86 130.81 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.197 0.522 . . . . 0.0 110.66 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.555 HD11 HD11 ' A' ' 292' ' ' LEU . 43.6 tp -101.16 155.01 18.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.855 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.435 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 53.9 mtt-85 -149.55 138.86 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.637 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 4.9 pt-20 -93.89 -175.0 3.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.941 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 28.1 t70 93.63 -75.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 C-N-CA 125.814 1.646 . . . . 0.0 110.148 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 9.5 Cg_endo -91.39 -5.72 3.94 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 121.182 1.458 . . . . 0.0 111.671 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.69 91.34 0.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.132 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.2 m-85 -140.5 121.21 14.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 41.7 tp -89.42 139.39 30.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.177 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 69.4 m80 -129.8 142.7 50.64 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -132.3 140.22 48.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.204 0.526 . . . . 0.0 110.848 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' HD13 ' A' ' 287' ' ' LEU . 5.1 m-85 -129.37 162.34 28.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -90.59 122.58 66.93 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.133 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.632 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -68.16 -15.21 42.48 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.184 2.589 . . . . 0.0 111.069 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.89 15.24 15.24 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.06 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -159.24 -112.72 0.32 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.993 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.04 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.33 -0.58 49.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.424 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 287' ' ' LEU . 4.4 m-20 -73.31 139.78 79.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 28.8 Cg_endo -61.79 118.8 5.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.019 1.812 . . . . 0.0 112.78 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.023 HD13 ' HA ' ' A' ' 278' ' ' TYR . 5.8 mp -84.15 -5.65 59.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.117 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.04 157.56 21.0 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.109 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -135.68 100.67 4.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.211 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 62.8 mt -84.43 88.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.689 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.577 ' NE2' ' HB2' ' A' ' 293' ' ' ARG . 13.4 t-80 -43.73 106.05 0.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.79 170.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 84.7 mt -87.23 -19.89 27.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.867 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.577 ' HB2' ' NE2' ' A' ' 291' ' ' HIS . 96.5 mtt180 -59.35 104.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.363 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 108.16 3.28 33.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.489 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 17.1 p -85.67 147.53 26.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 111.977 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 142.38 29.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 99.6 t -117.83 153.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.963 0.411 . . . . 0.0 110.406 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 316' ' ' GLU . 13.6 t -153.43 145.61 23.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.923 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.7 t -83.76 102.32 12.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.748 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 314' ' ' LEU . 12.7 t . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.614 . . . . 0.0 110.188 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.729 ' HG2' HD12 ' A' ' 314' ' ' LEU . 3.1 mp0 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.539 0.685 . . . . 0.0 112.314 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.82 132.27 54.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.955 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 335' ' ' ARG . 74.2 m-20 67.37 22.76 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.409 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 311' ' ' GLU . 1.3 tt -66.93 134.7 52.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.997 0.427 . . . . 0.0 109.94 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.453 ' N ' HD23 ' A' ' 314' ' ' LEU . 29.9 p90 -132.47 136.85 46.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.492 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -99.41 136.67 39.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.781 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.4 mt -115.89 110.84 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.3 mt -101.82 83.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.936 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 72.3 p -62.85 177.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.989 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -64.49 -13.32 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 110.929 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.88 -6.36 54.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.394 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.09 27.67 10.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.763 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.7 130.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -90.41 113.43 25.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 45.9 m-85 -95.46 119.35 33.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.475 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 3.0 m-85 -96.65 116.03 28.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.895 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 78.2 mt -127.31 157.75 39.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.673 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.3 mt-30 -135.99 139.65 43.32 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -110.06 160.68 16.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.336 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -55.64 -50.4 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.247 0.342 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 32.1 p -127.12 162.63 46.84 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.049 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.15 -43.17 61.69 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.393 2.062 . . . . 0.0 111.964 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 337' ' ' GLU . 17.8 tppt? -55.17 -44.92 75.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.036 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 7.7 tp10 -60.39 -52.34 65.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.033 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.565 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.5 ptt180 -59.35 -43.32 92.81 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.977 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.645 HG22 ' HE2' ' A' ' 340' ' ' LYS . 11.1 m -58.64 -40.52 83.62 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.646 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 333' ' ' LYS . 57.0 mt-10 -65.28 -33.15 75.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 121.259 -0.176 . . . . 0.0 110.973 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' A' ' 334' ' ' GLU . 76.7 m95 -73.43 -38.44 65.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.416 0.15 . . . . 0.0 111.106 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 336' ' ' THR . 97.6 mt -53.38 -54.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.645 ' HE2' HG22 ' A' ' 336' ' ' THR . 65.7 mttm -59.87 -40.24 87.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.709 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.64 -54.64 44.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.661 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.636 HG23 HD22 ' A' ' 292' ' ' LEU . 2.0 mp -64.79 -44.62 96.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.351 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -64.38 -36.79 85.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.3 ptp -81.21 -31.29 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.695 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -74.02 -29.87 62.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.457 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.47 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 42.3 t -67.16 -14.58 63.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.692 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.022 -0.424 . . . . 0.0 111.299 -174.475 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 242' ' ' ARG . 37.9 tt0 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.844 0.354 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 240' ' ' GLU . 1.8 mp0 -60.79 -28.28 68.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -104.55 -5.61 21.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.604 0.24 . . . . 0.0 111.1 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 31.8 mtp180 -64.93 -21.33 66.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 110.503 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.23 152.56 26.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.8 t -84.34 145.26 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.43 0.292 . . . . 0.0 110.665 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mp -69.82 114.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.412 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 270' ' ' GLU . 25.8 mm -78.99 -43.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.832 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.5 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 53.4 tttp -158.26 139.59 13.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.963 -169.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.424 ' HG3' HG21 ' A' ' 245' ' ' ILE . 1.4 mp0 -127.3 145.35 50.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.81 144.84 4.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.264 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 11.0 m -72.51 137.62 46.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 99.5 mt -133.65 163.26 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -90.74 123.73 34.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 327' ' ' LEU . 64.3 tttm -110.95 117.29 32.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.808 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 5.6 tp-100 . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.55 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 84.9 m95 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.255 0.55 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.92 126.3 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.182 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 81.6 t -91.11 104.34 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.018 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 278' ' ' TYR . 2.8 ptp180 -148.05 162.71 38.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.723 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 50.1 tttp -79.32 116.11 19.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.546 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 37.1 m-85 -102.31 124.94 48.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 111.852 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 245' ' ' ILE . 56.6 mt -119.08 128.92 75.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.799 172.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 47.7 tp -98.55 154.97 17.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.672 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 52.7 mtt-85 -147.66 136.24 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.582 0.229 . . . . 0.0 110.452 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.684 ' HG2' HD11 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -100.9 127.31 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 1.008 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.0 t70 154.36 -65.74 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.456 1.502 . . . . 0.0 108.844 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 19.6 Cg_endo -96.36 -8.25 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.635 2.223 . . . . 0.0 111.633 173.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 346' ' ' SER . . . 65.16 89.88 0.09 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.839 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 55.8 m-85 -139.87 129.24 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.044 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 290' ' ' ILE . 25.6 tp -94.55 134.09 37.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.209 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 73.3 m80 -120.47 129.74 53.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.853 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.543 ' HE1' HG13 ' A' ' 290' ' ' ILE . 0.9 OUTLIER -115.08 122.72 47.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.834 176.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.624 ' O ' ' HB2' ' A' ' 264' ' ' ARG . 50.6 m-85 -106.77 -167.63 1.31 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.751 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 17.4 t70 -125.82 129.55 24.29 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.755 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.4 Cg_endo -72.51 -19.15 25.22 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 123.16 2.573 . . . . 0.0 111.572 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.02 -28.29 12.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.09 75.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.236 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -175.84 103.07 0.07 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.748 0.419 . . . . 0.0 110.406 171.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -85.15 -14.03 48.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.625 0.726 . . . . 0.0 109.228 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.84 143.66 26.49 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.243 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.09 143.51 54.33 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.762 2.308 . . . . 0.0 113.412 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -80.39 -7.24 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.123 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 158.61 -179.41 34.3 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.427 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.71 128.95 27.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.471 0.177 . . . . 0.0 110.604 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.653 HD12 HD23 ' A' ' 275' ' ' LEU . 46.1 mt -79.11 136.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -86.53 80.48 8.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.588 HD13 HG23 ' A' ' 342' ' ' ILE . 64.9 mt -61.36 -59.55 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -18.95 86.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.941 1.4 . . . . 0.0 113.735 -172.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 109.81 20.67 7.52 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.433 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 30.5 p -93.1 145.57 24.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.599 . . . . 0.0 112.235 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.04 146.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.07 156.81 26.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 11.6 t -145.39 134.25 22.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 110.479 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 14.2 p -82.77 99.25 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.8 t . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.394 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.644 ' HB3' HD12 ' A' ' 314' ' ' LEU . 25.9 mp0 . . . . . 0 N--CA 1.441 -0.884 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.04 158.93 22.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.352 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.831 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 8.2 p30 41.41 45.66 2.74 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.308 1.005 . . . . 0.0 111.482 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.706 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -77.65 135.31 38.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.452 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -129.5 121.97 28.3 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.487 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 35.1 tt0 -92.2 138.68 31.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.551 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 94.6 mt -111.93 110.33 31.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.9 mt -96.48 85.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 40.4 p -60.98 175.85 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.876 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.53 -20.56 65.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.362 0.601 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.7 3.07 26.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.182 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 57.53 38.57 28.02 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.021 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.36 127.81 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.969 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -85.15 112.51 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 36.6 m-85 -98.36 125.25 43.42 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.55 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 48.9 m-85 -100.35 119.67 38.78 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.0 111.008 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 96.3 mt -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.507 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.583 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 25.5 mt-30 -142.65 150.17 39.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.367 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -108.46 -168.63 1.38 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.388 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.3 -38.78 17.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.398 . . . . 0.0 110.208 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 332' ' ' PRO . 61.9 p -119.48 149.3 47.54 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.644 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 34.2 Cg_exo -63.3 -14.82 44.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.559 2.839 . . . . 0.0 113.595 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -93.13 -32.81 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.449 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.37 -37.39 87.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 110.296 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.831 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.66 -43.79 97.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.22 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.66 ' HA ' HD12 ' A' ' 339' ' ' ILE . 5.1 m -57.21 -44.23 83.49 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.116 0.484 . . . . 0.0 110.39 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -60.56 -36.93 79.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.055 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.5 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 52.4 m95 -70.96 -30.69 67.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.508 0.194 . . . . 0.0 111.126 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 336' ' ' THR . 74.1 mt -58.94 -51.85 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 336' ' ' THR . 43.0 mmtt -53.07 -54.68 31.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.554 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -52.64 -57.18 10.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.814 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.588 HG23 HD13 ' A' ' 292' ' ' LEU . 35.4 mt -70.44 -42.77 78.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.369 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.76 -33.86 76.98 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.502 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.7 ptm -79.46 -20.97 46.09 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.614 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.96 -22.04 36.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.44 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 40.8 t -89.02 9.45 25.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 177.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 242' ' ' ARG . 36.9 tt0 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.62 -41.27 73.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.107 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.44 1.01 37.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.399 -173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.455 ' HG3' ' HA ' ' A' ' 239' ' ' GLU . 99.1 mtt180 -52.86 -40.6 63.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.7 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -82.48 137.63 17.16 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 245' ' ' ILE . 40.1 t -77.16 169.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.546 ' N ' HG12 ' A' ' 244' ' ' VAL . 71.7 mt -56.75 116.6 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.381 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 270' ' ' GLU . 32.9 mm -84.96 -38.79 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.958 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.627 ' HE2' ' CE2' ' A' ' 338' ' ' TRP . 80.5 tttt -169.21 141.49 2.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.716 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.744 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.4 OUTLIER -144.11 162.72 35.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.831 175.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.66 173.0 30.84 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.98 139.18 34.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.611 0.706 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.6 mt -143.72 160.85 39.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.4 mp -98.47 125.96 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -113.72 124.67 52.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.623 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 60.4 tt0 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.651 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.522 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 69.4 m95 . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.502 ' HD3' ' NH2' ' A' ' 264' ' ' ARG . 5.9 mtpt -105.38 140.76 38.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.128 0.49 . . . . 0.0 111.368 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.44 99.01 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.502 ' NH2' ' HD3' ' A' ' 262' ' ' LYS . 55.7 mtt-85 -116.57 148.38 40.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.033 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.31 110.54 18.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 20.1 m-85 -93.98 153.06 18.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.744 HG12 ' HB3' ' A' ' 248' ' ' GLN . 6.9 mt -144.96 125.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.815 0.697 . . . . 0.0 109.856 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.3 tp -99.85 145.39 27.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.102 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -149.56 131.43 15.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.8 OUTLIER -99.9 -170.72 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.672 -170.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.987 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 12.1 t70 95.02 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.661 1.584 . . . . 0.0 110.253 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.987 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.6 Cg_endo -91.38 -6.29 3.81 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 CA-C-N 120.859 1.342 . . . . 0.0 111.025 164.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.35 95.18 0.05 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.734 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 14.6 m-85 -137.62 115.27 11.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 44.7 tp -89.72 139.34 30.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.133 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 274' ' ' TYR . 75.5 m80 -130.24 144.3 51.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.416 ' HB3' ' CE2' ' A' ' 266' ' ' PHE . 8.2 p90 -131.4 139.05 49.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 110.712 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -119.56 -165.09 1.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.22 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -130.13 129.81 22.99 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 -17.08 22.26 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.854 2.369 . . . . 0.0 111.594 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.71 -12.18 17.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.237 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.86 84.32 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.91 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.54 117.32 0.2 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.447 0.641 . . . . 0.0 110.61 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -94.4 -30.54 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.825 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -75.23 142.41 75.3 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.778 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 125.92 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.163 1.908 . . . . 0.0 111.666 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.11 3.41 17.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.098 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 170.36 139.25 2.69 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -110.54 112.13 23.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.82 0.343 . . . . 0.0 110.308 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 63.8 mt -85.16 132.17 32.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.549 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.09 95.66 9.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.59 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.751 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 81.2 mt -79.87 -28.96 39.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.098 -172.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -52.97 103.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.88 0.372 . . . . 0.0 111.103 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 97.08 9.89 55.38 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.012 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' CYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.6 p -88.45 144.51 26.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.992 0.425 . . . . 0.0 110.778 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.01 144.62 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 91.4 t -119.38 150.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -148.59 142.01 25.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.463 -175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.7 t -76.36 108.5 9.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.915 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 51.3 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.189 0.519 . . . . 0.0 110.675 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.512 ' HG2' HD12 ' A' ' 314' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 313' ' ' ASN . 44.6 mt-10 -140.73 133.24 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' A' ' 335' ' ' ARG . 86.1 m-20 76.19 28.51 0.81 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.851 0.719 . . . . 0.0 110.411 -174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -77.06 126.29 30.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.319 178.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.58 125.49 47.92 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.572 ' HB3' HG22 ' A' ' 298' ' ' THR . 4.8 tp10 -86.41 136.32 33.16 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.893 -174.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.7 103.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.17 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.042 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.463 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 38.1 p -53.16 159.21 1.32 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.053 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.67 -1.59 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.902 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.15 4.46 53.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.125 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.81 27.74 11.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.355 172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.38 135.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -82.69 118.95 23.71 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -112.2 97.68 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.178 0.514 . . . . 0.0 110.033 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 87.7 m-85 -80.23 118.74 22.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.273 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 314' ' ' LEU . 87.6 mt -125.9 152.02 46.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 39.4 mt-30 -139.61 144.89 37.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.679 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -117.79 171.94 7.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.837 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.12 -69.04 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.499 0.499 . . . . 0.0 111.34 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 77.1 p -102.55 161.22 23.93 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.005 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' PRO . . . . . 0.641 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 68.3 Cg_exo -52.08 -44.45 45.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.545 2.163 . . . . 0.0 112.07 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 57.8 tttp -55.28 -50.01 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.364 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.54 -42.45 96.56 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.475 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 313' ' ' ASN . 7.0 ppt_? -66.95 -39.03 87.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.348 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' THR . . . . . 0.572 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -60.81 -41.77 96.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.838 0.352 . . . . 0.0 110.68 170.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 80.2 mm-40 -59.05 -44.67 91.84 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' TRP . . . . . 0.627 ' CE2' ' HE2' ' A' ' 247' ' ' LYS . 60.4 m95 -65.17 -36.21 83.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 336' ' ' THR . 99.0 mt -53.17 -53.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.4 mtmt -57.37 -42.18 81.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.709 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.82 42.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.122 0.487 . . . . 0.0 110.81 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 292' ' ' LEU . 2.1 mp -66.69 -40.99 87.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.495 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -64.77 -36.48 84.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.41 -30.86 33.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.088 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.94 56.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.677 0.275 . . . . 0.0 111.573 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.614 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 30.1 t -75.02 -22.78 58.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 347' ' ' ARG . 42.4 mtm105 . . . . . 0 C--N 1.327 -0.375 0 O-C-N 122.06 -0.4 . . . . 0.0 111.864 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.2 p 44.4 36.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 122.567 1.175 . . . . 0.0 111.981 -175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.9 123.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.629 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 237' ' ' LEU . 2.4 pt? -123.13 -164.99 1.26 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -51.11 130.24 25.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.293 0.568 . . . . 0.0 110.96 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.569 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 33.7 tt0 -55.23 -28.67 54.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.603 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 60.1 mt-10 -55.65 -37.01 67.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.403 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 237' ' ' LEU . 34.0 m-85 -103.44 0.46 31.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -71.33 -8.65 55.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.04 0.447 . . . . 0.0 110.52 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -107.64 143.17 15.94 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.23 151.87 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.317 0.579 . . . . 0.0 111.716 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.8 mt -53.25 127.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.162 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.494 HD11 ' CG ' ' A' ' 270' ' ' GLU . 41.2 mm -96.71 -44.84 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.766 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.524 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 60.3 tttp -164.98 132.59 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.52 -173.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.562 ' CB ' HG12 ' A' ' 267' ' ' ILE . 4.8 pt20 -132.91 141.35 48.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.319 0.58 . . . . 0.0 111.795 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 177.51 151.66 9.38 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.79 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 61.6 m -71.01 135.06 47.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.119 0.46 . . . . 0.0 110.116 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.542 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 94.0 mt -131.61 169.51 16.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 8.1 mp -95.0 117.58 30.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.12 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.83 119.08 38.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.249 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -61.56 111.06 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -151.07 86.74 0.14 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.726 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -74.28 69.57 1.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.435 0.636 . . . . 0.0 111.933 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -98.92 -53.34 3.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -130.99 -44.99 1.03 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.167 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -98.83 -165.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.543 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -108.19 -51.97 2.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.526 0.679 . . . . 0.0 109.723 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.532 ' CZ2' ' HG3' ' A' ' 311' ' ' GLU . 89.7 m95 -120.16 133.01 55.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.783 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 24.2 mtpp -110.62 151.5 27.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 0.0 112.246 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.2 101.73 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.2 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 96.7 mtt180 -132.62 154.6 49.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.741 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 40.6 ttmt -79.39 120.66 24.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.68 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 35.9 m-85 -103.89 117.2 33.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 248' ' ' GLN . 18.6 mt -114.83 127.0 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 42.5 tp -99.5 154.42 18.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.906 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -150.67 139.61 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.64 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.631 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 13.5 pt-20 -101.08 -169.95 1.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.595 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 270' ' ' GLU . 0.8 OUTLIER 95.64 -70.17 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 110.9 -178.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 271' ' ' ASP . 14.4 Cg_endo -97.97 -6.66 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.647 1.564 . . . . 0.0 111.876 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 70.13 93.95 0.08 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.501 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 33.6 m-85 -141.62 119.48 11.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.331 0.586 . . . . 0.0 111.953 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 290' ' ' ILE . 38.8 tp -90.86 140.13 30.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.278 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 70.9 m80 -127.65 139.67 52.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.103 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.514 ' HE2' HG13 ' A' ' 290' ' ' ILE . 1.3 p90 -121.7 136.25 54.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.264 0.554 . . . . 0.0 111.088 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.91 147.48 50.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.555 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.528 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 7.7 t70 -90.35 132.65 34.98 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 97.1 Cg_endo -72.57 -24.14 19.09 Favored 'Trans proline' 0 CA--C 1.517 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 111.293 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.93 -12.51 23.32 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.376 -170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.38 59.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.622 -1.275 . . . . 0.0 114.525 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -171.42 73.02 0.05 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.773 0.286 . . . . 0.0 111.136 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.19 -9.51 59.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.62 134.17 88.52 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.077 167.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.98 105.02 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.906 1.737 . . . . 0.0 112.439 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.73 -28.09 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.035 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.91 166.7 35.97 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.6 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -121.18 135.67 55.11 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.791 0.329 . . . . 0.0 110.376 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.7 HD12 HD23 ' A' ' 275' ' ' LEU . 27.7 mt -85.42 131.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -85.37 88.66 7.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.633 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.68 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 51.9 mt -76.56 -26.81 55.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.845 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 293' ' ' ARG . 21.4 ttt180 -52.37 101.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 95.85 10.49 56.39 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.877 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 11.4 p -90.73 147.72 23.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.919 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.07 146.24 17.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.15 152.46 13.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 14.3 t -145.98 142.42 28.65 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.678 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 40.7 t -83.73 105.3 14.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.46 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 55.8 t -70.79 130.89 34.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 -177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.78 29.09 0.13 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.576 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t 56.68 76.25 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.335 0.588 . . . . 0.0 110.068 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.97 33.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 311' ' ' GLU . 5.8 t -82.19 81.53 8.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.262 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -103.93 132.85 49.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.408 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.12 3.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.959 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 -168.94 1.79 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -78.3 153.36 31.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 67.8 m -68.47 76.87 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 111.508 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -84.72 -41.47 16.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.602 0.715 . . . . 0.0 109.193 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.894 ' HB3' HD12 ' A' ' 314' ' ' LEU . 8.9 mp0 -83.87 86.94 7.09 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.699 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.04 -68.42 0.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.926 0.87 . . . . 0.0 110.762 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 6.1 p30 -85.63 46.4 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 311' ' ' GLU . 0.7 OUTLIER -79.41 130.35 35.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.17 -176.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -127.67 134.0 49.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 36.9 tt0 -102.08 141.98 34.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.517 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.8 mt -116.34 110.8 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.0 mt -98.32 92.05 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.129 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.417 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 75.4 p -60.09 161.92 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.587 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.82 -17.62 61.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.23 0.538 . . . . 0.0 110.396 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.52 3.2 25.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.329 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 70.58 27.55 3.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.685 0.794 . . . . 0.0 111.834 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.61 126.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.019 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -91.35 113.62 25.93 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.23 111.43 23.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.208 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HD2' HD11 ' A' ' 314' ' ' LEU . 45.0 m-85 -85.77 115.28 23.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.784 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 99.0 mt -124.03 154.3 40.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.53 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 31.9 mt-30 -140.73 155.39 46.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.326 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.3 -174.81 2.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.357 0.598 . . . . 0.0 110.112 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 55.1 p -134.16 159.56 71.89 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.843 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.96 -32.48 97.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.681 2.254 . . . . 0.0 111.105 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 24.8 ttpp -59.45 -54.87 41.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.917 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 17.5 tp10 -63.92 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.465 -172.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 3.2 ptt180 -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.136 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.644 HG22 ' NZ ' ' A' ' 340' ' ' LYS . 88.0 m -58.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.798 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 4.8 mm-40 -60.73 -37.04 80.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.572 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.524 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 59.8 m95 -76.17 -32.95 59.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.62 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 335' ' ' ARG . 98.2 mt -54.63 -54.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.644 ' NZ ' HG22 ' A' ' 336' ' ' THR . 27.7 mtmm -56.8 -40.99 76.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.72 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.521 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.04 -56.09 25.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.134 0.492 . . . . 0.0 111.053 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.446 HG23 HD22 ' A' ' 292' ' ' LEU . 2.3 mp -66.34 -38.38 81.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.271 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.88 -41.02 92.07 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.64 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 12.6 ptm -71.95 -38.19 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.974 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -66.08 -35.83 81.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.396 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -69.18 -10.01 55.65 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.208 -0.307 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -72.66 -23.51 60.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.618 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.4 p -83.9 79.38 9.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.523 0.678 . . . . 0.0 109.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -123.68 63.64 0.55 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 82.3 mttt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.476 -172.108 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 235' ' ' VAL . 7.0 m-20 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 234' ' ' ASP . 30.4 t -74.74 74.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.559 0.695 . . . . 0.0 109.468 174.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.93 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.397 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 241' ' ' PHE . 1.9 pt? -136.65 -166.91 1.97 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.262 177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 18.8 mmtp -43.75 131.16 5.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.391 0.615 . . . . 0.0 111.948 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.866 ' HG3' ' HB3' ' A' ' 272' ' ' PRO . 7.8 tp10 -54.06 -35.01 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.055 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -55.77 -30.16 60.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.657 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.504 ' HB2' HD11 ' A' ' 237' ' ' LEU . 21.4 m-85 -113.23 2.42 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.132 -175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 239' ' ' GLU . 99.7 mtt180 -70.6 -35.78 73.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 110.04 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.38 150.05 51.36 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.585 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.4 t -81.39 145.64 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 122.724 0.41 . . . . 0.0 110.701 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.9 mp -70.44 117.9 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 110.378 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 270' ' ' GLU . 48.3 mm -85.52 -36.14 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.37 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.4 tttp -163.35 143.46 8.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.783 -171.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -133.13 157.55 45.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 148.84 155.82 6.87 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.074 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 6.9 p -76.21 141.02 41.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.198 0.499 . . . . 0.0 110.502 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 338' ' ' TRP . 96.1 mt -135.72 153.94 51.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 3.3 mp -86.59 117.5 25.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -103.08 119.2 38.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.555 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 260' ' ' ASN . 35.5 tt0 -65.24 123.45 19.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.728 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -157.95 124.08 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.363 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -65.8 159.2 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 72.35 -38.99 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.906 0.882 . . . . 0.0 112.067 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -86.18 57.46 4.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? 67.87 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 254' ' ' GLN . 64.6 t30 -170.16 -42.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.476 0.655 . . . . 0.0 109.47 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.553 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 93.2 m95 -120.45 124.66 45.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.513 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 5.5 ttpm? -113.53 160.92 17.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.882 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.5 t -111.98 111.3 35.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.343 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 95.0 mtt180 -137.42 150.64 47.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.05 172.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 36.2 ttpt -84.71 123.24 30.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.754 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 23.0 m-85 -97.77 158.86 15.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.315 0.578 . . . . 0.0 111.72 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 245' ' ' ILE . 7.9 mt -150.15 121.29 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.985 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 33.5 tp -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.013 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 51.7 mtt180 -146.48 134.08 20.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.742 0.306 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.642 ' HB3' HD11 ' A' ' 246' ' ' ILE . 37.0 tt0 -112.86 133.75 54.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.605 ' HB3' ' HE2' ' A' ' 350' ' ' LYS . 25.6 m-20 145.17 -54.45 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 125.733 1.895 . . . . 0.0 108.164 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.866 ' HB3' ' HG3' ' A' ' 239' ' ' GLU . 66.2 Cg_endo -100.04 -16.29 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 166.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.811 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.14 82.91 0.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.308 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 57.6 m-85 -143.62 124.53 14.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.413 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 51.1 tp -89.29 137.49 32.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -124.85 154.71 40.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.655 0.264 . . . . 0.0 110.304 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -147.34 144.49 28.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.5 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.095 ' HA ' HD13 ' A' ' 287' ' ' LEU . 2.6 m-85 -133.92 154.81 50.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.661 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 282' ' ' GLY . 5.5 t70 -87.19 136.42 33.72 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.482 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 93.9 Cg_endo -67.94 -19.82 45.71 Favored 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 123.01 2.473 . . . . 0.0 111.414 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.12 7.98 19.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.19 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . 171.19 140.23 2.98 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.266 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 72.66 102.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.608 0.718 . . . . 0.0 112.412 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -95.74 -6.59 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.221 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.8 132.56 51.08 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 10.8 Cg_endo -51.81 124.62 14.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.382 2.722 . . . . 0.0 114.004 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.095 HD13 ' HA ' ' A' ' 278' ' ' TYR . 6.1 mp -81.81 -26.38 34.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.384 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -174.64 174.26 46.5 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.742 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 275' ' ' LEU . . . -141.76 140.85 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.304 . . . . 0.0 111.011 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 38.9 mt -99.41 137.92 25.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.529 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -84.72 95.3 8.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.774 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.811 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 30.5 mt -77.77 -28.66 50.62 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.88 107.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.872 0.368 . . . . 0.0 111.142 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.67 13.59 62.67 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.276 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 15.8 p -87.29 146.86 25.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.258 0.552 . . . . 0.0 111.271 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.83 140.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.51 154.49 18.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -141.65 140.93 33.37 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.245 0.545 . . . . 0.0 109.928 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 7.6 t -87.7 99.13 11.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.746 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 45.6 t -81.7 110.23 16.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.45 39.55 0.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.021 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 8.5 t 57.28 69.34 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.072 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -137.18 78.62 1.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.136 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 44.0 t -170.55 178.11 3.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.414 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 76.6 -60.76 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.131 0.972 . . . . 0.0 111.916 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -171.35 -150.63 7.19 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.7 -51.85 60.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -80.72 116.09 20.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.607 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 54.3 m -75.88 83.53 2.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.383 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -62.58 -39.5 93.91 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.666 0.746 . . . . 0.0 110.245 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.46 87.61 3.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.877 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 162.57 13.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.609 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.884 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 11.1 p30 41.75 36.99 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.985 0.914 . . . . 0.0 112.259 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.4 OUTLIER -75.49 129.95 38.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.92 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -125.48 125.4 43.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 38.9 tt0 -96.16 137.01 35.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.212 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -114.4 108.97 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.37 88.22 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.468 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.3 p -62.78 171.45 2.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.269 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -65.3 -18.09 65.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.679 0.752 . . . . 0.0 109.541 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.5 -5.0 42.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.489 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 69.28 29.22 4.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.685 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.61 132.11 53.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.733 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.44 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 7.7 m-70 -90.23 114.32 26.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 63.2 m-85 -98.65 115.57 28.97 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 44.2 m-85 -91.38 115.68 28.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.018 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.508 ' O ' HD23 ' A' ' 314' ' ' LEU . 95.9 mt -128.7 151.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.582 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 26.1 mt-30 -142.36 154.92 45.05 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.901 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.88 -175.94 2.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.395 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -76.75 -37.21 56.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.211 0.529 . . . . 0.0 110.248 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 45.5 p -127.48 155.17 77.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.797 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 25.2 Cg_exo -63.23 -21.83 72.25 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.138 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.65 -30.79 17.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.581 0.229 . . . . 0.0 111.221 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -43.56 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.884 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.21 -42.62 95.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.17 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.524 ' HA ' HD12 ' A' ' 339' ' ' ILE . 11.8 m -58.64 -39.22 79.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 41.4 mt-10 -64.49 -36.75 85.19 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.689 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.446 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 68.8 m95 -72.72 -34.66 67.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.888 -0.142 . . . . 0.0 111.168 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 336' ' ' THR . 84.6 mt -53.15 -57.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 170.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -56.28 -41.97 76.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.971 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.466 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.17 -57.16 14.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.81 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.714 HG23 HD22 ' A' ' 292' ' ' LEU . 1.7 mp -60.94 -42.16 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.344 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.74 -42.29 97.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.552 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.545 ' HG3' ' N ' ' A' ' 345' ' ' ALA . 11.6 ptm -73.17 -40.84 64.49 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.739 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 344' ' ' MET . . . -61.2 -29.37 69.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.488 0.185 . . . . 0.0 111.179 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 33.1 t -68.03 -14.43 62.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -74.08 -43.91 55.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 35.9 p 62.18 124.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.345 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -69.22 -31.76 72.02 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.01 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.605 ' HE2' ' HB3' ' A' ' 271' ' ' ASP . 43.5 mtmt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.836 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -66.64 82.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.563 0.697 . . . . 0.0 110.888 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.33 120.23 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.9 mp -56.74 116.0 2.9 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 47.4 mmtm -88.75 -179.05 5.92 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.705 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.42 -35.36 75.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.722 0.773 . . . . 0.0 109.202 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 274' ' ' TYR . 11.6 mp0 -66.22 -12.27 55.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.069 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.97 -13.58 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 96.7 mtt180 -56.23 -24.53 42.87 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.65 141.53 18.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.174 175.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.22 153.01 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 23.5 mt -55.61 132.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.392 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 270' ' ' GLU . 42.9 mm -99.9 -42.09 10.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.331 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 59.8 tttp -166.59 138.12 3.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.208 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.447 ' HB3' HD12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -136.58 152.62 50.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.351 0.595 . . . . 0.0 112.392 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.67 157.18 9.76 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.656 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 31.8 m -77.07 144.74 38.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.801 0.8 . . . . 0.0 110.305 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.3 mt -142.01 165.39 27.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -96.87 119.03 34.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.542 -0.169 . . . . 0.0 110.542 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.88 120.62 40.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.48 115.45 4.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.925 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -103.1 -178.08 26.48 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.927 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 58.5 -159.81 0.27 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.558 0.343 . . . . 0.0 110.486 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 257' ' ' ARG . 4.0 ptp180 -87.08 55.71 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 110.691 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 68.53 87.26 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.159 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -168.11 -68.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.032 173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.76 161.82 18.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.027 0.442 . . . . 0.0 110.669 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 72.3 m95 -124.3 143.89 50.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.512 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.39 131.86 56.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.399 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.05 107.53 12.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.494 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -129.02 156.62 43.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 84.0 tttt -89.95 115.07 26.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.734 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 30.9 m-85 -101.96 118.24 36.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.021 0.438 . . . . 0.0 111.822 -175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' CE1' ' A' ' 278' ' ' TYR . 9.3 mm -112.49 127.33 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 292' ' ' LEU . 39.2 tp -101.32 154.48 18.75 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.622 ' HB2' ' HE1' ' A' ' 276' ' ' HIS . 79.9 mtt-85 -154.89 143.97 21.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 246' ' ' ILE . 6.3 pt-20 -100.84 -170.44 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.62 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.881 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 32.8 t70 93.13 -72.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.686 1.595 . . . . 0.0 110.498 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.3 Cg_endo -92.64 -3.05 3.66 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 121.124 1.437 . . . . 0.0 112.054 167.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.77 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.93 85.67 0.14 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.319 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.3 m-85 -130.71 129.85 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.753 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 29.0 tp -101.74 130.88 48.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.622 ' HE1' ' HB2' ' A' ' 269' ' ' ARG . 22.3 m80 -121.59 130.24 53.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.081 -172.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' A' ' 290' ' ' ILE . 8.5 p90 -119.7 133.28 55.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.883 0.849 . . . . 0.0 111.283 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.539 ' CE1' HG12 ' A' ' 267' ' ' ILE . 3.6 m-85 -115.15 149.07 38.21 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.263 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.578 ' HB2' HD11 ' A' ' 287' ' ' LEU . 0.3 OUTLIER -87.99 132.2 40.68 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.68 -15.92 41.57 Favored 'Trans proline' 0 CA--C 1.514 -0.503 0 C-N-CA 123.342 2.695 . . . . 0.0 111.038 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.11 2.23 34.37 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.31 -171.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.46 85.25 0.05 OUTLIER Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.799 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -178.04 107.06 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.275 0.56 . . . . 0.0 111.985 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -83.69 -46.67 12.03 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.72 134.75 46.81 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.238 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.41 137.03 58.08 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.856 2.371 . . . . 0.0 112.259 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 279' ' ' ASP . 58.1 mt -68.08 -29.35 68.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.945 -176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -167.73 147.0 11.1 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.558 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.04 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 66.1 mt -67.19 142.05 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.347 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -94.54 94.47 8.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.62 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.77 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 42.7 mt -72.68 -31.24 64.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.928 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -58.6 91.14 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 119.3 -3.68 13.87 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 292' ' ' LEU . 14.2 p -95.81 148.36 22.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.175 0.487 . . . . 0.0 111.419 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.92 150.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 339' ' ' ILE . 57.8 t -117.18 159.79 17.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.766 0.317 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 8.8 t -160.02 143.34 13.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.73 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.6 t -80.35 122.68 27.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 46.6 t -95.58 125.24 48.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 111.266 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.81 45.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.827 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.3 m 55.1 34.32 22.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.3 0.571 . . . . 0.0 110.0 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.424 ' H ' HG12 ' A' ' 300' ' ' VAL . 55.8 t30 -80.29 76.85 7.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.718 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 17.7 p -106.27 150.77 25.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.889 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -87.7 100.93 13.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 0.0 110.077 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 142.25 172.98 13.93 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 307' ' ' ARG . 67.5 mtt180 -96.4 172.22 8.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.661 0.231 . . . . 0.0 110.917 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 55.49 46.68 22.6 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.476 0.655 . . . . 0.0 110.974 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.0 p -64.55 119.32 10.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.554 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -104.99 5.18 32.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.241 0.543 . . . . 0.0 110.495 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.562 ' HB3' HD12 ' A' ' 314' ' ' LEU . 17.6 mp0 -74.56 125.87 29.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.73 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -135.34 132.16 37.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.726 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.56 35.12 11.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.0 OUTLIER -75.28 129.86 38.14 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.554 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -126.99 138.29 53.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 168.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.495 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 33.7 tt0 -100.7 133.41 45.19 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 78.5 mt -112.73 102.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.07 91.67 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.966 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.7 p -54.39 159.08 2.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.25 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.6 1.81 2.19 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.865 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -118.34 30.21 7.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.276 0.56 . . . . 0.0 110.428 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 64.8 31.05 11.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.961 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 t -108.78 124.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.195 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -88.88 114.69 25.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 6.9 m-30 -94.58 125.35 39.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.496 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 6.3 m-30 -99.74 114.73 28.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 110.847 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.77 153.28 38.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.386 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 26.4 mt-30 -139.52 142.22 37.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.058 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -115.09 165.61 12.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.68 30.2 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 71.7 p -113.82 159.04 37.39 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.086 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.4 -37.89 82.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.945 2.43 . . . . 0.0 111.816 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 30.1 mmtp -64.61 -47.91 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 338' ' ' TRP . 11.9 tp10 -55.94 -49.42 73.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.074 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 336' ' ' THR . 8.5 ptt180 -60.59 -43.82 96.95 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.611 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 339' ' ' ILE . 30.9 m -60.32 -37.69 81.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.752 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.503 ' HB3' ' HE2' ' A' ' 247' ' ' LYS . 76.5 mm-40 -63.73 -40.72 97.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.49 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 75.8 m95 -71.34 -33.0 69.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 336' ' ' THR . 98.0 mt -53.32 -57.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -58.75 -39.39 80.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.181 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.468 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -61.65 -53.01 61.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.206 0.526 . . . . 0.0 110.897 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.709 HG23 HD22 ' A' ' 292' ' ' LEU . 1.8 mp -64.27 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.265 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 97.8 mt-30 -63.81 -49.35 73.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.604 0.24 . . . . 0.0 111.34 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.4 ptm -70.05 -24.56 63.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.391 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.15 32.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.608 0.242 . . . . 0.0 111.061 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.7 t -66.66 -19.27 65.73 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.39 21.49 6.09 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.924 -0.485 . . . . 0.0 111.587 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 270' ' ' GLU . 39.2 p -100.07 167.24 10.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 77.19 53.21 5.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.258 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.079 176.766 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.9 t -77.37 61.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 122.043 0.925 . . . . 0.0 109.783 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.4 mt -98.95 102.13 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.569 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 241' ' ' PHE . 2.3 mp -55.37 109.65 0.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.951 0.882 . . . . 0.0 112.513 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 32.1 mmmt -82.47 -178.23 6.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.543 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 272' ' ' PRO . 36.5 tt0 -54.64 -38.99 67.53 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 52.3 mt-10 -52.9 -40.89 63.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.535 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.45 ' O ' HD23 ' A' ' 237' ' ' LEU . 12.4 m-85 -101.5 -15.64 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -166.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 25.3 mtp180 -53.12 -23.89 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -87.05 149.5 22.2 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.087 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 245' ' ' ILE . 97.4 t -85.94 158.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.111 0.482 . . . . 0.0 110.426 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mm -73.57 116.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.725 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.628 HD11 ' HG2' ' A' ' 270' ' ' GLU . 33.5 mm -83.3 -41.84 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -161.12 149.29 15.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -133.25 157.4 45.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.22 164.83 19.21 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.35 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 9.1 p -86.19 133.12 33.87 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.3 mt -133.63 155.97 48.72 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.8 mp -91.46 121.82 33.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -108.43 131.4 54.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 33.7 tt0 -77.75 146.28 36.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.964 173.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.98 19.47 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.656 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.22 124.14 28.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 59.43 50.33 7.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.809 0.814 . . . . 0.0 110.489 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -121.56 -174.06 2.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.713 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -77.05 -61.3 2.03 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.83 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -163.09 -167.39 1.47 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 252' ' ' LEU . 62.7 m95 -68.75 146.06 53.27 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 9.0 ptpt -134.08 165.27 25.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.535 0.683 . . . . 0.0 112.43 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.2 103.15 14.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.207 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.653 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 97.0 mtt180 -126.01 158.24 35.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.197 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.57 106.04 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.404 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.6 m-85 -91.12 148.09 22.61 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.395 0.617 . . . . 0.0 111.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 245' ' ' ILE . 21.0 mt -146.39 118.53 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.298 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 61.1 tp -93.03 139.46 30.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.202 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -139.31 127.67 22.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.785 ' HB2' HG21 ' A' ' 348' ' ' THR . 0.4 OUTLIER -91.1 -172.17 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.224 -174.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.976 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 38.4 t70 94.63 -76.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.66 1.584 . . . . 0.0 109.968 176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.976 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.4 Cg_endo -92.01 -5.67 3.59 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 CA-C-N 121.098 1.428 . . . . 0.0 111.262 166.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 66.31 98.32 0.05 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.975 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 41.4 m-85 -144.74 110.92 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.139 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.593 HD23 HD12 ' A' ' 290' ' ' ILE . 23.8 tp -89.56 121.1 31.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 61.7 m80 -112.58 155.09 24.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.078 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.54 141.46 39.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.351 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 283' ' ' ALA . 3.3 m-85 -127.57 166.45 17.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.948 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 27.5 t70 -95.13 123.4 57.29 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.653 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 83.3 Cg_endo -67.78 -17.53 47.32 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.391 2.728 . . . . 0.0 110.26 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.544 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -89.57 -1.65 58.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.261 -1.791 . . . . 0.0 111.205 -172.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.29 29.78 0.17 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.188 170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -129.0 111.78 13.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.37 1.085 . . . . 0.0 110.901 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.94 -12.66 23.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.831 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.19 141.81 96.48 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.416 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.6 108.78 2.32 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.468 2.112 . . . . 0.0 111.517 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.03 5.85 13.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.603 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 167.77 140.55 2.94 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.518 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.439 ' HB2' ' OE1' ' A' ' 240' ' ' GLU . . . -115.57 102.04 9.41 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.593 HD12 HD23 ' A' ' 275' ' ' LEU . 59.3 mt -70.82 123.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -82.52 87.11 6.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.017 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.678 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 78.9 mt -74.56 -27.61 60.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -48.44 99.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 92.54 18.79 40.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.957 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . . . . . . . . . 14.8 p -95.39 157.92 15.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.303 0.573 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.93 149.93 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 298' ' ' THR . 48.4 t -118.15 158.81 18.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.0 t -150.86 143.23 24.25 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.272 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.9 t -80.0 99.44 7.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.451 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.5 t -76.59 109.8 11.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.946 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -93.67 69.77 4.1 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.781 0.8 . . . . 0.0 109.469 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 309' ' ' SER . 35.2 m 64.43 85.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.469 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -112.91 23.27 13.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.794 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 56.0 m -135.26 160.94 36.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.997 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -123.48 135.58 54.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 0.0 111.173 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -140.92 -64.85 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -142.84 -39.54 0.33 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -141.73 23.73 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.196 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 61.8 m 56.21 67.52 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.718 0.77 . . . . 0.0 109.627 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.51 -33.27 73.53 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.936 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 311' ' ' GLU . 6.4 mp0 -58.15 89.86 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.512 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.56 -10.14 12.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.653 0.739 . . . . 0.0 110.772 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -122.55 29.77 6.77 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.897 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.2 tt -77.58 135.57 38.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.331 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -129.91 125.87 36.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 298' ' ' THR . 36.0 tt0 -93.62 136.92 33.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.129 -174.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -112.01 103.14 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.56 88.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.656 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 50.1 p -59.21 160.76 6.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.517 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.17 -8.97 27.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.384 0.611 . . . . 0.0 110.671 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.11 4.6 41.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.233 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 64.03 32.12 13.13 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.033 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.37 127.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.709 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -87.63 118.09 26.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 9.0 m-85 -98.93 117.91 34.51 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.6 m-85 -95.46 112.81 24.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.066 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 96.5 mt -126.67 156.41 41.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.728 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.515 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 30.6 mt-30 -139.45 145.29 38.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.672 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -112.69 176.48 5.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.455 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.96 -56.48 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.0 111.102 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 39.2 p -124.05 163.43 35.62 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.21 -37.84 40.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.725 2.283 . . . . 0.0 112.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 50.7 mtmt -62.91 -48.98 76.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.924 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -61.26 -41.89 97.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.145 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 339' ' ' ILE . 17.8 ptt180 -63.17 -42.15 99.34 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.635 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 339' ' ' ILE . 18.7 m -57.24 -42.3 81.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.767 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 11.1 mm-40 -57.47 -45.29 84.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.858 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -70.55 -31.15 68.08 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 336' ' ' THR . 89.2 mt -59.86 -56.99 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -55.46 -49.83 71.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.925 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.3 30.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 0.0 111.431 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 317' ' ' ILE . 13.5 mt -71.55 -41.06 72.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.081 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.69 -30.76 71.82 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.461 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.15 -40.79 21.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.695 0.283 . . . . 0.0 110.276 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.18 71.6 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.56 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 32.9 t -76.91 -0.35 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.772 0.32 . . . . 0.0 111.819 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 62.4 mtp85 -92.02 15.98 12.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.05 -0.406 . . . . 0.0 111.348 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.785 HG21 ' HB2' ' A' ' 270' ' ' GLU . 12.2 p -87.66 35.18 0.72 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.15 0.5 . . . . 0.0 112.08 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.52 68.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 82.5 mttt . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.87 176.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.9 70.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.366 0.603 . . . . 0.0 110.384 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.0 mt -106.03 87.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.26 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -140.48 -176.97 4.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 241' ' ' PHE . 49.9 mmtm -46.85 132.21 11.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.613 0.72 . . . . 0.0 111.007 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.592 ' OE1' ' HD3' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -59.59 -34.14 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.791 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 269' ' ' ARG . 20.7 mt-10 -58.63 -26.48 63.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.017 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 237' ' ' LEU . 4.9 m-85 -115.35 1.5 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.255 -174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.592 ' HD3' ' OE1' ' A' ' 239' ' ' GLU . 64.8 mtp180 -72.11 -4.62 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.71 150.83 18.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 72.8 t -81.13 147.8 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.153 0.501 . . . . 0.0 111.139 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 3.9 mt -70.36 111.82 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.575 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 268' ' ' LEU . 37.0 mm -77.82 -35.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.227 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -169.18 144.82 3.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.533 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.58 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.12 157.91 40.45 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.19 156.63 8.95 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.696 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 264' ' ' ARG . 12.9 p -75.17 137.69 41.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 0.167 . . . . 0.0 110.642 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.6 mt -140.33 159.21 42.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 262' ' ' LYS . 10.9 mp -97.78 120.41 38.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -109.33 123.49 49.39 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.454 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.46 140.18 58.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.917 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -118.15 -112.61 2.56 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.78 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -143.23 161.55 37.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 257' ' ' ARG . 16.3 mmt180 62.82 -170.48 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.755 0.659 . . . . 0.0 110.974 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.53 37.37 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.03 -17.9 18.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.5 ' HB3' ' HD1' ' A' ' 261' ' ' TRP . 4.0 m-20 58.94 -100.12 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.927 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 31.3 m95 -119.73 162.94 18.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.619 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 28.8 mttt -139.5 150.72 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.581 . . . . 0.0 111.526 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -92.96 99.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.9 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.746 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 70.7 mtt180 -124.06 164.67 18.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.394 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -94.26 110.64 22.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.694 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 17.6 m-85 -94.4 151.66 19.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.809 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 248' ' ' GLN . 13.0 mt -144.86 125.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.916 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.596 HD22 ' HB1' ' A' ' 341' ' ' ALA . 48.3 tp -100.09 147.64 25.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.286 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 68.6 mtt-85 -140.91 126.6 19.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.739 ' HG2' HG21 ' A' ' 348' ' ' THR . 19.0 tt0 -106.07 130.38 53.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.6 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.994 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.5 t70 148.39 -59.98 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 125.335 1.647 . . . . 0.0 108.36 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.994 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 11.2 Cg_endo -94.12 -10.41 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.44 2.093 . . . . 0.0 110.768 166.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.48 88.78 0.1 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.839 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -138.32 120.86 16.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 290' ' ' ILE . 33.3 tp -99.78 117.6 34.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.417 175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 0.7 OUTLIER -110.85 154.85 23.42 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.397 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -132.71 139.76 47.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.473 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -123.02 166.52 14.97 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.488 ' HB2' HD11 ' A' ' 287' ' ' LEU . 6.8 t70 -88.0 135.36 33.54 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.746 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.6 Cg_endo -70.39 -14.51 34.17 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 111.539 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.11 11.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.516 -171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 279' ' ' ASP . . . -163.33 136.21 4.17 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.989 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 75.19 123.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.856 0.862 . . . . 0.0 113.262 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.78 -2.74 58.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.75 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 286' ' ' PRO . 1.4 p-10 -85.71 146.15 43.2 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.562 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . 2.6 Cg_endo -75.77 141.47 24.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.169 2.579 . . . . 0.0 113.341 -170.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 279' ' ' ASP . 88.7 mt -96.09 7.46 46.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.957 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 143.63 138.08 3.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.646 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 276' ' ' HIS . . . -106.08 142.26 36.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.736 0.303 . . . . 0.0 110.76 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 275' ' ' LEU . 59.8 mt -98.41 131.99 44.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -88.38 91.88 8.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.702 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 56.5 mt -73.0 -32.43 65.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.647 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -61.24 96.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.098 0.475 . . . . 0.0 110.002 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 116.25 2.4 19.94 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.218 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.575 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 13.0 p -97.85 154.1 17.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.256 0.551 . . . . 0.0 111.455 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.9 t -119.5 150.45 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 298' ' ' THR . 48.5 t -119.75 158.38 21.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 7.6 t -160.11 136.65 8.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.013 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.6 p -73.2 138.32 45.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.164 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.745 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 59.0 t -103.68 131.28 52.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.107 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -85.16 42.7 0.96 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 312' ' ' GLU . 11.5 p 46.42 50.41 12.51 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.074 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -128.25 44.57 2.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.408 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.516 ' HB3' ' OE2' ' A' ' 311' ' ' GLU . 41.9 t -86.19 -72.46 0.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -177.04 90.43 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 310' ' ' GLU . . . -137.66 -159.02 8.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.672 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 307' ' ' ARG . 44.2 mtt180 -82.19 -63.37 1.39 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.33 0.586 . . . . 0.0 109.507 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -116.73 -60.89 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 67.5 m -163.28 98.16 0.92 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.82 -1.537 . . . . 0.0 107.169 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.683 ' HG2' ' HA3' ' A' ' 306' ' ' GLY . 7.6 mm-40 -96.44 -39.11 9.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.952 0.882 . . . . 0.0 109.432 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.673 ' HB3' HD12 ' A' ' 314' ' ' LEU . 26.4 mp0 -81.83 50.13 1.48 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.07 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.642 ' HA ' ' HB3' ' A' ' 302' ' ' SER . 33.4 mt-10 -73.1 -15.02 61.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 112.037 -172.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 328' ' ' GLN . 83.4 m-20 -122.27 20.67 10.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.22 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.745 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.8 OUTLIER -74.92 132.45 41.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.139 -178.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -131.0 133.02 45.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 43.6 tt0 -93.03 132.82 36.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.744 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 87.2 mt -113.24 105.29 18.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.84 90.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.679 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.575 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 20.4 p -59.56 176.66 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.98 68.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.555 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.58 -8.42 55.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.89 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 68.17 45.19 1.3 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.706 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.29 134.81 43.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 316' ' ' GLU . 34.1 m-70 -83.77 112.05 19.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 51.5 m-85 -99.69 103.51 15.18 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 15.9 m-30 -84.49 110.01 18.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.595 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 94.1 mt -118.37 151.89 36.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.508 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 36.0 mt-30 -136.18 146.03 46.4 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.282 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -108.52 171.99 7.1 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.876 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.02 68.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.033 0.444 . . . . 0.0 110.708 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -116.46 160.37 36.4 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.57 -23.67 76.21 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.027 2.485 . . . . 0.0 112.477 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.59 -38.67 23.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.597 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.543 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.4 tp10 -57.41 -44.07 84.27 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.48 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 339' ' ' ILE . 21.3 ptt180 -60.46 -40.8 92.51 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.173 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 340' ' ' LYS . 27.2 m -55.61 -45.24 77.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.503 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.426 ' HA ' ' HE3' ' A' ' 340' ' ' LYS . 74.7 mm-40 -58.94 -36.36 74.65 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.126 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.475 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 86.3 m95 -78.0 -35.32 50.16 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 343' ' ' GLN . 82.3 mt -54.25 -55.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 336' ' ' THR . 51.0 mtmt -58.7 -42.51 88.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.121 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.596 ' HB1' HD22 ' A' ' 268' ' ' LEU . . . -58.05 -52.14 66.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.919 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.26 -42.95 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 39.0 mt-30 -65.94 -33.45 75.86 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.462 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 14.7 ptm -80.83 -28.93 36.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.961 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 270' ' ' GLU . . . -80.99 -30.86 34.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.605 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 16.6 p -78.0 -10.85 59.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -92.53 29.78 1.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.879 0.371 . . . . 0.0 111.424 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.739 HG21 ' HG2' ' A' ' 270' ' ' GLU . 2.9 p -103.59 145.09 30.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 141.46 28.24 0.18 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.219 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.846 173.476 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 235' ' ' VAL . 7.4 p -77.76 71.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 122.623 1.201 . . . . 0.0 109.527 172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.1 mt -118.89 117.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.292 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -95.98 -174.96 3.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.335 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 78.8 mttt -53.71 138.26 35.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 272' ' ' PRO . 3.6 mp0 -59.11 -26.18 64.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.097 172.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 55.7 mt-10 -50.58 -31.67 16.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.738 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.589 ' HB2' HD11 ' A' ' 237' ' ' LEU . 31.0 m-85 -114.09 -5.85 13.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.432 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 79.8 mtp180 -80.48 -14.47 58.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -87.68 148.06 20.88 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.587 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 70.0 t -77.37 147.89 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.936 0.398 . . . . 0.0 111.221 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 268' ' ' LEU . 4.4 mp -67.31 119.81 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.91 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.8 -45.18 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.225 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.544 ' HE2' ' NE1' ' A' ' 338' ' ' TRP . 75.1 tttt -165.44 140.74 5.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.249 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.485 ' HB3' HD12 ' A' ' 267' ' ' ILE . 4.4 pt20 -134.32 156.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 111.293 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.47 156.38 8.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 73.5 m -78.44 131.48 36.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.165 0.482 . . . . 0.0 110.415 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 96.4 mt -133.68 150.55 51.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.4 mp -79.4 145.15 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 261' ' ' TRP . 25.9 mtmm -128.29 129.31 46.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.22 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 261' ' ' TRP . 50.2 tt0 -108.33 143.2 37.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.035 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 63.23 62.3 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.995 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -157.5 74.37 0.75 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 75.29 -23.97 0.23 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.856 0.862 . . . . 0.0 112.133 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -96.8 165.66 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.07 -73.66 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.144 0.497 . . . . 0.0 110.24 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -96.58 -178.15 4.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.612 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.577 ' CE2' ' HB2' ' A' ' 254' ' ' GLN . 70.9 m95 -62.67 133.35 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 35.7 mmtm -125.63 161.49 27.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 0.0 112.206 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.69 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.86 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.622 ' NH1' HD13 ' A' ' 287' ' ' LEU . 96.4 mtt180 -141.25 149.35 41.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.197 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -77.63 121.16 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.608 -169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.736 ' O ' HD13 ' A' ' 267' ' ' ILE . 21.7 m-85 -95.17 145.56 24.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.623 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 266' ' ' PHE . 16.4 mm -134.51 124.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 39.9 tp -100.92 147.55 26.01 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 240' ' ' GLU . 58.8 mtt-85 -143.53 131.75 21.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -174.9 4.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.446 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.996 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 13.7 t70 93.54 -75.89 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 125.83 1.652 . . . . 0.0 110.432 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.996 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 6.7 Cg_endo -92.23 -6.94 3.17 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 CA-C-N 121.344 1.516 . . . . 0.0 111.495 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 69.19 93.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.967 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 50.0 m-85 -138.63 112.52 8.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.156 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 46.4 tp -90.38 141.08 29.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.446 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 67.7 m80 -134.46 153.42 51.93 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.29 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -137.19 137.28 38.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.695 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' A' ' 267' ' ' ILE . 20.2 m-85 -128.13 164.09 23.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.234 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 281' ' ' ALA . 31.0 t70 -93.95 124.92 54.91 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-O 120.925 0.393 . . . . 0.0 110.428 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.59 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 90.4 Cg_endo -70.66 -21.3 29.48 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 123.669 2.913 . . . . 0.0 110.601 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.564 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -81.06 -21.02 40.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.185 -170.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.69 65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.071 -1.062 . . . . 0.0 113.859 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -160.45 120.75 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.852 0.326 . . . . 0.0 111.514 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -90.64 -15.47 30.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.26 137.11 86.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.175 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.3 122.32 9.12 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.074 1.849 . . . . 0.0 111.108 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.622 HD13 ' NH1' ' A' ' 264' ' ' ARG . 29.8 mt -81.29 2.85 26.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 161.08 156.83 8.43 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.521 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.92 124.42 43.17 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.633 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 50.4 mt -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -86.29 99.92 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.817 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.583 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 68.4 mt -75.86 -80.0 0.09 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.294 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.803 ' HG3' ' HA ' ' A' ' 350' ' ' LYS . 32.3 ttm180 37.71 -90.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -170.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -105.73 51.43 0.76 Allowed Glycine 0 C--N 1.317 -0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.996 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 28.0 p -90.54 122.02 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.062 0.458 . . . . 0.0 110.755 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.48 143.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.1 t -122.18 156.33 26.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 316' ' ' GLU . 10.8 t -145.34 138.43 26.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.169 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 32.9 t -80.36 99.14 7.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.925 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 25.3 t -81.63 101.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.457 0.646 . . . . 0.0 110.389 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.15 58.91 3.84 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.86 0.838 . . . . 0.0 108.798 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 64.0 m 65.76 29.11 10.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.397 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.552 ' HB2' HG13 ' A' ' 300' ' ' VAL . 14.1 m120 -63.06 -16.85 61.28 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.626 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 31.5 t -65.48 126.37 28.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.842 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.419 ' C ' HD22 ' A' ' 305' ' ' ASN . 0.2 OUTLIER 60.99 59.34 2.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.814 178.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.26 -86.15 1.3 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.95 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -148.41 -27.72 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -143.84 95.2 2.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.399 0.619 . . . . 0.0 111.768 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.9 t -101.52 -160.58 0.8 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 166.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -77.49 -36.7 52.42 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.883 0.849 . . . . 0.0 109.476 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.675 ' HB3' HD12 ' A' ' 314' ' ' LEU . 1.5 mp0 -52.3 113.44 1.04 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.589 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.45 178.87 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 162.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.1 m120 56.33 20.55 4.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.925 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -83.98 136.01 34.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.942 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 338' ' ' TRP . 23.1 p90 -133.36 118.77 18.85 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 166.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -87.2 134.46 33.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.119 -174.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.5 mt -109.01 104.72 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 21.4 mt -94.06 88.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.977 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 65.1 p -55.46 165.12 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.267 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -72.63 1.37 8.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -108.59 13.5 25.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.425 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 66.31 32.19 7.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.559 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.0 126.98 55.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -94.17 113.04 24.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.507 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 30.6 m-85 -96.92 138.58 34.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.476 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 51.6 m-85 -114.89 121.07 42.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.299 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 81.1 mt -133.69 155.45 49.71 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.881 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.6 mt-30 -135.65 135.83 40.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -103.51 175.36 5.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.545 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.83 -53.07 36.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 0.0 110.984 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 74.3 p -114.51 164.08 17.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.531 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 32.6 Cg_exo -61.34 -35.89 81.62 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.21 1.94 . . . . 0.0 111.255 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.82 -45.93 76.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.688 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.458 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 8.3 tp10 -55.95 -47.48 77.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.664 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 332' ' ' PRO . 0.6 OUTLIER -62.51 -44.42 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.944 -176.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -56.5 -36.97 69.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.58 ' HA ' ' HE2' ' A' ' 340' ' ' LYS . 14.3 mt-10 -77.18 -29.5 54.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.605 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.544 ' NE1' ' HE2' ' A' ' 247' ' ' LYS . 50.3 m95 -67.91 -32.32 72.71 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.235 -0.291 . . . . 0.0 110.537 171.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 336' ' ' THR . 90.1 mt -54.42 -56.32 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 168.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 337' ' ' GLU . 58.6 mtmt -52.14 -47.1 65.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.243 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -55.74 -55.79 28.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.327 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.432 HG23 HD22 ' A' ' 292' ' ' LEU . 2.2 mp -70.16 -36.25 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.902 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 18.5 mt-30 -73.54 -32.69 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.031 -0.418 . . . . 0.0 111.624 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 13.4 ptm -78.9 -26.41 43.81 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.616 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.14 -35.42 31.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 293' ' ' ARG . 3.2 p -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.01 0.433 . . . . 0.0 112.14 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -85.35 9.5 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.828 -170.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.4 p -85.2 -28.56 25.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.431 . . . . 0.0 110.224 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -136.62 43.73 1.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.869 -174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.803 ' HA ' ' HG3' ' A' ' 293' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.226 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.05 86.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.112 0.482 . . . . 0.0 111.037 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.29 97.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.7 OUTLIER -98.38 -167.47 1.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.031 -174.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.478 ' HB3' ' OE1' ' A' ' 240' ' ' GLU . 45.2 mmtm -82.67 152.74 25.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.923 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 242' ' ' ARG . 33.6 tt0 -54.96 -28.07 48.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.305 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.478 ' OE1' ' HB3' ' A' ' 238' ' ' LYS . 32.4 mp0 -56.05 -23.0 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 237' ' ' LEU . 1.8 m-85 -112.66 -2.57 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 91.8 mtt180 -75.61 -3.32 33.73 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.968 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 269' ' ' ARG . . . -96.23 160.3 22.14 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.53 145.95 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 117.299 0.55 . . . . 0.0 111.24 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 267' ' ' ILE . 6.7 mt -62.57 128.21 23.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.155 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.43 HD11 ' OE1' ' A' ' 270' ' ' GLU . 18.3 mm -94.85 -49.77 12.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.866 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 337' ' ' GLU . 51.8 tttp -155.17 137.76 15.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.539 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.0 OUTLIER -129.17 137.13 50.99 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 174.61 156.09 13.41 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.937 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 12.1 m -84.83 138.73 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.795 0.297 . . . . 0.0 110.291 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 85.5 mt -135.21 172.28 13.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 9.3 mp -97.52 122.88 41.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.282 175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -105.24 118.85 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.225 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 6.3 tp-100 -73.97 110.17 8.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 170.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.18 -62.13 0.27 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.512 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -138.68 135.16 34.53 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' A' ' 259' ' ' LYS . 8.8 mpt_? -64.91 171.29 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.914 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 257' ' ' ARG . 18.7 mtm180 75.42 -29.12 0.19 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.552 0.741 . . . . 0.0 110.418 -172.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 257' ' ' ARG . 29.4 mmtp -111.58 -35.8 5.68 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 67.25 -103.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.205 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.554 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 74.3 m95 -102.22 122.7 44.71 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.704 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.442 ' HD2' ' NH2' ' A' ' 264' ' ' ARG . 29.3 mttt -103.04 145.75 29.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.556 0.693 . . . . 0.0 111.873 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.91 105.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.23 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.701 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.4 mtt180 -135.34 151.41 50.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.258 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 87.9 tttt -89.93 121.56 32.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.017 0.437 . . . . 0.0 110.77 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 26.1 m-85 -100.81 123.75 45.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.601 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 248' ' ' GLN . 43.9 mt -115.8 125.81 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.363 0.602 . . . . 0.0 110.913 171.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 55.5 tp -101.49 156.06 17.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.044 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 243' ' ' GLY . 62.0 mtt-85 -148.34 138.81 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' A' ' 246' ' ' ILE . 2.6 pt-20 -105.45 134.75 48.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.531 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 1.005 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 37.9 t70 147.86 -61.59 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.846 1.659 . . . . 0.0 108.511 170.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 10.9 Cg_endo -94.08 -10.06 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 111.087 168.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.24 93.4 0.06 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.091 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.631 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 60.2 m-85 -145.53 133.38 21.22 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.127 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 290' ' ' ILE . 60.8 tp -95.9 141.18 29.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 32.6 m80 -130.18 122.99 29.2 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.454 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.31 127.81 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.366 0.603 . . . . 0.0 111.222 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -117.03 158.59 23.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.105 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.501 ' CB ' ' HB3' ' A' ' 283' ' ' ALA . 1.8 t70 -94.96 122.06 61.11 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.701 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -70.69 -19.29 31.86 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 110.776 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -98.87 -4.83 32.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.391 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.15 60.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.77 -1.205 . . . . 0.0 114.317 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.501 ' HB3' ' CB ' ' A' ' 279' ' ' ASP . . . -175.84 101.8 0.07 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.71 0.291 . . . . 0.0 110.851 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -89.34 -4.5 58.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.309 0.576 . . . . 0.0 109.901 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.31 138.68 41.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.64 112.51 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.769 . . . . 0.0 111.406 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.78 -21.1 66.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.138 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 179.9 129.59 1.36 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.057 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.06 104.72 16.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.679 HD12 HD23 ' A' ' 275' ' ' LEU . 39.8 mt -66.38 134.18 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.099 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -83.19 87.68 6.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.115 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 45.9 mt -74.05 -26.96 60.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.329 -173.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -51.37 101.52 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.816 0.341 . . . . 0.0 110.984 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 91.79 14.08 57.1 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.997 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.3 p -89.72 139.07 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.299 0.549 . . . . 0.0 110.96 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 6.4 t -105.22 144.48 14.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.38 155.05 21.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 316' ' ' GLU . 11.9 t -150.23 144.53 25.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.46 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.0 t -87.51 101.29 13.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 28.6 t -74.32 123.7 30.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.72 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.49 27.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 111.281 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.492 ' OG ' ' HA ' ' A' ' 312' ' ' GLU . 45.7 m 57.01 51.34 10.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.714 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -113.14 65.52 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 34.1 t -89.2 -65.92 0.97 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.135 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.29 -1.31 48.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.306 0.574 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 149.52 -160.63 28.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -66.75 -33.36 75.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.655 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.32 107.84 19.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.611 171.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.2 m -134.08 152.7 51.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.198 0.523 . . . . 0.0 110.55 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -84.68 -31.01 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.273 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.634 ' HA ' ' OE1' ' A' ' 328' ' ' GLN . 43.8 mp0 -67.5 68.69 0.1 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.031 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.492 ' HA ' ' OG ' ' A' ' 302' ' ' SER . 37.0 mt-10 -85.92 144.72 27.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 335' ' ' ARG . 91.2 m-20 64.33 30.4 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.229 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.9 OUTLIER -73.96 128.41 35.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.839 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -125.38 126.14 44.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 168.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.486 ' OE1' ' HE1' ' A' ' 326' ' ' PHE . 36.3 tt0 -91.51 138.05 31.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 96.9 mt -114.04 108.43 25.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.63 91.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.725 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 41.2 p -57.24 169.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -62.31 -27.89 69.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.69 -8.12 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.276 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 70.11 37.26 1.71 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.772 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 31.1 t -99.59 131.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.356 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -93.47 113.86 26.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 54.6 m-85 -99.76 127.76 45.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 16.1 m-30 -100.07 119.59 38.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.176 0.512 . . . . 0.0 111.188 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 93.1 mt -130.68 154.12 48.25 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.057 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.634 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 20.1 mt-30 -137.71 147.41 44.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.113 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 334' ' ' GLU . . . -120.44 147.59 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.848 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.48 -27.81 68.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.286 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 334' ' ' GLU . 38.1 p -119.1 142.52 32.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.441 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.84 -27.13 84.23 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.296 2.664 . . . . 0.0 112.508 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.595 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 62.7 mttm -71.74 -46.88 57.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.797 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 329' ' ' ALA . 7.1 tp10 -53.12 -49.5 66.4 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.358 0.411 . . . . 0.0 111.147 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' A' ' 336' ' ' THR . 11.4 ptt180 -60.53 -45.22 94.64 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.35 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 335' ' ' ARG . 9.9 m -57.8 -44.13 86.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.842 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 35.2 mm-40 -58.54 -43.17 89.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.478 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 71.1 m95 -71.89 -32.12 67.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 335' ' ' ARG . 95.6 mt -56.57 -57.07 10.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.1 mtmt -57.02 -49.81 74.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.892 176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -51.75 -54.28 30.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 111.45 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.512 HG23 HD13 ' A' ' 292' ' ' LEU . 10.7 mt -69.3 -42.83 81.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.782 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 339' ' ' ILE . 92.8 mt-30 -62.78 -39.47 94.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.402 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 15.6 ptp -76.89 -25.1 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.537 0.208 . . . . 0.0 110.963 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.96 60.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.979 0.419 . . . . 0.0 110.798 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 45.9 t -79.76 -3.98 49.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.498 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -77.91 -8.4 58.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 41.8 p -79.21 -18.07 53.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -85.66 60.75 4.64 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.912 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 52.2 mttm . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.946 175.345 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.1 t -66.04 94.45 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 66.2 mt -134.52 122.61 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.639 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -80.27 -170.62 2.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.84 -178.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.445 ' HB3' ' OE1' ' A' ' 240' ' ' GLU . 47.0 mmtm -66.0 160.13 24.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.34 0.591 . . . . 0.0 111.795 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' A' ' 272' ' ' PRO . 39.0 tt0 -62.62 -30.19 71.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.439 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 1.9 mp0 -59.01 -24.37 62.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.195 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.517 ' CD2' HD22 ' A' ' 237' ' ' LEU . 0.3 OUTLIER -111.66 0.28 16.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 239' ' ' GLU . 58.9 mtt85 -63.38 -26.96 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.082 0.468 . . . . 0.0 110.287 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -86.05 156.7 30.04 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.023 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.06 148.37 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.31 0.576 . . . . 0.0 111.682 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 267' ' ' ILE . 12.9 mt -56.1 115.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.793 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -84.58 -41.9 16.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.02 0.438 . . . . 0.0 110.251 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -167.56 152.02 6.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.277 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.548 ' CB ' HG12 ' A' ' 267' ' ' ILE . 8.7 pt20 -149.62 164.77 34.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.265 0.555 . . . . 0.0 111.818 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.28 171.57 28.6 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 59.4 m -86.07 139.71 30.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.752 0.776 . . . . 0.0 109.708 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 92.8 mt -141.48 166.51 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 11.0 mp -102.61 125.63 49.41 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.681 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -105.13 124.54 49.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.657 ' HG2' ' H ' ' A' ' 256' ' ' HIS . 31.5 tt0 -71.58 125.63 27.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.831 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -87.04 23.84 10.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.054 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.657 ' H ' ' HG2' ' A' ' 254' ' ' GLN . 1.3 m80 55.11 71.21 0.55 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 111.896 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 258' ' ' ARG . 82.4 mtm180 61.08 -159.1 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.048 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 257' ' ' ARG . 14.3 ttp180 73.58 -55.29 0.67 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.48 0.487 . . . . 0.0 111.583 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -120.56 -90.93 0.57 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.051 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -173.18 -163.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.569 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 53.5 m95 -95.74 139.04 32.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.341 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 252' ' ' LEU . 51.7 mttt -106.59 138.92 41.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 112.104 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 102.97 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.922 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.632 ' HA ' ' HD3' ' A' ' 280' ' ' PRO . 82.3 mtt180 -128.71 166.44 18.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.407 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -94.0 113.58 25.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.371 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 21.5 m-85 -101.97 128.18 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.415 -175.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.548 HG12 ' CB ' ' A' ' 248' ' ' GLN . 17.1 mt -121.86 130.81 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.197 0.522 . . . . 0.0 110.66 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.555 HD11 HD11 ' A' ' 292' ' ' LEU . 43.6 tp -101.16 155.01 18.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.855 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.435 ' CD ' ' HA ' ' A' ' 241' ' ' PHE . 53.9 mtt-85 -149.55 138.86 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.637 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 4.9 pt-20 -93.89 -175.0 3.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.941 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 28.1 t70 93.63 -75.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 C-N-CA 125.814 1.646 . . . . 0.0 110.148 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 9.5 Cg_endo -91.39 -5.72 3.94 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 121.182 1.458 . . . . 0.0 111.671 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 64.69 91.34 0.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.132 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 27.2 m-85 -140.5 121.21 14.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.637 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 41.7 tp -89.42 139.39 30.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.177 174.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 240' ' ' GLU . 69.4 m80 -129.8 142.7 50.64 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -132.3 140.22 48.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.204 0.526 . . . . 0.0 110.848 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' HD13 ' A' ' 287' ' ' LEU . 5.1 m-85 -129.37 162.34 28.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.715 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -90.59 122.58 66.93 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.133 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.632 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 92.9 Cg_endo -68.16 -15.21 42.48 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.184 2.589 . . . . 0.0 111.069 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.89 15.24 15.24 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.06 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -159.24 -112.72 0.32 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.993 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.04 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.33 -0.58 49.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.424 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.516 ' O ' HD12 ' A' ' 287' ' ' LEU . 4.4 m-20 -73.31 139.78 79.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.434 ' HA ' ' CD1' ' A' ' 278' ' ' TYR . 28.8 Cg_endo -61.79 118.8 5.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.019 1.812 . . . . 0.0 112.78 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.023 HD13 ' HA ' ' A' ' 278' ' ' TYR . 5.8 mp -84.15 -5.65 59.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.117 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -179.04 157.56 21.0 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.109 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -135.68 100.67 4.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.211 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 62.8 mt -84.43 88.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.689 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.577 ' NE2' ' HB2' ' A' ' 293' ' ' ARG . 13.4 t-80 -43.73 106.05 0.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.79 170.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.738 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 84.7 mt -87.23 -19.89 27.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.867 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.577 ' HB2' ' NE2' ' A' ' 291' ' ' HIS . 96.5 mtt180 -59.35 104.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.363 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 108.16 3.28 33.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.489 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 318' ' ' ILE . 17.1 p -85.67 147.53 26.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 111.977 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 142.38 29.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 99.6 t -117.83 153.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.963 0.411 . . . . 0.0 110.406 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 316' ' ' GLU . 13.6 t -153.43 145.61 23.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.923 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.7 t -83.76 102.32 12.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.748 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 314' ' ' LEU . 12.7 t -92.47 102.85 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.614 . . . . 0.0 110.188 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.747 ' HG2' HH12 ' A' ' 335' ' ' ARG . 21.0 mt-10 -91.53 74.75 5.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.665 ' HA ' ' HB2' ' A' ' 311' ' ' GLU . 87.7 p 60.71 122.48 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.814 -1.539 . . . . 0.0 112.182 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -172.08 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.954 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 308' ' ' LYS . 13.4 t -84.54 80.46 9.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.623 0.725 . . . . 0.0 109.502 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.28 117.75 6.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.391 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.67 -7.68 27.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.42 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.849 ' HA ' ' HE ' ' A' ' 307' ' ' ARG . 1.0 OUTLIER -126.89 -72.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.724 -0.28 . . . . 0.0 111.137 -178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 310' ' ' GLU . 6.9 tttp -177.41 164.55 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.92 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.1 m -99.66 70.97 1.69 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.127 0.489 . . . . 0.0 109.962 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 308' ' ' LYS . 8.6 mm-40 -91.7 -32.38 15.45 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.799 0.809 . . . . 0.0 110.52 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.729 ' HG2' HD12 ' A' ' 314' ' ' LEU . 3.1 mp0 -51.36 125.23 13.72 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.314 -174.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.82 132.27 54.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.955 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 335' ' ' ARG . 74.2 m-20 67.37 22.76 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.409 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 311' ' ' GLU . 1.3 tt -66.93 134.7 52.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.997 0.427 . . . . 0.0 109.94 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.453 ' N ' HD23 ' A' ' 314' ' ' LEU . 29.9 p90 -132.47 136.85 46.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.492 ' HB3' HG22 ' A' ' 298' ' ' THR . 34.9 tt0 -99.41 136.67 39.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.781 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 97.4 mt -115.89 110.84 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' A' ' 295' ' ' CYS . 13.3 mt -101.82 83.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.936 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 72.3 p -62.85 177.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.989 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -64.49 -13.32 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 110.929 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.88 -6.36 54.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.394 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.09 27.67 10.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.763 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.7 130.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -90.41 113.43 25.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 45.9 m-85 -95.46 119.35 33.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.475 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 3.0 m-85 -96.65 116.03 28.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.895 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 314' ' ' LEU . 78.2 mt -127.31 157.75 39.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.421 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.673 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 41.3 mt-30 -135.99 139.65 43.32 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -110.06 160.68 16.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.336 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -55.64 -50.4 70.28 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.247 0.342 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 32.1 p -127.12 162.63 46.84 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.049 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.15 -43.17 61.69 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.393 2.062 . . . . 0.0 111.964 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 337' ' ' GLU . 17.8 tppt? -55.17 -44.92 75.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.036 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 338' ' ' TRP . 7.7 tp10 -60.39 -52.34 65.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.033 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.747 HH12 ' HG2' ' A' ' 301' ' ' GLU . 11.5 ptt180 -59.35 -43.32 92.81 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.977 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.645 HG22 ' HE2' ' A' ' 340' ' ' LYS . 11.1 m -58.64 -40.52 83.62 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.646 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 333' ' ' LYS . 57.0 mt-10 -65.28 -33.15 75.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 121.259 -0.176 . . . . 0.0 110.973 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' A' ' 334' ' ' GLU . 76.7 m95 -73.43 -38.44 65.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.416 0.15 . . . . 0.0 111.106 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 336' ' ' THR . 97.6 mt -53.38 -54.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.645 ' HE2' HG22 ' A' ' 336' ' ' THR . 65.7 mttm -59.87 -40.24 87.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.709 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.64 -54.64 44.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.124 0.488 . . . . 0.0 110.661 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.636 HG23 HD22 ' A' ' 292' ' ' LEU . 2.0 mp -64.79 -44.62 96.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.351 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -64.38 -36.79 85.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 11.3 ptp -81.21 -31.29 33.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.695 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -74.02 -29.87 62.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.457 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.47 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 42.3 t -67.16 -14.58 63.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.692 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -109.36 18.13 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.022 -0.424 . . . . 0.0 111.299 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 23.8 p -90.41 4.2 51.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.256 0.551 . . . . 0.0 110.73 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -99.66 8.24 59.86 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.432 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.879 -0.582 . . . . 0.0 110.065 178.666 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.67 0.272 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.55 86.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.314 1.054 . . . . 0.0 110.36 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.0 mt -109.65 102.65 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.357 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 241' ' ' PHE . 1.9 pt? -134.52 -166.11 1.76 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.16 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 241' ' ' PHE . 14.2 mmmm -55.54 142.24 34.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.534 0.683 . . . . 0.0 111.152 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 242' ' ' ARG . 37.9 tt0 -64.95 -29.96 70.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.04 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 240' ' ' GLU . 1.8 mp0 -60.79 -28.28 68.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.565 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 29.5 m-85 -104.55 -5.61 21.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.604 0.24 . . . . 0.0 111.1 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 239' ' ' GLU . 31.8 mtp180 -64.93 -21.33 66.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 110.503 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -85.23 152.56 26.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.375 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 269' ' ' ARG . 42.8 t -84.34 145.26 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.43 0.292 . . . . 0.0 110.665 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 267' ' ' ILE . 3.0 mp -69.82 114.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.412 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 270' ' ' GLU . 25.8 mm -78.99 -43.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.832 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.5 ' HE3' ' NE1' ' A' ' 338' ' ' TRP . 53.4 tttp -158.26 139.59 13.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.963 -169.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.424 ' HG3' HG21 ' A' ' 245' ' ' ILE . 1.4 mp0 -127.3 145.35 50.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.81 144.84 4.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.264 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 265' ' ' LYS . 11.0 m -72.51 137.62 46.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 99.5 mt -133.65 163.26 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.0 mp -90.74 123.73 34.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 327' ' ' LEU . 64.3 tttm -110.95 117.29 32.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.808 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 5.6 tp-100 -62.55 104.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -91.29 -40.9 5.33 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.055 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -170.16 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.78 0.29 . . . . 0.0 110.898 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.693 ' HG2' ' H ' ' A' ' 258' ' ' ARG . 34.2 ttp85 -176.91 -177.39 0.76 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.693 ' H ' ' HG2' ' A' ' 257' ' ' ARG . 50.1 ttt180 70.82 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.508 0.723 . . . . 0.0 110.373 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -79.12 -26.81 42.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t30 69.79 -79.91 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.253 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.55 ' CH2' ' HB3' ' A' ' 326' ' ' PHE . 84.9 m95 -101.73 134.84 44.25 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.693 -172.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.92 126.3 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.182 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 81.6 t -91.11 104.34 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.018 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 278' ' ' TYR . 2.8 ptp180 -148.05 162.71 38.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.723 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 250' ' ' CYS . 50.1 tttp -79.32 116.11 19.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.546 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 37.1 m-85 -102.31 124.94 48.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 111.852 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 245' ' ' ILE . 56.6 mt -119.08 128.92 75.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.799 172.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 245' ' ' ILE . 47.7 tp -98.55 154.97 17.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.672 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 244' ' ' VAL . 52.7 mtt-85 -147.66 136.24 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.582 0.229 . . . . 0.0 110.452 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.688 ' HB2' HG21 ' A' ' 348' ' ' THR . 0.8 OUTLIER -100.9 127.31 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 1.008 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 25.0 t70 154.36 -65.74 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.456 1.502 . . . . 0.0 108.844 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 19.6 Cg_endo -96.36 -8.25 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.635 2.223 . . . . 0.0 111.633 173.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 346' ' ' SER . . . 65.16 89.88 0.09 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.839 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 272' ' ' PRO . 55.8 m-85 -139.87 129.24 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.044 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 290' ' ' ILE . 25.6 tp -94.55 134.09 37.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.209 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 266' ' ' PHE . 73.3 m80 -120.47 129.74 53.99 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.853 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.543 ' HE1' HG13 ' A' ' 290' ' ' ILE . 0.9 OUTLIER -115.08 122.72 47.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.834 176.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.624 ' O ' ' HB2' ' A' ' 264' ' ' ARG . 50.6 m-85 -106.77 -167.63 1.31 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.751 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 283' ' ' ALA . 17.4 t70 -125.82 129.55 24.29 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.755 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 264' ' ' ARG . 98.4 Cg_endo -72.51 -19.15 25.22 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 123.16 2.573 . . . . 0.0 111.572 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.02 -28.29 12.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.09 75.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.236 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 279' ' ' ASP . . . -175.84 103.07 0.07 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.748 0.419 . . . . 0.0 110.406 171.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -85.15 -14.03 48.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.625 0.726 . . . . 0.0 109.228 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.84 143.66 26.49 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.243 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.09 143.51 54.33 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.762 2.308 . . . . 0.0 113.412 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -80.39 -7.24 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.123 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 158.61 -179.41 34.3 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.427 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.71 128.95 27.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.471 0.177 . . . . 0.0 110.604 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.653 HD12 HD23 ' A' ' 275' ' ' LEU . 46.1 mt -79.11 136.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -86.53 80.48 8.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.588 HD13 HG23 ' A' ' 342' ' ' ILE . 64.9 mt -61.36 -59.55 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -18.95 86.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.941 1.4 . . . . 0.0 113.735 -172.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 109.81 20.67 7.52 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.433 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 319' ' ' THR . 30.5 p -93.1 145.57 24.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.599 . . . . 0.0 112.235 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.04 146.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.07 156.81 26.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 316' ' ' GLU . 11.6 t -145.39 134.25 22.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 110.479 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 14.2 p -82.77 99.25 9.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 38.8 t -83.83 118.65 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.394 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.39 139.7 46.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.6 m -47.83 95.69 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.578 1.174 . . . . 0.0 113.186 -166.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.31 112.67 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.568 174.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.48 21.08 2.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.13 68.65 0.76 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.218 0.532 . . . . 0.0 109.697 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 167.48 -123.18 1.1 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.053 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -135.48 143.84 46.06 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.054 0.142 . . . . 0.0 110.647 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 56.92 84.46 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.722 0.639 . . . . 0.0 112.026 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.9 p -80.44 115.19 19.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.333 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -90.27 -29.71 17.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.37 1.081 . . . . 0.0 108.254 170.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.644 ' HB3' HD12 ' A' ' 314' ' ' LEU . 25.9 mp0 -62.62 101.16 0.23 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.761 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -116.04 158.93 22.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.352 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.831 ' HB2' ' HG2' ' A' ' 335' ' ' ARG . 8.2 p30 41.41 45.66 2.74 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.308 1.005 . . . . 0.0 111.482 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.706 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 1.1 tt -77.65 135.31 38.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.452 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -129.5 121.97 28.3 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.487 ' HB3' ' CG2' ' A' ' 298' ' ' THR . 35.1 tt0 -92.2 138.68 31.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.551 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 325' ' ' TYR . 94.6 mt -111.93 110.33 31.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.9 mt -96.48 85.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 295' ' ' CYS . 40.4 p -60.98 175.85 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.876 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -67.53 -20.56 65.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.362 0.601 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.7 3.07 26.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.182 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 57.53 38.57 28.02 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.021 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 20.5 t -102.36 127.81 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.969 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -85.15 112.51 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . 36.6 m-85 -98.36 125.25 43.42 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.55 ' HB3' ' CH2' ' A' ' 261' ' ' TRP . 48.9 m-85 -100.35 119.67 38.78 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.0 111.008 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 252' ' ' LEU . 96.3 mt -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.507 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.583 ' OE1' ' HA ' ' A' ' 311' ' ' GLU . 25.5 mt-30 -142.65 150.17 39.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.367 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -108.46 -168.63 1.38 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.388 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.3 -38.78 17.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.398 . . . . 0.0 110.208 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 332' ' ' PRO . 61.9 p -119.48 149.3 47.54 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.644 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 313' ' ' ASN . 34.2 Cg_exo -63.3 -14.82 44.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.559 2.839 . . . . 0.0 113.595 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -93.13 -32.81 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.449 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.37 -37.39 87.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 110.296 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.831 ' HG2' ' HB2' ' A' ' 313' ' ' ASN . 0.3 OUTLIER -60.66 -43.79 97.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.22 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.66 ' HA ' HD12 ' A' ' 339' ' ' ILE . 5.1 m -57.21 -44.23 83.49 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.116 0.484 . . . . 0.0 110.39 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -60.56 -36.93 79.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.055 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.5 ' NE1' ' HE3' ' A' ' 247' ' ' LYS . 52.4 m95 -70.96 -30.69 67.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.508 0.194 . . . . 0.0 111.126 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 336' ' ' THR . 74.1 mt -58.94 -51.85 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 336' ' ' THR . 43.0 mmtt -53.07 -54.68 31.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.554 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 247' ' ' LYS . . . -52.64 -57.18 10.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.814 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.588 HG23 HD13 ' A' ' 292' ' ' LEU . 35.4 mt -70.44 -42.77 78.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.369 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.76 -33.86 76.98 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.502 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.7 ptm -79.46 -20.97 46.09 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.614 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -81.96 -22.04 36.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.44 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 273' ' ' ALA . 40.8 t -89.02 9.45 25.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -117.24 22.37 12.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.688 HG21 ' HB2' ' A' ' 270' ' ' GLU . 16.6 p -86.37 9.06 19.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.753 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -101.24 -53.04 1.03 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.467 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.42 176.143 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 235' ' ' VAL . 1.3 m-20 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.407 ' H ' ' HB3' ' A' ' 234' ' ' ASP . 7.2 p -66.28 75.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 122.548 1.166 . . . . 0.0 110.466 172.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 78.6 mt -101.33 106.64 19.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.42 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.462 HD22 ' CD2' ' A' ' 241' ' ' PHE . 0.7 OUTLIER -74.04 -165.48 0.31 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.197 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' A' ' 237' ' ' LEU . 81.4 mttt -56.07 166.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.942 0.877 . . . . 0.0 112.862 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 242' ' ' ARG . 36.9 tt0 -70.17 -29.12 65.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.584 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.62 -41.27 73.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.107 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.462 ' CD2' HD22 ' A' ' 237' ' ' LEU . 2.0 m-85 -101.44 1.01 37.81 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.399 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.455 ' HG3' ' HA ' ' A' ' 239' ' ' GLU . 99.1 mtt180 -52.86 -40.6 63.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.7 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 270' ' ' GLU . . . -82.48 137.63 17.16 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 245' ' ' ILE . 40.1 t -77.16 169.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.546 ' N ' HG12 ' A' ' 244' ' ' VAL . 71.7 mt -56.75 116.6 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.381 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 270' ' ' GLU . 32.9 mm -84.96 -38.79 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.958 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.627 ' HE2' ' CE2' ' A' ' 338' ' ' TRP . 80.5 tttt -169.21 141.49 2.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.716 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.744 ' HB3' HG12 ' A' ' 267' ' ' ILE . 0.4 OUTLIER -144.11 162.72 35.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.831 175.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 162.66 173.0 30.84 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.98 139.18 34.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.611 0.706 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 266' ' ' PHE . 95.6 mt -143.72 160.85 39.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 328' ' ' GLN . 10.4 mp -98.47 125.96 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -113.72 124.67 52.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.623 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 326' ' ' PHE . 60.4 tt0 -80.39 152.8 28.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.651 175.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 138.31 165.68 10.4 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.277 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 22.3 m170 69.97 136.72 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.652 0.739 . . . . 0.0 112.035 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 257' ' ' ARG . 11.6 ptt180 -79.07 158.86 27.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.465 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 60.8 31.91 20.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.596 0.712 . . . . 0.0 109.667 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -164.21 163.55 22.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.535 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 254' ' ' GLN . 3.8 p30 -129.96 -85.69 0.53 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.577 0.227 . . . . 0.0 110.837 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.522 ' CZ3' ' HG3' ' A' ' 328' ' ' GLN . 69.4 m95 -118.39 130.8 56.19 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.502 ' HD3' ' NH2' ' A' ' 264' ' ' ARG . 5.9 mtpt -105.38 140.76 38.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.128 0.49 . . . . 0.0 111.368 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 92.0 t -81.44 99.01 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.502 ' NH2' ' HD3' ' A' ' 262' ' ' LYS . 55.7 mtt-85 -116.57 148.38 40.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.033 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.31 110.54 18.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 251' ' ' LEU . 20.1 m-85 -93.98 153.06 18.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.744 HG12 ' HB3' ' A' ' 248' ' ' GLN . 6.9 mt -144.96 125.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.815 0.697 . . . . 0.0 109.856 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.3 tp -99.85 145.39 27.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.102 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -149.56 131.43 15.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 243' ' ' GLY . 0.8 OUTLIER -99.9 -170.72 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.672 -170.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.987 ' HB3' ' HD3' ' A' ' 272' ' ' PRO . 12.1 t70 95.02 -71.86 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.661 1.584 . . . . 0.0 110.253 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.987 ' HD3' ' HB3' ' A' ' 271' ' ' ASP . 5.6 Cg_endo -91.38 -6.29 3.81 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 CA-C-N 120.859 1.342 . . . . 0.0 111.025 164.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' A' ' 292' ' ' LEU . . . 63.35 95.18 0.05 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.734 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 276' ' ' HIS . 14.6 m-85 -137.62 115.27 11.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 290' ' ' ILE . 44.7 tp -89.72 139.34 30.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.133 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 274' ' ' TYR . 75.5 m80 -130.24 144.3 51.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.416 ' HB3' ' CE2' ' A' ' 266' ' ' PHE . 8.2 p90 -131.4 139.05 49.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 110.712 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -119.56 -165.09 1.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.22 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -130.13 129.81 22.99 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 -17.08 22.26 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.854 2.369 . . . . 0.0 111.594 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -103.71 -12.18 17.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.237 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 154.86 84.32 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.91 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.54 117.32 0.2 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.447 0.641 . . . . 0.0 110.61 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -94.4 -30.54 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.825 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -75.23 142.41 75.3 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.778 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 125.92 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.163 1.908 . . . . 0.0 111.666 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.11 3.41 17.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.098 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 170.36 139.25 2.69 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.665 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -110.54 112.13 23.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.82 0.343 . . . . 0.0 110.308 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 275' ' ' LEU . 63.8 mt -85.16 132.17 32.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.549 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.09 95.66 9.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.59 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.751 ' HB2' ' HB1' ' A' ' 273' ' ' ALA . 81.2 mt -79.87 -28.96 39.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.098 -172.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -52.97 103.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.88 0.372 . . . . 0.0 111.103 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 97.08 9.89 55.38 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.012 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' CYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 319' ' ' THR . 14.6 p -88.45 144.51 26.32 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.992 0.425 . . . . 0.0 110.778 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.01 144.62 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 316' ' ' GLU . 91.4 t -119.38 150.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 316' ' ' GLU . 15.1 t -148.59 142.01 25.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.463 -175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.7 t -76.36 108.5 9.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.915 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 314' ' ' LEU . 51.3 t -97.2 110.32 24.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.189 0.519 . . . . 0.0 110.675 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.17 51.52 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.419 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.2 t 68.38 104.15 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.846 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -178.11 50.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.131 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . . . . . . . . . 24.9 t -73.5 157.91 35.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.739 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.78 71.71 5.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.308 0.575 . . . . 0.0 111.059 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -156.56 -125.34 0.88 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.76 148.16 32.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 67.47 122.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.055 0.847 . . . . 0.0 111.834 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.0 p -68.17 107.81 2.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -107.76 -48.88 3.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.073 0.939 . . . . 0.0 109.683 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 311' ' ' GLU . 0.8 OUTLIER -61.75 138.66 58.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.751 -172.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 313' ' ' ASN . 44.6 mt-10 -140.73 133.24 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' A' ' 335' ' ' ARG . 86.1 m-20 76.19 28.51 0.81 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.851 0.719 . . . . 0.0 110.411 -174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.639 ' HB3' ' HB ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -77.06 126.29 30.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.319 178.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.58 125.49 47.92 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.572 ' HB3' HG22 ' A' ' 298' ' ' THR . 4.8 tp10 -86.41 136.32 33.16 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.893 -174.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.7 103.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.17 87.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.042 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.463 ' HA ' ' CB ' ' A' ' 295' ' ' CYS . 38.1 p -53.16 159.21 1.32 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.053 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.67 -1.59 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.902 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.15 4.46 53.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.125 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.81 27.74 11.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.355 172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 15.4 t -104.38 135.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -82.69 118.95 23.71 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -112.2 97.68 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.178 0.514 . . . . 0.0 110.033 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 87.7 m-85 -80.23 118.74 22.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.273 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 314' ' ' LEU . 87.6 mt -125.9 152.02 46.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 261' ' ' TRP . 39.4 mt-30 -139.61 144.89 37.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.679 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 335' ' ' ARG . . . -117.79 171.94 7.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.837 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.12 -69.04 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.499 0.499 . . . . 0.0 111.34 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 77.1 p -102.55 161.22 23.93 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.005 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' PRO . . . . . 0.641 ' O ' ' HG3' ' A' ' 335' ' ' ARG . 68.3 Cg_exo -52.08 -44.45 45.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.545 2.163 . . . . 0.0 112.07 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 337' ' ' GLU . 57.8 tttp -55.28 -50.01 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.364 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.54 -42.45 96.56 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.475 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 313' ' ' ASN . 7.0 ppt_? -66.95 -39.03 87.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.348 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.572 ' HA ' HD12 ' A' ' 339' ' ' ILE . 29.2 m -60.81 -41.77 96.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.838 0.352 . . . . 0.0 110.68 170.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 333' ' ' LYS . 80.2 mm-40 -59.05 -44.67 91.84 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' TRP . . . . . 0.627 ' CE2' ' HE2' ' A' ' 247' ' ' LYS . 60.4 m95 -65.17 -36.21 83.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 336' ' ' THR . 99.0 mt -53.17 -53.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 337' ' ' GLU . 54.4 mtmt -57.37 -42.18 81.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.709 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.82 42.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.122 0.487 . . . . 0.0 110.81 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 292' ' ' LEU . 2.1 mp -66.69 -40.99 87.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.495 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -64.77 -36.48 84.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.41 -30.86 33.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.088 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -76.47 -27.94 56.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.677 0.275 . . . . 0.0 111.573 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.614 ' HA ' ' CB ' ' A' ' 273' ' ' ALA . 30.1 t -75.02 -22.78 58.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 347' ' ' ARG . 42.4 mtm105 -101.34 25.32 8.41 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.06 -0.4 . . . . 0.0 111.864 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.6 p -82.5 112.14 19.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.891 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -144.16 10.82 2.04 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.346 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.124 179.268 . . . . . . . . 0 0 . 1 stop_ save_